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ABSTRACT 
 
My ethnographic project aimed to understand the policy context of the harm reduction 
paradigm in New Delhi, India and detail its implications for drug users on the ground. In order to 
do so, my research posed two key questions.  How are the state, NGOs and international 
organizations interact, negotiate and construct harm reduction in neoliberal India?  How does this 
new therapeutic regime shape the life of the recovering drug users- their recovery subjectivities, 
meanings and experiences?  My project tries to establish the complex linkages between policy 
and ground level practices laying out the real activities, culturally embedded practices as well as 
the global-local understanding of health and values that shape this treatment paradigm. Over the 
course of eight months from August 2008- April 2009 I conducted this multi-sited project using 
methods such as participant observation, in depth interviews, life-history interviews and archival 
research to collect data from both policy and practice contexts.  
In light of the spiraling rates of HIV, my research findings suggest that both grassroots 
organizations and global actors played a key role in bringing harm reduction to the forefront. 
Non-state stakeholders such as the NGOs, civic society organizations and bi-lateral agencies 
helped to shape policy, fund programs and provide expertise to the state. This research 
demonstrates the manner in which, the state adopted multiple ways of functioning, balancing the 
pressures and agendas of a complex web of local, regional and transnational actors. I detail how 
each stakeholder was involved in what I label as the  “politics of survival”.  They functioned in a 
highly charged atmosphere of competing economic stakes, fragile health politics and flexible 
stances on harm reduction.   
Drug treatment, as my research shows, became the site for new innovations and 
controversies. Harm reductionists promoted pharmaceuticals and needle syringe exchange in lieu 
of traditional abstinence-based programs. Rather than eliminating drug use and improving 
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overall health, risk reduction became the main goal. These temporary prevention systems did not 
fully account for the endemic inequities and poor health infrastructure of the country. I show 
how health gets negotiated within such adhoc conditions and the new meanings given to 
recovery within drug treatment.   
My project suggests that clients judiciously utilized these highly specialized services to 
forge their survival, while struggling to maintain their basic needs and escape the punitive justice 
system. The participation of these marginalized drug users in the harm reduction paradigm is 
both problematic and empowering. Injecting drug users were encouraged to become active and 
responsible managers of their recovery- a type of ‘biological citizenship’ laden with choices and 
rights. At the same time, they struggled to meet their basic needs in the absence of a strong 
public health infrastructure, an issue completely overlooked by the harm reduction model.  
         My project also addresses the tense dynamics between the clients and peer workers. 
Unlike other peer driven models, this treatment paradigm recruits both active drug users and 
recipients of harm reduction treatment.  My research documents that the boundaries between 
the provider and receiver were severely challenged, as each tried to outline his/her numerous 
roles as clients, peers, models and experts.  My dissertation highlights how this “mutant” 
worker juggles these identities and shapes a new type of recovery. I ultimately raise important 
questions about the feasibility of harm reduction within resource poor settings, issues of social 
justice for the drug user and the larger community as well as the ethics of this public health 
endeavor.  
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CHAPTER 1: INTRODUCTION 
THIS IS A WHIMPER. 
It is not a loud shout, or a shrieking wail 
 But something less…perhaps something else 
I am trying to build a response to what I saw during those days 
Not wanting to overwhelm you  
But just a little tremble for those who walked those streets 
I am registering their presence 
I am protesting 
THIS IS A PROTEST. 
I am not walking with a flag or singing songs of injustice 
It is through the pen I can share 
What I saw cannot be forgotten 
Forgetting is risky. 
In forgetting we lose our history and the future all at once. 
I am remembering 
THIS IS A MEMORY. 
Theirs, mine and ours- all intertwined, 
A bit shaky and never complete 
I am whimpering, protesting and remembering. 
(Moorthi, 2009, 2010) 
              
New Responses: Epidemics and Lives 
    A quiet yet dramatic shift is underway in India today.  Over the last few years the 
country has fundamentally begun to evolve its approach, response and treatment of millions of 
drug users and HIV positive citizens.  Broadly subsumed under the rubric of the globally 
accepted model of harm reduction, this new program aims to provide injecting drug users with 
services such as needle syringe exchange, peer education, volunteer counseling and testing, 
outreach, condom promotion and pharmaceutical substitution.  The programs and the 
overarching policy framework in India were spearheaded by a number of public, private and 
transnational actors.  Harm reduction, it appeared, was altering the approach towards not only 
health but also polity within the country.   
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My research began in 2008 just as the harm reduction paradigm was given a national face 
and a “governmental” voice.  I tracked the way this public health program began to develop roots 
and shape the lives of drug users.  At the policy level the harm reduction paradigm first emerged 
outside the purview of the state.  The Indian state, until this point, had only supported the 
abstinence-based model of drug treatment.  Harm reduction thus grew through an international 
network of funding, coupled with the expertise and infrastructure of international development 
actors as well as the cultural knowledge and local resources of grassroots NGOs.   
The positive results of harm reduction initiatives undertaken by non-state stakeholders   
and the pressure from community members forced the largely reluctant state to participate in the 
harm reduction paradigm.  It then became clear that questions of drug treatment policy and 
practice were no longer the sole domain of the state but instead were situated in the negotiated 
territories of multiple stakeholders.  My effort in this dissertation is to detail the chaotic, ever 
shifting and tenuous nature of relationships between these stakeholders; these relationships are 
inextricably linked to both global policies/demands and local realities/needs.  I show how in 
these transitory conditions the state re-invents itself at each point, as do the other actors- 
evolving their positions and roles.  My research shows that within such a policy context health 
and recovery are far from stable or bounded notions but instead get made and remade.  
    At the practice level, this paradigm brings the recovering drug user into central focus. 
The drug user under the abstinence-based paradigm was not only seen as a diseased non-agent 
but also as a 'non-citizen', one who did not participate in state activities or received much 
benefits from the state.  But these new harm reduction rhetoric and interventions highlight the 
drug user's active participation in the management of his/her own recovery.  The drug user is 
encouraged to use safely to not only protect himself /herself but also the community and the 
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state; the focus is on the management of drug users’ behaviors and harnessing their potential 
(O’Malley, 1999; Pratt 1999; Rose and Novas, 2005).   
I show how this brand of drug treatment in India while brought attention to the issue of 
drug use also rendered it visible primarily through the frame of HIV risk.  Harm reduction was 
also unfolding against the backdrop of increased pharmaceuticalization (health understood less 
as prevention/care more as access to medicine) and communitarization (health as a community 
owned and implemented, reducing state responsibility) of public health.  Further, the provision of 
these specialized services within the larger context of urban poverty, structural deprivation and 
social stigma forced both institutions and people to continually reconfigure harm, recovery and 
health in India. 
My specific objectives for this research are twofold a) to understand how harm reduction 
policies and practices are shaped by the state, NGOs and international organizations; and b) to 
understand how harm reduction is impacting the daily lives of recovering drug users.  I used 
ethnographic methods to ground these larger policies in the experiences, rationalities and life 
courses of recovering drug users, who were at the very center of these social transformations. 
During the course of this chapter, I will first provide the rationale for conducting the study in 
India and discuss the analytical framework of this research.  Next, I will detail the key concepts 
around addiction and harm reduction as well as lay out the theoretical arguments of my research. 
In the final section of this chapter I will provide a summary of the chapters of this dissertation.    
Estimating the “Problematic”  
 During the 1990s Asian countries began to witness the HIV epidemic, much after the rest 
of the world.  Even though the proportions of the AIDS epidemic are not as frightening as Sub-
Saharan Africa, it is clear that in terms of sheer numbers the Asian epidemic is staggering (Joint 
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United Nations Program on HIV/AIDS, (UNAIDS) 2010).  In Asia approximately 4.9 million 
people were living with HIV in 2009. India has the highest HIV population in Asia.  More than 
60% of the continent’s infected population, estimated to range between 1.7 million and 3.1 
million, reside in the country today (UNAIDS, 2009; NACO, 2010).  India ranks third in HIV 
populations behind South Africa and Nigeria in the globe (NACO, UNAIDS & WHO 2010).  
Approximately 75 million people in India are abusing substances (including alcohol), and of this 
186,000 inject drugs in India (NACO, 2010).  Current estimates show that nationally over 9% of 
IDU’s are HIV positive and in some regions 68% of IDU’s (northeast India) are infected with the 
virus (NACO, 2010).  These estimates are even more shocking when compared to the less than 
1% HIV prevalence rates among the adult population in the country (NACO, 2010).  
In June 2007 the national government of India revised the estimates of the infected HIV 
population in the country.  They reduced the number of the HIV positive population from 
approximately 5 million to approximately 2.5 million people (World Bank, 2011).  While 
launching the third phase of the National AIDS Control Program (NACP), Dr Anbumani 
Ramadoss, Union Minister for Health and Family Welfare claimed: 
Revision of estimates based on more data and improved methodology marks a significant    
  Improvement in systems and capabilities to monitor the spread of HIV, a sign of the    
            progress we have made in understanding the epidemic better.  This is welcome progress.    
Unfortunately, the new figures still point towards a serious epidemic with potential to    
expand if the prevention efforts identified in the NACP III are not scaled up rapidly and 
implemented in the desired manner.  We must remember that India has nearly 30 lakh 
people living with HIV.  These are people facing stigma, discrimination and irrational 
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prejudice everyday of their lives and need all our support and understanding (World 
Health Organization (WHO), 2007). 
            The international community and NGO sector were shocked by this drop in estimates and 
were worried about the efficacy of these new methods of data collection.  More significantly, 
there was widespread fear that funding pools would dry up as donors would seek to move to 
higher HIV prevalence regions across the world.  These fears seemed justified, if not slightly 
ironic, given that most funders had entered India on the assumption that there was a high HIV 
population concentration within the country.  Surprisingly despite the reduction in estimates both 
the government and the international community remained invested in HIV and by extension in 
harm reduction.  Dr Denis Broun, UNAIDS Country Coordinator voiced his support and 
commitment to the HIV program in India by saying:  
The trends evident from the latest estimates validate India’s national AIDS strategy. 
Taking encouragement from the new lower estimates, the national authorities should 
increase the strength of their HIV programs.  We must scale up efforts to reach universal 
access to HIV prevention, care and treatment.  Though the proportion of people living 
with HIV is lower than previously estimated, India’s epidemic continues to be substantial 
in numbers.  Despite the lower prevalence estimate, the cost of prevention efforts 
required to control the epidemic remains the same (WHO, 2007).  
The National AIDS Control Organization (NACO) in fact reported an increase in funds 
despite the change in estimates of HIV prevalence.  The National AIDS Control Policy phase II 
(1999-2007) received close to 415 million dollars in bi-lateral and international support for its 
programs (National AIDS Control Organization (NACO), 2007).  By the time phase III (2007-
2012) of the policy began, this international support grew close to 927 million dollars (NACO, 
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2007).  Harm reduction programs in particular also witnessed a steady growth since 2007 with 
investments in several new states.  The number of programs is growing each year with better 
services for drug users across the country (NACO, 2010).  Indian public health also saw 
resurgence during this period with the launch of the National Rural Health Mission in 2005.  
This policy focuses on strengthening health infrastructure and raise public spending on health 
from .9% of the GDP to 2-3% by 2012 (Ministry of Health and Family Welfare, 2005).  
The incident of the revision of estimates brought home one clear point- India was marked 
as an HIV hotspot and it was here to stay.  India’s unique status in the global development/health 
sector and its powerful symbolic significance in the fight against HIV has remained intact and 
continued to evolve. 
Locating Harm Reduction in New Delhi, India 
India, in many ways is the poster child of the developing nations in Asia.  After economic 
liberalization in the early 1990s followed by the structural adjustment plan (SAP) to revitalize 
the economy, the country has become an emerging economic giant.  Despite recent downturns it 
continues to boast a steady growth rate, attract large economic investments and has a burgeoning 
middle class.  Some experts claim that India will grow faster than any other large economy in the 
next 25 years (Economist, 2010).  It is also one of the largest democracies in the world with over 
one billion people.  India’s potentiality, one could argue is crucially dependent on maintaining its 
status as an educated, aware and safe country.  HIV/AIDS, the first major epidemic of the 
globalized era threatens not only India’s economic growth but most importantly can cause deep 
fracture in the gains in public health.  
   My project thus arrived at a crucial juncture in India’s history of public health and 
economic future.  I located my project in New Delhi for a number of reasons.  Latest NACO 
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estimates show that Delhi has a growing injecting drug using population with high rates of HIV 
prevalence (NACO, 2010).  The capital is also the fastest growing city in the country, with a 
population of close to 16 million (Government of India, 2011).  While the city has seen 
significant infrastructural growth with a burgeoning commercial and business community, a 
significant portion of this population remain left out from these developments, these include the 
city’s migrant, homeless and the urban poor.  These extreme demographics are easy to see in the 
landscape - large slums rest side by side to ostentatious malls and shopping arcades as well as 
grand multi-storied multinational offices.  Health disparities are especially marked and despite its 
exceptional status as the capital, each day millions are left without the most basic services to 
sustain life.  
In response to these issues a vibrant non-governmental sector and a committed civic 
society has emerged within the capital.  With the large presence of international offices and 
bilateral organizations New Delhi, has become the seat of both harm reduction policy and 
intervention.  In many ways New Delhi is representative of the harm reduction environment of 
the country and influences policies and interventions at a national scale.  It remains a city very 
much in transition and an exciting hub for health policy and change.  New Delhi is thus an ideal 
ground to study the emergence, politics and affects of this new model of intervention.  
   India’s experience is especially important to document, as other South Asian countries 
are keen to adopt and learn from the Indian model.  Further, this project is one of the first in 
depth, qualitative investigations of India’s harm reduction paradigm (policies, practices or 
underlying values) and its programs related to drug treatment.  Most harm reduction research in 
India continues to be HIV focused and is either quantitative or epidemiological in nature.  This 
research will be one of the first studying this new paradigm of drug treatment and recovery. 
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Thesis Analytics and Approach  
 My ethnography will describe and analyze the conflicts and tensions surrounding harm 
reduction policies and programs in India.  This task is especially challenging since the harm 
reduction paradigm impacts a wide range of actors and sectors both directly and indirectly. 
Within social work most research that study policy or interventions remain focused on impacts or 
processes without necessarily locating the concern in the larger socio-political, economic and 
cultural landscape that shape them.  Moreover, there aren’t many studies that examine the way 
policies filter down and shape the daily practices of people and in turn how daily life processes 
and actions make their way into altering policies.  
Also, quite commonly, studies tend to view policies or treatment paradigms as a black 
box- static or insular.  Researchers are less likely to talk about how social problems were 
conceived by the state, what were the logics and implications of such conceptions and the issues 
surrounding the building of national programs or the dynamics between the stakeholders.  The 
focus is usually located within a single site and aimed at evaluating outcomes rather than 
providing us with a grounded picture of the processes that were involved.  
  As a researcher, I was keen to address these issues outlined above and approach the 
harm reduction treatment paradigm as a set of dynamic meaning making practices of real people. 
By both talking to and observing policy makers, public health experts, donors, activists, NGO 
officials and recovering drug users, this research attempts to demystify how treatment paradigms 
come into existence, travel, flow adapt and influence social worlds.  I show in my work, that the 
policy arena, an ever evolving and often a contested space, shapes the everyday lives of clients, 
at the same time clients’ activities, behaviors and adaptations co-construct and re-shape these 
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very health policies.  Simultaneously, I engaged with the underlying processes of governance, 
the politics of health and the dynamics of human survival under harm reduction.   
My project also led me across multiple sites.  I followed harm reduction in hospitals, 
NGOs, donor agencies, government offices, communities and international development offices.  
I saw how the paradigm was adopted and transformed in these settings and delineate these 
‘affects’ in my work.  I also engaged with both the historical and the current socio-political-
economic and cultural contexts to understand the changes and transitions.  This attention to 
temporality allowed me to raise several questions.  How were these stakeholders aligning 
themselves in a way that was different from the past?  What were the unique implications of 
harm reduction on health as compared to previous periods?  How were drug users being viewed 
differently under these new conditions?  What were the limitations and possibilities of such a 
frame of reference for the future?  
I viewed harm reduction as a “problem space” (Ong & Collier, 2005) to examine broader 
questions of health and governance.  Foucault’s notion of problematization was especially 
important in developing such an analytic.  “Problematization is the ensemble of discursive and 
non-discursive practices that make something enter into the play of true and false and constitute 
it as an object of thought” (Foucault (1984) as cited in Castel, 1994).  Instead of trying to 
examine a condition and prepare a solution, it becomes important to reveal what makes these 
responses at all possible (Rabinow, 2007).  It views a social policy or even a treatment 
intervention not as a given but actually one that is shaped by a variety of historical conditions, 
social environments and power relations; it is dynamic and constantly evolving and it is 
constituted by those seeking to address the problem itself.  In adopting such a perspective social 
research asks-why is something considered a problem, what forces have come into play into “it” 
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being considered a problem and how is the solution developed in view of the problem.  For 
instance, I posed questions such as- what led to a risk focused construction of drug use?  What 
roles do developmental politics, growth in scientific knowledge about pharmaceuticals, 
emergence of evidence-based practice and human rights have to play in the development of harm 
reduction? 
 Given the rich interdisciplinary roots of social work I was keen to examine the limits and 
possibilities of such an analytic within social work.  Problematization brings forth issues of 
power, knowledge, expertise and transformation.  While there is an inherent danger of reducing 
‘problematization’ to critical thinking and reflexivity, there are several benefits of such an 
approach.  It can help social workers develop a more holistic perspective and instead of seeing 
issues in a static manner by using a single valence, problematization allows for multiple 
conceptualizations.  There is critique that such an analytic position can actually stifle social 
action.  I argue, however, that it can function as precipitator of innovative ideas and new 
methods of thinking, both on and, off the field.   
Adopting the ‘problematization’ perspective allowed me to view harm reduction as a 
phenomenon that was constantly evolving and somewhat unfinished; I attempted to understand 
the rationalities and logics that surrounded the evolution of harm reduction given the broader 
health context.  Such an analytic position was admittedly difficult to execute, both in research 
and writing as it can often lead to circular arguments or vague truisms.  Overall however, such an 
approach aided to the richness of my thesis helping me think in new ways about old problems. 
    A final note concerns my multi-disciplinary approach towards harm reduction.  Drug 
use has traditionally been field that has drawn a variety of points of view and my work drew 
deliberately and judiciously from public health, medical anthropology, sociology, development 
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studies and community health.  While each of these disciplines informed my work, I continued to 
be guided by social work’s own emphasis on macro-micro practice, ethics, politics, advocacy, 
activism and social policy.  
Addiction and Abstinence -based Treatment  
Narcotics represent in their essence, a desire for more than just the bare necessities of 
life.  The term narcotics, is closely associated with the Greek root pharmakon, which refers to 
both remedy and poison (Alexander & Roberts, 2003).  The ability of drugs, one hand, to 
alleviate pain, excite, provide pleasure and generate creativity while on the other, cause 
destruction and annihilation is both alluring and challenging.  Historically, most cultures and 
communities have some recorded history of drugs and though not always socially acceptable, 
drug use was never deemed a problem that required intervention.  Scholars argue that it was only 
during ‘modernity’, loaded with its ethical values on productivity and rationality, that for the first 
time in its history, drugs became constructed as a problem.  Also, as narcotics became widely 
available in the consumer phase of international capitalism, their impacts were more devastating 
and destabilizing than ever before.  Lovell (2006), claims “What distinguishes a good substance 
from a bad one is not inherent to the substance itself, it depends on the effect sought, the quantity 
taken, the means of administration, the frequency of the practice, the context, individual 
vulnerability – all of which are highly symbolized”.  
Today discussion about drug use not only draws upon much older debates about 
responsibility, free will, determinism, agency and power but also rests upon newer debates 
surrounding neurotransmitters, biology, physiology, and brain chemistry (O’ Malley & Valverde, 
2004; Valverde, 1999; Bourgois, 2000, 2003; Weinberg, 2002).  The National Institute of Drug 
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Abuse (NIDA)1 (2011), calls drug addiction “a complex but treatable brain disease”.  Social 
theorists point towards addiction’s more cultural dimensions calling addiction a disease of 
conduct, one that is emotional, interactional, temporal and relational (Denzin, 1993).  Addiction, 
most experts believe includes both psychological and physical dependency (NIDA, 2011)2.  
 Treatments for addiction and substance abuse have been historically driven by an 
abstinence-focus i.e. stopping the consumption of substances is necessary for treatment to begin.  
Despite the inherent contradictions of such a stance, one that expects drug users to quit drugs 
before they can be ‘treated’ for addiction, the abstinence model continues to reign in mainstream 
treatment literature and practice.  The treatment options within this abstinence model are varied 
and include- detoxification, cognitive therapy, behavioral therapy, psychotherapy and long-term 
psychosocial rehabilitation.  In such an abstinence model, drug use is considered problematic 
both for the individual and the community; drug users are viewed as deviating from societal (and 
moral) norms; they are considered non-productive and irresponsible members of society.  Drug 
users, despite completing treatment, are usually still considered “in recovery”; in some senses 
they can never be fully cured or trusted to remain sober.  
   I would also argue that the symbolic power of addiction is so sweeping that we now 
have a “culture of addictions”; people thus can be food addicts, gambling addicts, sex addicts 
and even relationship addicts.  Further, the mandates of the abstinence paradigm are so 
universally accepted that they are now readily translated to these different arenas.  Addicts, it is 
assumed, are easily tempted, difficult to control and always at risk of returning to their vices.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of 
the U.S. Department of Health and Human Services. They are the central agencies that address substance abuse 
concerns within the U.S. 
2 This means an addict has lost control over the usage of the substance, and will continue to use until intoxicated / 
‘high’/ is under the influence of the substance. Once he/she starts using the substance, they cannot stop and will 
crave for it if it is not consumed. The person will develop a tolerance towards the substance and may need more and 
more to achieve the same kind of feeling. 
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The response to this addicted culture has been quick and far-reaching.  A slew of life coaches, 
therapists, counselors and doctors have developed an entire industry of support, treatment and 
recovery around the tenets of abstinence, removal of desire and self-control.  But the results of 
such interventions are not as clear or as convincing as one would hope.  
     Abstinence-based drug dependence treatment strategies are often under resourced, ill 
equipped to match the changing landscape of drug use and require drug users to spend a 
substantial amount of time away from their families and communities (WHO, 2005).  Moreover, 
the prohibitive costs and problems in accessibility, keep those who need treatment away (WHO, 
2005).  Jared Richards, a harm reduction expert, shared with me that in his view the abstinence-
based model was the fall out of the 1930s 1940s ‘westernized Christian values’.  He points out:  
They set up Oxford groups and then the Alcoholics Anonymous (AA) groups and tended 
to increase this (focus on) abstinence, to the extent of socially stigmatizing those who 
could not stay away from alcohol.  The advent of 12 steps and Narcotics Anonymous 
pushed that onto the drug user.  So we (India) had groups forming rehabilitation (centers), 
boot camp type rehabilitation (programs), which would treat people like they were less 
than humans- they were criminals, which under the law of course they are… 
Jared claims that these abstinence programs are especially hard on those people belonging to the 
low socio-economic strata.  He argues:  
To ask somebody to take six months of their lives to go into rehabilitation, which means 
stop your work for six months, leave your family for six months, which is not very 
possible, either for him or for his family.  There have been a lot of times when we have 
put people into (rehabilitation centers) and their families come up and say why have you 
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done this, you have cut off our whole family income- that guy is fine, he is eating three 
meals a day but we have no source of income now, who looks after us?  
Those who enter treatment are often at a high risk of relapse; statistics vary between 50-
90% (WHO, 2005; NIDA & National Institute of Health, 2009).  Then why invest in treatment at 
all? Negative health and social impacts of non-treatment in addition to the high economic costs 
of addiction far outweigh the costs of treatment.  There is also a large industry of workers, as 
discussed earlier, in a variety of institutions such as prisons, hospitals, schools, community 
clinics and development agencies, invested in the business of treatment and recovery.  Millions 
of dollars are spent each year globally, on demand as well as supply reduction.   
Theoretically, drawing from Foucault’s argument on biopower, it could be argued that the 
problematic of addiction is given a new form through the very solutions sought to address it.  
Addiction to drugs represents one element of human urge that now needs to be governed and 
shaped and has given rise to an entire enterprise of health and recovery, which in turn sustains 
the problematic. 
Harm Reduction 
     The genesis of harm reduction in the 1960s-70s in Western Europe was in response to 
the deteriorating conditions of drug users.  Families, communities and societies ravaged by drugs 
struggled with the failures of abstinence-based treatment models and sought a different approach.  
Adopting a pragmatic rights oriented standpoint harm reduction adopted a middle path.  It 
focused on reducing potential harm caused by drug use, rather than on eliminating the actual 
behavior of drug use itself (Erickson, Riley, Cheung and O’ Hare, 1997).  It gained popularity in 
many nations in the West, including countries like Canada and Australia.  
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   Despite this, there was, and continues to be healthy skepticism about harm reduction’s 
viability for a large developing nation like India.  Early on small harm reduction programs, 
sustained by independent funding grants, were the only options available for drug users in the 
country.  The advent of HIV fundamentally changed the environment of treatment and 
intervention in India.  The government could no longer ignore the potential risks of such an 
epidemic and thus from a peripheral, local and small movement harm reduction grew into a 
national public health program to treat the problem of addiction.  More significantly, harm 
reduction has been able to transform drug use from a criminal and a medical problem into a 
public health concern. 
     The Indian model of harm reduction has drawn many elements from its global parent 
model.  However, given the complicated nature of the policy-practice environment and the large 
number of stakeholders present in India, there are many inherent contradictions and differences.  
I will now discuss some of these differences and complexities to provide a more nuanced picture 
of the Indian model of harm reduction.  
   First, one of the key features that separates harm reduction from other models of 
treatment is harm reduction’s acceptance of drug use. Harm reduction attaches no moral, legal or 
medical-reductionist strings to drug use (UNODC and Lawyer’s Collective, 2007).  Since drug 
use is seen as “normal”, the drug user is also seen as normal rather than a morally, criminally or 
medically deviant person.  It promotes itself as apolitical, value neutral and humanistic approach, 
parallel to the current new public health or healthy cities movement (Keane, 2003; Erickson et. 
al., 1997).  
There are no clear legal provisions to decriminalize drug use in India and “normalize” 
such behavior.  Under the Narcotic Drugs and Psychotropic Substances Act (1985) drug users 
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can be arrested and prosecuted for possession and or consumption of small quantities of drugs.  
In fact, provision of sterile injecting equipment for drug users may also amount to aiding and 
abetting of unlawful drug use and can lead to prosecution.  The National Aids Control 
Organization (NACO) under the Ministry of Health, which is responsible for HIV/AIDS 
prevention and treatment, endorses harm reduction and views it as the best way to address the 
drug-HIV pandemic (National AIDS Control Organization, 2006).  Despite their position on 
harm reduction, NACO has not addressed the issue of criminalization of drug use; NACO 
functions in a quasi-legal environment, one that continues to view drug users as deviant.  The 
National Institute of Social Defense (NISD)3, under the Ministry of Social Justice and 
Empowerment in-charge of drug abuse treatment and prevention within the country, continues to 
support the abstinence-based path and opposes harm reduction.  It views drug use as a criminal 
activity as well as a medical problem.  The state does not have one clear position regarding drug 
use or drug users, but instead conducts its harm reduction activities within such an undefined 
space. 
     NGOs like Sahai and Ashray have adopted harm reduction’s mandate more readily.  
They were clear in their acceptance of drug use as a part of normal life and viewed drug users, 
not as deviants, rather as human beings who needed their support.  International organizations 
like the UNODC and UNAIDS as well as donors like Bill and Melinda Gates Foundation also 
occupied the proverbial middle ground.  They were willing to support interventions and even 
harm reduction policies, but were less clear about how to address issues of deviancy or long-term 
systemic changes that were needed to alter the drug users’ position in society.  Sahiba Kaur, a 
harm reduction expert of UNODC, discussed this issue:  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 NISD funds over 300 drug treatment programs countrywide. 
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I mean within this whole harm reduction there is this whole debate on should we legalize 
and should we not.  I think our position is clear we are not for legalization but I think on 
the other hand we also understand addiction that you can’t expect that because I have sent 
you to treatment center that you would be free of drugs for the rest of your lives and also 
HIV has also compounded the issue, because you need to immediately at least save the 
person from HIV…but our position is I think clear that there is a drug user, he or she 
deserves access to treatment and deserves an enabling environment where he can access 
the treatment. 
 She highlighted that it was important to create supportive policies to aid treatment but 
not necessarily legalize drugs.  Despite a universal acceptance of harm reduction it became fairly 
obvious that there exist significant challenges in accepting the ‘normativity’ of drug use in the 
Indian context.  
   Second, within the global paradigm of harm reduction the drug user/client is seen as an 
active entity capable of making choices and participating in his/her own prevention, treatment 
and recovery (O’Hare, Newcombe, Mathews, Buning and Drucker, 1992).  Harm reducing 
behaviors are seen as the pragmatic choices that drug users/clients will make if there are enough 
incentives for recovery, easy availability of services, adequate knowledge about drug use and 
HIV.  This facet of harm reduction was in some senses, less problematic and more acceptable to 
stakeholders in India.  During our discussions many of them spoke about the individual’s right to 
‘choose’ treatment and their responsibility as institutions to support drug users health.  The 
Indian harm reduction paradigm seemed to be clearly advocating for the drug using individual’s 
ability to make choices and participate in society, despite the uncertain legal position accorded to 
them.  This created a complicated political context for drug users in India.   
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   Third, closely linked to this notion of individual choice is the focus on human rights. 
Harm reduction is founded on the principle of equity and justice- drug users must be given 
respect and dignity irrespective of their choice to use or not.  The Indian state promises equality 
and protection of life without discrimination as outlined in Article 14 and Article 21 of the Indian 
Constitution.  The Directive Principles of State Policy (guidelines to the government) provide 
similar provisions to protect the health of its citizens.  NACO also claims, “There can be no valid 
or effective response to HIV/AIDS without respect for the human rights, fundamental freedom 
and the dignity of human beings” (NACO, 2010).  Further, the “Right to Confidentiality, Right 
against Discrimination and Right to Consent” are other protections assured to the citizen by the 
state.  
   International organizations like the UN agencies promoted these ideas as a core 
principle of their work with drug users.  Sahiba Kaur shared her views about this issue:  
I think currently the U.N. position is very clear- its a rights based approach, the rights the 
drug user has to access treatment and to save his/her life and we are looking at providing 
these services immediately on a war footing really, so we need to quickly get the policies 
changed and we need to drastically pump in money for IDU programs …essentially the 
drug user must have access to harm reduction as well as treatment’.  Both human rights 
and individual choice for health were thus integral to how the Indian harm reduction 
paradigm was thought about and promoted.   
Fourth, this focus on individual rights has led some critics of harm reduction (globally) to 
propose that harm reduction works mainly at the level of the individual especially those 
considered at high risk, rather communities as a whole.  Upon further investigation it became 
clear that a similar claim could be made about the Indian harm reduction paradigm as well. Dr. 
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Alkesh Kumar from NACO and Rajat Dhingra a UNODC drug expert were quick to clarify that 
such a focus on specific target groups was a proven strategy in other countries.  Individual 
changes were basically seen as proxy for community change and larger issues of poverty, 
employment and paucity of resources could not become the mandate of the harm reduction/HIV 
program.  Dr. Alpana Deshpande, a public health specialist from WHO highlighted that:  
The basic problem is that no one has defined harm reduction, people have listed what the 
components ...this is what you need to do in terms of harm reduction so some people who 
come from a community setting tend to define is very broadly.  They want to address 
HCV, TB, marginalization, homelessness and mental illness but there is no resourcing for 
that because the government is not going to put any money in it and the HIV program is 
not going to put any money in it because at the end of the day that’s not their problem. 
            Jared Richards, the head of research at Ashray (NGO) in contrast to these stakeholders 
argued for a more expansive perspective. He claimed: 
            Harm reduction is basically the reduction and prevention of HIV and HIV transmission. 
That would be the classical- but you can expand it to cover physical harm, social harm 
economic harm.  So we are looking at reducing all those sorts of harm.  It is (usually) 
individual focused at the micro level but at the macro level there is also the concept of 
community harm with that to reduce criminalization- not only individual it is also 
community.  
            Other NGO leaders also were in agreement with Jared’s viewpoint but saw the pitfalls of 
spreading themselves too wide in terms of their mandate, especially when they worked in 
communities that faced multiple challenges.  Funding demands, high targets and programmatic 
concerns further placed limitations on the nature of harm reduction work these organizations 
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could carry forward whether at the individual or the community level. Farah Dastoor clarified 
some of these ideas: 
Well in terms of its interventions and what these specific activities are targeted at, yes of 
course they are targeted at the individual – they are of course encouraging them use clean 
needles, come into clinics to receive their substitution medication.  But, I wouldn’t say 
the harm reduction is completely divorced from the larger structures especially if 
they…because it pushes people to think beyond the pre dominant paradigm and main 
stream thinking of drugs itself is bad… There is another layer to everything and the fact 
that it recognizes that giving up drugs is not easy and is also not desirable for a lot people 
even though larger society may think drug free is good, but its not practical its not real 
and for a lot of drug users its not something they wanted to do or they want to do at the 
pace that society wants or expects them to do …So I think that sort of thinking or that 
level of reality check and more pragmatic ways of addressing the issue of drug use has 
come because of harm reduction. 
The fifth and the final element of the harm reduction paradigm in India is the focus on 
HIV.  Harm reduction as I suggested before, gained its momentum in India mainly as a strategy 
to reduce AIDS.  UNODC documents clearly present harm reduction as a “hierarchy of 
achievable goals”, where they accord highest priority from the most “pressing but preventable 
health hazards such as HIV/AIDS” to reducing drug use itself (UNODC, 2007).  However, all 
stakeholders agreed, that in the last few years, HIV prevention has superseded all other goals of 
harm reduction in India.  Farah Dastoor supports this and said:  
The problem lies again is that harm reduction tends to take a very narrow AIDS control 
approach, which I am afraid it has taken in India.  India boasts of now all services- like 
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substitution, needle exchange, antiretroviral or counseling condoms etc., but has that 
really changed the state of affairs for drug users… that thinking has not really percolated 
down or has transmitted down to the classical drug sector- be it drug dependant, demand 
reduction sector or the punitive sector which is your jails, your courts, police… 
Rajat Dhingra from UNODC places this HIV exceptionalism in perspective, “I can tell 
you we have an understanding with UNAIDS that two out of three, of every dollar that we 
receive, is meant for HIV prevention in the context of drug use”.  Clearly the government’s harm 
reduction activities are also under NACO and this has only furthered harm reduction’s status as 
solely an HIV prevention strategy.  NGOs like Ashray and Sahai though balance other foci such 
as drug reduction, overdose prevention and rehabilitation but their funding mandates are rooted 
in HIV reduction.  Despite strong lobbying by stakeholders, with the government, to broaden the 
mandate of harm reduction and include more services for drug users, the current focus remains 
squarely on HIV.   
Overall, the Indian harm reduction model while may not have a clear political/legal 
stance towards drug users it supports their choice to seek treatment as well as upholds their rights 
and freedoms.  It focuses on largely individual level HIV prevention strategies, which exists in a 
highly fractured socio-political environment.   
  By this discussion I hope to have shown that the definitions and boundaries of harm 
reduction are not very clear or stable.  Dr. Sanjiv Murthy, a veteran public health expert suggests 
that this confusion of stances and positions is not as much of a problem.  Dr. Murthy claims that 
Indian harm reductionists are:  
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Not really tied down or bound to any one particular ideology, if it works then we do it.  
There is no one who is wedded to one particular philosophy, unlike the west where there 
are those who believe in harm reduction and there are those who believe in abstinence.   
He also claims that the difference is very much artificial and the two philosophies are 
interconnected.  Abstinence is the ultimate goal, but it seemed no one is in a hurry to get there 
yet.  In fact instead of recovery, it is a continuum of care model that best represents harm 
reduction’s goals.  Jared Richards from Ashray echoes these ideas of continuum of care:  
See everybody’s concept of recovery in terms of drug using is this linear concept- from 
drug use to detoxification, to rehabilitation, to after care, to abstinence- that doesn’t work. 
What we need to have is some kind circular mechanism where drug user can join in at 
any point and leave at any point so if we have a continuum of care which have 
components of – outreach, drop in center, the general health component, (care for) TB, 
HIV testing, ART component, the after care- the rehabilitation, residential care 
component.  (Drug users) have a choice to join in any point of time, and leave at any 
point in time, which they do anyway.  So that basically gives them the best chance of 
survival, because, the ultimate goal of harm reduction is the prolongation of life.  
Theoretical Frameworks 
    Drug studies and HIV literature. 
Majority of social work research constructs substance use as either a criminal problem or 
a medical disease (Sussman and Unger 2004) and is largely quantitative in nature.  However, 
more recently interdisciplinary social science research has shown the influence of cultural norms, 
values, popular perception, economic disparities, substance availability, geographical positioning 
of communities, health resource disparities and the influence of social policy on drug use 
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patterns and behavior (Singer, 1995; Singer and Baer, 1995).  These scholarly works have 
greatly contributed my own framing of addiction within the Indian context. 
Ethnographic studies such as those conducted by Kane (1981), Taylor (1993), Bourgois 
(1998) and Stead, MacAskill, MacKintosh, Reece and Eadie (2001) vividly describe the lives 
and stories of drug users and the dynamics and interactions that shape drug use within 
impoverished communities.  These studies focus not only on subjectivities, identities, 
motivations and trajectories of drug users; but also on the structural inequities such as poorer 
facilities and services, substandard housing, poor planning and underinvestment; increased 
stressors from crime, violence and incivilities; and the negative social and psychological climate 
within these contexts.  By locating personal narratives drug use and addiction within the larger 
narratives of socio-cultural decay and distress these researchers were able link the micro 
behavior with the macro concerns.  This work is thus an important foundation for my own 
research that intends to re-contextualize drug use and recovery within macro concerns.  Further, I 
will forefront the stories, lives and experiences of recovering drug users placing the notion of 
subjectivity at the center of my work. 
The harm reduction literature in particular has been central to my work.  In the past few 
years’ questions about the efficacy/ functioning of various harm reduction measures and the 
underlying philosophy has generated much debate and critique (DesJarlais, 1995; Fischer, 
Turnbull, Poland and Haydon, 2004; Moore, 2004).  A large number of studies both within social 
work and other related disciplines have examined harm reduction interventions such as needle 
syringe exchange programs (NEP), pharmaceutical substitution programs and outreach efforts.  
Overall these studies have found that harm reduction strategies promote health seeking 
behaviors, reduced the likelihood of HIV infections or other blood borne viruses, increased 
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exposure to primary care and different treatment regimes and reduced injecting behavior (Wodak 
& Cooney, 2005; Ksobeich, 2003; Bourgois, 2000; Friedman and Alicea, 2001; Gibson et. al., 
2008).  In reviewing the literature were several aspects of harm reduction interventions studies 
that I used to understand my own experiences in the field. 
Drawing from the work of Holt (2007), Gomart (2004, 2002), Koester, Anderson, Hoffer 
(1999), Ning  (2005) and Pound et al., (2005) I looked at how harm reduction interventions were 
re-configuring drug user subjectivities.  These researchers’ investigated ideas of will, agency, 
resistance and coercion in the drug treatment context.  In the study conducted by Gomart (2002, 
2004) of a French methadone clinic, she details how the staff placed ‘generous constraints’ on 
the clients.  These rules, regulations and practices were not meant to create a ‘passive, dependent 
or immobile’ client, instead, it is through substitution that the drug user can learn to connect, 
form relationships and participate in society.  In her work she argues, freedom from addiction is 
thus not an absolute kind of freedom but one that emerges through, in some senses by courting 
dependence in a controlled fashion. 
Ning (2005) also addressed such issues in her work in a methadone clinic in Canada.  She 
pointed out that drug users are often categorized as liars and unreliable but instead her work 
showed that this problematic behavior could be better understood as ‘complicity to achieve their 
own objective’.  Unlike Bourgois (2000) whose work proposed that methadone clinics could be 
viewed as oppressive and strict sites of social control, Ning instead suggests that clients found 
ways within these regimens to serve their own needs.  Holt (2007) developing this line of 
research challenges any clear binary between agency and dependency.  In his work, clients 
struggled to see methadone as a treatment as it required dependence on medication.  He further 
suggests, given the larger (neoliberal) emphasis on becoming a rational and risk-averse subjects, 
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clients’ anxiety about dependence often increased, when entering substitution programs.  
Building on their commentaries, I challenged the dichotomous stances that view drug users either 
as dependent, passive and governed by discipline or as rebellious and non-conforming.  I draw 
on this literature to present a more nuanced view of drug users participation and resistance to the 
harm reduction paradigm. 
Research by Sharma et al., (2003), Bastos & Strathdee (2006), Rhodes et al., (2007), 
Fraser (2004) and Panda & Sharma (2006) on needle syringe exchange programs was critical in 
shaping my arguments around the usefulness of such interventions in reducing drug use, their 
effectiveness in the Indian context and the treatment issues that emerge in such conditions.  
Harm reduction programs that have used the needle syringe exchange and out reach have found 
benefits, especially for the hard to reach street users (Des Jarlais & Semaan, 2005;Gibson, Flynn 
& Perales, 2001).  Studies show that drug users understood the risk of HIV/AIDS and tried to 
reduce risks by exchanging used needles for sterile ones (Rhodes, et. al., 2003; Ksobeich, 2003).  
Despite the positive indicators supporting needle syringe programs, there are many legal, 
structural and geographical barriers for drug users.  For instance, though disposable needles are 
available at pharmacy stores, IDU’s may avoid these stores both out fear of arrest, stigma or 
poverty (Cooper, Moore, Gruskin and Krieger, 2005).  Other factors that act as barriers include 
the unavailability of needles in drug injection sites (for instance when the NEP is closed, and 
there is craving) and if the drug user is desperate to use drugs he/she may not bother with a clean 
needle4; fearful of being caught or arrested at the exchange site; drug users are also often afraid 
that carrying injecting equipment would place them at legal risk and they would rather share 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 There was a strong craving and drug withdrawal will overcome any risk perception of the drug and how it will be 
considered as a threat to the individual. 
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needles at the public injection site (Rhodes et. al., 2003; Small, 2007; Cooper, Moore, Gruskin & 
Kreiger, 2005).  
Research found that drug users often had misinformation about the status of 
asymptomatic HIV infected people, inadequate knowledge as to how to cleanse needles 
effectively and lack of awareness of one’s own HIV seropositivity (Bryant & Treloar, 2006; 
Perngmark, Vanichseni & Celentano, 2008; Golub et al., 2007).  The fear of being known as 
HIV positive was another barrier against safe injecting practices (Golub et al., 2007).  Research 
has found that those drug users who are unable to inject themselves and 'hangers on' who 
'contribute nothing to the acquisition of the drugs, are often the last to use the needle and at the 
highest risk (Gossop et al., 1997). 
Sub cultural rules and norms about use also played a role in shaping safe or unsafe 
injecting behavior.  For instance a person with the greatest resources (largest amount of pooled 
money, or provided the injecting equipment), regardless of HIV status, had the right to inject first 
(Unger et al., 2006; Crisp, Barber & Gilbertson, 1998; Kozal et al., 2005).  The gender and 
sexuality of those present may at times be more important in deciding who is allowed to inject 
first (Latkin, 2007; Degenhardt, 2005; Crofts & Hay, 1991; Marsh & Loxley, 1991).  Those who 
supply their home as a venue for injecting or those denied first use on a previous occasion as 
well as individuals who inject others were likely to be rewarded with first use (Johnson & 
Williams, 1993; Crisp, Barber & Gilbertson, 1997).  Assertive individuals were more likely to 
secure the first use of a needle and syringe, as may those persons who need to overcome 
withdrawal symptoms or claim to have veins, which require a very sharp needle (Crisp, Barber & 
Gilbertson, 1998). 
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At the interpersonal level sharing needles with friends or partners was often seen as a 
sign of trust and intimacy and this may have prevented drug users from using sterilized injecting 
equipment.  Loxley and Ovenden (1995) found that sharing usually took place with a close friend 
or lover.  Respondents felt that sharing with friends was safe, as long as they knew the friend for 
a long time, or he/she came from the same social circle as the respondent.  However, a closer 
examination of what 'knowing' meant indicated, that it was seldom related to an in-depth 
knowledge of the individual's sexual and drug using history, and only occasionally associated 
with HIV testing.  Other practices such as the mixing of drugs in one syringe and measuring out 
a portion of the solution into other syringes (known as frontloading and backloading), also places 
IDUs at high risk (Page & Jose, 1999; Crisp, Barber & Gilbertson, 1997).  
Research conducted on opioid substitution therapy provided key insights about the 
main concerns surrounding such interventions.  Methadone is the most commonly prescribed 
synthetic opiate in drug maintenance programs and has been in use since the 1950s and 1960s. 
However, more recently Buprenorphine is being used for substitution, especially in many Asian 
countries including India5.  Opioid substitution therapy is one of the most evaluated strategies 
of harm reduction, especially methadone substitution (Pauline & Kreek, 2004; Marsch, et al., 
2005; Kinlock, Gordon, Schwartz & O’ Grady, 2008).   Several studies have also evaluated 
Buprenorphine maintenance therapy and found that it was strongly associated with a drop in 
criminal behavior, better health outcomes and improvement in social conditions  (Gibson et al., 
2008; Johan, Syanborg, Dybrandt, Kreek, Markus 2003; Gowing et al., 2006; Wood, Kerr & 
Montaner, 2007).  The efficacy of pharmaceutical substitution improves if it is in conjunction 
with psychological interventions, counseling and behavior therapies  (Bruno, Gregory, Patrizia, 
2007; Greenberg, Hall and Sorenson, 2007; Grubber, Delucchi, Kielstein and Batki, 2008).  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Naltrexone and Levo alpha acetyl methadol (LAAM) are some other pharmacological agents. 
	   28	  
The studies conducted by Bourgois (1995, 1998, 2000, 2003, 2009) were especially 
important in helping me shape my discussion around embedded contexts of drug use, the nature 
of harm reduction interventions and the bio-politics of pharmaceutical substitution therapy in 
particular.  His provocative work highlights the daily struggles of drug users on the street and 
within clinical settings.  He challenges traditional notions of risk and outlines the ways in which 
drug users are written out of public policy and provided isolated services that do not reflect the 
complexities of their needs.  For Bourgois “social suffering” and “everyday violence” create 
conditions where drug users face institutionalized apathy and brutality.  His work documents the 
ways in which the daily suffering generates what he calls “destructive subjectivities” of the 
“righteous dopefiend” which permeates all spheres of social and institutional life.  Building on 
these similar ideas, I drew from Paul Farmer’s seminal work (2005), which exposed the way 
power inequities generate structural violence in different global locations.  The problems of 
economic survival compounded with disease create conditions where people are faced with acute 
challenges.  His work details how the connection between structure and agency often are difficult 
to establish, but through an investigation of circulating power networks, he shows how these 
become linked as old inequities lead to new conditions of social injustice.  I used his conception 
of structural violence to detail the context of deprivation surrounding drug users in India. 
 Joao Biehl’s (2007) work in Brazil and Diddier Fassin’s (2007) work in South Africa, 
was especially important in understanding the interplay of a ‘new state-society’ partnership 
where patients are encouraged to participate in their recovery.  Biehl’s work highlights how the 
state only responds specifically to these group needs, leaving out broader ‘life sustaining 
assistance’ for the entire population.  Biehl’s work grounds the struggle of the Brazilian state and 
its people amidst the international developmental and pharmaceutical politics, showing why 
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certain people benefit, while the marginal are left behind.  Fassin’s AIDS ravaged South Africa 
is the site where previous inequalities of the apartheid era are re-arranged in this world of 
disease, testing, pharmaceuticals, human rights and private experience.  In his book Fassin lays 
out the diverse ways in which citizenship and health come into question as the struggle for 
resources continues.  For both Biehl and Fassin the human diseased experience becomes the 
landscape to show how states continue to engage in politics of exclusion while at the same time 
embracing this new culture of social justice, equity and pharmaceutical rights.  
   Risk literature.  
   The harm reduction paradigm in India has ushered in the discourse of risk in both 
policies and interventions.  The discussion of risk today has become the dominant mode of 
thinking about not merely drug use and HIV but public health in general (Petersen & Bunton, 
1997).  I draw from a rich theoretical body of work that examines the dimensions of risk and its 
relevance to our discussion on harm reduction.  
Scholars argue, that this shift towards a ‘risk focused’ response is more than strategy of 
efficient containment of large public health epidemics.  In fact, it reflects the new nature of 
governance and approach to management of populations within states (Foucault, 2003; Rose, 
1996; Bunton, 2001).  These scholars postulate that states are extending the neoliberal approach 
(are equated with a free market- maximized competition and free trade achieved through 
economic de-regulation, elimination of tariffs, and a range of monetary and social policies 
favorable to business and indifferent toward social, environmental and welfare needs6 ) from 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 Neo-liberalism refers to the reduced influence of the Keynesian welfare state economics and the ascendance of the 
Chicago School of political economy -- von Hayek, Friedman, et al. Neo-liberalism is most often invoked in relation 
to the Third World, referring either to NAFTA-like schemes that increase the vulnerability of poor nations to 
globalization or to International Monetary Fund and World Bank policies which, through financing packages 
attached to "restructuring" requirements, often adversely impact the political institutions and social formations of 
these nations (Brown, 2003). 
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polity and economy to social actors, institutions and policies.  Classical liberalism, with a 
welfare rationale, emphasized the responsibility of the State for the care of its citizens.  But 
under neo-liberalism a new thinking has evolved where there is an increased focus on costs and 
benefits, even social interventions are looked via the lens of profitability and competition. 
Moreover, these principles are filtered down to individuals/clients participating in these social 
programs (Brown, 2003).   
To understand how broader practices of governance and power come to bear upon 
individual selves I draw on Foucault’s theory of power.  Instead of viewing political power as 
something that tries to dominate, subjugate and deny individuals, Foucault highlights how power 
can be more usefully understood in its ability to shape and create human beings as particular 
kinds of subjects (Rabinow, 1984).  It is not to say that the political system denies any ‘real 
freedom’ of the individual to act.  Instead Foucault’s work draws attention to how political 
actions, technologies and strategies are devised in a way to promote individual and 
entrepreneurial actions in every sphere of life (Rose, 1993).  
Individuals, for Foucault are both the subjects and objects of power; “ individuals are 
always in the position of simultaneously undergoing and exercising power.  They are not only its 
inert or consenting targets; they are always also the elements of its articulation” (Rabinow, 
1984).  This relationship between human subjects and political power is clearly one that requires 
empirical investigation.  However, it most powerfully provides us tools to rethink about policy 
logics and its impact on citizens7. 
Citizens, these scholars argue, are now responsible for the “care of the self” (Rose, 1999, 
2001; Gordon, 1991; Rose and Miller, 1992).  With increased involvement of private enterprise 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  	  The logics of such rationality are not always easily visible or as fully bound; these leakages in thinking can inform 
our thinking about power. 
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in the business of social services, lowering of investments by governments in welfare and 
increased activism among patients and affected groups, this move toward “individualization of 
care” is quite evident.  Rose (1998) discusses: 
The guidance of selves is no longer dependent on the authority of religion or traditional 
morality, it has been allocated to ‘experts of subjectivity’; who transfigure existential 
questions about the purpose of life and the meaning of suffering into technical questions 
of the most effective ways of managing and malfunction and improving ‘quality of life’.  
These new practices of thinking, judging and acting are not simply private matters.  They 
are linked to the ways in which persons figure in the political vocabulary of advanced 
liberal democracies- no longer as subjects with duties and obligations but as individuals 
with rights and freedoms. 
Rose most effectively draws Foucault’s thinking in helping us to understand how the 
human being is re-configured as ‘homo –economicus’, which means that all aspects of human 
life and institutional action are based on such a calculus of utility, benefit, supply or demand 
(Brown, 2003).  Individuals are given the freedom to make rational and responsible choices 
(Dean, 1999).  It is this same ‘economic rationality’ that has popularized risk as a crucial 
component of health interventions.  Risk is considered a reliable and calculable measure that is 
thus viewed as a more ‘sound’ way to make investments in the social sector.  By reducing the 
qualitative element in these calculations, these risk models claim to be more effective as they 
reduce behaviors, affect and actions to variables and categories (O’Malley, 1999).  
    Within public health there has been a marked increase in preventive medicine and 
promotion of a healthy lifestyle as well as fields like epidemiology and statistics have grown in 
prominence and played an important part in evolving categories of at –risk subjects, surveillance 
	   32	  
of populations and disease profiles (Miller, 2001; Petersen & Lupton, 1996).  Also the growth of 
patients’ rights and the consumer movement have created greater awareness and impacted how 
health is perceived (Rose, 2005).  Knowledge about risk is essential to make proper healthy 
choices for the modern citizen and thus has become an important in the fight for better services 
and treatment.  
    Overall, I have argued that the emergence of risk in health can be traced to three main 
developments.  First the shift from a welfare focus to a neoliberal form of governance led to an 
increased emphasis on economic driven thinking.  This approach paved the way for risk to 
emerge as a mechanism of social control and intervention, as it was believed to be more 
‘economical’ in terms of investing financially in those key areas that are proven 
‘scientifically/statistically’ (Gordon, 1991).  The state is keen to invest in those areas that were 
going to provide the maximum return.  Second, the growth of preventive medicine, which 
promotes healthy behavior for the present based on future calculations as well as the growth of 
disciplines such as epidemiology and statistics have reinforced the primacy of numbers and 
calculations over other forms of knowledge.  Third, social movements and rights based struggles 
have evolved into consumer centric logics where the choice to be healthy is given freely.  There 
is debate about how these three elements are interlinked and the primacy of one factor over the 
other.  However, for the purposes of our discussion it is vital to recognize all three elements as 
crucial in the evolution of risk.  Beyond these reasons, risk has also gained ground because 
development in research, which established the link between problematic behaviors and 
illness/disease.  
I have also argued that this risk based approached has had profound implications on how 
marginalized groups like drug users are viewed.  Some scholars argue that risk-bearing subjects 
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are quite often considered in isolation i.e. both in terms of the conception of the problem and in 
terms of its inevitable solution (Bourgois, 2009; Moore, 2004).  Lovell (2002) and Burris et al., 
al. (2004) highlight that risk as a concept tends to largely focus on individual behaviors without 
necessarily examining larger issues of poverty, stigma, discrimination, legal barriers and lack of 
supportive health infrastructure.  In fact risk, these researchers’ argue, is quite often abstractly 
connected to specific populations without necessarily examining the peculiar contexts that create 
risk in the first place (Moore and Fraser, 2006; Duff, 2003)8.  Notions of risk and vulnerability 
(Rhodes, Singer, Bourgois, Friedman & Strathdee, 2005; Ezard, 2001) reinforce individualism, 
moving the burden away from the state or social environments (O’Malley, 1999; Pratt 1999).  
  These scholars propose that drug users are reconfigured into risk subjects they are 
obliged to adopt a ‘calculative and prudent personal relationship to risk and danger’ (Petersen & 
Bunton 1997).  They also highlight that drug users must not only care for themselves but are 
given the freedom to choose health.  Without acknowledging the constraints or limitations that 
impact their lives, public health, social work, medicine and law then question stigmatized groups 
like injecting drug users about their ‘irrational choices’ (Moore, 2004).  Risk then presents a 
unique conundrum.  While on one hand its usefulness as a concept in identifying groups most 
vulnerable, highlighting healthy options and promoting a preventive stance is undeniable.  On 
the other hand, as I have argued before its application within the field generates grave concerns 
especially for the struggle of better resources, equitable treatment and just laws.  
   Some efforts have been underway to shift this view of this overly calculative and 
context free vision of risk that masks inequalities related to gender, ethnicity, race or poverty   
(Bourgois, 2009; Rhodes, 2002; Bourgois, Lettiere & Quesada, 1997; Friedman, Jose & 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 These ‘risk models’ no longer focus on the concrete subject of intervention instead on the aggregate. The 
individual is considered only in terms of the relationship with broader risk bearing categories; focused on the 
patterns of understanding the characteristics of aggregates and distributions8 (Pratt, 1999). 
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Stepherson, 1998).  One of the most prominent approaches in this direction is one of ‘risk 
environment’ proposed by Rhodes (2002).  “A risk environment approach seeks to understand 
the environmental determinants of harm as a means to creating ‘enabling environments’ for harm 
reduction” (Rhodes).  This ecological approach aligns well with the approach of social work and 
its person-in –environment paradigm as well.  These studies in risk have important implications 
in my investigation of risk reducing interventions such as needle syringe exchange, condom 
promotion and outreach.  Studies by Rhodes (2002), Moore and Fraser (2006), Lovell (2002) and 
Moore (2004) were especially useful in evaluating the way risk discourse shaped harm reduction 
interventions in the field and ultimately framed drug users responses. 
   Studies on biological citizenship. 
Beyond the risk-focused interventions harm reduction in India has brought in 
pharmaceutical interventions like Opioid substitution therapy (OST).  Pharmaceuticals have 
increasingly come to dominate medical responses to epidemics across the globe and as 
researchers’ have noted, changed the way they engage with the state.  To better understand these 
relationships I draw on an emerging body of literature on biological citizenship. 
Citizenship has evolved with transformations in society and polity.  Throughout the 18th 
and 19th century, the notion of citizenship was largely civic and political (rule of law, voting, 
administrative boundaries etc.) and linked to the nation-state (Rose, 1993).  The citizens were 
duly contracted to the state through myriad laws, rules and regulations that provided legitimacy 
to their existence.  However, it was during the 20th century the notion of rights expanded to 
include social rights (health, education, employment, housing, equal opportunities etc.) giving 
primacy to human dignity, life and liberty  (Rose and Novas, 2005).  Modern citizenship is 
egalitarian in nature, a reciprocal relationship between rights and duties that requires a 
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framework (like courts, hospitals, parliaments etc.) for recognition and mechanisms through 
which they can be fulfilled (Faulks, 2000).  With the expansion of social rights in the political 
sphere, the right to access to health care and medicine became critical for citizenship.  
Further, the growth of pharmaceutical and biotech companies, expanding HMOs, 
privatization of medical care and rising costs as well as inadequate health insurance safety net 
have all brought health into central focus in current debates (Petryna, Lakoff & Kleinman, 2006;  
Rose, 2007).  The growth in global mobility has heightened concerns regarding the spread of 
disease and epidemics as are seen in cases of the Avian flu, AIDS/HIV, SARS etc. has also 
forced states to participate more fully in the health of citizens. 
However health is not an absolute/determinant concept.  It is essentially an indeterminate, 
relative or elastic concept that is seen largely as the absence of problems.  This indeterminacy 
about health especially becomes significant in discourses about citizenship.  Health thus cannot 
become a direct aspect of citizenship i.e. government can provide conditions to support it but not 
really guarantee it (Osborne, 1997).  Further health has no absolute boundaries and these flexible 
lines make it more ambiguous to demand as right or duty.  We see that many states are pulling 
out of older curative models of nationalized health initiatives and moving towards a different 
model of public health.  The old system primarily focused on establishing hygiene and reducing 
disease/illness (Ashton & Seymour1988).  Some scholars argue that the nature of this new public 
health is reflective of  ‘neo- liberalism or advanced liberalism  (Gordon, 1991; Rose and Miller, 
1992; Rose, 1993).  In this neo-liberal environment, these researchers highlight that the 
individual is expected make ‘healthy choices’ after evaluating the risks and take the 
responsibility for shaping their own biological lives9.  The healthy body is now an important 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 There is greater focus on the duties of the citizen and their social obligations. But these discourses are not restricted 
either to national boundaries or a single generation (Turner, 1990).  
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signifier of moral worth -where the individual can express self-control, self-discipline, self-
denial, and will power (Crawford, 1994)10.   
Foucault’s work based on investigations of the penal system and other social institutions 
such as the clinic, attempted to provide insight into how the modern state in the century engaged 
with its citizens.  In doing so, Foucault theorized the way power moves from the abstract realms 
of state politics into the everyday life of its citizens- shaping them from the inside out. Foucault 
argued that modern states were no longer interested in as much to take life or repress it instead 
they were keen to foster life11.  It is this notion of power that he termed biopower.  Foucault 
defines biopower as “what brought life and its mechanisms into the realm of explicit calculations 
and made knowledge-power an agent of transformation of human life” (Foucault, 1976).  
Biopower was unlike sovereign power (the earlier form of state power).  The aim of biopower 
was no longer to end life, but to move through it and shape it completely (Foucault, 2003)12. It is 
through biopower that Foucault draws the link between the state and the individual, with such an 
understanding of power he proposes that citizens are harnessed to participate in the state 
processes. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 The consumer body has become a key marker of identity- as subjects constructs themselves in conformity with 
social norms and as separate and distinctive from other selves (Falk, 1994). This attention to the body is not only to 
ward off disease but also aesthetic. A body industry has emerged (gyms, fashion magazines, medical establishment, 
pharmaceutical industry) extolling the healthy, risk averting body (Koval, 1986). Along with this has developed an 
increasingly sophisticated array of experts of both mind and body (plastic surgeons, psychologists etc..)  
11 In Foucault’s early work such as Madness and Civilization (1965) and later books The Birth of the Clinic (1989) 
such as Discipline and Punish (1978), he lays down his early thesis on subject formation. These books were based 
on detailed historical study of institutions (such as prisons, clinics, hospitals) and disciplines (such as criminology, 
psychiatry and medicine) in Europe from early 18th century to modern times. They trace the diverse ways through 
which individuals were drawn from populations (such as diseased, the insane and the deviant) identified, classified 
and isolated for apparently humane reasons. These practices of power and knowledge objectified specific groups of 
individuals. These modes of division can be jointly called ‘dividing practices’ (Rabinow, 1984). Foucault traces the 
interconnections of these dividing practices with the growth of scientific disciplines-that provided rationales and 
techniques to categorize and contain populations (spatially and socially). 
12 The administration of bodies and the calculated management of life carefully supplanted the old power of death 
that symbolized sovereign power. Bio power was an important part of the development of capitalism – the 
controlled insertion of bodies into the machinery of production and the adjustment of the phenomena of population 
to support the development of economic processes ( Rose, 2007). 
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From the 17th century this power over life evolved in two basic forms (these were not 
antithetical), they constituted two poles of development linked together by a whole intermediary 
cluster of relations.  One of these poles was centered on the body as a machine, its disciplining, 
the optimization of its capabilities, extortion of its forces, the parallel increase of its usefulness 
and its docility, its integration into the systems of efficient and economic controls; all this was 
ensured through procedures of power- an anatomo-politics of the human body (partly drawn out 
in his later texts of governmentality).  The second pole formed somewhat later, focused on the 
species body- the body imbued with the mechanics of life and serving the basis of the biological 
processes; propagation, births, and mortality, the level of health, life expectancy and longevity 
can cause these to vary.  Their supervision is effected through an entire series of interventions 
and regulatory control- a biopolitics of the population (Rose, 2007).  The disciplines of the body 
and the regulations of the population constituted the two poles around which the organization of 
power over life was deployed. 
 Today there is indeed a proliferation of knowledge, institutions, laws and services that 
have focused on the human body as a site of transformation. The term biological citizenship is 
used to encompass all those citizenship projects that have linked the conceptions of citizens to 
beliefs about the biological existence of human beings, as individuals, families, lineages, 
communities, populations, societies and species (Rose and Novas, 2005).  Rose and Novas argue 
unlike the age of eugenics there are different ideas about the role of biology with respect to the 
state.  The biological responsibilities of the citizen are transforming, propelled by new 
technologies that are able to investigate, predict and go beneath the surface- thus the body in its 
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very material sense of genes, molecules, tissues, organs and muscle becomes evaluated and 
useful/useless (Rose and Novas, 2005; Sunder Rajan, 2006). 13  
The shaping of biological citizen involves more than just the state.  It now involves 
public bodies, private corporations, health providers, insurers and individuals themselves.  This 
means reshaping of the way in which persons are understood by authorities – political 
authorities, medical, legal personnel, penal professionals, potential employers, insurance 
companies- in terms of categories such as the chronically sick, disabled, blind, the deaf etc.. 
Biological citizenship can be individualizing to the extent that individuals begin now to use the 
biomedical knowledge to understand their own selves, which can affect self- perception and self-
beliefs (Rose and Novas, 2005).  In fact, this biological knowledge intersects with the regime of 
the prudent and enterprising individual that is actively shaping his/her life through acts of choice.  
Now responsibility for the self includes both the corporeal and genetic/ molecular.  These 
citizens are encouraged to find new ways / techniques of managing their everyday life, in relation 
expert knowledge.  In fact carrying the similar prudence to their daily life activities and fitting 
seamlessly with the larger goals of the risk-averse society.  These citizens must inform 
themselves about current illness, susceptibilities and predisposition, take appropriate steps, 
conduct life responsibly in relation to others, the enactment of such responsible behavior become 
routine and expected (Dumit, 2006; Ong & Collier, 2005).  
Biological citizenship can also be a collectivizing conception, in that it links citizens 
through a number of different ways.  Rabinow (1999) proposes the notion of ‘biosociality’ to 
reflect these new biosocial groupings14.  There is a proliferation of patient groups/ those afflicted 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 Certain vital developments have already become routine in medical care such as genetic testing, amenocentrisis, 
ultra sound etc.. These have brought forth a new perspective in viewing the human body and machinations. 
14 He argues that while older forms of classification of bio-identity such as race, gender, class continue to exist, they 
are now being refined, re-constituted and changed under this new knowledge. 
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by similar somatic concerns.  They are refusing the mere status of patients and forming ‘bio-
social’ groups/ collectivities (some communities are linked electronically).  These biosocial 
groupings around a specific health concern have a long medical history.  But unlike before when 
such collectivities were at odds with the medical establishment, these new groups are more 
involved with the medical establishment, know greater amount of specific medical knowledge- 
‘informational bio-citizenship’ and knowledge/expertise about one’s own problems (Rabinow & 
Rose, 2006).  They are making demands of the state to get better treatment, ending stigma, 
gaining access to services, and exerting their rights bio-citizens.  According to these researchers’ 
activism and responsibility are a part of the obligation of the active biological citizen – one who 
must live through acts of calculation and choice (Petryna, Lakoff & Kleinman, 2006).  These 
activities and responses of the biological citizen recast the notion of citizenship, from a top down 
notion (state bestowing rights) to a bottom up concept. 
Now our discussion turns to one particular manifestation of these new health ties between 
state and citizens (biological citizenship) that is mediated via pharmaceuticals.  The emergence 
of pharmaceuticals within health care has in a short while radically altered the response and 
approach to disease.  In the case of addiction the change towards using pharmaceuticals for 
treatment has been rather slow and mired in controversy.  Based on our previous discussion, the 
availability/ non -availability of large-scale pharmaceuticals to marginalized drug using 
populations can be viewed as one such ‘citizenship’ project.  It is I argue, similar to Biehl (2007) 
and Ecks (2005) conception of a type of engagement with not only the state but with other civic 
institutions that make pharmaceutical care available and possible.  Pharmaceutical citizenship, 
thus ‘redefines belonging, exclusion, duties and rights'  (Ecks).  In some ways such a form of 
citizenship relates to people’s access to these pharmaceuticals (who is left out), implications of 
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taking pharmaceuticals on their other rights as citizens (can they fully participate in civic life) 
and the ability of citizens to shape their survival through pharmaceuticals (what kind of life is 
grantee through these pharmaceuticals).  Ecks based on Dipesh Chakrabarty’s (2000) argues that 
there is a friction between citizens who are patients and entitled to medication because he/she is 
fully a citizen and those who can only realize their potential as a citizen through the practice of 
medicine taking.  
In extending this argument to the case of harm reduction in India, one can clearly see that 
it is this kind of tension that underlies the dynamic among those promoting and taking OST 
medication.  This literature was extremely useful in analyzing and interpreting the broader 
political and social implications of the OST program in India.  Drug users were now being re-
cast into pill popping medicated citizens, who, my project argues evolving a new relationship 
with the state mediated by the medication.  Governance had moved away from more punitive 
structures and drew on a more fundamental element of life to ‘govern’.  My work draws from 
this body of biological citizenship literature to discuss and critique these ideas.  
   New modalities of governance and expertise. 
      Harm reduction much like HIV has impacted multiple levels of polity.  Previous 
national epidemics usually resulted in vertical health programs controlled by government bodies.  
But these newer epidemics not only cross traditional geographic boundaries in their impact but 
involve an entirely new set of partnerships between government, non-government, quasi-
government, bi-lateral and transnational bodies.  There are a variety of researchers’ who have 
attempted to study the impact and relationships of such stakeholders and how they have come 
together to study both disease and health. 
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I have drawn from the theoretical work on governmentality literature that renders drug 
policy and practices ‘thinkable in new ways’ (O’Malley, 1999).  Drug researchers argue that the 
present drug policy and practices reflect the changes from such a classical liberalism model to a 
model of neoliberal governmentality (O’ Malley; Valverde, 1999).  The classical liberalism 
model, with a focus on welfare and the promotion of healthy lifestyle (Lupton, 1995), saw drug 
consumption as problematic, addictive and dangerous.  The drug addict itself was seen as a 
deviant, whose ‘desiring subject and body’ needed to be ‘disciplined’ (Bunton, 2001).  The neo 
liberal or advanced liberal strategy adopts a more inclusionary approach instead (Bunton). By 
this we mean that today neoliberal governance relegates the responsibility of health and well 
being to the individual.  There is a redrawing of the social and health policies by promoting 
enterprise and self-reliance.  Social work and physician based care is giving way to self help and 
help lines and clients are taking on the status of being a ‘consumer’15 (Rose, 1996).    
Previously, social problems were addressed through central planning and the state took 
part in providing majority of the services.  Under this new system the competitive private sector 
meets ‘consumer demands’ and there is a ‘pluralization of intervention technologies’ or 
therapeutic options available for the person to use (Rose, 1996, 2007).  From welfare for those 
individuals in need, it is broadly shifting to a system of monitoring the health of the population 
and identifying abstract factors that are deemed liable to produce risk in general (Armstrong, 
1997)16.  Populations are being increasingly managed on the basis of their risk profiles such as 
age, social class, occupation, gender, locality and consumption (Bunton, 2001).  The state must 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
15 It would be important to examine how these new conceptions of self-reliance differ or support older ideas of self-
change and responsibility that exist in the much older Alcoholics Anonymous philosophy. 
16 This kind of thinking developed first in the private sector – practices of insurance companies, private security 
firms and commercial enterprises, concerned to reduce the costs of crime that fall on them (Garland, 2001). 
Commercial and insurance based thinking about crime control focuses upon reducing or displacing the costs of 
crime, prevention, rather than punishment and upon minimizing risk rather than ensuring justice. Only in the late 
1980s did it begin to influence state agencies and practices.  
	   42	  
now function by such rationalities (in many cases to the detriment of itself and its population as 
seen in the case of the Third World); calculation of cost and benefit becomes central to all state 
practices.  Now social policy must ‘meet profitability tests, incite and unblock competition, and 
produce rational subjects, it expands the entrepreneurial principle within the social sphere- thus 
linking the neo-liberal governmentalization of the state with the development of a neo-liberal 
social sphere and neo-liberal subjects (Brown, 2003). 
While the state itself is not the center of my study – its emergence and transformation are 
key to my understanding of the formulation of health-harm reduction policy.  Mitchell (2006) 
writes that the state ‘is an object of analysis that appears to exist simultaneously as a material 
force and as an ideological construct’.  While Marxist functionalist perspective saw the state as 
the instrument of the capitalist class interests there were others who saw the state as bounded 
institution, distinct from society regulating populations within the territory (Sharma and Gupta, 
2006).  More recently theorists have adopted a more critical stance and interrogated that the state 
in fact can be seen in relation to or as a result of the relationships between different social 
institutions such as the family, civil society what form the state takes, the everyday practices that 
constitute the state (Abrams, 2006), especially arguing that the boundary separating civil society 
and the state is an effect of power relations (Rose, 1996).  
As serious questions are raised about the state’s cohesive, unitary, autonomous and 
authoritative status in citizens’ lives, Mitchell (2006) lays out that this reification of the state is 
itself something that is constituted through certain practices and discourses17.  By such a turn in 
the analytic, the state is deconstructed into processes, techniques, roles and institutions and the 
emphasis shifts towards the way it governs, appears, enacts and transforms social bodies.  In 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
17 Rose (1996) and Abrams (2006) argue that disciplines like political science and other social sciences have helped 
to shape this view of the state’s own specific role and its relationship with those it governs.
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moving away from an assumption that the state is at center of social institutions, and instead by 
investigating how the state comes to assume such a position as the co-coordinator of governance 
of social and individual conduct, “it forces us to reconsider the ‘mechanics of rules and workings 
of power through such apparently mundane state activities such as collection of taxes, 
distribution of food to the poor or the issuance of passports” (Sharma and Gupta, 2006).  Power 
is dispersed and emerges in these roles and processes of non-state institutions, communities, and 
individuals (Foucault, 1991; Rose, 1996).  
Ferguson & Gupta (2002) highlights that it is more important to study the mechanisms by 
which the ‘state’ comes into being as the “supreme” authority, one that manages all other 
institutional forms and social relations.  By drawing from such an anthropological view of the 
state, which shows its multi-layered, multi-centered and dynamic nature it attempts to at the 
same time lay out how the state can yet appear coherent and unified.  For Ferguson and Gupta 
the state can be excavated through the study of non-state institutions such as the family, 
community and economy, and these sites can in-turn be better understood through lens of 
governance and state rule that shape the everyday (Sassen, 1995; Ong, 1999).  
 I also draw from literature that examines the role of NGO’s and other private or 
transnational organizations in the sphere of public policy and practice.  Social theorists propose, 
that the emergence of NGOs can be specifically linked to neoliberal approach to governance and 
the ‘roll back’ from traditional welfare/development tasks; government is thus encouraging 
private / quasi private players like NGOs to adopt these roles (Kamat, 2002; Escobar, 1995).  
This move is often times couched in terminology of empowerment, self –governance and 
personal responsibility for welfare and development (Sharma, 2008).  However, these notions are 
usually defined in ways, which not only ignore local realities but also often replace old 
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hierarchies with new ones, now based on “expert” construction of knowledge and practices.  I 
especially discuss these ideas in my work while describing the new roles peer workers occupy in 
the harm reduction paradigm. 
The state itself, by “privatizing” these functions, is able to govern and manage without 
fully taking on the responsibility of welfare for its citizens- thus functioning more profitably; the 
NGOs, quite often remain within the framework of the state’s functioning and almost become a 
disjointed arm of the state.  However ethnographic accounts have shown us that the theoretical 
tool kit of governmentality does not completely account for the often messy and complex 
relationships between the state and NGOs, especially in the context of the growing influence of 
international actors.  The clients and NGO workers often behave contrary to mandates and 
further challenge any neat categorizations.  But overall this theoretical frame of governmentality 
allows us as researchers to problematize state and non-state institutions and critically examine 
their identity in terms of practices, processes and actions instead of assuming them abstract 
wholes.  
Non-profits in particular, have grown tremendously in the last few years, especially in 
countries like India.  They have become a major provider of services for the state- as we see in 
the case of HIV.  Research by Salamon (2002) shows that these organizations occupy a variety 
of roles besides service provision, they are involved in advocacy, representing the needs of 
communities, community building and even creating value.  Salamon’s research highlights that 
this new wave of non-profits have adopted the enterprise culture- they are now competing, 
marketing, viewing their clients as products, segmenting their markets and differentiating 
themselves from others.  They have also begun to build their own infrastructure and taken on a 
business like approach to their work.  These changes as I have highlighted before reflect the 
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neoliberalization tendencies of the social sector in general and also reveal the way in which 
development, health and other social issues have now be rendered readable in new ways.  
     Kamat (2002) and Escobar (1995) show that these changes in the non-profit sector 
have increasingly also started to find new political links with organizations globally and thus in 
some ways bypassed the national governments.  The state’s roles have evolved into the 
administrative, knowledge management and decision-making arenas and the non-profit and 
global organizations have stepped in to take over the daily tasks of intervention.  Research 
specifically focusing on the contracting system and the welfare state also has important 
implications for my work.  Over time as social services have become increasingly burdensome, 
expensive and unwieldy states have begun to contract with the private and non-profit sector to 
provide these services.  Research shows that this balance between the public and private sector is 
changing as the private sector is now more and more dependent on the government to sustain it 
and the government is redefining its own relationship with the citizen in such cases (Smith and 
Lipsky, 1993).  While contracting can appear to be a good mixture of government and non-
government several issues of social justice, equity, geographic differences (non-governmental 
organizations are reluctant to work in certain regions) and division of resources become 
problematic.   
     HIV related research has particularly shown that these policy shifts have new 
implications for the global-local policy space.  Swindler (2007) argues that with many different 
actors are engaging in new partnerships that cannot be easily classified.  Aradhana Sharma 
(2008) who also draws from theories of neoliberal governmentality to talk about the growing 
prominence of the transnational discourse of empowerment and the role of NGOs/quasi-civic 
bodies.  Especially in the context of India, foreign funding has helped to support the growth of 
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the non-state actors.  Sharma highlights how increasing NGO presence points towards growing 
privatization of government tasks/roles.  But, she argues that the Indian state cannot completely 
relinquish these tasks, especially as the post colonial state gains its legitimacy through these 
tasks.  Sharma’s ethnography of a government supported NGO, shows however that the 
distinctions between the state and the non-state are not as clear as activities, funding and political 
agendas criss-cross to create a complex bricolage of power, agency and roles. 
 Kavita Misra’s work (2006) on the rise of the non-governmental sector, in providing 
HIV/AIDS related services in India, is another critical contribution in this direction.  Misra uses 
Foucault’s theories on governmentality to show how the “modern” Indian state gains legitimacy 
in some ways by both ‘constructing’ the crisis of HIV/AIDS and then attempting to manage it by 
using discourses of expertise on health and risk.  This expert discourse is also used by NGOs and 
ties these local actors/institutions with global institutions to change the way the AIDS (and a 
variety of related issues) is addressed in the Indian context.  NGOs and the state work in an 
uneasy relationship and embedded within their struggle for health are deeper battles regarding 
the body, sexuality, cultural politics and individual freedom.  Thus, NGOs working on 
HIV/AIDS emerge as critical socio-political actors often undertaking fluid and multiple roles and 
troubling neat categories of governance, rights and health. 
Tanya Murray Li (2006) examines how notions of development are constructed and 
operationalized by the government, especially as failures are shaped as successes and 
populations struggle to assert/demand rights from the state.  Li’s work highlights the goings-on 
within contemporary states, where hegemony and domination are “terrains of struggle”.  Citizens 
and often even government officials compromise and negotiate with the state as it continues to 
both fail and hold promise for them.  While my own work does not directly address the imagery 
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of the state, it does attempt to understand how the state is participating in addressing a public 
health concern.  I seek to draw from Li’s work, as I attempt to understand how the citizens and 
non-state actors learn to negotiate and re-imagine the state in their interactions.  
Ferguson and Gupta’s (2002) key ethnographic study of a maternal health project in India 
and shifts in the social sector within African nations has also influenced my understanding of 
these transactions between state, non-state/transnational actors and citizens.  Their study 
questions any pre-conceived spatial or hegemonic mappings of state or non-state institutions.  It 
instead forces us to reconsider how one must study these entities as they interact, combine 
forces, challenge and reconstruct social policy and practice. 
Overall these studies provide an important theoretical foundation for my to understand 
the new ways in which governance and expertise is understood and analyzed within current 
contexts. 
Organization and Chapter Summary 
   The dissertation includes a total of six chapters.  This includes the Introduction, 
Methodology, as well as five findings chapters titled- Cracked Wide Open, Revolving Doors, A 
New Kind of Survival-Laying Risk Bare, Pharmaceuticalization of Health and Models, Mutants 
and Experts. The last two chapters of the dissertation are the Conclusion and References. 
  In the Introduction chapter, I discuss the key issues surrounding my research, the 
analytics and the research literature. The Methodology chapter details the actual process of 
conducting the research, the research design and the data analysis.  The third chapter, Cracked 
Wide Open explores the historical conditions that shaped the emergence of harm reduction.  I 
intend to both highlight the emergence of a new modality of drug treatment as well as the 
construction of injecting drug users as a high-risk group.  This chapter will delineate the 
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historical involvement of key stakeholders such as the government, NGOs and show how harm 
reduction emerged as the solution for rising rates of HIV. 
  The fourth chapter, Revolving Doors, continues to examine the role of the stakeholders 
and their dynamic relationships.  The lines dividing ‘state’ and ‘non-state’ activities are 
increasingly becoming hazy, also with a health -welfare and a rights-based focus the state role is 
not shrinking as many neoliberal theorists suggest but shifting in diverse ways.  The neoliberal 
state is continually evolving its role as manager and knowledge producer at the same time as it 
forefronts its position as health/welfare provider.  Confronting the tenuous links that separate the 
global from the local this part examines how the global agendas, funding flows and expertise 
travel to and within the harm reduction networks.  Extensive research, developing of local 
disease networks of affected people, technical training, crafting new risk groups and 
professionalizing the practice of health are only some of the widespread ‘impacts’ of the global 
development agenda on the daily politics of harm reduction in India.  I show how the Indian drug 
treatment sector participates and resists these processes of both knowledge production and 
management –discussing the implications of such collaborations and divergences for drug 
treatment in India. 
 The fifth chapter called A New Kind of Survival- Laying Risk Bare, discusses the 
needle-syringe exchange programs.  These are critical sites where drug users are first inducted 
into this risk-focused health practices.  However without adequate resources NGO’s often are 
forced to ration out limited supplies of clean injecting equipment.  I discuss the notion of 
‘embedded (within the context of use) risk’ instead of harm reduction’s notion of behavioral risk- 
proposing that the latter abstracts the conditions under which risk is created and sustained.   
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Engaging with the moral economies (Bourgois, 2009) that shape both drug use and street life I 
show how daily exchanges of risk are integral to both survival and health.   
  The sixth chapter titled Pharmaceuticalization of Health describes the rituals 
surrounding Buprenorphine substitution therapy specifically invoking the image of the kneeling 
open mouth drug user- ready to receive the dosage of Buprenorphine from the NGO worker. I 
discuss this ‘voluntary’ nature of this submission and its inherent problematic assumptions of the 
deviant, untrustworthy and risky drug user.  As recovery gets reduced to largely medication and 
dosages, healthy life becomes inseparable or dependant on a pharmaceutical life.  I argue that 
this limits possibilities of health rather than expands it (as the model claims) leaving those 
unwilling or ineligible outside the purview of recovery.  This section also highlights the 
programmatic issues that surround pharmaceutical substitution within the country locating it 
within debates of drug treatment in social work. 
   As public institutions fail to provide even the basic services and stigmatize drug users, 
these patient-citizens are increasingly turning to NGO’s/civic organizations to make demands, 
seek services and organize themselves.  NGO’s are conduits through which drug users become 
‘visible’ to the state and become relevant within the national discourse.  I argue that harm 
reduction services have helped to create political categories that drug users are able to attach 
themselves to, expand their reach and even bring non-injectors and their families into these 
‘circuits of care’.  It is through the generation of formal and informal networks that these citizens 
are able to chart out new ways of living within the neoliberal state.  Using examples of the NGO 
ID card, the HIV status/CD4 count or hospital records I discuss how old strategies of survival are 
weaved within this new network of disease and health to survive. 
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The seventh chapter is called Models, mutants and experts, which discusses the 
experiences of the peer workers.  The ‘ peer workers’ are not only the frontline providers of harm 
reduction services but also the walking symbols of the ‘success’ of the program itself.  Thus, on 
one hand, these peer workers must become and often are perceived to be the harbingers of a 
controlled, if not drug free, lifestyle.  While, on the other hand, the peer workers constant return 
to drug use or failure to reduce harm in their lives reveals not only the dangers of drug use itself, 
more significantly, the fragility of this ‘bio-regime’ as a whole.  These  ‘not good enough peer 
subject’s’ are then, at once harm reduction’s ideal front and its most vulnerable or destabilizing 
link.  This tension between the progressive and the risky peer worker represents harm reduction’s 
own strains within the Indian context.  This section draws out how the drugs-AIDS industry is in 
fact creating a creamy layer of experts that link themselves to local contexts without necessarily 
contributing to grassroots activism or sharing resources with the larger affected populations.  I 
argue that the development sector politics, limited resources, shifting global agendas and fragility 
of their positions all contribute to the constitution of this particular type of insular local expert. 
  The Conclusion chapter traces the knowledge, practices, policies and services that 
constitute drug use under harm reduction as a public concern.  Drug users in effect represent one 
of the most marginalized categories.  Their lives have little political and social significance in 
most spheres- rendered important only through their potential to spread disease and harm.  My 
effort is not only to raise their voices but also listen to our own as we rationalize life and living, 
hope and survival.  I conclude my linking how private concerns are constituted into a national 
drug crisis and get reformulated through policies, daily practices and private responses.  Agency 
and structures collide in ethnographic intersections that seek to enrich social work discussions on 
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emergent diseases, health system responses, state participation and community involvement. The 
final chapter is titled References and includes all the citations.       
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CHAPTER 2: METHODOLOGY 
My ethnographic research aims to understand the health policy context of the harm 
reduction paradigm and examine its impacts on drug users in the city of New Delhi.  I began this 
project with the intention to examine the way the city’s dispossessed, addicted and 
disempowered were securing their health using the harm reduction network of programs and 
interventions.  However, during my preliminary fieldwork I quickly realized that this story 
would be incomplete without investigating the broader role of NGOs, government, civic society 
and bilateral organizations.   
Guided by my research questions, I went to New Delhi in August 2008 to conduct 
fieldwork for eight months until April 2009.  The design of this project involved multiple 
methods- participant-observation in both intervention and policy settings, semi-structured and 
life history interviews with 75 stakeholders as well as analysis of reports, policies and 
programmatic and other textual material.  Each of these methods of data collection occurred 
simultaneously and informed each other.  Most sites were pre- planned but others were included 
as they emerged to be critical during my ethnographic inquiry.  By immersing myself in the daily 
lives of drug users, policy stakeholders and peer workers I was able to go beyond viewing harm 
reduction as a uni-dimensional program. 
   My interest in this research topic began during my years as an undergraduate student in 
New Delhi, when I began working at Sahai (NGO) for a research project.  Drug use issues 
became a core component of my work in the ensuing years as I expanded my knowledge about 
the local cultures of drug addiction and treatment in different parts of India.  I returned to New 
Delhi once again in 2005 to volunteer as a research assistant for Sahai and then a few years later 
in 2007 to collect preliminary data for my doctoral dissertation.  During this second visit I 
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became more deeply acquainted with Ashray another NGO, which focused on drug treatment.  It 
was during this last visit that I also began to notice the shift in priority from abstinence treatment 
to harm reduction.  Harm reduction had suddenly gained ground and become the new ‘it’ 
phenomenon; harm reduction programs were getting the bulk of attention and funds while the 
abstinence-oriented programs were barely pulling through.  Lawmakers, activists, NGO workers 
and public health specialists all spoke about harm reduction as if it were a ‘magic bullet’ and 
were excited about the prospects it held for reversing the HIV epidemic in India.  My visits to 
specific projects of these NGO’s only strengthened these observations.  Armed with new funding 
to initiate these programs and I noticed that multiple non-state actors were now involved in the 
construction of this treatment paradigm.  Harm reduction had given rise to a number of 
compelling concerns around health, social justice, treatment access, development, 
pharmaceuticals, state participation and citizenship, that ultimately became the key concerns of 
my dissertation.  This became the turning point for my dissertation project and helped to shape 
my final ideas, research questions and approach. 
   In this chapter I will detail the research questions that guided my study, the 
ethnographic approach, the research design, site description, data collection and analysis 
procedures as well as the ethical concerns that arose during the course of my study.     
Research Questions 
     During the course of my research I was guided by two main research questions.  
1) How do the state, NGOs and international organizations interact, negotiate and shape 'the 
harm reduction paradigm'? I specifically examined: 
• How is harm reduction conceptualized and promoted in the policies and programs of 
the Government of India?  
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• What are the ways in which international agencies shape and influence these harm 
reduction policies and intervention programs?  
• What are the diverse ways in which NGO’s make harm reduction operational in their 
programs and interventions?  
2) How is harm reduction impacting the everyday lives of drug users in recovery? I specifically 
looked at: 
• What are the ways in which these people incorporate harm reduction into their 
everyday life and what meanings do they give these practices?  
• How does harm reduction shape the subjectivities of drug users?  
• What are (if any) the differences in the experiences of recovering drug users with 
diverse programs of harm reduction?  
• How is the relationship between the drug users and the state /NGOs changing under 
harm reduction regime? 
An Ethnographic Approach 
    My research adopted a multi-site ethnographic design.  My motivation to adopt this 
design was primarily driven by my interest to examine the policies and programs of harm 
reduction through multiple lens- socio-cultural, political-economic and historical.  As I discussed 
before, most studies within social work, view the actual construction of treatment paradigms as a 
black box.  My work approaches the harm reduction treatment paradigm as a set of dynamic 
meaning making practices of real people, one that changes across contexts.  To best understand 
these processes and the complex inter-linkages between policy, interventions and social lives I 
chose the ethnographic design. 
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   The ethnographic framework has other key features that made it appropriate for the 
type of study I wanted to undertake.  By looking at particular social phenomenon both within the 
current context and over time, ethnography allows the researcher to study the phenomenon in 
different time frames.  I was keen to view historical events as elements of my analysis and not 
merely the backdrop to my study.  An ethnographic approach allowed me to understand the 
logics, power dynamics and rationalities of the events in the past and the way they continue to 
shape the future of this treatment paradigm.  Instead of a snap shot of program/policy I was able 
to see the way harm reduction shifted, evolved and developed over time.   
    Ethnography also adopts multiple epistemological positions- on one hand it 
understands phenomenon as constructed and subjective, while on the other it also views 
phenomenon as objective and real.  To me, as a researcher, this inter-subjective stance i.e. real 
events and objects exist in the world but the frames of understanding that we apply to view them 
can lead to different implications and affects within our lives, was crucial in the way I 
approached social realities of my field site.  I did not to engage in false reductionism or claim 
that all reality is but a perspective.  Instead, I argue it is important to remain both ‘experience 
near’ (Geertz, 1973) while recognizing my own role as an ethnographer that is putting together 
this ‘social world’.  Hammersley (2002) provides a pragmatic approach towards balancing these 
dichotomous positions and refers to it as subtle realism.  He argues that research investigates 
independent and knowable phenomenon but all knowledge is based on human construction.  For 
instance, harm reduction includes ‘real’ treatments such needle syringe and pharmaceutical 
substitution, which have visible and measurable impacts on reducing unhealthy behaviors. 
However this reduction in risky behaviors can also be perceived by some stakeholders, as a way 
to control or shape unruly populations and promote neo-liberal conceptions of personhood.  I 
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was especially interested in adopting such an inter-subjective or subtle realist stance in order to 
examine these diverse perspectives of risk reduction and the varied implications it held for my 
participants. 
    Ethnography rests on the tension of ambiguity between the known and unknown i.e. it 
allows for the researcher to travel and change lines of inquiry as the phenomenon itself 
transformed.  Even though I had conducted preliminary inquiries and had clear research 
questions, I had to remain flexible enough to move, challenge and shift my focus as the project 
evolved.  At times I had to redraw or review the boundaries within which the exploration was to 
occur.  I had originally, for example, intended to interview only the officials working exclusively 
on harm reduction but soon realized that issues of drug use and harm reduction came under the 
purview of HIV/AIDS specialists.  This meant, I needed to extend my reach and examine harm 
reduction within the broader context of HIV.  I also had to move across a variety of settings from 
hospitals, training centers, research institutes, drug recovery clinics, bi-lateral organizations and 
global funding agencies following the trail of harm reduction activities, interventions and 
programs.  While some of these sites were pre-determined others became significant during the 
course of my inquiry.  An ethnographic approach allowed for this dynamic movement even 
within a well-defined research space.  
   As a final note, most qualitative research, and ethnographic accounts in particular, are 
often de-valued as they are seen as invalid or too local to have any usefulness outside the specific 
setting of the study.  I will now discuss these issues of validity, reliability and generalizability. 
   Guba and Lincoln, (1982) argue that the validity of research knowledge must not be 
based on the fact that “we were there and the participants know”, instead researchers must 
remain vigilant about the assumptions and inferences are made, the data that constitutes evidence 
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and the rationality behind an argument.  In my study I undertook many steps to assure the 
validity and reliability of the data collected.  In doing so, I do not revert to post-positivist 
explanations of neutrality, confirmability and credibility.  Instead, the validity and reliability of 
my findings rest on prolonged engagement with concern and my participants, persistent 
observation over time and across contexts; and using different methods such as observation, 
interviews and textual data.  I also used member checks i.e. going back to some of the 
stakeholders to confirm my findings and interpretations.  I have painstakingly tried to assure the 
reliability of the accounts by triangulation of data from multiple sources, including multi-vocal 
narratives, and generating accounts that are authentic to my experience within the field (Lincoln 
and Guba, 1985; Mishler, 2000).  
    Another critical issue related to ethnographic work is the concern of generalizability 
i.e. the way can one particular example, case study, population or context be used to explain the 
phenomenon overall.  Quantitative studies instead use logics of sampling and statistical theory to 
mitigate concerns of generalizability and claim qualitative lacks the ability to do so because of 
the specific nature of its study and small sample size. My research is based in New Delhi and 
focused on the dynamics of harm reduction within this context.  At the same time, I view it as a 
site to observe the interaction of diverse stakeholders, ideas and processes as they unfold and 
understand their implication for broader issues of treatment, public health and governance that 
can be applied globally.  The danger here is to then assume all specific examples are but 
illustrations of larger, complex and more abstract concerns.  To avoid such a misstep, I advocate 
instead a dialogue between the micro and macro. 
  In describing the extended case method Michael Burawoy (1991) highlights the manner 
in which the researcher can examine ‘the macro world through the way the latter shapes and in 
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turn is shaped and conditioned by the micro world, the every day word of face to face 
interaction’.  Burawoy argues that the goal of good social scientific research is to not only to 
learn about a situation but also from that situation- to make claims that will have validity beyond 
the current context.  By connecting specific processes, events and observations to other examples 
in different contexts by using theoretical frames, the specific can become generalizable.  But it is 
not always theory confirmation that assures generalizability some times though there are 
departures from theory similar results, descriptions of issues and contexts of phenomenon can be 
also generalizable.  My work hopes to both contribute to theory and the silences/gaps in the 
theory, as well as recoup marginalized voices of addicts who are often written out of ‘scientific’ 
renditions of addiction. 
Research Design 
I am including a table to show the various elements of the ethnographic research design. 
Research 
Question 1  
Sites Sampling Inquiry details 
1. How does 
the State, 
International 
Organizations 
and NGOs 
shape harm 
reduction ? 
Participant 
Observation 
1.Policy 
/Advocacy 
Meetings 
 
2.Trainings for 
peer workers 
 
3.NGO forums 
 
4. NGO projects 
of Ashray and 
Sahai 
 
 
These sites were 
chosen based on 
their relevance to 
the research 
concerns 
1. Policy /Advocacy 
Meetings-3  
 
2.Trainings for peer 
workers-2 
 
3.NGO forums-3 
 
4.Ashray and Sahai 
project sites in Nadi 
Nagar and Kharagpur- 
3 Months at each site & 
approximately 10 hours 
each week.  
 
 
 Interviews 
1.Government 
Officials 
 
Snowball and 
purposive 
sampling 
1.Government 
Officials- 3 
 
2.NGO workers- 34 
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2.NGO workers 
3. Bi-lateral 
Funders/ 
International 
development 
organizations 
 
4. Public health 
consultants 
 
5. Civic society 
leaders 
 
 
3. Bi-lateral 
Funders/International 
development 
organizations- 6 
 
4. Public health 
consultants-9 
 
5. Civic society 
leaders-8 
 
 Textual 
Analysis 
Review of policy 
documents , 
research related 
specifically to 
harm reduction, 
annual reports, 
program 
documents and 
bilateral/internati
onal agencies 
documents 
 
 
Relevant 
documents were 
identified by the 
researcher and key 
stakeholders 
 
 
Over 50 documents, 
materials and reports 
were included in the 
analysis 
Research 
Question 2 
Site Sampling Inquiry details 
How is harm 
reduction 
shaping the 
lives of 
recovering 
drug users  
Participant 
Observation 
Ashray and 
Sahai projects at 
Nadi Nagar and 
Kharagpur 
(NGO’s, New 
Delhi) 
 
 
Snowball and 
purposive 
sampling 
 
 
All clients who 
accessed the harm 
reduction treatment 
programs. 3 Months at 
each site & 
approximately 10 hours 
each week. 
 Life History 
Interviews 
Ashray and 
Sahai projects at 
Nadi Nagar and 
Kharagpur 
 (NGO’s, New 
Delhi) 
 
 
Snowball sampling 
 
 
17 clients were 
interviewed. All were 
male except 1 female. 
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Site Selection  
Unlike most traditional ethnographies however, my research was embedded in multiple 
sites that were chosen based on the dynamic nature of harm reduction and evolved organically 
during the course of the study.  In this section I discuss the different sites and their contexts.  
     As I discussed in the previous chapter I had chosen New Delhi as my site to 
investigate this new model of public health.  The city has a high drug-using population and some 
of the longest running harm reduction programs in the country.  Its importance as a site is 
enhanced by the presence of major international organizations and government offices, making it 
a critical center for harm reduction policy and intervention.  I will now describe the main settings 
within New Delhi. 
   Policy meetings. In order to understand how various policy stakeholders interact and how 
harm reduction policies and programs are formulated I chose certain policy settings to conduct 
my research.  Since harm reduction policy is largely subsumed under the HIV rubric I attended a 
number of events/celebrations, policy meetings, advocacy sessions and trainings that were 
related to both HIV and drug use.  The advocacy meetings were usually hosted by the civil 
service organizations and NGOs usually in collaboration with the UN agencies.  Trainings for 
peer workers were conducted by NGO workers but supported by the government.  Strategy and 
policy focused meetings were a collaborative joint effort by a number of different agencies and 
often included the government as well.  
I was usually invited to these meetings either by the NGO workers or by one of the civil 
society agencies.  The meetings were held in public halls, conference centers and a few times 
within the offices of the stakeholders.  I chose these events based on the importance and 
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relevance to the key focus of the research.  The policy meetings and those focused on advocacy 
provided insight into inter and intra stakeholder dynamics.  It helped to shed insight into the way 
the stakeholders’ talk about and frame harm reduction; they also were useful forums to see how 
each stakeholder interpreted issues of health and treatment.  NGO forums and training sessions 
were equally useful in providing information about activism, issues of knowledge transfer, 
problems in training workers on harm reduction and diversity in perspectives about harm 
reduction.  I was unable to attend any donor meetings or high-level policy negotiations due to the 
confidentiality concerns.  
These are the following organizations whose officials I interviewed during the course of 
my study 
1. Government 
• National AIDS Control Organization (NACO) 
• Ministry of Social Justice and Empowerment (MSJE) 
• National Institute of Social Defense (NISD) 
2. International Organizations 
• United Nations Office of Drug Control (UNODC) 
• United Nations Joint Program on HIV/AIDS 
• World Health Organization (WHO) 
• World Bank  
3. Bi-lateral Organizations 
• DFID (British Development Organization/PMO) 
• GTZ (German Development Organization) 
4. Civic Society/NGO/Public Health Consultants  
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• Lawyers Collective (civic society) 
• SPYM (NGO, Delhi) 
• All India Institute of Medical Sciences (hospital) 
• HIV/AIDS Alliance (Research/ Consulting) 
• Futures Group (Health Consultants) 
• Bill and Melinda Gates Foundation (Donors/implementing organization) 
• Clinton Foundation (Donors/implementing organization) 
• Population Council (Research/ Consulting) 
• Family Health International (Research/ Consulting) 
• India Network of Positive People (civic society) 
• Delhi Network of Positive People (civic society) 
• Indian Harm Reduction Network (civic society) 
• SASSO (NGO, Manipur) 
• Emmanuel Hospital Trust/ORCHID (Hospital/Non-profit North-east) 
• HIV/AIDS CARE (health organization) 
 
   NGO settings. To understand the way harm reduction programs were being implemented on 
the ground and to learn about the life experiences of drug users and peer workers I chose to 
situate my study in two NGO settings.  
    Sahai and Ashray18 are two of the most prominent harm reduction NGO's of the 
country and they served as the primary sites for my fieldwork.  I focused on the pharmaceutical 
substitution and needle exchange programs in the communities of Kharagpur and Nadi Nagar. 
These programs were run by these NGOs, in conjunction with the Government and international 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
18 Name changed 
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agencies.  These programs are in the highest drug-using sites of the city and were considered 
successful models by these NGOs.  Both of these organizations were also chosen because of their 
involvement in a wide range of activities beyond providing harm reduction services.  These 
include policy formulation, participation in national and international alliances, conferences or 
coalitions, partnering with foreign universities and transnational organizations to conduct 
research/interventions and supporting both state and non-state actors in the country.  
    Over nine years ago I first came into contact with Sahai (in Hindi means support) 
during the course of my undergraduate research thesis.  Through the research process, I began to 
learn about the organization and its crucial role in pioneering drug recovery in India for over 
twenty years.  Sahai was clearly a leader in the field, with vast experience and multiple projects 
within Delhi.  Sahai is a therapeutic community that was started in early 1980s by Regis 
Monterio and his wife.  Sahai’s most famous legacy is its 70-bed drug rehabilitation center, in 
the heart of the city.  They also run a hospice care for HIV positive drug users, a women’s 
treatment center and many community projects across Delhi and few other states in India.  
Over the course of the next few years I also came into contact with Ashray (meaning 
shelter in Hindi) a sister NGO of Sahai.  Established in the 1980s by Owen D’ Souza a 
recovering drug user, Ashray began as small peer led organization that worked on issues of urban 
poverty and drug use.  Over the next twenty years it grew into a large NGO with projects all 
across the city of New Delhi and India.  Owen shared, “Ashray started off as an agency not 
involved in drug use we simply were looking at issues related to health, related to justice, related 
to a national context of poverty…our roots were Christian since we emerged from a Christian 
rehabilitation center”.  It was hybrid organization of professionals and “affected” individuals, in 
the early 1990s their focus shifted more specifically to drug use issues and later HIV.  Ashray 
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has played a critical role in bringing harm reduction discourse into the mainstream drug 
treatment paradigm.  It undertakes direct intervention work funded both by international donors 
and the national government.    
   Both Ashray and Sahai began their journeys together.  Their leaders are closely related 
to each other, thus over the years the organizations have collaborated and exchanged knowledge, 
projects and even staff.  However, their divergent histories are reflected in their practices of harm 
reduction services as well.  Ashray’s mandate is to address drug use within the context of urban 
poverty and harm reduction programs were seen as pragmatic and necessary response to 
community needs.  Most of Ashray’s staff is currently on the harm reduction program and clearly 
identifies itself as a “harm-focused” organization.  Sahai on the other hand has essentially always 
first seen itself as an institutionalized drug abuse treatment program.  Harm reduction services 
have been added to Sahai’s repertoire much later, in response to changing needs of clients and 
knowledge about drug treatment services.  In fact, most of Sahai’s staff at its projects followed 
an abstinence model of recovery.  The balance between these two elements remained an essential 
source of tension and strain within the program.  
I will now provide a brief description of the actual field sites of the projects in Nadi 
Nagar and Kharagpur to detail context of my research. 
   Ashray, Nadi Nagar, New Delhi. “People either come here dead or come here to die”, was 
how Muquim a street drug user described his community of Nadi Nagar19 (community by the 
river, in Hindi) during my very first visit to my field site in 2008.  I had only traveled about two 
hours from one end of the bustling and modern New Delhi to the other end of the city. Moving 
from a car, to a train (metro) and then finally to a rickshaw, I finally reached the community 
located in the heart of “Purani Dilli” (old city in Hindi).  The journey itself was not extraordinary 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
19 Name changed 
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in fact I knew many who made this journey every day for work, business or to see family.  But I 
also knew as a native that this was a different world- a chasm so wide that the two hours felt 
more like traveling back two decades.  
    The walled city20, with its labyrinth of small lanes and crumbling old forts, which 
nestle small industries and shops, is bursting at it seams. Nadi Nagar, a Muslim dominated 
community most known for housing Delhi’s busiest crematoriums21 is also the site of Ashray’s22 
(meaning shelter in Hindi) oldest projects and one of the country’s first harm reduction 
interventions.  The road leading to Ashray’s project is lined with chai (tea) stalls, dhabas (street 
restaurants) serving eggs, rice and dal (lentil), barber shops as well as street vendors selling 
brightly colored marigold, jasmine and rose garlands, wood, woven mats and other materials 
needed for the last rites.  As evening falls, the vendors and businesses are replaced by hundreds 
of Delhi’s homeless, who sleep on the pavement protected by the tall white and dilapidated walls 
of the ‘ghats’ (Hindi term for an area built on the river bank with a series of steps leading to the 
river, often used for ceremonial rituals and bathing) of the river Yamuna.  
     At every 20 feet of the road a set of broken cement stairs lead you up from the main 
road and then down to a narrow alley.  The alley way is lined with brick homes, small temples, 
open public toilets and abandoned buildings.  As I walked along through the alley, between the 
rubble and mayhem I caught sight of the river, sparkling brightly in the morning light.  But this is 
an illusion of course, because much like the rest of this Dilli (Hindi term for Delhi) the river 
Yamuna too is dying.  Clogged with industrial toxic waste, city sewage and filth from domestic 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 Old Delhi has remained the capital from the Mughal period, once the seat of power and culture. It has many old 
forts, palaces and buildings. The old city is enclosed by an old fort wall enclosing 1500 acres with many gates. 
While the physical walls have been broken down or demolished over the years, the area remains cut -off from larger 
currents of development within the city. 
21 The reference to death is recurrent and both directly in reference to the city’s dead who come here to be burnt as 
well as the large number of homeless and poor migrants who seem to flock here as if only awaiting death. 
22 Name changed 
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pollution- the Yamuna was probably the community’s biggest symbol of decay.  I wondered, and 
not for the last time during my fieldwork, how Ashray’s workers kept hope alive in such 
desperate surroundings. 
Ashray has two separate sites in Nadi Nagar, one that provides OST (opioid substitution 
therapy), abscess management and Needle Syringe Exchange Programs, funded by the central 
government’s National AIDS Control Organization (NACO).  The second site barely a mile 
away, funded by the Delhi State Aids Control society (state government) provides only OST and 
abscess management services.  Each project site had 2-3 small rooms and a large courtyard 
where the activities were carried out. 
    My days at Ashray would usually begin around 10 am watching as workers cleaned 
and set up, in preparation for the clients.  I roughly spent equal time at both the sites of Ashray.  
The Nadi Nagar projects are Ashray’s flagship sites and thus became a natural choice for me to 
study and observe. Ashray’s Nadi Nagar project started almost 10 years back and over the course 
of these years it has been funded a variety of international and national institutions.  According 
to many of the clients the range of services (from nutrition, shelter, job placement or even water 
for bathing and grooming, clothes, and education) are shrinking ever since the government has 
taken over funding. 
   Sahai, Kharagpur, New Delhi. Sahai’s 23(in Hindi means support) Drop-in center (DIC), was 
located a few kilometers away, in the Muslim dominated community of Khargpur24-northeast 
part of Delhi.  Largely composed of evicted groups from other regions of the city (during the 
1980s urban renewal programs), it includes a fair mix of low and middle-income homes- the 
community is considered still “in transition”.  I had taken the sleek and shiny new metro 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
23 Name changed 
24 Name changed 
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(subway) to reach Kharagpur25 on one of my first trips to the field site.  However, once outside 
the train station, I was barely able to pay any attention to the vista of the community that 
stretc.hed before me.  I was busy navigating the crowded Kharagpur roads.  Careening buses, 
overflowing community taxis and speeding rickshaws have literally made this main road a death 
trap26.   A large and equally busy over bridge adds to the chaos of this intersection.  Under the 
bridge is a dangerous, dusty, noisy, narrow dirt patch, which happens to be home to a large 
number of street drug users and their families.  As I was crossing the road I noticed them, they 
went along their daily chores ignoring the cacophony around them, later I would get to know 
some of these families through outreach with Sahai staff.  
     Once on the other side, I made my way from the crowded road and into a small lane 
lined with homes and shops that were tall enough to block the sunlight.  After walking a few 
dingy blocks, I noticed a small board that signaled the entry to Sahai’s offices.  The DIC would 
usually open by 9 am each morning.  The staff would begin their day by cleaning the rooms, 
sterilizing medical equipment and setting up their workstations.  The center had four rooms, all 
stacked up one behind the other.  The front room was for dispensing medicine and abscess 
management.  The largest room was right behind it, this is where the clients would stay all day, 
usually watching T.V., chatting, sleeping and eating.  The room next to it was used for 
counseling and staff meetings.  The last room included a small kitchenette and a computer for 
administrative work.  Funded by a private agency Sahai had greater flexibility in terms of its 
role, but because of the limited time for which funding was available Sahai’s work was always 
restricted. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
25 Even though Kharagpur is an old community it is not adequately connected to the main city- the introduction of 
the metro seemed like the biggest development the area had seen in a long time.  
26 This road junction was in the top two roads of Delhi in terms of accidents. 
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    I had first met Regis during my undergraduate research project and while physically he 
hasn’t changed much- the cockscrew curls, the lean frame with his famous footballer legs and 
bright eyes, it is clear running this NGO has taken its toll.  The current economic climate has 
meant that many of Sahai’s oldest projects including its famous rehabilitation center have had to 
downsize or completely shut their doors.  A large number of his old staff have either relapsed, 
died due to overdose/ HIV, or have moved to other organizations. During my fieldwork the NGO 
was not only undergoing its toughest financial crisis in years but also facing a crisis in its staff. 
 Sahai and Ashray have evolved into their present roles as harm reduction NGO’s through 
different routes – while Ashray has grown organically, Sahai has been a late entrant.  However 
on the ground both these NGO’s negotiate similar community conditions, structural barriers and 
stakeholder dynamics.  As I moved and worked between these two NGOs, I was able to meet 
hundreds of clients (a term that was commonly used to refer to drug users by the NGOs) who 
came everyday to both Ashray and Sahai’s centers in Nadi Nagar and Kharagpur.  It was through 
these relationships, interactions and stories that I began to see how “gestalts of recovery” and 
“environments of care” were created differently by each of these NGOs. 
 
Data Collection  
The first month of my fieldwork was spent in renewing old contacts, developing 
schedules with the NGO’s and making linkages with a variety civic society institutions, 
international organizations and activist groups.  While my previous relationships at both Sahai 
and Ashray were very helpful in gaining a foot hold in the NGO sites they were also surprisingly 
useful in opening doors in the policy arena.  The leaders of both Ashray and Sahai are well 
respected in the field and it was their goodwill that helped facilitate meetings with both 
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government and bi-lateral agencies.  Most policy officials and experts were extremely busy and 
found it challenging to given me enough time to discuss issues in detail, thus often leading to 
multiple meetings and many informal conversations.  After an initial set of interviews it was 
through a snowball and purposive sampling method that other specialists were identified.   
   Within the NGO context, the staff at both Ashray and Sahai were especially helpful in 
facilitating the initial interactions with the clients, guiding me through the community and 
keeping me safe.  While I realized that this may prevent clients from directly approaching me, it 
was the only way to negotiate these contexts.  Clients at Ashray were used to researchers and 
opened up to me almost immidiately talking about their addiction, critiquing Ashray and 
discussing their concerns.  The organization had a much larger space and open lay out that 
offered more opportunities to interact with clients informally.  At Sahai, clients were not really 
sure about my role and more slow to open up.  The daily routines and the physical lay out 
(especially the cramped space) allowed for little individual interaction with clients – without the 
presence of NGO workers.  A watershed moment was the time when the organization had to shift 
their premises a number of times.  These transitions provided a greater opportunity for 
interaction and helped me establish a relationship with many clients.  
    I had originally planned to spend six months with both NGOs, dividing my time in a 
week.  However upon reaching the field, I realized it would be more productive to spend three 
months in each site exclusively and gain a deeper understanding of the dyanmics of each NGO.  I 
would usually spend time until mid afternoon at the NGO site, by which time bulk of the client 
related work would be completed.  Both NGOs would shut down by 4pm, workers would spend 
an hour after that for paperwork.  During the afternoons I would set up appointments to conduct 
interviews with other stakeholders i.e. government officials, public health experts, lawmakers, 
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funders, bilateral agency experts etc..  On days when there were conferences, workshops or 
policy meetings I would prioritize those over visiting the NGOs.  Over the course of week I 
would spend approximately fifteen to twenty hours at the NGO sites.  The rest of the time was 
spent conducting interviews with stakeholders, attending conferences, workshops or meetings 
and collecting textual material. 
Methodology and Sampling  
In this section I will provide details about the methods used and sampling procedures to 
collect data. 
   Research question 1. How does the State, International Organizations and NGOs shape harm 
reduction? To answer the first research question I employed several methods: 
   Participant observation in policy settings.  Participant observation in policy settings was 
necessary to understand the actual processes, activities, negotiations and conflicts that gave form 
to the harm reduction policies.  As outlined before I conducted participant observation in a 
variety of policy settings and focused my primary attention on a few key players. 
   The stakeholders that I observed most closely included- the government bodies of 
National AIDS Control Organization as well as Ministry of Social Justice and Empowerment and 
their bureaucrats, the NGO’s Sahai and Ashray and their workers, as well as international 
organizations and donors, such as the United Nations Office of Drug Control (UNODC), The 
Joint United Nations Programs on HIV/AIDS (UNODC), and the Bill and Melinda Gates 
Foundation (BMGF).  I also paid attention to the participation and roles of civic society groups 
like People Living with HIV (PLHIV), Indian Harm Reduction Network and Lawyers Collective. 
All of these stakeholders were chosen due to their prominent role in harm reduction policy and 
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programming as well as their dominant presence within the New Delhi HIV-drug use sector. 
These stakeholders represented a diverse set of perspectives and points of view.  
   Within the policy context, I conducted participant observation where key stakeholders 
(NGOs, bilateral organization, civic society and government) converged to discuss harm 
reduction policy and interventions.  I attended NGO led and government sponsored training 
workshops for outreach workers, national conferences for injecting drug use, HIV and Hepatitis, 
where both government, bilateral organizations and civic society were represented, workshops 
conducted by technical experts, national coalitions of people affected by drug use and HIV as 
well as public health campaigns and advocacy group meetings. 
 Each of these settings provided unique opportunities to understand stakeholders’ views 
as well as actions with regard to shaping harm reduction policy, developing risk focused health 
strategies, new ways of thinking about addiction or recovery and adapting human rights to the 
discourse of harm reduction.  It was also useful to understand their relationship with other 
stakeholders.  
In each context that I observed I took special care to inform the facilitator about my role 
and permission to be present.  In some cases when this was not possible I informed the 
stakeholders I was observing, about my goals prior to the meeting.  Over time, most stakeholders 
had either met me or heard of my work and I no longer needed to explain my special presence at 
these settings.   Despite the large group of stakeholders involved, the key representatives who 
participated in these meetings remained relatively small and limited.  This made my task easier, 
as I was able to easily identify and track these stakeholders across a variety of contexts.  
   My role as a participant observer in these contexts was challenging. I would take 
copious notes about their interactions, affect, speech and body language. Even though I was 
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focused on these key stakeholders I would also make notes about other groups present at these 
meetings.  I paid attention to formal rhetoric and public discussions as well as informal 
conversations.  Throughout this process there were times when I could not take notes, but would 
do so after I returned home.  As I became more familiar with the stakeholders I began to notice 
patterns of interactions, specific agendas, cliques or alliances, specific stances, ways of 
communicating, power balances and hierarchies; special events, arguments, and negotiations 
were key areas of interest to me as a researcher, since it helped to especially highlight the 
stakeholders’ viewpoints. 
I also slowly began to participate more actively at some of these meetings, trainings and 
workshops, by actually engaging in discussions or group activities.  While I had developed 
individual relationships with each stakeholder, in these forums I had to appear neutral and not 
aligned to any one group.  This was not only a delicate balance of diplomacy and engagement 
but sometimes stressful due to the underlying tensions that existed between the stakeholders.  
   Participant observation in NGO settings. A crucial element of the participant observation was 
to understand the specific role of the NGOs.  I conducted extended participant observation at 
both Sahai and Ashray.  I was primarily working at the community project sites but also spent 
time observing the NGO workers when they attended policy meetings.  
    In order to fully understand the role of the NGO I roughly followed two groups of peer 
workers/NGO staff.  The first group of about four workers from both Sahai and Ashray were 
involved at the administrative, research and policy level work.  I would shadow them as went to 
policy meetings, conducted trainings, attended workshops and managed the harm reduction 
programs on the ground.  This group was educated, English speaking and belonged to the middle 
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or upper middle class socio economic group.  All these workers were men and were aged 
between 30-60 years. 
 The second group that I observed included eight key workers from both the NGO’s, who 
were involved in direct intervention on the ground.  I would observe this group of staff as they 
conducted their interventions (needle syringe exchange, counseling and outreach).  This group 
was largely composed of Hindi-speaking, semi-literate and belonged to the lower economic 
class.  This skewed sampled represented the composition of the group.  My sample group 
included one female but the rest were male, their age range was 20-50 years. 
   I chose members of each group of peer workers based on their willingness to participate 
as well as their role and position within the NGO.  The pace and routine of both these groups of 
peer varied and I had to constantly adjust depending on their schedules.  For the first group of 
workers there were no set routines and I was often asked to join them on a moment’s notice to 
attend a meeting or training.  The second group of workers had a much more clear set routine of 
certain activities within a day and I would follow them as they went about their activities.  
   All clients and staff knew my role as a researcher, though some did not completely 
understand its purpose.  I would usually take field notes during the time I observed and they even 
dubbed me as the ‘lady with the notebook’.  I took note of their manner of service delivery, 
interaction with clients and other stakeholders, involvement with the community, how they 
translated abstract concepts of harm reduction into practice and their stances within different 
policy contexts.  Whenever possible I would help in administrative tasks like taking down names 
and ages during outreach, compiling data for their annual report, help file paperwork, develop 
presentations and conduct a SWOT analysis.  
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   Semi-structured interviews with stakeholders. The semi-structured interviews were conducted 
with key members of each of the aforementioned stakeholder groups and other important 
stakeholders.  These members were chosen through snowball sampling.  The NGO heads 
provided a list of names and contacts of key people involved in harm reduction work within the 
capital.  I would usually contact them and set up an initial meeting to meet them and share about 
my work.  Following this meeting we would set up a mutually convenient time for a second 
meeting and interview.  I found that over the course of two meetings there was better rapport 
building and time to engage in a more detailed discussion of the issues at hand.  It also helped to 
clarify previously discussed concerns and validate previous comments.  In some cases where the 
participants were too busy to meet twice again I would have a formal interview and often follow 
up with an informal telephone call.  I would also talk with these stakeholders during the course 
of participant observation at various policy settings. 
The interviews itself were usually conducted in the offices of the stakeholders or in a 
private space.  The questions included the context of harm reduction policy, its history in India, 
the rationale behind these new interventions, the perceptions and concerns about harm reduction, 
the relationships with other stakeholders, the perceived benefits and problems with harm 
reduction.  The interview protocols are attached in the appendix.  Even though the questions 
were pre-formulated, I would usually include few follow-up probes based on the answers.  I also 
made certain adjustments in the questions depending on the person I was interviewing and based 
on their expertise/role.  As I went along the interview process I began to frame questions more 
effectively based on my previous experience.  The interviews lasted approximately for an hour to 
an hour and a half and were conducted in English and Hindi.  All the interviews were recorded 
and transcribed.   
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    At the end of each interview I would ask the participant to refer me to other 
stakeholders within the field.  I continued this process of sampling until I had reached data 
saturation i.e. the interviews were revealing no more new information.  I tried to meet with at 
least two members from each organization who worked at different levels within the 
organization.  Since harm reduction is fairly new and an emerging field the number of people 
working on this issue specifically are limited.  I was able to access most key national and 
regional leaders in the field through this process.  
    Semi-structured interviews with NGO workers. Similar to the interviews with the 
stakeholders, I conducted semi-structured interviews with NGO heads, project co-coordinators, 
out reach workers and counselors.  These interviews were aimed to shed light on the role of the 
NGO in promoting harm reduction both within the grounded contexts of practice and the policy 
contexts.  
    These members were chosen through both snowball and purposeful sampling.  I first 
asked the NGO heads to provide me names of key people within the organization that I could 
interview.  At the conclusion of those interviews, I asked for referrals to others within the NGOs. 
I also interviewed those peer workers with whom I conducted participant observation (both 
groups of peer workers) as well other key workers within the NGO.  Sample size was determined 
by the data collected i.e. once I reached data saturation I stopped conducting more interviews.   
    Since most of these workers were also ‘in recovery’ my questions explored not only 
their professional roles and views about harm reduction (especially issues around service 
provision, client relationships, funding concerns, community issues) but also their personal 
experiences.  These interviews were particularly helpful in clarifying my observations and 
understanding their actions.  By triangulating the data in this manner, I was able to gain a better 
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sense of their perceptions, rationalities, pressures and negotiations around what they called ‘harm 
reduction’.  Similar strategies were used around questions, probes, confidentiality concerns and 
question formulation, as discussed in the previous section. 
   Textual Data. I reviewed textual material -policy, legal and administrative documents related 
to harm reduction, newspaper articles, reports and policy briefs and NGO literature, to 
supplement my primary data and historically contextualize the research.  I collected this 
literature from the stakeholders’ offices and public libraries.  My sampling of this material was 
driven by questions generated in the observation and interview data and the research questions. 
Since there is very little scholarly work on drug related issues, the main data source is the in-
house research and reports of development agencies and NGOs.  I collected all key materials 
dating as far back as the early 1990s when the HIV epidemic first began.  
   Research question 2. How is harm reduction shaping the lives of recovering drug users? 
The methods employed to answer this question included:  
   Participant observation in NGO settings. Within the intervention context, I conducted 
participant observation with recovering drug users or the ‘clients’ of Ashray and Sahai.  I wanted 
to gain insight into the actual daily life struggles of clients and go beyond their words. 
Observation data is also a powerful way to both validate narrative data but also raise concerns 
that would have been otherwise ignored.  I observed the clients of the two projects of Ashray and 
Sahai as they accessed harm reduction services.  I focused on how they accessed the two main 
services - Opioid Substitution Therapy and Needle syringe exchange programs.  I paid attention 
to their actions, comportment, affect, talk, interactions with NGO workers and other clients.  
    I would take detailed notes to keep track of these interactions and though I could not 
take notes during outreach I made a record of the events upon reaching home.  I noticed both 
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short term and long-term changes- especially noting how those who participated in the programs 
enacted their recovery.  The process of participant observation was both tedious and 
enlightening.  While it was not always easy to keep track of the events in the NGO, considering 
the large number of people who came and complex number of activities that occurred almost 
simultaneously it also became an incredible source of information.  I was able to crosscheck 
assumption, challenge my own ideas and reveal discrepancies in the people’s thoughts and 
actions.     
The regular clients of these two programs were all male with only one female client.  The 
only time I saw other female clients was during outreach in the red-light areas of the city. 
However, since these women never came to the NGO for other services I did not include them in 
my study.  The clients ranged in age from 18-65 and belonged mainly to the lower middle class. 
Most of the clients possessed very little education and were without any formal form of 
employment.  Many had a criminal background (besides their use of drugs) and a large number 
were HIV positive. 
   Life history interviews with drug user clients.  In order to gain a deeper understanding of the 
lives of these clients, their trajectories of drug use, their current struggles with recovery, street 
survival and harm reduction I conducted life history interviews with clients of the two harm 
reduction projects.  The sampling procedure was both purposive and snowball sampling. Project 
heads first provided me a list of clients who they identified as ‘stable’ (can provide consent and 
understand the implications of their participation) and willing to participate in an interview. 
These clients had spent a minimum of two months in the program and a maximum of about two 
years. Since many clients were continuing to use drugs and had other mental health concerns the 
NGO heads were mainly responsible for recruiting.  After each interview I asked the client to 
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provide a referral to other clients.  After seeking the required clearance from the NGO head I 
would approach the new client asking them if they would like to participate in the study.  
    I would choose a secluded place to conduct the interview and would often sit with the 
client for more one single session.  These interviews would last for about one to two hours and 
were recorded and later transcribed.  These interviews began with a small set of probes the 
questions were driven by the narrative of the client.  The questions were focused on their 
experiences as a drug user, treatment issues, acceptance and understanding of harm reduction, 
problems with the NGO, community/family concerns and outlook for the future.  I also asked 
about their specific impressions of the services such as needle syringe exchange, outreach and 
OST.  I have attached an example of the protocol in the appendix.  After the interview I would 
continue interacting informally with the participants and keep hearing updates about their lives. 
These recorded interviews were later transcribed verbatim. 
Data Analysis 
     One of the crucial challenges in analyzing ethnographic data is to manage the vast 
quantity of data collected as well as evaluating, interpreting and theorizing.  During the first 
stage of this process I transcribed each interview verbatim.  This was a long process that 
continued over a few months and extended for about five hundred hours.  Since some of the 
interviews were in Hindi, I transcribed them in Hindi and later translated them for the purposes 
of this dissertation.  Transcribing and translation are often seen as the first step in the data 
analysis process.  This is because both of these procedures require a first level of transformation 
of data from oral to verbal.  During this process I was careful to make notes about the emotions, 
context of the interview and body language that provided the framework for this talk.  
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   Next, I analyzed these transcripts using strategies of both content and narrative 
analysis.  After multiple readings of each transcript I highlighted critical themes/concepts, using 
an emergent coding scheme (Denzin and Lincoln, 1994).  This process involved a close reading 
of the interviews, selecting key quotes that reflect important ideas related to our research 
question.  I paid attention to both overt and latent content i.e. focusing on participants’ talk and 
their intentionality.  I also made note about the overall patterns, ideas and focus of these 
narratives as a whole.  Since there were a large number of themes, they were further divided into 
specific domains.  
   During the second stage of analysis, I organized my field notes of observations. These 
notes were collected over eight months in a variety of different contexts.  I began by first 
identifying key events, special occasions and important transitions that were critical to my 
research questions.  Next, I highlighted the processes, long-term shifts and overall patterns that I 
had observed during my time in India.  I followed this by identifying key concepts that emerged 
and began to make connections to broader contextual factors as well as historical changes. 
Finally I made a matrix of key concepts, and ideas based on these observations to help me shape 
my theoretical arguments. 
   During the third stage of this process I reviewed the textual data to help fill in the gaps, 
provide a context and inform my ‘field knowledge’.  After completing all these steps of data 
organizing and analysis the next and final stage was focused on interpretation and theory 
building.  I identified key events, conversations, ‘thick’ descriptions (Geertz, 1979) and ‘analytic 
insights’ from field notes, identified and compared them with the specific thematic domains -to 
look for patterns, explanations and differences (between speech and activities).  These were then 
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interpreted and examined through specific theoretical frameworks such as drug studies, bio-
citizenship and the heath-development framework. 
The Drama of Ethnography 
 Ethnographic research is both challenging and conflicting; extended periods of 
engagement with communities can create multiple ethical and research dilemmas.  As a social 
worker, intervening and ‘improving’ social practices and behaviors define one’s role.  However, 
as an ethnographer it was important observe and balance one’s participation without always 
actively intervening.  This was especially challenging when I witnessed questionable social work 
practices and clients’ rights being violated.  Clients would also often directly seek me out to 
voice their issues with the NGO and its staff.  I couldn’t necessarily step in on all occasions and 
struggled on the appropriate course of action many times.  On certain occasions I spoke with 
Muquim (project head, Ashray) and Brian (project co-coordinator, Sahai) without blaming or 
naming the staff members, instead framing it as a concern of managing staff burnout, 
maintaining client adherence and rights of both parties.  
    At other times even though I clearly saw clients stash away their medication, I took the 
decision to neither stop them nor alert the staff  (for whom this was a major concern).  This was a 
difficult stance because I knew that they were injecting these substances that were likely to block 
their veins and cause severe abscesses.  However, I recognized that these practices were long 
standing and most likely would continue if they were forcefully stopped.  I did engage with 
clients on many occasions to discuss reasons around dosage, illicit use and safer practices.  
The only times I intervened actively in cases was when clients would directly ask me for 
help regarding abscesses, wounds or injuries that were either being ignored or given less priority 
by the NGO.  Often the over worked NGO staff would overlook clients’ health issues.  My 
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intervention would help redirect attention and address these concerns in a timely fashion.  This 
balance between staff and clients is delicate and it was important for me as a researcher to 
maintain good relations with both groups without compromising on values of either good 
research or basic humanity.  
Ethnographic fieldwork involves both a deep commitment to the concern and rich 
engagement with the community that does not end once the data collection finishes.  I continued 
to think about and communicate with some of my participants even after I left India.  The 
incompleteness of such a format of research opens up many possibilities for learning, revising 
and creating for the future.  
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CHAPTER 3: CRACKED WIDE OPEN 
Re-imagining, re-imaging, re-casting and re-cycling 
Repeat, Repeat, Repeat, Repeat 
Returning, refurbishing, refining and re-collecting 
Repeat, Repeat, Repeat, Repeat 
 
There was never a problem of Nasha (drugs) 
Only these people. 
There was never a problem of Nasha (desire) 
Only these people. 
There was never a problem of Nasha (addiction) 
Only these people. 
There was never a problem of Nasha (loss of consciousness) 
Only we people. 
We can only be free until we return to where we became entangled. 
(Moorthi, 2010) 
 
The advent of global diseases, advancements in pharmaceutical technology, growth of 
bio-medical knowledge and shifts towards diseased focused activism has fundamentally altered 
how states across the world respond and adapt in matters of health.  With increasing number of 
stakeholders participating in the actual policy making, programming and delivery of health it has 
become important, now more than ever before, to examine and understand these relationships 
between states (governments), NGOs (non-governmental organizations), civic institutions, bi-
lateral agencies, international development organizations and diseased communities.  In this 
chapter I chart out the historical conditions, social environment, political milieu and cultural 
processes through which harm reduction interventions have come to exist in India.  
 Once considered to be a peripheral response towards drug abuse, harm reduction has 
recently gained immense popularity and more formally been inducted into the national 
government’s strategy against HIV.  In many senses, harm reduction does not exist as an isolated 
paradigm of drug treatment in India.  It is subsumed under the behemoth political, social and 
economic structures and institutions created to fight HIV/AIDS in the country.  Hence to 
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excavate its presence and detail its actual impact on the people was quite difficult.  Yet, it is 
important to study harm reduction’s peculiar form in the Indian drug treatment context, due to 
the long term and far reaching consequences on health and polity.   
The harm reduction model in India is unlike any other the state has seen.  It functions as a 
shadow policy and health model that remains quasi-accepted and fluid.  Its emergence is the 
result of unique networks and collaborations of a globalized health sector that has grown despite 
contrary repressive policies governing addiction.  Unlike other national health interventions, 
harm reduction’s status highlights the liminal spaces where governance is negotiated and 
translated into programs for marginalized groups.  I inquire into the way the substance abuse 
problematic shaped.  What forces led to its construction and in what fashion was there a response 
generated?  
Over the course of this chapter I discuss the emergence of the paradigm of harm 
reduction.  Unlike other health programs in India harm reduction did not emerge from a top 
down approach.  In fact, I argue, harm reduction grew through the complex arrangements and 
networks between grassroots organizations and international organizations.  Later even though 
the government adopted this model, it remained in the shadow of the HIV policy struggling 
between competing philosophies and conflicting political stances.  Despite these contradictions 
and dynamics harm reduction has not only recast drug use as a national issue but also evolved a 
new approach to drug treatment and expanded its reach to multiple sectors and regions.  In this 
chapter I trace the historical conditions of drug use and HIV as well as the contemporary 
discourses of public health to make an argument about how harm reduction came to exist and 
what it reveals about governance and policy within modern nation states.  
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   Encountering the national drug problem. 
As I began my work in the field, one of my first tasks was to map the scope of drug abuse 
in India.  I quickly realized that this task was not simple, in fact numbers were deeply political 
and the contemporary drug narratives inherently contradictory.  In fact, whenever I spoke about 
my research to family, friends and colleagues in India, they expressed surprise asking- Do we 
even have a drug problem in the country?  While the occasional rave party, escapades of a 
famous film star or drug addicted teens catches the media’s attention, the national imagery of 
drug use continues to be largely in the context of crime- peddling, smuggling and narco-
terrorism; drug users are usually labeled as male, poor and migrant (Datta, 2010).  In the national 
imagery, drug use was considered to be an issue of the northeastern states of India.  Then why 
was I, a researcher in the U.S., even bothering to study this peripheral concern? 
 India has a long and complicated relationship with drugs.  Mythology, culture and 
customs richly document its heady presence in the psyche, affect, narratives and life ways of 
Indian communities.  But the more lasting and perhaps murkier narrative, as one of India’s most 
recognizable illicit exports, clearly overshadows any cultural references.  Today drugs can be 
easily procured in any narrow lanes of India’s crowded cities and small towns.  Every evening a 
car entered the parking lot of my upper middle class neighborhood in Delhi.  The three youth 
occupants spent a few hours using drugs and then sleeping, while its affects wore off- a scenario 
that was unthinkable a few years back.  These youths I learnt later, procure drugs from the 
neighboring slum areas, which was an emerging hotbed for all kinds of narcotics.  No longer are 
drugs bounded in poor and marginal spaces, they are quickly bleeding out into all spheres of 
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social life of the urban landscape in India.  The increased availability of drugs both licit and 
illicit then makes drug use a uniquely hidden issue, one that is very much in plain sight. 
Historically, opium and cannabis were used in many parts of India.  They were both 
culturally accepted and socially ritualized.  Their availability was especially aided by the fact 
that geographically, India lies between the highest opium producing regions of the world, the 
Golden triangle (Laos, Myanmar, Cambodia, Thailand) and the Golden Crescent (Iran, 
Afghanistan and Pakistan) (UNODC, 2005).  India is also one of the world’s largest producers of 
licit opium, a large portion of which is diverted to the illicit drug markets of cities like Delhi and 
Mumbai (Machado, 1994).  Opium was generally consumed unrefined within the Golden triangle 
till the 1940s (heroin was unavailable).  Opium was exported to the laboratories of Bangkok, 
Hong Kong or Marseilles to be processed into heroin (McCoy, 1972).  However over the last few 
decades, the transforming geo-politics of the region forced heroin refinement laboratories to 
move closer to the opium fields27.  The Burmese military cracked down on dissident ethnic 
groups involved in heroin production and alternative routes to the lucrative western markets 
arose.   
These new overland routes from Myanmar to Yunnan Province of China and then onto 
Hong Kong crossed into the northeastern states of India (particularly the north -eastern states of 
the country. Assam, Meghalaya, Sikkim, Tripura, Arunachal Pradesh, Manipur, Mizoram and 
Nagaland28), bringing drugs to the country’s doorstep (McCoy, 1991).  India also became a 
major port for drug trade to the west after the revolution in Iran.  Other factors like improved 
laboratory techniques in previously “cultivating only nation” and the availability of cheap 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
27 Since Heroin takes up less volume and is easier to hide than opium and this transition decreased the costs and 
chances of detection. 
28 The last four states share a common international border with Myanmar, the world’s second largest illicit opium 
producing country. 
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production chemicals aided the introduction of abundant and cheap heroin into south Asia, 
especially in India (McCoy, 1991).  
Not only did drugs flow easily through these international borders, the injecting drug 
using epidemic also become widespread by the 1980s (UNODC & Ministry of Social Justice and 
Empowerment, 2006).  National apathy towards this region, added to a lack of information about 
drugs and disease 29 further compounded the issue.  Brown sugar, a cheap derivative of Heroin, 
cost about Rs. 30 per gram (around $ 2 dollar), it soon replaced opium and cannabis as the drug 
of choice (West, 1992; Dorabjee and Samson, 1998).  Most users ‘chased’ or inhaled heroin, 
injecting drug use was not common during these early years, since the purity of the drug was 
high.  In Delhi, hospital data indicates a 60% increase in the demand for drug treatment during 
1980 and 1984, which is attributed to increased availability of heroin due to this transit traffic 
(Dorabjee and Samson, 1998).  The emergence of brown sugar in the market led to an increase in 
its addiction among the low -income group across the country (Jiloha and Sain, 1992).  
However the major change in drug use pattern occurred when India enforced the Narcotic 
Drugs and Psychotropic Substances Act (NDPS) in 1985, based on the Single Convention of 
1961 (U.N.).  Countries such as the U.S. via the U.N. forced (with the threat of withdrawing aid) 
many developing nations to change their national strategy in keeping with ‘international 
conventions’ (Dorabjee and Samson, 2000)30.  Until the early 1980s opium was available to 
registered users from Government of India authorized shops (Dorabjee and Samson 2000). But 
under the new restrictive law there were severe sanctions placed on both using and cultivating 
illicit opium. The U.S. global ‘War ON Drugs’ had found a new frontier.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
29 It was not until 1989 that as a part of a national study an assessment of drug abuse, drug users and drug prevention 
centers was carried out in Dimapur (Nagaland), Imphal (Manipur), Guwahati (Assam) and Shillong  (Meghalaya). 
30 India is a signatory to three UN Conventions- Convention on Narcotic Drugs, 1961; Convention on Psychotropic 
Substances, 1971; Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. 
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    The NDPS Act shaped a criminal regime, punishing all aspect of drug use- “with 
extraordinary powers of enforcement, diluted rules of evidence, included presumption of 
culpability and reversed the burden of proof” (Tandon, 2008)31.  This Act was modified in 2001 
to include provisions like different legal sentencing for possession versus consumption and 
options for treatment instead of jail – more humane sentencing for dependent drug users 32. 
Section 71 of the Act however also empowered the government to establish drug rehabilitation 
centers for those who needed medical attention. Other provisions included: 
The Government may, in its discretion, establish as many centers as it thinks fit for 
identification, treatment, education, after-care, rehabilitation, social reintegration of 
addicts and for supply, subject to such conditions and in such manner as may be 
prescribed, by the concerned Government of any narcotic drugs and psychotropic 
substances to the addicts registered with the Government and to others where such supply 
is a medical necessity. 
           The Government was clearly working with a punitive or medicalized perspective towards 
drug use, in-line with global practices and knowledge.  Jared Richards (research head of NGO 
Ashray) discussed some of the implications of criminalization with me: 
When the NDPS act was first enforced the user if he got caught with any amount of 
drugs, (he) would immediately pay for it 10 years- non-bailable offence, now its okay- if 
its a smaller amount he is sent for treatment or lesser sentence- one of the points we had 
to argue for that was putting the guy into prisons doesn’t really help because your cost for 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
31 Raju v. State of Kerala AIR 1999 SC 2139 where appellant was sentenced to 10 yrs & Rs.1 lakh fine for 
possession of 100 mg heroin worth Rs. 25. Absence of withdrawal seen as evidence that accused not drug 
dependent. Supreme Court held such small quantity could not have been meant for sale. 
32 However these ‘lighter punishments’ have not necessarily decreased police brutality and violations against drug 
users or clarified who and when immunity is provided to drug users. Moreover, the treatment options provided as an 
alternative to jail term are restricted to traditional abstinence treatment centers and do not include harm reduction 
interventions.    
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prison is much higher than our cost for keeping him in the DIC (Drop-in center)- the legal 
proceedings cost a hell of a lot, number four your not helping him in the prison- your 
looking at a closed environment lot of people, TB is rampant, Hepatitis B, is rampant- we 
are not helping anybody (from a public health perspective as well)… 
Efforts to curb the heroin supplies through the NDPS resulted in “heroin droughts”, 
leading to a sharp hike in the street price and lower quality of brown sugar (Dorabjee and 
Samson 1998).  Drug users found a more cost effective way of getting the same ‘high’ shifting 
towards injecting drug use.  Mixing of injecting drug users (IDU) with non-injecting users 
further popularized injecting drug practices among peers (Manning, 2001).  Anecdotally drug 
experts also cite another reason for the transition towards injecting drug use.  Faced with 
agonizing withdrawals, many heroin dependent users sought medical assistance.  This assistance 
included the administration of the injectable form of Buprenorphine (BP), a pharmaceutical 
substitute for heroin (Kumar 1997; Panda and Chatterjee 1997; Dorabjee and Samson 1998).  
Drug users realized the benefits of this new drug33 and by the late 1980s and early 1990s 
injectable BP gained popularity, becoming a huge epidemic in the big cities (Nizamie & Sharma, 
1990; Biswas, 1994; Dorabjee 1994; Panda and Chatterjee 1997).  The Government attempted to 
monitor and control abuse of BP by removing the tablet form from the markets, making it 
available only in select rehabilitation centers / hospitals.  However, the injectable form of the 
drug continues to be available in pharmacies and the pills are easily procured in the black 
markets.  By 1992 injecting drug use had spread and established itself all across the nation 
(Sarkar et al., 1991; Kumar and Daniels, 1994; INCB 1996; Bhardwaj, 1995) .  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
33 There were many reasons why drug users preferred this BP to heroin33. It took care of their withdrawal from 
heroin; this legal drug was easily available in pharmacies; it was also one-fourth the cost of heroin; clinically it was 
much safer- unadulterated, manufactured with strict quality control and had little potential for an overdose. 
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   After the 1980s drug use emerged as a significant trend across many states in India 
even though alcohol still is the most widely abused substance.  The injecting epidemic in 
particular saw a sharp rise in the early 1990s coinciding with the spread of the terrifying HIV 
epidemic.  The most recent estimates of drug use are based on the National Survey conducted by 
United Nations Office on Drugs and Crime (UNODC) and Ministry of Social Justice and 
Empowerment in 2001-2002 (UNODC & Ministry of Social Justice and Empowerment, 2004).  
The National Survey34 estimates 73.5 million persons are dependent on substance in India alone, 
of which 62.4 addicted to alcohol, 8.75 million are cannabis users, 2.04 millions are opiate users 
and .29 million are addicted to sedative hypnotics. . The survey also indicated that other drugs 
such as Sedatives/Hypnotics, volatile substances, Hallucinogens, Stimulants and pharmaceutical 
preparations were also abused.  While the proportion of drug users is still very small compared to 
the general population of over one billion, most experts believe that these numbers under 
estimate the exact extent of the problem. As the sample size was small (40,697 males only), the 
estimates can at best be taken as a broad approximation of the total numbers.  
   For more current data I had to rely on rapid assessments (small surveys with limited 
samples) conducted in different regions with drug using populations.  Rapid assessments in 
Punjab and Haryana reveal rising rates of drug use in these states (UNODC, 2009).  A rapid 
situation assessment (RSA) was also carried out in 2005-06 in India by UNODC in drug 
treatment sites across the nation. 5800 drug users participated in this survey (93% males and 7% 
females).  It was found that 80% used alcohol, 76% used cannabis, 76% used injectable 
Buprenorphine and 76% used heroin by injection.  70% were smoking heroin and 64% used 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
34 This National survey took the combined inputs of the National Household survey on drug and alcohol abuse 
(conducted in 2001), the drug abuse monitoring system (DAMS), rapid situation assessments and thematic studies 
together to provide these estimates. 
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propoxyphene, 78% of this sample switched from non-injecting to injecting use, with 51% 
reporting sharing behavior (UNODC, 2007).  
Current research suggests that extensive use of heroin and pharmaceutical drugs is on the 
rise in major cities including my field site of New Delhi (UNODC, 2007; Datta, 2010). 
Approximately 14% of injecting drug users in Delhi is HIV positive, an extremely high statistic 
compared to less than 1% adult prevalence rate (NACO, 2010).  Most drug users are male, 
belonging to the lower socio-economic strata and a large proportion are homeless (UNODC, 
2005).  Drug use in India continues to be a male phenomenon, a rapid assessment survey carried 
out in 2001-02 showed that an average of 7.9% of women used drugs and about 7.5% women 
were using in Delhi (2.8% were injecting drug users).  Majority of drug users are illiterate, a 21% 
literacy rate overall but Delhi and few other metropolitan cities (including north east states) have 
a higher literacy rate of about 44% (MSJE & UNODC, 2004).  Poverty, lack of employment and 
homelessness are the main concerns for most drug users across the nation (UNODC, 2005).  In 
the north-east states, though (unlike the rest of the country) most drug users are home based, 
their struggles are around issues of employment and resources (UNODC & MSJE, 2006). 
When I concluded my fieldwork in Delhi in April 2009 there were no updated estimates 
of drug use and treatment, the situation has not changed even until I submitted this dissertation, 
in late 2010.  Overall there are two key factors one must consider in examining this issue of 
numbers and the problematic of drug use.  First, is the lack of accurate and reliable estimates for 
the issue of drug use within India.  There are large gaps in our knowledge about the exact nature 
of how many people are using, what and how do they use, demographics and life circumstances 
impacting their use.  This has partly to do with the nature of the concern – drug users tend to 
remain at the margins of society, often difficult to access.  Most data about drug users is 
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collected through treatment and detoxification centers.  This skewed sample is then used to 
extrapolate for trends in the larger population, creating a margin for error and problematic 
assumptions.  Often times NGOs and international organizations carry out small surveys and 
independent mapping exercises.  Usually, these are restricted to the heavy drug using regions and 
urban centers like Delhi, Mumbai and Kolkatta.  These small studies help to provide a quick and 
textured picture of emerging drug use issues across the country, though again must be viewed 
with caution.  Also a large part of the data collected within the country is linked to the United 
Nations drug database.  In fact, it was challenging to find detailed national level data about drugs 
and drug use independent of the UN system35.  Despite the deficiencies this data was quoted 
widely, referenced and used by all agencies to support claims of the emergent injecting drug 
epidemic. 
    Second, some public health experts claim that this paucity of accurate estimations 
reflects, a much broader issue, the way drug use is perceived both by law -makers and the society 
at large.  For the longest time, drug use was treated as somewhat the stepchild in the social 
sector- experts believed that substance abuse was not a national problem of importance.  The 
statistics while shockingly large in absolute numbers are still proportionately impacting a much 
smaller population and in a country of whose development agenda is firmly dominated by 
poverty, unemployment, education and basic nutrition, drug use seems almost a luxury concern, 
one that could easily wait its turn.    
Today, though awareness around drug use has certainly improved, as I suggested at the 
start of this section, the public perception of drug use is still vague and there is a tendency to 
undermine the issue.  The notion that drug use is in fact a national problem, that is both directly 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
35 There are many smaller studies that report drug use prevalence and incidence but none of these comprehensively 
can provide a national picture. Most of this UN data is however collected with the help of Government of India 
(various ministries) and local NGOs. 
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and indirectly impacting a large number of people in social, psychological and economic terms is 
still not widely acknowledged.  Drug use has only recently and perhaps a little reluctantly been 
acknowledged as a national problem.  Its ascent in the funding and development agenda can be 
almost solely attributed to the associated risk of HIV. 
   An epidemic on the rise, the early responses.  
Manipur state AIDS Control Society has accorded the title of Brand Ambassador of 
HIV/AIDS to Mr. Khundrakpam Pradipkumar, recently crowned Mr. Manipur (60 kg 
wt), who has been living with HIV for over a decade now.  His mission as an 
Ambassador is to take a leading role in spreading HIV/AIDS messages to people, 
particularly the PLHAs to motivate them to ‘live and achieve’ even with HIV in them. 
Pradipkumar’s journey from a CD4 count as low as 16 in February 2000 to being 
crowned the best body builder of the state in his category in 2007 is indeed a message to 
the thousands of PLHAs in the state that ‘being HIV positive is not the end of the world’. 
Besides his courage and endeavor, Pradipkumar’s success is attributed to the invention 
of  Ante- retroviral Therapy (ART), which he has been receiving since 2000.  His CD4 
count by July-August 2007 reached 367.  He is a member of the MNP+ (Manipur 
Network of Positive People), an enrolled client at ART centre and an inspiration among 
the fellow HIV positives of the state  (Manipur State Aids Control Society website, 
Retrieved 2009). 
A brand ambassador for a deadly disease – seems at once appalling, empowering, and 
novel.  Later, the profile very briefly mentions that Pradipkumar had been an injecting drug user. 
He had started using drugs at the age of 13.  A large part of his youth he had spent injecting 
heroin (no. 4), taking tranquilizers, cough syrups and popping pills.  Before HIV, it would be 
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unthinkable for an injecting drug user to be featured as an ambassador on a government website. 
It is a testament of HIV’s powerful ability as a disease, to shift entire narratives of drug use- 
making the illegal and problematic drug history visible and permissible through a new prism. 
Drugs became all but a prologue to Pradeepkumar’s main heroic chapter as an AIDS mascot.  It 
is this very kind of uneven association that that marks the broader history of drugs and HIV 
within the country.  
Currently approximately 2.5 million people in India are living with HIV/AIDS (World 
Bank, 2010).  Estimated adult prevalence in the country is .34%  (males -.44%, females-.23%). 
87% of HIV infections are still occurring through hetrosexual routes of transmission while parent 
to child infections are about 5.4%, injecting drug use at 1.6% and men who have sex with men 
1.5%. (NACO, 2010).  India is experiencing ‘a heterogenic epidemic’ i.e. its patterns are diverse 
within a large nation like India36 (NACO).  In six states Maharashtra, Tamil Nadu, Andhra 
Pradesh, Manipur and Nagaland the rates of HIV are four to five times higher than the rest of the 
country (NACO).  Within some groups it is a ‘concentrated epidemic’ with a very high 
prevalence among injecting drug users IDU -9.2%, men who have sex with men (MSM)- 7.3% 
and female sex workers (FSW)- 5.4% (NACO).  Other high-risk groups include transgender 
(TG) and bridge populations like migrants and truckers.  Trends from global and national level 
agencies show that these groups contribute to 75% of infection in Asia (UNAIDS, 2008). 
In 1986 India’s first case of HIV was diagnosed among sex workers in Chennai, Tamil 
Nadu (Simoes, 1987). By the end of 1987 of the 52,907 people tested 135 were found to be HIV 
positive and 14 had AIDS (Kakar & Kakar, 2001).  The northeastern states of Manipur, Mizoram 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
36 Among IDUs, Maharashtra (24.4%), Manipur (17.9%), Tamil Nadu (16.8%), Punjab (13.8%), Delhi (10.1%), 
Chandigarh (8.6%), Kerala (7.9%), West Bengal (7.8%), Mizoram (7.5%) & Orissa (7.3%) have shown high 
prevalence of ≥5%. Trends among IDUs are on a decline in Manipur, Nagaland and Chennai while there is a clear 
rise in Meghalaya, Mizoram, West Bengal, Mumbai, Kerala and Delhi (NACO 2008). 
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and Nagaland37 were the worst affected in terms of the HIV epidemic (Panda, 2002).  There was 
both genuine fear and lack of knowledge, both about the disease and the systems needed to 
manage it.  Dr Ghosh (1986), a prominent public health specialist voiced some of these concerns 
at this time:  
Unlike developed countries, India lacks the scientific laboratories, research facilities, 
equipment, and medical personnel to deal with an AIDS epidemic.  In addition, factors 
such as cultural taboos against discussion of sexual practices, poor coordination between 
local health authorities and their communities, widespread poverty and malnutrition, and 
a lack of capacity to test and store blood would severely hinder the ability of the 
Government to control AIDS if the disease did become widespread (1986).  
HIV/AIDS, it seemed would expose the many weaknesses of the Indian public health 
system –poor rural health, the failures of the blood bank system, poor monitoring of health 
programs, lack of focus on nutrition and general health, mismanagement of resources, difficulties 
in accessibility as well as prohibitive costs of health.  Dr. R.V. Ramalingaswami, former director 
general of the Indian Council of Medical Research, in a Time magazine article in 1986, 
articulated the national sentiment at the cusp of this pandemic, “we in India have been shaken 
and face a moment of truth” (Pierce, Pratap & Vollers, 1986).  
 This account of the early phase of harm reduction would be incomplete without the story 
of Manipur and the northeast states of India; not only, were these states be considered the 
birthplace of harm reduction intervention in India, but Manipur was also the first state to include 
harm reduction in its state policy in 1996.  The experiments in intervention, policy and 
interactions between stakeholders that occurred in these regions, became blueprints for the harm 
reduction model at the National level, much later.  Due to fieldwork commitments in New Delhi 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
37 Manipur and Nagaland are high prevalent states in the country in terms of HIV. 
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I could not travel to the north-east and no clear document trail existed, it was through interviews 
with living activists and public health experts (many have succumbed to HIV and others have 
moved organizations, countries or professions) that I began to piece together this early history of 
harm reduction in the country.  As with most histories it was ridden with conflicting information, 
conflation and gaps.  And as with most memories ordinary people became heroes while others 
disappeared all together in the narratives.  These are some of those histories. 
The state of Manipur was one of the worst hit by the early wave of the epidemic, poor 
health infrastructure, high rates of drug use and the paucity of knowledge created a deadly recipe 
for a crisis.  The first case was detected in 1989 and injecting drug users (IDU’s) were the first to 
be impacted.  Injecting drug users are at a high risk for both being infected and passing 
HIV/AIDS because of frequently sharing of injecting equipment as well as engaging unsafe 
sexual practices in the broader context of poverty, stigma and marginalization (Golub, et al., 
2007; Rhodes, Singer, Bourgois, Friedman & Strathdee, 2005).  But it was a study published 
soon after that sent shock waves through the community and in the power corridors of the state.  
A group of drug users were tested for HIV without their consent, not only did more than half test 
positive, but also their names were published in the local newspapers.  
   Dr. Khom, who works with Emmanuel Hospital Association (EHA) a prominent HIV 
coalition, recounts these early days:  
I was working the state government of Manipur public health officer in a district of 
Churachandpur district – when the epidemic started … since then Manipur was also 
identified as a potential hotspots or an or epicenter.  The government of Manipur at that 
point of time set up a surveillance unit as a part of the public health group…in 
collaboration with ICMR (Indian Council of Medical Research) office in Calcutta…we 
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used to collect samples of injecting drug users and sex workers … few of the samples 
collected were positive that’s when all hell broke loose kind of thing there was a 
‘tamasha’ (Hindi word meaning commotion) in the (legislative) assembly, they 
(demanded) the list of the names (of HIV positive patients).  
More than half of all injecting drug users within the state had become positive in the year 
following the detection of the first case.  The HIV prevalence rates in the state shot from 0-80% 
in a matter of few months (Prakesh, 1996; Sarkar, Chatterjee, McCoy, Abdul-Quander & 
Metsch, 1996) 38.  
    Some of the earliest responses to the epidemic came from the grassroots.  NGO’s like 
SASSO in Manipur, began to realize that alternatives to the abstinence-based approach were 
needed.  Until now, the only treatment approaches for drug users included rehabilitation and 
detoxification services.  Moreover, some of the abstinence- focused centers, particularly in the 
northeast, were notorious for using force and treating drug users in an inhumane fashion.  They 
also had a high rate of relapse and required a long commitment from the both the drug user and 
their families.  In order to understand the scope of the issue and community needs, the NGO’s 
and international organizations began to conduct mapping studies. Dr Khom shared:  
When we did those studies that’s when we had a lot of interaction with the communities 
and again and again what we heard is that you know harm reduction… we need to be 
protected you know, (they were) very scared of getting (HIV) infection, I mean we need 
to be protected-what is that you can do for us and that’s when we said we are willing to 
do this (harm reduction), if this is something that is going to help…. sure we are willing 
to do it so without necessarily going to wait for a policy from the government… 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
38 Today the state has hardly .2% of the country’s population with almost 8% of HIV positive cases in the country 
(Manipur State Aids Control Society, Retrieved 2010).  
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These early efforts at harm reduction functioned in a quasi-legal space, in that, there were 
no laws or policies supporting these actions.  Dr. Khom highlighted that some of these programs 
began by small independent NGO’s who were simply responding to the crisis they were 
witnessing on the ground. Farahana Dastor, a civil rights lawyer also noted that:  
Harm reduction in India basically took roots within the community with say a handful of 
by a handful of organizations that were set up by drug users themselves and worked with 
drug users in slums.  They were having just start up programs or just services without 
really thinking about its legality or how they are going to continue it or how they are 
going to sustain.  They (did so) without much planning, piloting or scientific background, 
but nonetheless what was important was that it was rooted from the ground, it came from 
the bottom up rather than the other way around.  And secondly, it was about courage 
about strong action, which people thought was needed and without really waiting for 
approvals from x,y, and z, realizing the urgency of the situation and getting things on the 
ground.  But having said that it also affected the manner in which other formal agencies 
like the state or other institutions, which dealt with drug use and drug dependence took 
to, harm reduction – harm reduction was then quick to be dismissed as some thing on the 
side, not really a matter of larger public health concern. 
Sakhin, head of SASSO (prominent NGO in the northeast) recalls, “We didn’t know what 
we were doing was harm reduction, but we were already doing these things”.  He told me that 
before the epidemic most of their focus was on “getting clean, but the relapse rates were very 
high and there was fear (and shame) in going back to the center”.  In fact, SASSO began with the 
“collective effort to stay clean (from drugs)”.  Simultaneously, they believed it was important to 
“remove stigma and not just be considered as a useless person, who is not able to do anything, 
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instead focus on helping the community and the people who are there”.  To emphasize this latter 
element, the SASSO members would clean roads, clear garbage, and participate in community 
activities.  They also brought awareness to the plight of drug users through street plays and 
campaigns.  Dr. Khom added that these peer outreach groups “would distribute (clean drug) 
paraphernalia, (conduct) bleach and teach programs, (provide) distilled water, spirit and things 
like that and interact with the drug users”. 
Sakhin highlighted that “one of the biggest challenges we have is that we are living 
(north east) in the conflict zone where you know lots of insurgency groups are there and apart 
from that pressure groups is very strong out here”.  Many of these groups would take violent 
action against people who were identified as drug users. For instance, they would cut off a drug 
user’s limbs or threaten their families.  Drug users were thus underground, afraid to seek help, go 
into recovery or even accept clean injecting equipment.  They were more likely to share 
equipment in the shooting galleries (drug using spots) and contract HIV or other blood borne 
diseases. Sakhin stated:  
In the initial stage there were comments/ feedback from the community people, saying 
that you guys are encouraging the user community to use drugs...we had a series of 
meetings …only after that slowly people realized and began to accept both drug users and 
harm reduction. 
Another key effort during this period included the establishment of one of India’s first 
needle syringe exchange programs in Manipur, in 1995.  This collaborative effort was sustained 
by the research and financial support of Aus Aid, the technical expertise of the Macfarlane 
Burnet Center as well as the guidance of local public health experts.  This led to the formation of 
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Shalom (Society for HIV/AIDS and Lifeline Operation in Manipur), which grew into the 
region’s most well respected drug-HIV organization.  
Back in Delhi, Ashray had at the same time decided to experiment with small-scale 
needle syringe initiatives, in the drug-ridden parts of the city.  The Bangladeshi illegal migrant 
population had brought with them the injecting epidemic and many drug users were dying 
because of untreated abscesses and HIV.  Owen D’ Souza (Ashray head) also used his own funds 
to begin opioid substitution therapy using oral Buprenorphine.  “At that time, no one wanted to 
fund us”, he told me with a smile.  Today of course, in hindsight, he realizes the risks he took in 
launching the program without any visible support- financial, technical or administrative.  Jared 
Richards the project head of Ashray also shares some of the experiences of these struggles:  
It took a long time it took approximately 12-14 years of lobbying with the government on 
harm reduction. (But) we had to convince ourselves first, we didn’t come into the picture 
with the belief that it works.  So in 1992 informally we started our own pilot with 
Buprenorphine (an Opioid substitute), then we expanded it into a full-fledged project in 
1993.  Our head we had this idea that there people on the street who don’t’ want to quit 
and we are not helping them by taking them out of the environment and putting them into 
rehabs which is what we were doing and he read about this drug called Buprenorphine 
and he said lets try it out and we did.  We started very small the first pilot maybe had 
about 10 people on it and then when it worked- when we found that it was well accepted 
people liked Buprenorphine instead of going to their pusher for heroin, jobs were being 
stabilized and people just had a healthier lifestyle, then we extended it up. 
“We became the translators of harm reduction to the drug using communities”, shares 
Owen. SIDA and local drug experts like Dr. Khom and Dr. Talukdar were instrumental in 
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shaping these programs39. By the middle of the 1990s, the non-state harm reduction interventions 
finally began to garner the government’s attention.  Dr. Khom recalls, “We published, so we got 
lots of publicity before we know it…. a lot of questions were (being) asked to the state 
government- what’s happening (about harm reduction). They (Manipur state government) had to 
say that it is a good practice (since it was more successful than any other intervention)”. He 
specifies that they kept calling it a “model intervention” or “pilot project”, since they were 
functioning outside the legal boundaries. It also kept their work from being slotted into any 
specific pre-existing scheme and program. They presented their work in a number of conferences 
across Asia and other countries became interested in these harm reduction efforts in India; this 
helped to generate both support and funding.  
As Dr. Khom puts it, “It has been a long journey of harm reduction… of selling the idea 
of harm reduction”.  The roles of NGO’s like Ashray and SASSO, international agencies like 
WHO, UNDCP as well as bilateral organizations like DFID, NORAD, Aus Aid (Australian 
Government’s International Development Agency) and SIDA (Swedish Government’s 
International Development), emerged significant in this early phase of harm reduction.  These 
harm reduction efforts began on a small scale in the northeast and metropolitan cities of India 
and over time grew to other parts of the country. Overall this early phase of harm reduction is 
mainly marked by the collaborations of NGO’s, international organizations and bi-lateral 
agencies40. Though NGO’s saw their own role as crucial one cannot discount the role played by 
these bi-lateral agencies. While NGO’s on the ground were engaging in harm reduction activities 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
39 Ashray during this period approached Oxfam, who already had programs in the north-east states and asked for 
their support in helping SASSO expand their programs of harm reduction. With Oxfam’s support and Ashray’s 
technical expertise, SASSO was able evolve its own program. They conducted a situation assessment followed by a 
sensitization and awareness program focused on harm reduction. 
40 Since I was not able to gain the perspective of the officers from SIDA and Aus Aid (both agencies have since 
stopped their harm reduction programs) my understanding of these years was based solely on the views of the NGOs 
involved. 
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without necessarily labeling it so, the bi-lateral and international organizations were participating 
more purposefully drawing on the global harm reduction paradigm to shape these local efforts. 
These programs were able to do a couple of key things. First they were able to devise unique 
programs that suited local needs with incredible regional diversity. Also, their flexible funding 
structures and well-endowed funding pools allowed these agencies to develop well-designed and 
comprehensive programs.  They were not driven by funders’ specifications rather grew from the 
ground up, remained dynamic and evolved as community needs changed.  Second, the bilateral 
agencies had specific expertise in harm reduction and thus were able to draw in both technical 
and financial support for these projects from both within and outside the country.  Harm 
reduction was well established in many western nations and these bilateral agencies were able to 
bring in those practices to bear upon the Indian context.  The Indian NGOs were able to adjust 
and reformulate some of these strategies into their own harm reduction work creating a hybrid 
model. Third, these projects, though small, were not only able to demonstrate the viability (and 
issues) of harm reduction in India but also brought forth the nature and extent of drug use within 
the country.  Even though HIV was became a central organizing feature for these services. 
Fourth and finally, they paved the way for introducing a greater participation of transnational 
organizations within the Indian health policy –practice context, which had the potential to 
transform the harm reduction space in India.  
   Government responses- the evolution of the harm reduction paradigm.  
In 1986, shortly after the first case of HIV was detected, the government responded by 
constituting the National AIDS Committee (NACO, 2005).  Established under the Ministry of 
Health and Family Affair the program’s principal activity was limited to monitoring HIV 
infection rates among risk populations in urban areas.   The National AIDS Control Program I 
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was launched a few years later in 1992 and lasted until 199941 (NACO, 2006).  It was the first 
large-scale public health effort to prevent the spread of HIV.  The main goal was to co-ordinate 
the national response towards HIV, raise awareness and improve surveillance (NACO, 2006).  
The National AIDS Control Organization (NACO), a semi-autonomous body was formed the 
same year to oversee this national effort. This effort was aimed at slowing the spread of HIV 
infection 42 (NACO,1999).  This plan established the administrative and technical basis for 
program management and also set up State AIDS Control (SACs) bodies in 25 states and 7 union 
territories (NACO, 2006).  During this policy period public information campaigns were started 
to address stigmatized/taboo topics like sex, drugs and sexuality.  The National Blood 
Transfusion policy was launched as well as the entire blood bank system was revamped, the 
sentinel43 survey was instituted to monitor prevalence (Kumar, 2008).  STD clinics were set up 
and new drives to promote condoms were initiated as a part of this policy initiative (NACO, 
2005). 
    Several international donors such as the UK Department for International Development 
(DFID), the Norwegian Agency for Development Cooperation (NORAD), USAID, the Ford 
Foundation, the International Development Association which is a wing of the World Bank, the 
United Nations Development Program (UNDP), and the United Nations Drug Control Program 
(UNDCP), agreed to support the NACP (Kumar, 2008).  The final estimated cost of NACP-I was 
US$27.5 million from the government of India, $2.2 million from the WHO, and International 
Development Agency credit of $84.2 million (Kumar, 2008).  The government, at this point, was 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
41 This first phase was extended to 1999 when it was realized in 1997 that barely half of earmarked funds had been 
utilised. 
42 It focused on initiating a national commitment, increasing awareness and addressing blood safety. It achieved 
some of its objectives, notably increased awareness. Law banned professional blood donations.  
43 These are described as “sentinel” because they are meant to indicate trends, not provide comprehensive 
information. Blood samples collected from the sentinel sites are tested for HIV to give a “snapshot” picture of HIV 
prevalence in those sites. 
	   103	  
still trying to understand the disease and constitute an effective response.  Harm reduction, was 
not even acknowledged by the government formally and neither was it fully understood. 
Around 1994-95, the Government supported All India Institute of Medical Sciences 
(AIIMS) began its own efforts at harm reduction. AIIMS is India’s premier academic and 
teaching institution.  Their drug treatment hospital is functional both as a clinical service 
department and academic institution.  Funded by the Ministry of Health AIIMS, has played a 
critical role in shaping the national drug abuse control program.  Using a medical model they 
were keen to apply harm reduction intervention for both alcohol and drug use.  Their efforts were 
mainly focused at testing Buprenorphine maintenance and developing broad guidelines and a 
protocol for treatment.  Dr. Chatterjee, the head of the drug treatment center at AIIMS, shared 
that during this period they tried to convince the government to expand Buprenorphine 
maintenance to heroin users.  However, the government and the Narcotics Control Bureau (in-
charge of trafficking and supply reduction) were squarely opposed to such a recommendation. 
AIIMS continued its efforts offering scientific evidence and participated actively in national 
meetings to share their perspective.  Though they remained closely linked to the government’s 
efforts in shaping policy over the next decade, their impact was limited in the larger community 
context, especially in terms of activism and advocacy.      
Until 1997, a strong denial persisted among decision makers of the existence of injecting 
drug use beyond the northeastern states in India, calling it negligible and insignificant 
(UNDCP& Government of India 1995).  Despite a reported increase in drug injecting all across 
the country, as early as 1990 (Chowdhury and Chowdhary, 1990; Naik et al., 1991), there was 
little data available on the prevalence and incidence of HIV infection among injecting drug users 
(Sarkar, et al., 1993; Singh, Mattoo, Malhotra & Varma, 1992).  In fact it was only as late as 
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1999, for the first time, the National AIDS Control Organization (NACO) Policy document 
included Mumbai, Calcutta, Chennai and Delhi as cities with substantially large numbers of 
injecting drug users that were deemed at risk of HIV infection (NACO, 1999).  Drug use could 
no longer could be dismissed and nor could the threat of HIV overlooked.  NACO, begun the 
process of mapping, investigating and re-organizing the systems of public health, even though 
harm reduction specifically was not yet on the agenda.  The country, it seemed was on the cusp 
of something new and radical.  
The harm reduction model began evolving from a peripheral intervention into a national 
program in the next few years, fairly rapidly.  NACP II followed the first policy period from 
1999 until 2006.  It undertook a more long term, behavior change centric approach to reduce the 
spread of HIV44 (NACO, 1999).  NACP II had a larger scope of activities and also received far 
greater financial support of around 445 million dollars from groups like USAID, DFID, Aus Aid, 
CIDA, UNDP, Global Fund and the World Bank (Kumar, 2008).  This type of support was 
virtually unheard of and drew the attention of the nation’s public health sector almost 
immediately. 
Instead of a broad prevention strategy NACP II adopted a targeted intervention (TI) 
approach aimed at high-risk groups (HRG’s) (NACO, 2006).  Globally this public health 
rationality was governed by the thinking that given the disproportionate HIV prevalence (as 
highlighted above) among these high-risk groups- female sex workers (FSW), men who have sex 
with men (MSM) and injecting drug users (IDU’s)45 (as well as bridge populations like migrants 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
44 Under this phase, India continued to expand the program at the state level. Greater involvement of NGOs and 
other sectors and line departments, such as education, transport, and police. Capacity and accountability at the state 
level continues to be a major issue and has required sustained support. 
45 Those drug users who have injected in the last three months.	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and truckers), it would make most sense to invest with these groups.  By saturating these HRGs 
the spread of HIV could be stemmed and the general population would be spared. 
NACP-II set up more than 1,000 TIs, mostly through non-governmental organizations, 
for the HRGs (NACO, 2006).  The projects were meant to use peer educators to counsel, provide 
condoms through social marketing and give information to encourage a change in behavior.  The 
country also was divided into high and moderate prevalence states, based on the high-risk 
populations as well as high and moderate vulnerable states based on the demographic 
characteristics of the population.  While community level interventions like public health 
campaigns, STD clinics and improvement of the Blood bank system continued, TIs were to 
become the new modality of all HIV related care henceforth.  Under this phase the government 
also began to expand the program at the state levels.  Managerial, technical and financial systems 
were also set up to develop and implement focused strategies to reduce HIV prevalence among 
high-risk groups (NACO, 2006). 
 For drug users specifically, these changes in the national agenda were certainly 
encouraging.  However, there were certain limitations in terms of the number of TI’s for drug 
users and the scope of services that were provided.  For instance, the government was still 
reluctant to start providing Opioid Substitution Therapy (OST) at this time.  Part of this 
reluctance was driven by the lack of expertise within the government and part were the legal 
barriers preventing the provision of Opioid to drug users.  Prerna Kapoor who works for 
UNAIDS, details some of these issues: 
At (those) NACO meetings they (were) saying that the HIV funds are not there to support 
the OST programs- the Ministry of Social Justice and Empowerment (MSJE) can do that, 
that’s not our forte and the MSJE said we will not support harm reduction- some amount 
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of ping pong and one didn’t know what was going on.  Some amount of pressure from 
community groups and donors has played and important role and I think community 
groups were ready to take it on and there were donors who were ready to support it. 
Even though small-scale projects by Ashray and other NGOs’ had shown the 
effectiveness of OST, it was not until the “five cities” project supported by DFID, that the central 
government really began to take notice.  This DFID funded project started in 2005 and continued 
until 2007, funding was channeled through the Program Management Office (PMO) 46.  Harm 
reduction projects from four networks reached out to more than 100,000 IDUs across India 
(DFID, 2007).  NGOs carried out extensive advocacy work to influence an attitude change 
among various stakeholders.  But most crucially OST was established in four urban and three 
rural sites across the northeast states of Manipur and Nagaland, and in eight further states and 
three union territories including Delhi (HLSP Institute, 2006).  More than 4,500 IDUs benefited 
from OST and over two thirds successfully completed treatment or were in treatment at the end 
of the project. 
   I met Aakansha Jain, who was working with one of the projects in the northeast to 
understand more about this project.  Aakansha recalls: 
 This was the largest OST program in India till date in Manipur and Nagaland, it started 
looking at 800 IDUs, it ended up being 1200 and it went to 1800 because it was 
flexible...the donor was flexible and we were managing’.  At this point, the government 
of India had not yet adopted OST. They questioned OST both as an effective strategy and 
a viable intervention, both in terms of funding and expertise.  It was only a 14-month 
project and we realized that there was physical change in people who went through OST 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
46 PMO developed a Challenge Fund to encourage community-based innovation and emphasized fostering links 
between civil society and government.  
	   107	  
we were able to demonstrate and the states really became conscious of the effect- the 
positive impact of harm reduction.  
Despite the encouraging results, after three years, DFID decided to withdraw its support 
for the OST program.  Aakansha talked about some of the tensions and pressures of this 
transition period: 
National AIDS Control Organization (NACO) also had to respond and again there was a 
lot of policy and advocacy activities and we started preparing papers saying so many 
people are on OST and we have to do something about and again we wrote to DFID 
saying you have to extend it you cannot just over night withdraw. Simultaneously we 
were also trying to find out what was the optimum period for OST.  
Prerna Kapoor shared, “When DFID was phasing out of it, basically the government was 
left with a program, which they had to take forward, because we just don’t leave people who are 
on OST and that led to funding it (by the government)”.  
Aakansha, who now works with HIV/AIDS Alliance, talks about the collaborations that 
ultimately helped to launch OST in India:  
In that period different people contributed at different levels47.  SPYM (a national NGO) 
contributed in a big way…they were linked very closely to the NGO’s working with the 
Ministry of Social Justice…they (NGO’s) were basically involved in demand reduction 
but extended to harm reduction and started also understanding about OST.  They did a 
mapping and we realized that in India there is a lot of drug use, which was needed. 
Ashray (NGO), in the process of networking again started discussing with a lot of SACS 
(State AIDS Control Societies) (the usefulness of harm reduction).  Manipur (and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
47 In 2004 UNODC in collaboration with AIIMS had also begun a small pilot project in five centers and later 
expanded this to 15 centers across the country. 
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Nagaland) immediately showed an impact the other projects working in the area realized 
that ...  I think two basic things happened one was the impact- it really brought the 
attention of NACO, because Manipur and Nagaland were the main challenge because 
progress of drug use and HIV...and then this (OST) was seen as a very workable solution, 
supplying needle syringe yes was important and we had to continue that and that was part 
of it, condoms was part of it (as well).  There were smaller studies, which showed that if 
the person was on OST the adherence to ART (Anti-retroviral treatment) also improved 
and those things started getting documented and so it brought the attention of national 
organization. 
Another key development during this stage was the entrance of the Bill and Melinda 
Gates Foundation (BMGF).  Not only did the presence of BMGF dramatically increase the 
financial resources available for HIV but it also included a new format of functioning.  I will 
describe their strategy in further detail in the next chapter.  BMGF’s focus on high-risk states in 
many senses galvanized the government and public health sector in these areas.  During this 
phase they conducted independent mapping exercises to understand the issues and began to 
identify areas to invest especially in terms of personnel, materials and resources.  In addition, 
they also helped to set the People Living with HIV network, which has over time grown into the 
largest public disease network in the country. 
 In 2007 a government delegation supported by UNAIDS and UNODC went to China to 
see the OST program, to learn and gain a better understanding.  This exposure, Rajat Dhingra a 
UNODC expert, claimed was crucial.  NACO officials were able to see how another Asian 
country with many of these similar concerns could effectively manage and run such a program. 
This acted as a final precipitating factor in shifting the dynamics around OST and the adoption of 
	   109	  
harm reduction.  NACP III was launched in 2006 and will continue until 2012 (NACO, 2006).  
The financial support, amounting to about 842 million dollars, has come from organizations like 
the Global Fund, the Bill and Melinda Gates Foundation, USAID, DFID and the World Bank 
(Kumar, 2008).  Overall, NACP III has been by far the most ambitious in its scope and 
implications for both HIV and harm reduction. 
NACP III48 formally included  “harm reduction strategy” in 2007 and initiated the opioid 
substitution therapy (OST) program for 40,000 injecting drug users across the nation49 (NACO, 
2008).  NACP III aimed to dramatically scale up targeted interventions, with an aim to halt and 
reverse the epidemic (NACO, 2006).  “Government will encourage NGOs working in the drug 
de-addiction area to take up harm minimization programs as part of the HIV/AIDS control 
strategy in areas which have a large number of drug addicts” (NACO, 1999, paragraph 5.10).  It 
included an integrated package of prevention, care and support and treatment with the aim of 
reducing incidence.   
According to NACO most recent estimates there are 1531 Targeted interventions across 
the country (NACO, 2010).  By developing guidelines and training modules for health care staff 
and services, this new policy aimed to improve the quality of medical care for AIDS.  It planned 
to further decentralize its activities from the state to the district level and also involve various 
government departments and the private sector in its efforts.  At the end of 2010, TI’s covered 
1.7 million most at-risk people, (53% for FSW, 72% for IDU, and 82% for MSM) (NACO, 
2010).  The city of Delhi has about 68 TI’s one of the largest numbers in the country.  These 
interventions were implemented by NGOs and community based organizations, which have 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
48 NACP III evolved through a year ling preparatory process through consultations with communities, national 
experts, affected communities. 
49 While majority of the OST programs are government funded there are some smaller projects that are directly 
funded by international development agencies. 
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become the backbone of this new program.  Partners like BMGF, WHO, USAID, UNODC and 
UNAIDS are heavily involved in this program by providing technical management and financial 
expertise.  
   In the shadow of HIV- building the harm reduction model in India. 
I have shown thus far that harm reduction policy and intervention did not evolve in a 
linear fashion but developed through a series of interactions, negotiations and collaborations. 
Through this process, of incremental changes, small research projects, advocacy and 
international support of grassroots interventions, harm reduction has become a major policy and 
practice initiative in India.  Jared (project head of Ashray) over a cup of hot chai in his office 
summed up these changes: 
 The last year has seen great changes in the Indian state health – health policy- the 
Ministry of health has gone fully out to start up and scale up Buprenorphine, the whole 
Harm reduction concept has been shifted around, we are doing it the right way, we are 
following WHO guidelines, developed our own country’s protocols, we are starting with 
accreditation.  Before the government started giving us cash we had to get funds from 
outside of India for Buprenorphine and before the laws were changed we had to find a 
loophole and the loophole we found was that we were doing long term detoxification. 
Long-term detoxification is still under what Buprenorphine is given on for the sake of the 
drug control.  We had to change laws to allow them (IDUs) to come to the DIC (Drop-in 
center) without any harassment, we had to lobby for those laws, and we had to lobby for 
the NDPS act to be changed.  
Harm reduction policy and interventions in India hold many lessons for us both as social 
scientists and social workers.  Two decades ago it was virtually impossible to imagine that a 
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country like India would have evolved one of the most forward thinking drug and HIV policies 
in the world.  Today, harm reduction as a paradigm has established itself changing the way in 
which Indian drug users can access and treat themselves.  
In this chapter I have argued that this development of harm reduction as a quasi-legal 
policy has emerged despite governmental opposition and reluctance.  The success can be 
attributed to the new partnerships between transnational players and local groups.  However, as 
HIV itself became a large-scale issue, it recast drug use, especially injecting drug use as a 
national problem.  Harm reduction, which thus began as a radical alternate to the government 
position was soon take over by the government.  This government adoption of harm reduction is 
not complete, since certain Ministries continue to have reservations.  But the government 
involvement has been able to extend the harm reduction program many areas and also brought 
about greater standardization, greater investment and overall increased attention about the issue.  
From a social work policy perspective this chapter shed new light about the way health 
policies evolve and develop and the new roles states come to occupy during this process.  Drug 
use, which was until very recently considered a dangerous affliction, through the framework of 
AIDS acquired a more legitimate position with regard to the state.  The state by itself was pushed 
into participating in this program and reformulating its own perspective about drug use and 
treatment.  NGOs and bilateral organization in a large part are responsible for transforming the 
terrain through community level initiatives, advocacy and lobbying.  Unlike, other models of 
health where the citizen is seen as the end point of the intervention and policy, harm reduction 
placed the citizen and the disease at the center of all discussions.  Also the interventions and 
policies directly fed into each other- as the policy evolved so did the interventions, which in turn 
shaped new policies.  There were a large number of actors involved in drug treatment and they 
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were spread across many regions with a diverse set of interests; before harm reduction they 
existed in isolation.  Harm reduction played a crucial role in bringing them together, address 
issues and create a new response - one could say it became an organizing field.  This would not 
have been possible without the presence of harm reduction.  
I called harm reduction a shadow policy, for it grew under the umbrella of HIV. It also 
was never really conceived fully or as comprehensively as it came to exist later.  While in some 
ways it has greatly compromised the way harm reduction is perceived within the public health 
context, in other ways it has actually been a boon for the paradigm.  HIV had the global 
development sector support- financial, technical and most crucially in terms of public voice. 
Without the momentum and strength of the HIV industry, harm reduction would have found it 
difficult to break ground.  
In conclusion, I argue that harm reduction emerged as a unique solution under the Indian 
HIV problematic.  While there were other ways in which drug treatment could have been 
addressed, harm reduction emerged as salient.  The local advocacy, international pressure and 
successful demonstrations of its effectiveness all made harm reduction the ideal solution. 
Through this process stakeholders, communities and government got connected into networks of 
care and support.  Stigmatized behaviors came out of the shadows and one could argue, this 
helped to propel changes, which grew far wider than the domain of health and polity.  In the next 
chapter, I undertake a more critical discussion of the nature of these relationships. 
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CHAPTER 4: REVOLVING DOORS 
Here they come 
Here they go 
Problem seekers? 
Maybe! 
Problem solvers? 
Perhaps… 
But where do they go and what do they solve 
 
Us..,Them…where is the resistance 
Should there be some? 
We were separate us and them… 
No, we became them and they us. 
 
Undoing of health 
Bringing new beats to old relationships 
Life gets treated in new ways 
People become clients 
Addiction becomes risky 
Politics becomes disease 
Money becomes governance  
Now, what are the beats? 
 
Who are these new problem seekers and problem solvers…? 
(Moorthi, 2011) 
 
   The coming of HIV/AIDS in India was a litmus test for the country’s fledgling and 
overburdened health system. In the process of fighting the epidemic, the country began to chart 
out a radical alternative for drug treatment in the form of harm reduction.  Both public and 
private stakeholders worked together to build the “the nuts and bolts of the program”; 
simultaneously they worked to garner public support for these interventions, formed and tweaked 
policies, conducted research, trained workers, evolved protocols and addressed the changing 
needs of the community.  The terrain was uneven and harm reduction services seemed to have 
generated an entirely new set of struggles, hierarchies and tensions between the players.  I call 
this the “politics of survival”.   
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These policy directives have evolved a program of treatment that draws from global best 
practices, universal ideals of human rights and new social technologies of risk and 
pharmaceuticalization.  At the same time there is a growing community based, grassroots health 
movement that is drawing from ideals of broader health mandate that is grounded in political and 
social justice.  Harm reduction programs and policies thus seem to reflect these dualities of 
global-local and public –private, an uneven terrain or perhaps hybrid amalgamation, where 
agendas are often temporary, perspectives easily replaceable and ideals fluctuating around the 
economies of survival.  This chapter undertakes a critical investigation of this harm reduction 
environment to examine its ramifications for governance, health and citizenship. 
   At the intersections of the healthy welfare state. 
  HIV, both in its scope and impact, shook governments and health systems in a way that 
older responses and frameworks were rendered weak.  India is traditionally considered a welfare 
state.  But even before the advent of HIV, the country was struggling to redefine itself under the 
pressure of structural adjustment reform.  Post HIV, the conditions changed radically; states had 
to reframe their own participation in health provision, with the advent of international 
organizations, NGOs, bi-lateral agencies.  These changes were not solely seen in the public 
health arena, but could be seen in the larger development sector as well (Kamat, 2002; Misra, 
2006).  However, it was in the domain of public health and specifically HIV where the affects of 
such changes were particularly dramatic and worth further examination.  
   Health is considered a public good, one that will serve to benefit the entire community 
or country beyond the single person (Smith and MacKellar, 2007).  However, most welfare states 
including India have found it difficult to ascertain the exact nature of their role or the level of 
involvement required to address the health needs of their citizens.  Today, there are several 
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questions raised about whether health is best served by the public utility model or instead must 
involve private markets (Biehl, 2007).  Even more fundamentally, the very definition of health 
has expanded over the last few decades.  Research shows that not only is health connected to 
social, structural and environmental causes (Bourgois & Schonberg 2009; Farmer, 2003) but also 
that, health can be impacted by conditions that travel across political and geographical 
boundaries (Scheper-Hughes, 2005; Petryna, Lakoff  & Kleinman, 2006).  The rise in 
communicable diseases coupled with growth in medical technology, the pharmaceutical industry 
and health-focused activism have all sealed the future conception of health as an issue with a 
global reach (Epstein, 1996; Nguyen, 2005).  Health thus continues to remain both indeterminate 
and nebulous at best, leaving scope for much debate and discussion about the state’s 
participation in providing appropriate services, structures and supporting conditions.  
   The welfare state, not only must make sense of these newer conceptions of health but 
also carve a niche for itself in the evolving health market place, which today includes many non-
state stakeholders.  More significantly, the position of the welfare state, in terms of a political 
and sovereign entity, has come under attack during the current period of neo-liberalization and 
globalization (Yeates, 2001).  Financial, activist, medical, pharmaceutical and social networks 
surrounding public health issues now seem to inter-penetrate and shape what is occurring within 
the health sphere of each state (Biehl, 2007; Petryna, Andrew Lakoff, Arthur Kleinman, 2006).  
Some theorists argue, that the state has always had certain constraints on its functions, for 
instance, in choosing different development strategies or deciding on resources allocation 
(Weiss, 1997, 2000; Deacon, 1999).  But most agree that the last few decades have witnessed 
qualitative shifts in the way states participate in the new global economy (Brown, 2003).  They 
also point out that the state is no longer the principal actor in social policy contexts, it has 
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become one of the many actors, which include transnational corporations, international 
bureaucracies, business and professional organizations and social or political movements  
(Freidman, 1999).  Since states are no longer the sole authority or mediators, these scholars 
suggest that the state cannot be always seen as representative of the people’s will (Sassen, 1998). 
Sovereignty, according to Sassen (1996) is not the sole purview of the state.  Thus, the crisis of 
the state is often also seen as a crisis of democratic institutions (Martin and Schumann, 1997).  
 The responses to these threats regarding the scope and function of the welfare state have 
been varied.  Scholars like Ferguson (2006) argue that the state has not necessarily lost power or 
there is less regulation but in fact there are new configurations of state power that now deserve 
our attention.  This growing body of literature that looks at the way the state continues to govern 
through and within non-state institutions- a type of “governmentalization” of power that shapes 
bodies and communities.  
Ong (2008) in her work suggests that neoliberalism “ can be conceptualized as a new 
relationship between government and knowledge through which governing activities are recast 
as nonpolitical and non-ideological problems that need technical solutions”.  Her work 
significantly addresses how governments try to optimize their functions through the “technology 
of neoliberal governance”.  She further argues that within postcolonial, authoritarian and post 
socialist societies neoliberalism is often introduced as “exception” i.e. “market-driven 
calculations” are used to manage populations and administration of special spaces. Such 
exceptions result in the creation of populations who are given either unique social protection or 
lose certain privileges; this create zones of exclusion and inclusion.  This exception to the 
welfare mainstream can result in unequal distribution of rights, entitlements and even lead to 
new formations of citizenship; in fact, citizenship can get linked to new spaces thus, re-
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articulating and re-defining its very essence.  She provides the examples of South-east Asia 
where zoning has lead to special spaces, which attract foreign investment, technology transfer 
and international expertise. Thus non-contiguous spaces get administered differently with 
“graduated” or variegated sovereignty”. “ As corporations and NGOs exert indirect power over 
various populations at different scales” there are “overlapping sovereignties” that mark this 
environment.  
Sharma (2006) presents another important argument in this vein. Her work shows that 
there is a co-mingling of the old welfare type of rule with the newer forms of neoliberal 
governance in terms of empowerment.  State power on the ground often seems to traverse in 
complicated ways that reflects local realities, multiple histories of development and democratic 
institutions and diversity in the relationships between the state and its citizens.  State institutions, 
in Aradhana Sharma’s work, work closely with non-state organizations.  This reflects global 
neoliberal trends that seek to “detach or autonomize entities of governance from state institutions 
by spreading the art of self government” in order to move the burden of development from the 
state to social bodies.  However, she also argues that, “ the contemporary Indian state cannot 
fully relinquish its development and welfare functions because its legitimacy rests precisely on 
such functions”.  Furthermore, activism, welfare and empowerment initiatives remain a powerful 
corrective force against the negative affects of neoliberalization/globalization.  Gough (2000) 
suggests that these issues acquire a particular complexity in the global South as compared to the 
North.  He argues that there is a wider range of historical and institutional factors involved in the 
politics of the South and a dynamic “state” whose position in social, economic and political lives 
cannot be assumed apriori. 
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 The other responses to these changes in the welfare state have come from scholars like 
Biehl (2007).  His work focused on the HIV ridden populations of Brazil show that rather than a 
top-down form of control it could be understood as a “market –based biopolitics”.  He proposes 
that the government is not using AIDS therapies as techniques to govern populations and manage 
bodies rather “poor AIDS populations acquire temporary form through contested engagements 
with what is pharmaceutically available.  The political game here is one of self identification and 
it involves new economics of survival”.  He argues that populations get loosely tied through 
medicine, disease and health into diverse relations with the state, which is, “ pharmaceutically 
present but by and large institutionally absent”.  
In my own work I found that the notion of the welfare state continued to hold ground and 
shape the interactions with other stakeholders in many important ways.  There was a clear sense 
amongst most government players that drug users required medical attention and social support. 
Drug users were considered by the state as an important bridge population at the risk for 
spreading HIV.  They were a public hazard and the control of the infection was key to securing 
the health of the larger citizenry.  The state was able to lay claim to the position of primary 
sovereign authority to initiate as well as sustain the large public health HIV enterprise.  It was 
able to bring together a large number of players, give direction and build new structures for 
health.  I show that this was not necessarily a top down type of model but rather a more 
managerial role occupied by the state.  
The harm reduction paradigm was also reflective of a new form of governance that was 
more dispersed and disaggregated in the institutional and social networks.  It was now 
coordinated and consolidated within non-state institutions, communities and even individuals 
(Sharma & Gupta, 2006).  Citizens were encouraged to self-govern their health and reduce risk. 
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Unlike other health issues, drug use involves a significant assertion and application of individual 
choice. Drug users were thus to be held accountable for their behavior and placing others at risk.   
At the same time the state recognized that substance abuse was an issue of national 
security. Both narco terrorism and narcotics trade were significant threats and the government 
was clear about using punitive action to control, segregate and discipline ‘dangerous’ drug users.  
Governed by the political, economic and social pressures, I argue that the state adopted and 
occupied multiple positions at the same time.  It transformed its role in relation to these various 
non-state actors and evolved with needs on the ground.  Despite claims that the state was losing 
its relevance within the current neoliberal climate, my work shows that the state tended to 
incorporate many different and contradictory frames of functioning; it continued to exert 
influence and shape the lives of its citizens in powerful ways.   
As questions of the state and health are placed at the center of my inquiry, it becomes 
important to understand some of the global discourses of public health that have shaped the 
trajectories of Indian state’s participation in harm reduction.  
  Public health: tracing its impact on the Indian state. 
    The traditional drug treatment sector in India is dominated to a large extent by the 
private/NGO sector.  This is not surprising considering that the Indian health care system is the 
most privatized50 in the world (Phadke, 1994). 83% of health care expenses borne privately i.e. 
2/3rd of Indian households rely on the non-governmental sector for health care according to the 
National Family Health Survey (International Institute of Population Sciences, 2009). Health is 
not a constitutional right (though other constitutional elements are interpreted in lieu), within 
India, though Article 41 and 47 of the constitution include provisions for the well being of its 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
50 When I refer to private providers it includes to non-governmental organizations, local trained birth attendants, 
traditional healers etc.. 
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citizens.  Citizens tend to seek private health care to address their everyday illnesses.  They only 
depend on the public health system for major health needs or long-term hospital stay.  Ramesh 
Bhat (2000) in his analysis of the Indian health system shows that shrinking budgets have 
impacted the way the Indian state is able to attend to secondary and tertiary care.  Low budgetary 
allocations have created several imbalances. P.C. Sharma (IANS, 2010) of the National Human 
Rights Commission describes it thus: 
There is a paradoxical situation in India. On one side, we have super specialty medical 
centers, which cater to the needs of patients requiring specialized and speedy treatment 
and on the other hand, a very large number of our population remains deprived of basic 
medical facilities and healthcare.  
            India adopted the declaration of the Alma Ata Conference (WHO,1978)51 as evidenced 
by its National Health Policy (NHP)52 of 1983 and promised to provide comprehensive, 
universal, equitable and health care services for all.  However, there were several gaps in the 
actual implementation process.  Most countries found this broad notion of community 
responsibility and participation as impractical, expensive and expansive.  Over the next few 
decades instead it was the concept of  “selective primary health care” which was instead 
advocated; the focus shifted from communities to funding agencies with experts.  The Indian 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
51 It brought the primary health, at the center of global policy agendas. It proclaimed ‘health, as a state of complete 
physical, mental and social wellbeing, and not merely the absence of disease or infirmity, is a fundamental human 
right and that the attainment of the highest possible level of health is a most important world-wide social goal whose 
realization requires the action of many other social and economic sectors in addition to the health sector. 
Governments have a responsibility for the health of their people, which can be fulfilled only by the provision of 
adequate health and social measures. A main social target of governments, international organizations and the whole 
world community in the coming decades should be the attainment by all peoples of the world by the year 2000 
(enshrined in the slogan Health for All by 2000) of a level of health that will permit them to lead a socially and 
economically productive life. Primary health care is the key to attaining this target as part of development in the 
spirit of social justice.’  
 
52 It focused on primary healthcare infrastructure, close co-ordination with health-related services and activities (like nutrition, 
drinking water supply and sanitation), the active involvement and participation of voluntary organizations, the provision of 
essential drugs and vaccines; qualitative improvement in health and family planning services; the provision of adequate 
training; and medical research aimed at the common health problems of the people (WHO, 2009). 
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government also primarily pushed vertical programs that addressed specific aspects of health 
needs such as ORS, breastfeeding and immunization (Hall and Taylor, 2003). 
    The mid 1980s saw a significant global policy shift towards a “new public health 
movement”. The essence of this movement was enshrined in the Ottawa Charter.  It attempted to 
go beyond bio-medical understandings of disease towards a social and environmental conception 
of health (Rhodes, 2002; WHO, 1986).  The Charter continues to guide policy and discussions 
around public health to this day.  This development coincided with the emergence of HIV /AIDS 
and parallel to which harm reduction began to grow as a community based pragmatic strategy 
that focused on drug users needs (Stimson, 1995; Des Jarlais, 1995).  Despite these changes in 
the global perspective, conditions within India remain largely unchanged.  As discussed before, 
the punitive NDPS Act came into force during this time.  Addiction treatment was mainly 
abstinence-based and restricted to hospitals and detoxification centers.  Harm reduction was not 
even considered in the public radar within the country.  
   The late 1980s saw the global markets reeling from the “oil shock”.  This period of 
economic downturn left most developing nations floundering.  By the 1990s India was pushed to 
adopt structural adjustment policies; the government was forced to cut spending on social sectors 
especially health and education (Panchamukhi, 2000; Baru, 2003).  The percentage of people in 
India below the calorie norm of 2400 calories increased from 65% in 1987-88 to 70% in 1993-94 
(the height of SAP); allocations to health sector declined from 3.3% to 1.7% from pre reform 
period to post reform period; investment on health infrastructure also saw a decline during this 
period (Panchamukhi, 2000).  
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World Bank’s World Development Report (World Bank, 1993) titled “Investing in 
Health”53 reflected this global change.  Significantly, the report introduced the concept of 
Disability Adjusted Life Years (DALY) as an index of health.  By combining health years lost as 
a result of premature mortality and years lost as a result of disability it sought to provide a more 
calculable measure of health. ‘An important source of guidance for achieving value for money in 
health spending is a measure of the cost effectiveness of different interventions and medical 
procedures- ratio of cost benefits i.e. DALY’s’ (World Bank).  The report squarely linked 
improved health to economic benefits or human capital development rather than social 
development.  Most importantly it advocated a lesser role for the government, shifting the burden 
of health provision to private providers and the individuals themselves (Hall and Taylor, 2003). 
This report marked yet another shift in the paradigm of public health creating severe challenges 
for the poor and marginalized to receive adequate care, especially in developing nations.  
 Anjana Kothari a senior health consultant with the Futures Group provides some 
perspective on these changes: 
 In the last 7-8 yr, (the) shift is towards privatization… and that is one of the marked 
shifts in the history of health systems in India.  We are seeing the introduction of 
insurance systems being promoted in a big way in the last couple of years.  Government 
opening its insurance market to private players- a package deal with the focus on 
privatization.  For a very long time (the government did not) respond to changing needs. 
Now they thought the way to deal with it is to open the market and allow private 
providers to come.  You have states like UP and Bihar, who found it so hard to manage 
the PHC and Community Health Center they just contracted it out to the private 
providers.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
53 Bill Gates claims to have been greatly impacted by this report.  
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We have private players that have outsourced little things like annual maintenance 
contracts to private providers; sometimes they have outsourced the whole management of 
the PHC to private providers.  Other times just like specific things like maintenance and 
supply, laundry, which we don’t think are such big issues but they are very big issues. 
Most of the hospitals if you see- if you analyze the data from National Family Health 
Survey, what people complain about is long waiting hours, bad treatment lack sanitation 
most of our hospitals don’t have a system for hospital waste management. 
As the Alma Ata deadline of 2000 approached it became clear that India like other 
developing nations, was far from achieving its goals for “Health for all”.  In 2008, WHO 
released the World Health Report, titled “Primary Health Care- Now more than ever”.  This most 
recent return to primary health care (including concepts of equity, social justice, participation, 
health system approach and social determinants of health) is far more comprehensive reflecting a 
broader impetus to bring people to the center of all global health programs.  However, there are 
still considerable challenges in terms of engaging communities, involving governments, civic 
society and multi-lateral partners.  For India in particular this shift is reflective in the National 
Rural Health Mission (NRHM) 2005-201254 (Ministry of Health and Family Welfare, 2005). The 
policy aimed to strengthen the primary health system in the country.  
 While India adopted many of the global policy mandates on paper, the actual impact of 
these frameworks on the Indian health system is less easy to describe.  Often there was a lag or a 
dissonance between global policies and the response from the Indian government.  In this 
analysis, I found that HIV acted as watershed moment for the country.  India quickly recognized 
that to both combat the illness and participate in this changing health industry it needed to align 
with international agendas and actively adopt globally accepted models, strategies and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
54 The National plan of action aimed to improve the health care delivery system of India. 
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discourses.  Kothari and other stakeholders highlighted that this new age of contracting, 
insurance and health systems management that are clearly signaling other new changes in India. 
    Through this reading of health and welfare in India, I have tried to place harm 
reduction within the broader discourse of global public health.  The historical shifts in public 
health helped to generate heterogenic health strategies in India and most significantly helped to 
create enough traction for the successful adoption of harm reduction by the state.  The re-
contextualization of drug treatment, within harm reduction and HIV was partially shaped by 
these public health traditions.  They have helped to reorient the conversation about drug users, 
grounded in values of human rights, social justice and community participation.  
   Government structures of care for drug users.  
Every state that signs up to the Political Declaration at this Commission (on Narcotic 
Drugs) recommits the UN to complicity in fighting a catastrophic war on drugs.  It is a 
tragic irony that the UN, so often renowned for peacekeeping, is being used to fight a war 
that brings untold misery to some of the most marginalized people on earth.  8000 deaths 
in Mexico in recent years, the destabilisation of Colombia and Afghanistan, continued 
corruption and instability in the Caribbean and West Africa are testament to the 
catastrophic impact of a drug control system based upon global prohibition.  It is no 
surprise that the Declaration is unlikely even to mention harm reduction, as it runs 
counter to the primary impact of the prevailing drug control system which, as the past ten 
years demonstrate, increases harm (Kushlick, 2009) 
            Barely a year after the introduction of OST, the Indian delegation, composed of members 
of the Ministry of Revenue, took a clear stand against harm reduction at the International 
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Commission on Narcotic Drugs55.  Since licit opium production continues to be a high revenue 
earner for the country, drug policy in India continues to be monitored by the Ministry of 
Revenue.  Even though harm reduction interventions have gained prominence in the last few 
years very little advocacy work was carried out  (by either NACO or Ministry of Social Justice 
and Empowerment) with the Revenue Ministry.  For most health experts in India, who have 
fought long and hard for harm reduction, this international statement was a reflection of the 
failure of India’s health policy apparatus to co-ordinate their response to drugs and HIV.  These 
very contradictions were the hallmark of the drug treatment sector in India.  
   In no place was this more visible than in terms of the overall structures of care provided 
by the government.  The government department promoting harm reduction efforts in India is the 
Ministry of Health and Family Welfare (MOHFW).  Established under this Ministry is the 
National AIDS Control Organization (NACO), which is directly responsible for all harm 
reduction activities currently within the country56.  State AIDS Control Societies (SACS) 57 
which are autonomous bodies, at the state level and District Aids Prevention and Control Units 
(DAPSU) at the district level are the decentralized bodies that manage HIV prevention and by 
extension harm reduction work in the country.  As I have detailed before, only a small proportion 
of drug users are at the receiving end of harm reduction services. In fact, abstinence focused 
services continue to remain the mainstay of the Indian drug treatment sector.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
55 CND is the central policy-making body of the United Nations in drug related matters. It also monitors the 
implementation of the three international drug control conventions and is empowered to consider all matters 
pertaining to the aim of the conventions, including the scheduling of substances to be brought under international 
control.	  D	  
 
56 Altogether 33 Union ministries and departments of the Government of India have mainstreamed HIV/AIDS 
prevention in their day-to-day functioning and thus have special programs. 
57 SACS boards have representation from key government departments, civil society, trade and industry, private 
health sector and networks of people living with HIV.	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     To understand these intricate dynamics I went to visit one of NACO’s chief program 
officers Dr. Alkesh Kumar.  He explained to me that despite NACO’s leading role in the harm 
reduction work in India, it was actually severely constrained in its functioning.  NACO had to 
work within the broader framework of the NDPS policy and in conjunction with the Department 
of Home, the Narcotics Control Board, Ministry of Social Justice and Empowerment (MSJE) and 
the Planning Commission.  This of course did not include working with the dozens of 
international organizations and NGO’s that are partners on a variety of projects with the 
government.  The government i.e. NACO, Dr. Kumar pointed out was now spending a majority 
of their time managing these various relationships, creating funding mandates, developing 
treatment protocols, training peer workers and generating the structure within which harm 
reduction could work. 
    The Ministry of Social Justice and Empowerment (MSJE) is the nodal ministry for 
drug demand reduction, prevention, assessment and treatment.  Despite the growing momentum 
to support harm reduction MSJE has largely stayed out of the domain of harm reduction. MSJE’s 
interventions focus on abstinence policies for the wider group of substance users i.e. alcoholics, 
non injectors as well as injectors (MSJE, 2009). However, their role in the overall drug treatment 
environment cannot be undermined.  Under MSJE, it is the National Institute of Social Defense 
(NISD) that undertakes all critical tasks related to drug treatment.  There are about 251 drug 
treatment centers supported by the Ministry of Social Justice and Empowerment during the year 
2008-2009.  These centers, located all across India, provide abstinence-based  rehabilitation 
services to drug users (MSJE, 2008)58.  A senior bureaucrat with MSJE Mr. Basu, explains: 
 Our focus is to rehabilitate the drug users in their own profession and lead a normal 
social, personal and family life and we also address a much larger audience – we not only 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
58 Many NGOs on their contract were blacklisted for non performance last year, this list was widely circulated.
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target injecting drug users we target all those who are using drugs – we also focus on 
social family integration- we take focus on withdrawal, counseling and vocational 
counseling, behavioral change, yoga. We are in demand reduction … so we are not 
supporting any drug taking behavior – our approach is to rehabilitate them and 
abstinence… so we are not supporting any (author emphasis) drug taking behavior.  
Ministry of Health Family Welfare (MHFW) also runs 122 de-addiction/detoxification 
centers across the country (MHFW, 2011).  These centers adopt a medical model of addiction59 
and mainly focus on addressing the physical symptoms of drug addiction with an abstinence 
focus.  Given the burgeoning numbers of clients that require drug treatment services these 
government run programs are clearly unable to cover the vast majority of clients.  Hospitals and 
private de-addiction clinics aside there are hundred of NGOs, international bilateral and 
multilateral organizations as well as foundations and international NGOs that are also providing 
drug recovery services in the country.  
 During my fieldwork period the government was in the process of streamlining the 
services, identifying gaps or duplications and developing standards of care.  International 
organizations and NGOs played a significant role in service delivery.  To further understand 
these state and non-state stakeholder relations I will now undertake a more in-depth examination 
of these arrangements.  
   Public –private partnerships. 
  It was coming to the close of my fieldwork in India and I had been invited by to attend a 
two-day consultation titled “Developing Advocacy Strategy for IDU Living with HIV- the way 
forward”.  Supported by FHI, Avahan and INP+ it was one of the first forums that was placing 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
59 The contemporary medical model attributes addiction, in part, to changes in the brain's mesolimbic pathway. The 
medical model also highlights that addiction may be the result of other biologic, psychological, or social conditions. 
Within the disease model of addiction, a genetic predisposition is believed to be present. 
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IDU issues at the center of the HIV struggle.  Over the course of one and half days over fifty 
different organizations working with IDUs, including civil rights groups, HIV AIDS groups, 
international organizations and funders shared, argued and discussed a whole host of concerns 
related to IDUs.  The Consultation aimed to develop advocacy strategies for injecting drug users 
living with HIV in India.  At the end of the Consultation they planned to put forth a strategic plan 
in front of the government to inform their policy for IDUs.  
 As I stood in the reception area of the conference hall during a break from the morning 
session, I could easily pick out the UN representatives dressed in vibrant expensive silks and 
well cut suits, chatting in dulcet tones in the corner.  The large contingent of drug activists and 
NGO personnel dressed in more casual clothes formed a stark contrast sharing hugs, making 
loud jokes and exchanging cigarettes.  Besides these two groups there were public health 
specialists, government officials and members of civic society organizations.  This third group 
was harder to pick out and were clearly also more flexible in their social interactions.  
   NACO’s senior bureaucrat Amrita Pandey had agreed to come during the final phase of 
the meeting to learn about the consultation’s outcomes and present the government’s point of 
view.  Later that afternoon dressed in an elegant silk sari Amrita Pandey walked in, accompanied 
by her colleagues.  I was surprised to see the entire room stand up to receive her.  It was a 
significant gesture of respect and awe not often seen in relation to government officials, who 
were often perceived as obsolete and irrelevant.  After intently listening to the report from 
meeting and making notes she opened the forum for questions.  The queries were focused on the 
inefficiencies in the system, the lack of availability of medicines, delays in providing testing 
equipment, lack of government supervision in critical care and the future of harm reduction in 
India.   
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Unlike the usual bumbling and unaware government official Ms. Pandey fielded the 
questions deftly displaying both insight and critical awareness of issues. She was both open to 
critique and cautious in her responses. Quite like a modern CEO she drew on up to the minute 
information from her colleague’s laptop and her own Blackberry.  Towards the end of the 
discussion she spoke authoritatively about the modern role of government.  She was clarified that 
NACO was keen to support the NGOs’ work, visit project sites to make sure they deliver 
services and co-ordinate with international agencies.  However, she pointed out that it was the 
role of the NGO’s to act as a third eye and make sure that these procedures are being followed; 
NGO’s had to help in providing services and become the “eyes and ears” of the government on 
the ground.  The Government, she pointed out, must now focus on managing technology, 
materials and people; rights and advocacy related work were considered beyond the purview of 
the government.  Despite Ms. Pandey’s clear demarcation of such a division of roles, it was 
never as easy to point out these differences on the ground.  I often saw an overlap of roles, 
funding structures, opinions and a criss-crossing of agendas.   
Today, there are a dizzying number of international organizations that have become 
involved in the fight against HIV and by extension in some form involved in harm reduction 
work.  These non-state or “private” organizations are in most cases part of hybrid structures of 
governance with the state or “public” stakeholders. Such alliances are broadly labeled as public 
private partnerships (PPP).  PPP’s have become key to running large-scale public health 
programs and harm reduction in the sphere of drugs and HIV is no exception in India.  Within 
harm reduction there are many different types of PPP models currently functioning in India.  
First, there are Government funded and NGO run programs providing services e.g. Ashray was 
supported by NACO and Delhi State AIDS Control Society.  Second, there are UNODC 
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supported projects that are largely demonstration projects or research pilots that also provide 
OST and other harm reduction services.  Third, there is Government and UN supported 
collaborative efforts to provide harm reduction services.  Fourth, there are harm reduction 
projects run solely by bi-laterals, international funding agencies and global organizations.  Fifth, 
NGOs also are often times providing one or more harm reduction services within their larger 
mandate (There are other types of alliances as well, which I have not covered in this section). 
   Steven Rao one of the leaders in People Living with HIV movement in India suggests 
that now it almost ceases to matter who provides the services, public/private. But what does 
matter is that “it should be providing a good service to the common people –accessible, 
affordable, free...”.  The Government, he claimed can negotiate and help make it profitable for 
private players to enter the health care market.  For Mr. Rao and many other NGO leaders the 
“post HIV” development sector was about opportunity, seeking alliances with all kinds of actors 
irrespective of ideology.  I wondered about this ethical suspension where all actors were 
claiming to be equal partners in the noble fight against this deadly disease.  Were my ideas about 
difference, discordance and diversity outdated in a world that was about harmony and 
functioning?  To understand these interactions between the stakeholders I identified three key 
areas  - policy construction, program planning and donor coordination and development of harm 
reduction expertise (technological and knowledge based support).   
I studied the construction of NACP III policy to understand these state and non-state 
interactions better. Anjana Kothari, who worked with the Futures Group, shared with me her 
experience of coordinating multiple stakeholders during the shaping of NACP III.  The third 
installment of the HIV policy was “developed through a major consultative, participatory, 
inclusive and transparent process” Bahuguna, 2005 retrieved December 2010).  In an 
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“unprecedented move the government threw open its doors to its citizens to critique the flaws of 
India's existing National AIDS Control Policy (NACP) and offer suggestions to strengthen the 
third phase of the plan, NACP-III” (Bahuguna). 
 The National Government constituted a Planning Team that included consultants from 
various sectors to better identify address current gaps and further decentralize the response.  The 
Planning Team established fourteen thematic working groups, which included representatives of 
the Government, private sector, development partners, academics, scientists, and implementers 
including civil society organizations and networks of people living with HIV/AIDS.  In addition 
to these consultations, there was a structured e-forum through which stakeholders contributed 
their inputs.  There were other consultative meetings held with communities, community based 
organizations as well others who may not have had the opportunity to contribute to the policy 
development.  Over the course of many months NACO involved hundreds of stakeholders, 
NGOs, community leaders and civic society participants to engage in one of the largest exercises 
in participatory policy building.  Even though there were several issues during the course of this 
policy building process, it was an impressive feat given the complexities of such a large nation 
and the constituents. It also allowed these groups to understand the policy structure and 
composition.   
There were many areas of the policy that generated concern and debates, for instance the 
length of OST support for drug users and the scope of services provided under the rubric of harm 
reduction.  However overall, most stakeholders viewed the process of policy construction 
favorably.  It showed the willingness of the government to consciously and creatively engage 
with the non-governmental, transnational, civic society and community based groups in shaping 
the national agenda. Furthermore, the transparency and involvement of civic society created an 
	   132	  
open loop of communication and discussion rarely seen within policy circles.  The expertise of 
these non-state stakeholders combined with their financial influence helped to increase their 
voice in this policy process.  The state continued to remain the main player in policy 
development but its inclusive approach was a significant shift from previous efforts.  
Next, I studied the arena of program development and donor relations.  HIV had brought 
a whole host of players into the field and naturally there were hierarchies, both in terms of scale 
of their involvement and the budgets allocated to the program in India.  At the top tier are global 
organizations such as UNAIDS60, UNODC61, WHO62, World Bank63, Bill and Melinda Gates 
Foundation, Clinton Foundation64, the Global Fund to Fight AIDS, Tuberculosis and Malaria 
(GFATM)65, UNDP66, UNFPA67, USAID68 and now PEPFAR (President’s Emergency Plan for 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
60 The Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS is the main advocate for global action 
on the epidemic. It brings together ten UN agencies including UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, 
ILO, UNESCO, WHO and the World Bank. The mandate of UNAIDS in India is carried out through the Joint UN 
Team on AIDS and the Theme Group on HIV/AIDS, with representatives from each cosponsor. UNAIDS works 
closely with the Government through the National AIDS Control Organization and other key partners including 
State AIDS Control Societies, civil society, the academia, the private sector etc. (UNAIDS, 2009). 
61 United Nations Office of Drug Control & Crime in South Asia (UNODC), in partnership with the Ministry of 
Social Justice and Empowerment, is working towards mainstreaming HIV/AIDS and drug abuse concerns in the 
ongoing programs supported by the government. A majority of UNODC, ongoing and completed projects aim to 
prevent the spread of drug use and related drug-abuse-driven HIV transmission, especially among vulnerable 
population (UNODC, 2008). 
62 WHO’s Country Office in India (WCO-India) has a long history of supporting several programs of Ministry of 
Health and Family Welfare, Government of India. The Country Cooperation Strategy (CCS) developed by WHO 
India for the period 2006-2011 forms the basis for delivering technical assistance in collaboration with the 
Government of India, the states, development partners and civil society. When the National AIDS Control Program 
was launched, WHO assisted the government in the formulation of strategy and plan for the implementation of 
prevention and control activities (WHO, 2006) .  
63 In 1991 the Government of India and the World Bank expanded their collaboration in infectious diseases control 
programs, and by 1992 the first National AIDS Control Project was launched with a World Bank credit of $84 
million. For the second phase of the National AIDS Control Program, a World Bank credit of $191 million was 
provided. The Bank has worked closely with the Government of India and other donors in the preparation of the 
third National HIV/AIDS Control Program (NACO, 2007, retrieved December 2010). 
64 The Clinton Foundation (CF) established its program in India in the year 2004, working very closely with NACO 
in partnership with UNAIDS. It supports the efforts of the government in care and treatment program for people 
living with HIV/AIDS. The Foundation set for itself a target of supporting treatment for 100,000 HIV/AIDS patients 
by 2007. Towards that goal it helped in training of private doctors, providing CD4 machines and technical 
consultants to NACO specifically for GFATM implementation. Clinton Foundation has made available high level of 
training for the Government of India by periodically bringing large number of technical experts from around the 
world (NACO 2007, retrieved September 2010) .  
65 The Global Fund for HIV/AIDS, Tuberculosis and Malaria (GFATM) is an international health-financing 
mechanism, which is committed to accelerating the reduction in morbidity and mortality caused by HIV/AIDS, TB 
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AIDS Relief).  In the next tier are bilateral agencies such as Aus Aid69, NORAD, DANIDA, 
DFID70, SIDA and GTZ71.  Followed by this there is an entire spectrum of smaller groups, 
charities and foundations that have their own agendas and funding pools.  In addition there are 
foreign Universities, community organizations, civic society groups, churches, missionary 
organizations and a whole host of other unorganized actors as well as informal groups that are 
keen to participate in the unfolding AIDS drama.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
and Malaria. Since its inception in 2002, the GFATM has committed $7.1 billion to over 136 countries through 
approximately 450 grants. The Global Fund is responsible for an estimated 20 percent of all international funding in 
support of efforts to combat HIV/AIDS, and approximately two-thirds of global funding for programs against TB 
and Malaria (NACO 2007, retrieved September 2010).	  
66 UNDP’s role in HIV was fairly minimal until 2004, except a few programs with NGOs, private sector and positive 
networks. By 2005, UNDP set up its HIV/AIDS Unit.  It received support from DFID for the initiatives to control 
trafficking and HIV/AIDS. It has also initiated specific programs/studies around health insurance and macro-
economic impact of HIV. Under NACP-III, UNDP has offered financial support to NACO for expanding the 
mainstreaming initiative at the level of NACO and SACS (NACO 2007, retrieved September 2010). 
67 UNFPA supports countries in using population data for policies and program to reduce poverty and assist in 
providing quality reproductive health and family planning services. The UNFPA Fifth Country Program (1997-
2002) of $100 million was the organization’s largest assistance program worldwide. It was designed to reflect 
agenda post International Conference on Population and Development (ICPD).UNFPA Country Office has 
established case management services for Reproductive Tract Infections (RTIs) and Sexually Transmitted Diseases 
(STIs). It works closely with the primary health care centres and laboratories.  Currently, UNFPA has three major 
interventions: promotion of condoms for dual protection, provision of RTI services at primary health centers and 
community activities to orient panchayat members on HIV/AIDS (NACO 2007, retrieved September 2010). 
68 USAID implements HIV/AIDS prevention, care and treatment as part of the President’s Emergency Plan for 
AIDS Relief. Efforts include HIV prevention in high prevalence states and among high-risk groups, and care and 
support to children infected or affected by HIV/AIDS. The program focuses on reducing HIV transmission through 
behavior change communication among vulnerable populations, however does not support harm reduction . In 2004, 
USAID scaled up care and support activities. The CDC provides technical assistance and training to NACO in 
HIV/AIDS control and prevention. Until 2009 USA maintained a ban on federal funding for needle and syringe 
exchange programs (NACO 2007, retrieved September 2010). 
69 AusAID has an agreement with UNAIDS for the South Asia region, under which it supports several regional 
initiatives including an HIV/AIDS program for the Northeast region in India.The key priority sector for Australia's 
aid program in India is health, and it includes HIV/AIDS, education, and water and sanitation (NACO 2007, 
retrieved September 2010).  
70 Department for International Development (DFID), India supports the Government of India’s efforts towards 
achieving the poverty reduction, health and education sector in the past couple of years. These are national program 
primarily financed by the Government of India but with a variable counterpart share from state governments. 
Support for the HIV program has moved from projects and direct support to the states in the 90s to a program 
approach and support for the national program under NACP-III, where DFID is the first donor to go for pooled 
funding. DFID’s experience in the five states in the initial years contributed in a large way in influencing national 
policy and the formulation of future phases of the national program (NACO 2007, retrieved September 2010). 
71 GTZ’s HIV/AIDS program operates within the framework of the National AIDS Control Program.  It facilitates 
dialogue with industry associations and civil society groups to promote more effective services and products for 
HIV/AIDS prevention (NACO 2007, retrieved September 2010).	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 Anjana Kothari provided some insight into the way these different actors came together. 
She shared that in the beginning: 
The problem in the donor coordination meeting was that- you had 20 people or 10 people 
from the UN organization, you had people from Swedish CIDA, Canadian CIDA, World 
bank, global fund, DFID, all sitting around the table and not being able to take any 
decisions and come to any agreements. So one of the first things we did was, we 
introduced an entry ticket approach- any entity bringing 10 million dollars or more per 
annum towards HIV program will be part of the donor co-ordination at the national level. 
Put people of the same funding level together, their stakes are similar, they want to see 
value for money, they want to see result, so they are much more focused on what are the 
results, so to remove the discrepancy in the expectations of various players we 
introduced.  It was also helpful to make the different units work together.  
In 2004 Government of India requested smaller bilateral donors to discontinue their 
support or channel it through the UN or NGOs72.  Larger donors (Global Fund, World Bank and 
DFID, but not BMGF) were asked to channel most or all their funding through NACO73. 
Programs that outside NACO or SACS are now expected to use the NACO reporting system. 
India a late signatory to the Paris Declaration on aid effectiveness adopted ‘the Three Ones’ 
principles (one Agreed Action Framework, one National HIV/AIDS Coordinating Authority and 
one Agreed National M&E System).  Such efforts at harmonization can place constraints on 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
72 Of the smaller bilateral donors that provided funds for HIV, Canada and the Netherlands pulled out in 2004, and 
AusAID and SIDA supported a regional NACO office in the North East through the joint UN program there. 
73 Resource needs for NACP-3 are estimated at US$2.8 billion. Less than 2% of overall expenditure is through 
Official Development Assistance (ODA), but for HIV the percentage is much higher at 65%, if the World Bank 
credit of 10% is counted as a government contribution. Approximately half of the funds for NACP-3 are channeled  
through NACO, including those from GOI (US$715 million), Global Fund (US$446 million), World Bank 
(US$281million credit) and UK Department for International Development (DFID) (US$202 million). The UN 
system has committed over US$80 million to NACP-3 (partly through NACO). Bilateral donors and foundations 
support the national strategy, largest being the Avahan project (US$356 million) supported by the Bill and Melinda 
Gates Foundation (BMGF) (UNAIDS, 2009). 
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innovation and reduce possibilities of NGO initiatives that are not “mainstream”.  There are also 
concerns “about the cost-effectiveness and sustainability of HIV interventions that become 
overly donor dependent, for example, free treatment, special HIV link workers and financial 
support for PLHIV” (UNAIDS, 2009).  
    Despite all this talk about equality and aligning of agendas significant differences and 
tensions existed among these actors.  These differences became even more pronounced when I 
began investigating the arena of implementation.  Stakeholders were often keen to work in 
specific regions, the allocation of which was made through much compromise and negotiation.  
Anjana Kothari shares the Director General, NACO during these meetings would say: 
 We want to continue maintaining the focus on 150-160 category A districts (high 
prevalence of HIV), so then she would open it up saying we want consistent action, in all 
the category A districts and then people (external stakeholders) would offer how they 
want to support it, where they want to support it.  So which of the donors can provide 
support for which of the districts. 
The other forms of donor co-ordination were related to financial management and 
balancing budgets.  At the state level the donors would map out the districts and areas they 
would focus on.  The state government’s were then advised by the center not to spend as much 
funds in these areas but ‘redefine their role’ in these regions.  If a new donor would come in they 
would thus have to adjust their interests based on such divisions of power and responsibility.  
Anjana highlighted that these negotiations were often difficult, biased and uneven. Certain states 
received more importance than others. Anjana pointed out: 
 When HIV started, it was initially stated in a couple of north east states and then down 
south, so many donors wanted to work in these areas – so the government also responded 
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with the standard public health approach- focus where the issue is, so that’s where they 
focused.  In my understanding when the BMGF entered into the country, they put up 
almost a parallel structure, even though there wasn’t a written agreement with NACO for 
a very long time (they have it now).  But at the state level they tried to work out districts 
with SAC (State AIDS Control Organization)- because they had a very big program.  The 
funding of the BMGF was equal to funding for NACP II and only focusing on 6 states 
and only on prevention, so that was a lot of money.  This gave opportunity to show how 
different approaches can work in the country at scale they were not one of pilots that the 
UN typically does, which then they find very difficult to replicate.  But they did things at 
scale and …however it meant that at the field level (experience of care, structures) there 
were concerns around the way funds were being spent.  If you have a doctor whose is 
getting 2000 and another getting paid 8000, its going to make a difference …the way 
NACO responded to this was coming up operational guidelines and operational 
guidelines- lot of times was spent in the first year of NACP III- was spent in shaping 
operational guidelines- and as you know these are legal documents.  So operational 
guidelines standardized the approach as well as costing.  Now that still does not prevent 
extra budgetary support from doing their own things but now its more a good will 
gesture- its more and more tendency to fall in line with what NACO has prescribed.  
The differences between government supported interventions and privately funded ones, as 
evidenced above, created an inequality in terms of services and resources.  The government 
recognized the dangers that such a differences in investment can make- both on and off the field.  
In order to address this difference the government began the process of organizing all services 
under a similar protocol.  
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   The state also recognized that there are certain tasks were better when left to the private 
sector.  Kirtana from UNAIDS shares an example: 
 If you are talking about condom promotion in the context of HIV, you could just put the 
condoms in the primary health center and hope that people would use it.  But you actually 
have a social promotion and mobilization around condom promotion, so you find ways 
that the condom reaches that last outlet –people are able to access it.  So you are 
supporting your health system through a partnership, which could be with Hindustan 
latex or with any other company (that has expertise in social marketing).  We’ve had 
experiences in states where we have been able to increase the use of condom manifold 
through private intervention.  I am believer of the public health system because that is 
what the common man will use in rural areas and even urban areas.  I agree that a large 
number of people go to the private sector but I think when you are looking at services per 
se.  There are certain services that are better managed by the private sector and I think we 
have to find those niche areas to support the public health system74.  
Abhishek Gupta with HIV AIDS Alliance highlights: 
There is a give and take which is happening where the government is to some extent 
trying to influence donors mindsets and where their money flows, but at the same time, 
the donors, because they are getting a seat at the table are beginning to negotiate with the 
government about what the approaches should be and what the government needs to 
think.  So I think the relationships will probably mature in the next 5 years of NACP III. 
Where I think one would see probably a more rounded response from the point of view of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
74 Another example she shares is the in Gujarat where Reliance Industries has taken over the public health care 
centers in certain areas and are running it a more efficient manner. She specifically pointed out that ‘private’ today 
could include civic organizations, health networks and even community organizations all of who were important 
partners in this fight against HIV. 
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the government. 
 Finally in the arena of expertise development, international agencies like the UN played 
a crucial role in providing the technical support to the government as they developed protocols 
and frameworks of functioning.  Kirtana Singh, head of HIV programs at UNAIDS shared that 
their own role as a global organization had seen such a transition as the program had grown and 
evolved: 
 What one is seeing is that apart from sustaining what one has started, you can see a lot of 
initiatives being taken on by NACO, on expanding the existing program, put up 
initiatives or proposals to expand that and really make it a good quality program…(thus) 
they are working with people like Dr. Sunil Seth (an independent drug expert), UNODC 
is bringing in international experts-so is Gates foundation- We recently had a meeting 
with DG (Director General) on the larger program.  And her request to UNODC was that 
all I need from you is support for scaling up the OST program- drop everything else you 
are doing, that is important but not so important but support us on this.  
Kirtana highlights that the UN agencies played an important role in ‘packaging’ the 
model in such a way that it became acceptable to all parties concerned.  Sahiba Kaur of UNODC 
notes that UNODC has been able to juggle and work with both Ministries of Social Justice and 
Health with two opposing viewpoints.  Given that the larger mandate of UNODC is demand 
reduction their natural allies were the Ministry of Social Justice and Empowerment, however 
with time the momentum shifted towards harm reduction and their participation in this newer 
paradigm has become more significant.  Some NGOs and public health specialists feel that this 
type of ‘dual’ position of UNODC actually works against the harm reduction movement whereas 
others highlight that the entire sector of drug treatment seems to straddle both perspectives- 
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abstinence and harm reduction all at once. 
   UNODC also partnered with Government of India to take over the DFID supported 
OST sites and “prepared” them for a smooth government transition.  Sahiba Kaur shared, 
“UNODC helped the government to do evaluations of all these sites, to see which ones they 
could take over and which ones were just not providing any services”.  UNODC also became a 
conduit through which funding for these sites flowed until the accreditation process for these 
sites was completed.  Rajat Dhingra, a senior technical officer shared that their role was to make 
sure these sites met the NACO guidelines on targeted interventions for injecting drug users “and 
provide catalytic support in absorbing these sites under NACO’s own NACP III policy”.  The 
“preparation” of these sites also includes “a lot of training and capacity building for the 
implementing staff so that includes doctors, pharmacists and support staff”.  UNODC has 
established an additional learning center on OST with AIIMS (India’s leading government 
hospital), they have also established such centers in other south Asian countries where OST 
projects are active, thus supporting governments to generate more research knowledge on the 
issues75. 
  Dileep who worked with Ashray (NGO), shared his frustration about the importance 
given to these international agencies, “only about three to four years ago they (UNODC) were 
totally against harm reduction and (now) suddenly they barged in, they started hiring consultants, 
started publishing manuals on harm reduction, OST with methadone, OST with Buprenorphine”. 
This was a crucial issue of contention with NGOs who had often worked longer on the street 
than these UN “experts”.  UNODC has helped to develop ‘tool kits’ for Buprenorphine 
maintenance therapy, needle syringe exchange and other harm reduction strategies; these tool 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
75 One of the key research projects launched by UNODC is a Rapid Situation Research Assessment to understand 
the impact of harm reduction programs. 
	   140	  
kits became precursors to the Government of India’s own training modules.  UN’s role was 
crucial in knowledge generation, research, documenting, training and development of expertise 
has brought with it global standards of care, evidence based practices and shaping of more 
transnational model of harm reduction76. 
   Sahiba Kaur was clear there was a definite  “comfort level” between the UN and 
government.  They worked with the Government on many projects, trainings of peers and 
workshops, she says “we invite them, they invite us, essentially we go through the government, 
they sign on our project documents and agree to partner on projects.  The interaction with NACO 
and MSJE has been good and been constant”.  This trust is most evidenced when the 
Government reaches out to them for both information and perspective on different issues.  
Sahiba shares some examples: 
 When the government comes and says look can you provide us with the information or 
give your comments on this document or can you organize the evaluation for us by 
independent experts… so I think we are seen as a partner, we are seen as a ‘valued’ 
partner, also as someone who is unbiased.  So I think it has been quite good and even 
now especially on the Buprenorphine front its been quite good and last year NACO wants 
to do a pilot on methadone as well and so they approached us and said look you prepare 
us a concept note and send it to us because we want UNODC to do the pilot so I think 
that sort of the sign of trust and understanding I think the relationship is good.  
UN agencies were taking the national lead in supporting government efforts to legitimize 
harm reduction.  They were seen as a ‘neutral’ agency not aligned to any one particular 
government department.  As a transnational development organization, with great social 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
76 It is important to note that quite often these UN publications involve NGO and government officials. Also there is 
this large deficit about knowledge about harm reduction, which UN officials are helping addess. 
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currency in the development sector, their sanction was helpful for NACO to maintain credibility. 
NACO understood the political hierarchies and was consciously seeking these ties.  For the UN 
this relationship was critical to their presence in the country.  Kirtana from UNAIDS highlighted 
that the HIV program is all about partnerships- “between government, non government and 
donor agencies (UN and other bi laterals), I think it is really very strong, which defines the future 
direction- which is also helpful”.  
  From the government’s perspective the response towards such collaborations was much 
more guarded.  Sankalp Sinha a technical officer for NACO felt that despite the talk of 
collaboration there was quite a lot of ‘competition’ among the UN agencies to prove their 
expertise.  He also pointed out that these organizations there were considerably distanced from 
ground level realities, government officials on the other hand, were more keenly aware of these 
issues.  There was similar hesitation voiced by Dr. Alkesh another government bureaucrat of 
NACO.  He claimed that the international organizations were driven by global shifts in agendas 
and were often keen to address specific project oriented concerns.  In contrast to this, the 
government was aware of these global foci but successfully shaped its policy in response to the 
community’s needs.  
     Bi-lateral organizations often collaborated with the UN agencies and the government 
on projects and participated actively in the macro policy environment.  These relationships were 
strongly governed by factors such as the host country politics; European agencies tend to be 
more open to harm reduction as compared to the U.S. government and this impacts the types of 
programs they fund in India.  The economic interests of each country and the relationship with 
the Indian government also impacted the nature of their participation in the harm reduction 
programs.  The relationships between these organizations would change as their investments 
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within the country changed (increase or decrease).  Cross cutting agendas, bargaining and 
collaborations complicate this policy environment. 
 Non-govermental but governmentalized.  
NGOs have traditionally occupied a key role in drug treatment and in the broader 
development sector in India.  As discussed earlier in this chapter some of these NGO’s were 
pioneering harm reduction efforts even before the government became involved in this area. 
Both within India and globally NGO’s have had an important role to play both in the 
development sector but also more specifically in the drugs and HIV sector.  
The evolution of NGO’s in India was marked by a growing disenchantment with the 
Indian state, which despite its socialist leanings was failing to meet the needs of its poor and 
disenfranchised citizenry.  After independence India was keen to build a strong nation built on 
the promises of social justice, peace and equity.  However by the 1970s and 80s it became 
evident that there remained stark inequities partly the result of skewed government policies.  
Severe critiques were levied against the ‘trickle down’ modality of growth and development that 
served to only support the industrial and urban sectors of India (Nandy, 1987; Shiva, 1989; 
Kothari, 1988).  
During these years the country saw the resurgence of Naxalities (violent communist 
groups) and other Maoist groups.  They adopted a revolutionary stance against perceived 
injustices and building from a peasant base and community focus they challenged the status quo. 
At the same time there was also the rise of other non-political groups that began to fight for a 
variety of social concerns, these included charitable organizations, religious and civic bodies as 
well as community organizations.  Non-governmental organizations began as an offshoot of 
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these institutions and over time developed a unique space of their own, ultimately becoming a 
significant site for social and political activities within the country.  
    Under this new harm reduction regime the role of the NGO has developed into a 
service provider primarily.  Roughly over 500 NGOs are currently involved in the drug treatment 
sector (FINGODAP, 2006 retrieved 2010) and close to 130 NGOs are linked with the 
government to provide harm reduction services.  With the support of international agencies the 
government now ‘outsources’ care- giving functions to NGOs quite unlike other public health 
models. The government recognized that in most cases NGO’s were well versed in harm 
reduction services and was keen to partner with them (due to their prior experience in running 
their own programs or expertise gained by managing the pilot projects launched by international 
agencies).   NGOs also possessed the necessary skills to mobilize communities and understood 
the needs of the communities far better than any other organization.  
This collaboration with the NGOs was both beneficial and problematic.  Experts argued 
that NGOs found it difficult to balance their ‘care-giving’ functions with their advocacy 
functions.   As a result, I observed that the NGOs were submerged under the everyday problems 
of service provision and did not have the time to address systemic concerns.   However, unlike 
before NGOs were now given a seat of importance on the “policy table”.   Their involvement in 
trainings, development of promotional material, research and protocols are some of the ways that 
the NGO’s are being incorporated into the processes of state care model.  
   Abhishek Gupta, a HIV expert from HIV/AIDS Alliance provided some additional 
perspective on the nature of these NGO-government relationships: 
The NGOs are much more in touch with reality, much more representative of the voices of 
the community and therefore all the several issues which relate to individual agency and 
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rights is something which the NGOs are constantly advocating with government for so 
whether people are not getting treatment, whether harm reduction is not being accepted at 
the community level, if testing kits are not available, substitution therapy is not 
available… those are the kinds of things NGO are fighting for besides providing services. 
Now very often the government is aware of these issues but needs to be reminded of these 
issues on a constant basis.  I think today the government is far more open to hearing 
various voices from the field as it was say 5-10 years ago and I think that has also 
happened because of the evolution and the maturation of HIV within the country and the 
increased realization of the dependence on NGOs and on (patient) networks to be able to 
deliver the programs. 
 I mean the government cannot do without the support of the NGOs as simple as that and 
that message is far more clear now within the government than it was earlier.  So I do 
think that there was a little bit of opening up from the government side though still they 
find it hard because you know it’s a constant criticism of their own program, their own 
thinking their own strategies, which are also often determined by various political agendas 
and foci- but at the same time the only way to influence them is through the voice of the 
people, through the movement, which is what the NGOs bring to the table so they are 
forcing the government into corners very often and winning small battles every now and 
then. 
Dr. Alpana Deshpande of the WHO shared the benefits of having NGOs in the mix of 
service provision.  She pointed out, that unlike the bureaucracy that has its “own system in place, 
they are accountable to several other agencies, they have their auditors…the NGOs function in a 
much more flexible and unregulated environment”.  This adaptability is essential for a successful 
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community level program.  Government programs were more likely to face restrictions, NGO’s 
on the other hand much more flexibility.  Dr. Alkesh from NACO, however claimed that quite 
often the NGOs ‘had the heart but not the head’ i.e. they were not trained to provide the multiple 
types of social, psychological and medical services needed.  He felt that even a simple program 
such as needle syringe exchange required expertise, planning, and management, which was often 
lacking in the working of the NGOs.  
 While Dr. Deshpande from WHO supports such a government and non-government 
partnership, she argues that the state must contribute more heavily in the health sector and 
“NGOs need to be made more accountable they need to work around sustainability and 
equitability of the partnership…”.  To address some of these gaps in knowledge and practice, 
NACO had begun trainings, workshops, developing protocol for interventions and even a process 
of accreditation for the NGOs and NGO workers.  
I had the chance to participate in one of the training sessions that was conducted by 
NACO.  The State Resource Training Center provides most of the training for the partners of 
harm reduction; they had in turn outsourced the task to Alfred Da Cunha, a peer worker from 
Sahai.  Many of the NGO’s that the state had partnered with were either following an abstinence-
based program or were not specifically trained to provide services to drug users.  NACO thus 
had the daunting task of not only educating them about harm reduction but also about drug use in 
general.  However, NACO did not have enough in-house experts that had the time or enough 
field experience, hence was ironically hiring from within the NGO community to educate other 
NGOs.  
   During the training session Alfred gave detailed instructions on the intentions of the 
new model of harm reduction.  He told them that the focus of harm reduction was not to 
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eliminate drug use but more simply to avoid HIV risk.  The motive of the training was to 
standardize care and eliminate the idiosyncrasies of their local cultures of therapy and recovery.  
I noticed that the bulk of the training was focused on convincing the workers about the 
usefulness of such a model, since there were many skeptics and long-term Narcotics Anonymous 
followers among the peer group.  Advocacy functions were given less importance as was seeking 
connections and networks within the community to support the drug user beyond recovery. 
Finally, the training was heavily focused on documentation, accounting and auditing their time 
on the field.  There was a clear sense that with the involvement of the government, the NGOs 
had to become more accountable and record keeping was key to this process.  
 While the NGO’s considered themselves experts in the field, these trainings functioned 
to “re-educate” them in the technical processes of a national program; drug treatment in the 
community was clearly now being “disciplined”.   With Bill and Melinda Gates attempting to 
transfer their projects to community-based organization in a few years, the stakes are indeed high 
for training these community drug treatment organizations.  
    Kirtana at UNAIDS highlighted that the training of these community level 
organizations was a key challenge for the national program: 
In Mizoram, they had no clue- they didn’t know what an outreach work worker should 
do, what a peer educator should do, they did not have a doctor or nurse.  That kind of 
handholding is really intensive and I am hoping that this year and the next year there 
really would be a good structure in place to strengthen this program because we know 
that one can reach out to the last person through NGOs and CBOs but you do need closer 
support for these groups and you do need consistent monitoring.  NGOs are normally set 
up by a person, who is committed who’d like to do something for the community, but 
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beyond that you are looking at a program that is complex… you do need a lot of support. 
And that really is the challenge right now NACP III.  
Dr. Khom identified similar issues “One of the things that didn’t work is that you have 
well meaning NGOs coming up lots of them really committed to health – but with little idea 
about or understand about the harm reduction issue itself ”.  He argues that most drug treatment 
organizations come with the philosophy of abstinence “so for them it takes a long time to switch” 
to harm reduction.  He also identified that some NGOs are church based and have moral 
concerns about harm reduction.  He acknowledges that most NGOs have very little monitoring 
and quality control and with greater focus on accountability and evidence, NGOs will have to 
improve their functioning in order to continue to receive support.  He feels that one of the 
reasons the government has been slow in expanding the harm reduction program is the lack of 
capacity of both NGOs –the implementing partners and the inability of states to provide adequate 
training and support.  
I am saying there has to be minimum system in place- storage of drugs, make sure how 
the Buprenorphine is kept properly (the rooms, temperature), distribution, entry, 
screening follow up – all these things have to be in place – now I don’t think in many 
targeted intervention locations are very confident- that is one side, the other side is how 
many of the SACS officials are conversant with this to be able to follow it up properly 
what temperature it has to be kept, what is the supply chain system , follow up system so 
they are slowly going slow on that. I think we need to push further… 
NACO has also been impressive in bringing a number of regional NGO’s to the center 
stage thus increasing their visibility and exposure, while at the same help to forge alliances 
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across groups.  However, building consensus was not an easy task, there were crucial differences 
among regions and the NGOs. 
I had an opportunity to understand these differences during one of the meetings that I 
attended during my fieldwork.  The meeting was focused on the rights and needs of the injecting 
drug using population.  Over twenty-five harm reduction NGOs’ were attending the session from 
across the country.  The discussion was centered on setting priorities for a policy document that 
would represent the key needs of IDU’s.  The divisions between the NGO’s became clear quite 
early on.  Older organizations from the northeast and from New Delhi were keen to push for 
second line of ART medication, better testing facilities and a larger focus on OST programs. 
These organizations were involved with harm reduction efforts for about a decade and were keen 
for more advanced services and structural changes.  The newer organizations were keen on 
support, training and better coverage of their clientele; many of these organizations were from 
the South and Western parts of the country.  Issues like stigma and discrimination remained 
important for all NGOs across the country, except in the northeast where drug users are usually 
more accepted.  However, in order to bring about long-term change all NGOs recognized that 
HIV and harm reduction needed to be “mainstreamed” in the Indian public health care system. 
Kirtana from UNAIDS pointed out:  
Until you integrate this program with the larger health program HIV will still be 
struggling. It needs a different focus as well because of the stigma and other issues but at 
the same time it must be a part of the state health program. Otherwise it will remain this 
vertical program implemented by NGOS and CBOs – there is this huge pressure to scale 
that up; the capacity to manage that scale is not completely there in many states so it is 
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not an easy situation to be in where a large part of your program is sitting with NGOs and 
CBOs.  
Abhishek Gupta from HIV/AIDS Alliance also concurred with this view: 
We need to sort of merge the entire HIV response within the national rural health 
mission, so in which case this vertical response to HIV may actually change which means 
you may not have the small NGOs working at the grassroots level as much as they are 
working now, there will still be a Non governmental component to the response but 
probably not like today- tomorrow it might be led by the government machinery the 
health machinery, which today is in shambles. 
   A booming business of health. 
The underlying philosophies and logics of care based on my fieldwork also represented 
often seemingly opposing and antithetical worldviews of the diverse stakeholders.  The ideals of 
human rights, equity and social justice were clear remnants of the global paradigm of public 
health and harm reduction and had found their way into the Indian policy and intervention sector. 
In addition there was a clear focus on the “economics of health”, with an emphasis on greater 
efficiency, investments in areas of high returns models of health related more clearly on 
productivity.  These tensions shaped the daily decisions of harm reduction policy and more 
crucially trickled down to the practices of harm reduction as well.  
   To understand these unique dimensions of harm reduction I turned first to one of the 
largest funders and policy influencers in the Indian harm reduction circuit.  After many phone 
calls and emails I was finally able to secure a meeting with Kanika Ghosh.  She was the young 
dynamic ex-management consultant from New York who had returned a few years back to lead 
and shape the Gates Foundation multi-million dollar initiative within India.   
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The Gates Foundation is one of the largest funders of public health programs not only 
within the country but also across the globe.  They contributed close to 258 million dollars and 
more recently added another 100 million (Bill and Melinda Gates Foundation, 2009, retrieved 
September 2009).  Their approach to health, thus, influences and frames not only their own 
programs but also those of their funding partners including the Government of India.  Hence, 
their perspective towards both health and overall development is important to understand in any 
analysis of the harm reduction programs in India.  I was slightly surprised to learn that our 
meeting would not be held in some plush office in south Delhi but instead within the freshly 
renovated government offices of the NACO.  While the larger government building was 
dilapidated, the AIDS offices were well designed, airy, with their walls adorned with colorful 
posters and some local art.  
   Kanika spoke authoritatively about the role of Bill and Melinda Gates in India, “our 
work with the government was to help the government wherever we can and wherever we were 
asked to.  An MOU was signed in 2006 for the Avahan/Gates Foundation to provide technical 
and managerial support to the government to scale up some of its high risk programs”.  She 
highlighted that both “adhoc and more formal support was provided as a part of this MOU, 
including secondment of staff over to NACO, we have helped them with guidelines where 
required we have provided training as required, modules in all of the above areas”.    But it was 
not always like this: 
When we came in people were actually denying we had an HIV epidemic and people 
especially the government was very very leery of us as an organization- but close 
working with them and also proving what we have actually done has helped put the 
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credibility of our organization and hopefully the methods have spoken for our themselves 
in some ways. I would rate our partnership in nothing short as strong. 
Kanika also importantly detailed the role and trajectory BMGF adopted when it came to 
India: 
In terms of the Government we didn’t start working with the government, we made 
grants directly to NGOs and continue to do so- however the foundation’s policy in India 
or policy in general is not to replace government or market or not to crowd any of them 
out, it is really to be catalytic investors…we are not permanent funders …we know the 
money will run out one day, we know the foundation corpus expires 50 years after their 
(Bill and Melinda) death. So we started investigating (whether) the natural owners of the 
epidemic could take ownership and adopted two strategies, one is to transition our efforts 
back to the government and to transition our efforts to the community itself they will then 
demand these services than be recipients of the services so community mobilization is the 
linchpin of all of that. 
Kanika was clear that their effort was to develop a program that would work on a large 
scale and effectively curb the epidemic.  She shares that their effort was and continues to be 
largely focused on not as much proving the harm reduction model, which has been already 
demonstrated to work, but instead launch at the scale where it can have a strong impact on India. 
In an interview that Kanika gave to a Global health blog she draws a strong parallel to private 
business enterprise.  She pointed out: 
It’s similar to any business model that you can find in the private sector, where there’s a 
focus on the customer as the beneficiary of the services being sold – or delivered in the 
case of health.  In the private sector that’s buying toothpaste; in the public sector it might 
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be the impact in terms of lives saved.  In the context of HIV prevention in India, the 
recipients of prevention services (sex workers, men who have sex with men, injecting 
drug users) need to be part of the delivery, as peer workers (a “sales force”) and be 
leaders of community-based organizations delivering the interventions.  So the question 
is-Are you able to design for scale?  Do you have a clear denominator? Are you focused 
in your intervention?  Are you integrating across your value chain even within one area? 
Are you measuring everything you do, which is a very critical piece of any good 
business?  Then you think about executing for scale, what does that mean, operationally 
and tactically?  Are you organized to the point where you can implement on a large 
scale? Large businesses do not just implement in one little place, otherwise they don’t 
make enough money.  Similarly, with impact, I think you want to have a greater span. 
Clearly this position of the Gates Foundation was exemplified in first the nature of their 
funding and activities since they had entered the country.  Their focus was on high-risk groups, 
in areas of high prevalence, using globally accepted models of treatment, and involving the 
affected community in all areas of program implementation.  With a heavy emphasis on creating 
structural infrastructure such as testing facilities, clinics and drop-in centers as well as on ‘softer’ 
infrastructure such as creating a trained outreach/peer staff, developing accurate mapping of the 
concern and establishing linkages with community organizations.   
Critics of the program cite many issues with their approach- from the ideological i.e. the 
Gates Foundation has used an business model to approach public health to the economic, i.e. 
high salaries and technical investments did not necessarily make a difference to the people on the 
ground (Flock, 2009). Globally these criticisms are being increasingly voiced by a small number 
of public health activists and civic leaders.  Their claims that the Gates Foundation is largely 
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pushing technical interventions, without addressing more structural and cultural contexts has 
been soundly refuted by the Foundation.  Both Government of India and public health specialists 
in India have responded to these critiques very cautiously- highlighting the needed for continued 
support- highlighting the complex and interdependent relationships between these stakeholders.  
   Over the next few years Avahan (Gates Foundation’s India office) will be slowly 
transferring many of its projects to Government of India.  In fact, some public health specialists 
note that there was a clear “scaling down of role from an implementer to packaging the 
learnings’ from Avahan” from 2006 (Rao, 2010).  There are also concerns about structural and 
functional capabilities of the State Aids Control Organizations and their ability to manage as well 
as monitor these Avahan ventures.  In addition the incentives to staff and investments in the 
program of Avahan led programs is far higher than the publicly funded health programs of 
NACO (Rao).  All of these point to serious issues in terms of transfer and maintenance of 
quality.  Given Avahan programs exist in some of the highest at risk regions with most 
vulnerable groups, this transition has greater implications for the overall harm reduction model.    
   While my fieldwork did not include any direct observation of the Avahan funded 
project it was clear they exerted considerable influence in the macro policy context.  The areas 
this was most visible was the way most funders and government spent their money, the 
frameworks adopted towards harm reduction measures and the focus of implemented programs. 
Prevention for a country like India was key to stop the epidemic, considering the low rates of 
prevalence and a large portion of the funds went into infrastructure and technical support.  This 
meant needle-syringe exchange programs and OST were getting a good proportion of the funds 
as they were framed as risk reducing measures as was outreach.  However, nutrition, 
psychological counseling or long-term rehabilitation was either seen as uneconomical or 
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ineffective in ‘halting’ the epidemic.  The Government and other funding agencies also were 
following such logics and thus there was an overall consensus in such efforts.  
  Non-injectors and alcoholics were considered less risky groups despite prevailing 
knowledge about their high-risk behaviors and health vulnerabilities.  Harm reduction programs, 
according to Avahan literature, was subsumed under the “business of prevention of HIV” and the 
emphasis according to Kanika Ghosh was on the creation of an “aware consumer”, getting an 
individual “who otherwise did not care about health to care about health that’s some of the 
biggest benefits”. Kanika highlighted that this process also involved: 
 Creating demand for services especially in HIV prevention for sex workers, men who 
have sex with men, and injecting drug users. These populations are marginalized, they’re 
underground, and they’re very dispersed. Also, creating demand for services can create 
solutions for sustainability. If a service is demanded by the community then, whether it’s 
from the government or from other NGOs, funding can be found.  
While Government of India, in particular, did not use such a language necessarily there 
was recognition that health investments must be made in areas where there was ‘evidence’ of 
returns.  
    Generating a paradigm of harm reduction. 
  The unfolding dynamics of the different stakeholders in the harm reduction paradigm in 
India have brought forth the highly unstable and fickle nature of the politics that surround this 
sector.  Clearly the state is becoming increasingly involved in the health of drug users in a 
manner that was not seen before, though it is adopting two diverse routes to secure it. 
On one end it is becoming a manager of sorts by delegating many functions, developing 
expertise and creating a cadre of workers and institutions that are ‘non-state’, to provide harm 
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reduction services; while on the other hand it is re-investing in public health in more of 
traditional welfare state model to provide care for its general citizens, of which drug users are an 
important segment.  No doubt the approach to health has also evolved in this process, with 
greater emphasis on evidence base practice, research, risk management, economic evaluations 
and creating a more aware, responsive, choice bearing consumer.  
    However, this development was far from even or cohesive, multi-stakeholders each 
with their own perspective on care and health were creating many competing discourses within 
the harm reduction paradigm.  There was also a great range of service quality, lack of adequate 
monitoring/supervision, disruptions, corruption and delays – making it difficult to necessarily 
advance any overarching model that was reflective of any one particular ideology.  Halmshaw 
and Hawkins (2004) highlighted that many international organizations support or channel their 
funding through government intermediaries, a trend clearly seen in India.  However, this can act 
as a problem especially as the government may not have the capacity to adequately absorb the 
funds and disburse it fairly.  In fact these researchers argue that government often suffer from 
their own biases and may tend to standardize approaches to the problems instead of promoting 
innovation and independence of community based organizations.  In the case of harm reduction 
in India all of these trends were visible especially as the government tried to build a new 
framework for drug treatment and health and remove local difference.  The balance between 
adopting a basic minimum standard for provision of services and providing a conducive 
environment for new strategies to emerge was difficult and not well executed in the contexts, that 
I observed.   
   Bilateral agencies and international organizations though often at the cusp of new 
trends and developments from across the globe, lacked street credibility and knowledge of the 
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local culture of drug treatment.  While they were using NGOs and community based 
organizations to overcome this gap, it left big questions about who could be considered the ‘real 
experts’ and what type of cache did expertise bring with it?  NGOs in particular were being 
pulled from their anti-state and advocacy positions to almost become service arms of the 
establishment.  Their own cultures of therapy was now being rewritten in a new language of risk 
and pharmaceuticals- their participation in the model entailed a revision and re-visiting of their 
old methods of recovery.  This era of accountability was important especially in a sector that has 
remained unregulated thus far.  However, in the same vein harm reduction programs were 
originally most lauded for their flexibility and adaptability, which this new 
‘governmentalization’ is definitely questioning.  
   This interweaving of public, private, government, non-government and civic society 
was how harm reduction was being built.  Administratively, financially and ideologically this 
paradigm clearly showed that there were no permanent allies or enemies.  Though the 
stakeholders were invested in certain positions with regard to drugs and harm reduction, they 
were often flexible across a range of issues and were willing to collaborate and work together.  In 
some senses the current climate of funding structures, grants and the very scale of the projects 
makes it such that no one stakeholder can work alone.  Surviving in a system of revolving doors, 
where new partners entered as old ones left, was both difficult and challenging.  In terms of even 
mapping these diverse groups is extremely challenging partly because these actors keep evolving 
and changing their roles, alliances and positions.  Swidler (2007) discusses these complexities 
through evolving a multi-level universe of actors that are interacting simultaneously with a 
diverse set of players and are thinking about boundaries in unusual ways, especially about nested 
hierarchies and social processes.  Traditional categories of local, regional, national, international 
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and global, she argues will not work very well in these new ways of thinking about harm 
reduction and there must be in fact a greater emphasis on interpenetration of actors, permeability 
of boundaries and their own roles as well as the way they come to understand the way they 
function in the larger global conditions.  
   But one of the key points that my fieldwork underscored was that despite these 
interdependencies and overlapping of roles and responsibilities each stakeholder was vested in 
maintaining a separate identity.  The Government continued to push its role as a welfare provider 
with critical goals of health and well being for all. NGOs talked about the necessity to remain a 
watchdog for the people and committed to the cause of communities in the city. Bi-laterals and 
international organizations focused on their global legitimacy of being organizations committed 
to health, rights and risk reduction.  In the reification of their identities as separate and unique 
they seemed to almost overlook the everyday practices of governance and disciplining that was a 
crucial mark of their relationship.  
Harmonization was a key “organizing” concept and seemed to dominate harm reduction 
discourse in India. However, I could see that it ended up masking the inherent differences, 
peculiarities and discordant world-views, in order to bring all actors together.  In this fight for 
survival as agendas intertwined, beliefs got suspended and alliances were made. The temporary 
and instrumental nature of these relationships do not undermine the impact they had on the 
policy and practice front.  Dr. Sunil, an HIV expert in the region, claimed: 
We are not really tied or bound to any one particular ideology, if it works then we do it. 
Abstinence is the ultimate goal- but it seems no one is in a hurry to get there yet, in fact it 
is a continuum of care model and one needs to look at it with that perspective.  It is a 
practical position that one must adopt and not completely buy the idea that drugs do 
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harm.  There is no one who is wedded to one philosophy unlike the west where there 
those who believe in harm reduction and there are those who believe in abstinence.  He 
also claims that the difference is very much artificial and in fact there is no point to the 
fight’. 
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CHAPTER 5: A NEW KIND OF SURVIVAL- LAYING RISK BARE 
The city is. 
Unwieldy and rough. 
It can draw you in and let you die. 
Created almost tempestuously, ungrateful city. 
Drawing me within and keeping me lost. 
 
My feet touch the ground and feel a prick. 
These paths are my home and my maiden voyage. 
Time rearranges itself for me. 
Building new ways for me to travel. 
 
My hands feel the walls, railings and leaves. 
They shiver and coil. 
Emotions come and go in this fractured heart 
Am I fixed or not moving 
 
Grabbing, shoving, pushing and heaving…let me be. 
Diving, pulling, plunging and piercing…let me feel. 
(2007,2011) 
  
 
   Broken lives. 
   In this chapter I discuss the conceptualization of survival within the context of harm reduction.  
In detailing the contexts and conditions of the two NGO sites, where I conducted my study I shed 
light on how the various types of harms generated on the street and the responses of a truncated 
harm reduction treatment paradigm.  I argue that risk becomes a category devoid of context, 
limiting and often even preventing clients from seeking health.  By placing the lives and 
experiences of drug users at the center of my work and demonstrating the daily practices of 
recovery and rehabilitation I hope to lay out the complicated ways in which harm reduction is 
extending lives but also reshaping them in new ways.   
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Usha, 35 years: 
I was born in Calcutta, after the death of my mother my father married again.  Today the 
reason I am into drugs is because of my step mother.  Till my father would be around the 
house she would act as if she cared about me, but after he would leave…he wanted me to 
go to school.  I would get prepared to leave for school and then she would say what will 
you do by learning how to read and write…she would beat me, I would have to do all the 
work around the house.  When I was 12 years old a boy came to stay in the house close 
by.  He would pick-pocket and he would give money to my mother to keep at our house.  
My stepmother greedy for money- I don’t know what she told my father, but she fixed 
my marriage to him.  He gave my mother Rs. 5000 and we got married, though I didn’t 
go to his house until I matured.    
     As days went by I became pregnant and I noticed he would come home late and then 
soon stopped coming home at all.  I found out that he was stealing.  Sometimes he would 
get caught and released.  I also realized that he was taking smack.  I would feel bad, we 
had a small child and here he was taking smack.  I would sit all night with him as he 
smoked, I asked him what are you taking, and he asked me to try.  One day he came 
drunk and he had some pills as well, he took a big stick and started beating me- all these 
marks over my body, and he has only given them to me.  Another day, he took a huge 
stick and blade and placed it next to him and forced me to try smack.  He beat me with 
the stick and then used the blade to make a mark on my neck.  After that day I started 
taking smack.  He also taught me how to steal.  I would steal in the railway station and 
use the money for drugs.    
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The breaking point in the marriage came when her husband started cheating on Usha, 
fights ensued, culminating in a separation.  Her life after the separation was difficult and she 
finally decided to leave her daughter with her mother and move to Delhi to try her luck.  She 
landed in Nadi Nagar and in some time found a partner.  She had two sons with him and 
continued to use and abuse drugs.  She tried quitting by going to a full time rehabilitation center 
but found it difficult to leave her husband and children for such long periods.  Usha was the only 
woman I met who was on the harm reduction program.  She lived in a small makeshift hut on 
walkway of one of the main roads of Nadi Nagar.  She would come each day and take OST 
medication for herself and her husband.  Usha reported that she had all but stopped her drug use 
though occasionally she would use drugs.  She found this type of community-based program 
helpful, because it meant she could continue attending to her family’s needs.  Usha claimed 
unlike other women she was not a prostitute but instead begged for food and money.  She talked 
about joining a midway home, educating her children and getting a job.  When I left she had not 
made any plans yet to leave.   
Dalbir, 49 years: 
I am from Punjab, district Amritsar.   I have been here in Delhi for at least 8 years.  I was 
a truck driver in Amritsar, from Delhi to Bangalore and from Bangalore to Delhi.  Amidst 
this I had an accident, after this accident I came to Sahai, here I come to tend to my 
wounds.  They are healing now.   
    My father was in the Air force and my mother a housewife…I have two brothers and a 
sister.  I left my studies when I was young and would go with my uncle to Pakistan to 
smuggle goods in black.  From here we would take betel leaves and alcohol and bring 
back opium.  I was about 14 years old then.  My dad tried to stop me but I did not listen 
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to anyone.  I would make about Rs.   3000 each trip.  Slowly I started drinking and soon I 
was taking smack.  I had to then leave home, because by then I had started stealing and 
doing drugs.  At that time I had no idea about drugs, that I could lose my home, I could 
lose my family, at that time I did not know anything.   
 Dalbir got married and his wife knew little about his drug use.  During this time he 
would sustain himself and his family by driving tourist cabs and later buses.  Even during the 
height of his addiction he continued working, often causing accidents.  Dalbir belonged to an 
emerging high drug using belt of north India, close to the Pakistan border.  Drug use, especially 
injecting drug use rates in these regions have been on the rise in the past few years.  Low rates of 
unemployment, a violent history of terrorism and separationist struggles have left their mark on 
the youth of these troubled parts.  He recalled, “ I got into drugs because when I did not get love 
from my home, that’s why I got into drugs…the environment was also bad, inside the house, the 
environment outside- there were no jobs.  ” 
   Dalbir was on Sahai’s OST program but had also tried a variety of other recovery 
options before his current stint in the program.  At different points he had gone through 
detoxification and abstinence focused rehabilitation.  While these would work for short periods 
but inevitably he would return back to drug use.  Even though he claimed he was clean, the staff 
were very sure he was using other substances besides his medication.  In the last few years he 
had lost all contact with his wife and children.  He was keen to heal his wounds and return to 
Amritsar.  He was currently living on the street, without any steady job or income.  As I was 
leaving he assured he would be around when I returned.   
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Survival dynamics.   
In September of 2008, I began my work in the communities of Khargapur with the NGO 
Sahai and in Nadi Nagar with the NGO Ashray, in Delhi.  Both these grassroots NGOs at the 
time were struggling in different ways to provide basic harm reduction services to the city’s 
poor, homeless and addicted.  Despite being located within the national capital region, which has 
in the past few years seen exponential growth in civic infrastructure and resources, these 
communities seemed to be stagnating- almost forgotten.  They had for the most part been 
neglected to such an extent, where shockingly even the most basic of services such as water, 
electricity and sewage were considered a luxury.  Drug users, had to struggle even more in order 
to survive within this larger context of marginality.  With poor public health options available, 
unemployment and exclusion from civic, social and economic resources they were critically 
endangered.    
     But when I arrived all of this was slowly changing.  A large reason for this change 
was that a growing number of drug users had begun to receive care and support through the harm 
reduction services of Ashray and Sahai.  These services were no longer emphasizing abstinence 
or recovery but rather encouraging risk reduction.  Over time I came to understand how this 
perspective engendered a unique kind of survival for the drug users that participated in the 
program.  In the next two chapters I attempt to delineate the nature of this new survival, 
specifically looking at possibilities, opportunities and limitations that these harm reduction 
services created for drug users.  But before I do this, it is important to dwell on this notion of 
survival itself and why I chose it over the much more familiar term recovery.   
  Drug users have for long been a highly stigmatized group, however as I have shown 
previously, the emergence of HIV brought about a crucial change.  As a high-risk group with the 
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potential to spread HIV, they could no longer be ignored.  Drug users were now to be 
specifically targeted through a variety of harm reducing interventions.  These interventions were 
to serve many purposes – reduce health risks, manage the epidemic and also bring one of the 
hardest to reach groups into the purview of the state and civil society.  Drug users were no longer 
seen only as patients or criminals but as potentially productive, responsible and health seeking 
citizens.  The mandate thus for harm reduction, was broader than the traditional boundaries of 
drug treatment and recovery.  The term ‘survival’ reflects a more refined understanding of life 
under this new regime.    
    Recovery as a term was also rather nebulous and narrow.  In some senses failed to 
capture how I saw drug users negotiate their daily lives.  They were no longer within clinical 
environments leading isolated lives but instead out in the world struggling to navigate the social, 
medical, cultural and experiential aspects of a harm-reducing environment.  Drug users/clients 
could adopt a variety of lifestyles, both with and without drugs- each of which was shaped by 
harm reduction services.  Clearly this was not a passive or submissive relationship between the 
providers and clients and nor could be understood in the limited confines of any single 
environment.  Instead I viewed them as subjects who were constantly evolving, managing, at 
times manipulating and adapting to extend their lives.  Survival encompassed this conscious, 
adept and vital life force that was at the same time unfettered, courageous and perilous.  The 
term survival, for me as a researcher emerged from a place of hope, not of naïve kind but from a 
deep acknowledgement of lives and wills that were broken yet became fertile grounds for new 
possibilities.  It is this “survival” that I discuss in through my work.    
   In this chapter, I lay down the routines and practices of drug users who are participating 
in these harm reduction programs.  My focus is to highlight how drug users experience the 
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specific risk reduction components of the program namely abscess management, counseling, 
HIV testing and needle syringe exchange.  In doing, so I investigate what changes these services 
bring in the lives of drug users, in their ways of thinking and negotiating their social 
environment.  Most crucially, I reflect on the implications of this risk focus on notions of health 
and rehabilitation.   
Risk inherently is a combination of abstract factors, which render more or less probable 
the occurrence of undesirable modes of behavior (Pratt, 1999; Castel, 1991).  For social workers 
in India the concern was not as much to solve the addiction problem, as it was to reduce risk for 
HIV.  Drug users, were now to be treated as responsible consumers of services rather than 
dangerous subjects.  Risk ends up focusing on the consequences of problematic actions such as 
substance abuse and not as much to address the actual problematic of people using substances.   
‘Their primary aim is not to confront a concrete dangerous situation but to anticipate all the 
possible forms of irruption of danger.  Prevention promotes suspicion to the dignified scientific 
rank of calculus of probabilities.  To be suspected is no longer necessary to manifest symptoms 
of dangerousness or abnormality –it is enough to display whatever characteristics the specialist 
claim can be responsible for the preventive policies towards risk’ (Castel).    
   Since most of this research on risk and harm reduction was based on western contexts I 
was keen to investigate its usefulness to understand the Indian harm reduction paradigm.  I also 
recognize that risk, as an organizing approach cannot be done away with.  As a social work 
researcher I had to participate in the process of reinvigorating risk as a concept that would keep it 
relevant and sensitive to the needs of the most marginalized.  I begin this discussion with 
detailing the overall framework of drug rehabilitation in India.   In the next two sections I will 
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broadly discuss the actual day-to-day experiences of injecting drug users as they experienced 
risk, harm and these preventive services.   
   Displacing recovery.   
Early in my fieldwork I realized, that to fully understand how recovery under harm 
reduction was working within India, I needed to pay attention to the construction, functioning 
and delivery of these services.  The advent of harm reduction I found had crucially shifted not 
only the conceptions of health/recovery but also fundamentally altered how rehabilitation 
services were reaching people.  Thus the routines of recovery became essential to understand 
recovery itself.   
   Before delving into these dynamics it is important to preface this with a broader 
discussion of rehabilitation services in India.  Most traditional (both government supported and 
non-government) rehabilitation centers in India run on some version of the Minnesota Model, 
which is based on the AA philosophy77.   Usually operated by recovering addicts, these centers 
often employ workers who lack adequate expertise in the field and possess poor therapeutic 
knowledge.  In fact, with little monitoring and lack of adequate laws protecting clients, the 
rehabilitation centers at times use questionable practices to force clients into ‘recovery’; many 
cases of human rights violations have been widely reported in the media.  These centers have a 
standard protocol applied to all clients irrespective of the specific nature of addiction, age, sex or 
social conditions.  The recovery period often involves long stays in an isolated institutional 
environment (usually three months).   Not only is this difficult for the socially disadvantaged 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
77 The Minnesota Model approach (Hazeldon, 2010) is typically characterized by a thorough and ongoing 
assessment of all aspects of the client and of multimodal therapeutic approaches. It may include group and 
individual therapy, family education and support, and other methods. A multidisciplinary team of professionals (e.g., 
counselors, psychologists, nurses) plan and assist in the treatment process for each client. The assumption is that 
abstinence is the prerequisite. Treatment provides tools and a context for the client to learn new ways of living 
without alcohol and other drugs.  
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groups who may have families that require their economic support but also presents a 
considerable challenge when the recovery period ends and clients must return/adjust back into 
their community life.   Private rehabilitation centers in India are also notorious for extracting 
huge sums of money in return for their services.   With few (free) government sponsored 
rehabilitation centers actually working and private rehabilitation centers becoming too expensive 
for drug users to afford, harm reduction services have become the only option for most injecting 
drug users seeking care and support.   
  When harm reduction emerged in India, it thus truly represented a new and dynamic 
model of recovery.  It aimed to provide a variety of options, flexible schedules, community based 
care and a client oriented recovery program.  Services were now to be structured around the 
needs of the clients who would actively shape their recovery.  Delivery of services was to be 
provided largely by peer workers who emerged from the community itself.  In contrast to the 
existing services harm reduction’s promises were indeed enticing and empowering.    
    Sahai and Ashray presented two subtly diverse models of harm reduction even though 
they shared many similarities in focus and practices.  To start with, both these organizations 
focused on the same clientele i.e. injecting drug users (IDU).  These clients were usually either 
rag pickers or employed as informal labor; a few clients had regular jobs as clerks, security 
guards or rickshaw pullers.  However a large number of them were unemployed and would have 
to steal or beg to survive.  IDU’s are considered at high risk for HIV and Hepatitis as well other 
diseases such as TB.  The term injecting drug user referred to any drug user who had been 
injecting in the last three months (as defined by the NGOs themselves and National AIDS 
Control Organization).  This definition was rather vague if one considered the realities on the 
street.  Many drug users, for instance, were known to turn to injecting during times when drug 
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quality was poor and resume non-injecting routes such as snorting or smoking when drug quality 
improved.  In other cases many non-injectors reported to having experimented with injecting for 
short periods as well.  Further, a majority of drug users on the street were non-injectors 
(including alcoholics) who were equally likely to engage in risky sexual practices or risky 
behaviors that increased their chances of HIV and Hepatitis.  Risk then, was far more widespread 
than assumed through such arbitrarily imposed categories such as ‘injecting drug users’.  Both 
the NGOs intimately understood these issues and tried to expand their reach to ‘non-injectors’ as 
well, but were constrained by both time and funding agendas.  Hence their overall focus 
remained on current injecting users who formed a small but highly risky subpopulation.   
  Both the community projects of Sahai and Ashray in Delhi were also similar in that, 
they were based on the drop-in center model (DIC).  This model aimed to provide a 
comprehensive care package for the drug users at a community based site.  Besides outreach, all 
other services were provided at the DIC.  A good way to understand the role of the DIC is to 
view it as a nerve center.   On one end it receives all kinds of information, gathers expertise and 
adopts strategies while on the other end it uses this knowledge to shape people’s lives in the 
community.  Clients came Sahai and Ashray mainly through outreach or referrals.  This meant 
that peer workers played a key role in convincing injecting drug users to engage and participate 
in the program.  Other times injecting drug users heard about the program from current clients 
that came to the center.  The promise of medicines, tea or food, rehabilitation, job placement and 
recovery were all key motivating factors for clients to enter treatment.   
  Beside these basic similarities Sahai and Ashray worked slightly differently.  For Sahai, 
the DIC was seen as an entry point through which clients could then access other services and 
ultimately move towards abstinence.  At Ashray the DIC itself, was in some senses, the end goal.   
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Though some clients were referred to other long-term rehabilitation services if they chose, 
reducing immediate drug related harm was the main focus at Ashray.  This essential difference 
become more evident to me as I began to see the pathways of recovery charted out for the clients 
in the two organizations.   
  Uttam, one of Sahai’s outreach workers, would often cajole the clients by saying, 
“Come to the center, there you will get needles if you want, medicine to help with your 
addiction, counseling, HIV treatment…if you like we can also send you for rehab and from there 
on we could help get you a job”.   Sahai was promoted as a one-stop shop, where clients would 
have the freedom to pick and choose the services they wanted.  They sought a long-term 
relationship with the clients, where the ultimate goal for them was abstinence.   Bhagwan Das, a 
counselor at Sahai emphasized that the main demand many clients’ had was  “Bharti kara do” or 
admit us.  All they wanted purportedly was to be admitted into a full time rehabilitation program.  
The reason for such a demand, according to Bhagwan Das, was that most drug users continued to 
‘believe’ that an abstinence oriented rehabilitation program was the best way to recover.  Of 
course, the added benefit of having food and shelter was also an important motivation.   
Inevitably, Bhagwan Das shared, 90% of the clients either returned from such recovery programs 
without completing the program or would relapse immediately upon their return.  Harm 
reduction, he discussed, was still a new concept in these communities and not many clients were 
able to grasp its implications completely.  In fact Bhagwan Das shared that in the beginning 
Sahai would offer regular detoxification services, “so that they could begin to trust us, realize 
that the organization is doing good work”.  Abstinence was valued more than this new form 
‘recovery’.  
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   Averting disease, courting addiction: life at Sahai.    
 It was fairly early in the morning and the doors of Sahai had just opened to admit its first 
few clients as I walked in.  Only this past week I had begun my fieldwork in Kharagpur and was 
slowly becoming accustomed to the schedules of the NGO, its workers and clients.  I noted that 
Aslam, a thin wiry peer worker, had already begun to boil a huge aluminum container with water 
for chai.  As we sat down for the regular morning prayer meeting, the aroma of hot chai began to 
waft through waking everyone.  Prayer, I came to understand was a key element of the spiritual 
foundation of Sahai; it grounded each day’s activities.  But the hot chai was no less important- it 
kept hunger at bay and was almost considered the life force of the NGO.    
   The central room, which housed the clients during the day, was not a large space and 
usually cramped and noisy.  However, during this morning prayer time with only a few clients 
and staff present, it seemed strangely peaceful.  Unlike other harm reduction initiatives in the 
city, Sahai continued with this tradition of prayer, a hangover from its old roots as a ‘therapeutic 
community’/drug rehabilitation center.  Clive an old timer of Sahai usually led these meetings.   
He was a recovering drug user and also a devout Christian, which shaped both his prayer 
‘sermons’ and his role as a peer worker.  The songs they sang in these meetings were usually a 
mixture of Sahai’s traditional rehabilitation prayers like ‘Ae maalik tere bande hum’78 and 
Christian hymns (Sahai’s head is a Christian and it clearly influences the spiritual element of the 
organization).  I tried to sing along with the prayers that I knew.   I saw some clients’ only 
mouthed the words while others sang loudly and slightly off key.  Most of them had shut their 
eyes and looked asleep as their heads nodded off.   I wondered if they had a restless night on the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
78 ‘Oh Master, we are your servants; May our actions be such; That we walk in virtue, and shun wrong. 
So that we laugh as life-breath leaves us. Ironically, the song was first sung in a Hindi film by jailed inmates but 
soon became a nationally popular prayer.  
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street.  This shabby and nondescript room perhaps offered them temporary respite from the night.   
The prayer’s tempo began to build slowly.  Saif, (NGO worker) had started to drum loudly on 
the chair and soon all the clients had opened their eyes and sang with gusto, they clapped their 
hands, their bodies moving to the rhythm.  The hypnotic voices and the drumming reached a 
crescendo and then suddenly everything became quiet.  After the prayer ended the atmosphere in 
the room shifted, all heads turned to Clive to hear him talk.   
  Clive took this time to share a moral lesson and spiritual teachings and finished the 
session in a typical AA (Alcoholics Anonymous) fashion asking God for forgiveness for wrongs 
done.  Before ending the prayer Clive informed the group that a couple of Sahai’s clients were in 
a critical condition and asked everyone in the room to pray for their health and safety.  The 
moment was poignant, as I watched, unable to shut my eyes, transfixed at the weary and tired 
faces before me- asking God for forgiveness, health and healing.  This heavy intermingling of 
spirituality, AA and harm reduction philosophies was evident in many daily recovery and 
rehabilitation rituals of Sahai in particular.  These discordant bodies were draw in through a 
patchwork of these older traditions of rehabilitation programs and newer modalities of care 
within harm reduction- affect and pharmaceuticalization it seemed moved hand in hand.    
   After the morning prayers, the staff began to prepare for their day.  Kiran, who was in 
charge of abscess management, began his daily routine - cutting gauze, tearing the lint, washing 
the equipment, cleaning out gloves (they would usually reuse gloves until they tore) and 
sterilizing all the instruments.  Well built, quick witted and charming, this young Nepali 
recovering drug user would keep clients entertained as he tended to them efficiently and with 
dignity.  The latter was particularly difficult to do since clients were treated in the main room of 
the office with no curtains or room dividers.  The public was privy to everyone’s wounds -
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privacy was a luxury neither Sahai nor its clients could afford.   About an hour had gone by and 
now the NGO was buzzing with clients, a few had already started to line up for treatment of their 
abscesses.  I watched as they lay down one by one on the rickety bed lined with old rubber sheets 
and a stained pillow and Kiran did his best to tend to these scratches, blocked veins, infected 
wounds and deep gashes.  Addiction left its mark and the decaying bodies were a painful 
reminder of the life ‘outside’.    
  Particularly troubling to me was the rate at which clients returned, sometimes for 
months on end to tend to the same wound.  Poor hygiene, continued drug use, lack of adequate 
medical supplies and inadequate medical knowledge and training of the workers themselves were 
to blame.  However, Freddy, the project supervisor was quick to point out that since Sahai started 
its services the number of abscesses and their severity had drastically reduced.   Drug users were 
reluctant to go and seek the free services of the government hospitals because of the long wait, 
poor service and discrimination.  Private health care was out of reach for most drug users and a 
large number of them would simply die because of the lack of care.    
One morning a few weeks later Kiran looked over to where I was sitting and asked me if 
I wanted to see a maggot infected wound.  I quickly refused glancing at the client, who himself 
had turned his head away from his own leg.  My refusal was not understood, since a bad abscess 
usually generated great interest.  Clients and staff would gather around the wound just to see the 
damage.  Slightly disappointed at my refusal to see the wound Kiran continued his work, steadily 
removing maggot after maggot, there were hundreds.  As he worked he remarked, “You 
shouldn’t have ignored the abscess for so many days”.   Clive, who had been watching this was 
also clearly disturbed by the scene, he kept looking over at the client and reiterated, “We are 
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giving you free needles, take them from here next time you want to inject…and don’t wait for so 
long before coming here, you could lose a leg like this”.   
    Abscesses meant failure, failure to reach out and provide enough clean needles that 
would prevent infection; failure to help drug users transition from invasive to non-invasive 
modes of using and of course a larger failure of the system to prevent illness or disease.   For the 
drug user it was seen as a failure of a harm reducing life and for those who had transitioned to 
the oral substitute, an abscess was the most obvious sign betrayal of their adherence to their new 
medical regime.    
  During the time Kiran tended to abscesses, Bhagwan Das as well as Prakash Singh had 
begun their work in the counseling room.  The two worked well together in providing a whole 
host of services to the clients.   This included taking case histories, pre and post test HIV 
counseling to drug users, assisting clients transition from needle syringe exchange programs to 
OST or detoxification/rehabilitation, talking with family members, conducting sessions with 
clients of the DIC and supporting with clients on ART.    
  Due to confidentiality concerns I was not able to witness these counseling sessions but 
would indirectly discuss them with both clients and staff.   These sessions seemed to primarily 
convey two messages- HIV prevention and freedom from an addictive life style.  Every potential 
new client was told to come to the center and make an ID card and meet with the counselor.   
The ID card served as a reference for all future interactions with the staff and NGO.   The 
counselor uses this first meeting to also take their case history and develop a rapport with the 
clients.   Due to time pressure these interactions often were short and without much privacy.   
Prakash, due to his AA orientation encouraged clients to explore detoxification and rehabilitation 
options whereas Bhagwan Das on the other hand promoted OST more fully.   But both 
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counselors recognized that substitution medication was most effective with new clients as it 
helped keep withdrawals at bay and supported them through this toughest phase of recovery.    
   The other key emphasis of counseling was on HIV testing.   Almost every client was 
‘encouraged’ to get tested.   Funding mandates dictated that the NGO must test as many ‘risky’ 
clients as possible.   Clients were then give basic information about HIV and its risks before they 
go for their “khoon ka test” (blood test).   Usually Victor would accompany clients for these tests 
and help process their results.  After the test, post-test counseling is conducted with the clients.   
Since most clients are not aware about HIV, one of the main tasks for both the counselors was to 
explain the nature of the disease itself.   Prakash Singh, for instance, would spend considerable 
time explaining how HIV can be contracted and spread, what it does to the system and the 
precautions each person must take to maintain health.  Clients who tested positive were 
especially encouraged to either move away from drugs completely or at the very least move to 
OST.  The process was slow and it would take many sessions for clients to fully understand the 
implications of their disease.  Most clients continued some form of drug use and failed to 
maintain adherence to ART regimes. During the course of my fieldwork period approximately 60 
clients were on the OST program.  Close to a 100 clients were on the needle syringe exchange 
program and around 20 clients would come each day for tending to their abscesses or seek 
counseling for various issues.    
 The clients on OST would be encouraged to spend the day at the DIC itself.   The 
essential purpose for this was to keep them away from drugs and street life.   At times Sahai 
would conduct sessions with the clients on issues of HIV, risk and addiction.  However, during 
my time at the DIC these sessions were few and far between, usually the clients would spend 
their day watching TV, chatting and sleeping.  No food was provided by the center and clients 
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would often complain about this oversight.  Freddy, the project supervisor, told me no funding 
agency was willing to fund a nutrition component and clients had to seek food for themselves.   
By around 4 pm the DIC would shut down and the staff would spend the rest of the day finishing 
paper work.    
   After clients had completed six months or more on OST Sahai would encourage them 
to taper their doses and move to an abstinence treatment program.  In fact it would even have 
regular detoxification sessions to prepare clients.  Sahai’s own abstinence program was facing 
financial troubles and thus clients would be referred to an outside program.  One of the other 
incentives given to clients for moving out of OST was the referral to the midway home.  The 
midway home was run by Sahai and helped drug users to find jobs in local factories and offices.   
Clients from Sahai’s various programs would be sent there after they had been stabilized on the 
abstinence programs.    
    Ideally the harm reduction model was designed to help drug users transition from the 
needle syringe exchange program to OST and finally towards an abstinence treatment but this 
rarely occurred.   Clients would often move back and forth between these steps –stopping, 
relapsing and re-starting.   As clients rotated in and out of the DIC, it was clear that reducing 
harm was not enough.  In fact, Sahai was in no way, shape or form ready to meet  all the 
demands of the clients completely.  Drug users on the other hand seemed to show little faith in 
the state systems- whether it was health care or judiciary.  They were outcasts, stigmatized, left 
forgotten in the corridors- suffering and death then did not seem as the exception but the rule.   
Over time, I began to see how this hopelessness with street life and larger systems continued to 
plague what happened within the NGO itself.   As drug users tried to piece together their lives 
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through the limited resources provided by the NGO, the role of the absentee state seemed to only 
become more apparent.    
   New realities of recovery: life at Ashray.   
  After completing three months at Sahai I began my fieldwork with Ashray in late 
November.   Ashray had two offices in Nadi Nagar and I would alternate between them to get a 
complete picture of their services and interventions.  While one site solely focused on the OST 
program and limited abscess management, the other site provided all the key harm reduction 
services.   Ashfaq Mallik, the project manager, during one of our first meetings explained how 
things worked at Ashray, “I don’t have a fixed schedule, things happen and I have to adjust”.   It 
probably, I soon realized, was the best way to understand the multiple activities that seemed to 
occur almost simultaneously at Ashray.   The day would begin fairly early for the staff and client 
volunteers who would spend the first hour of each day cleaning and setting up the office space.   
In the first site, there were three rooms each designated for a specific purpose- abscess 
management, administration and doctor’s visits as well as dispensing OST.   
 In the second site the office was small and mainly used for administrative purposes or 
counseling.   Bhuvan the counselor and Ashfaq the project manager would usually be found 
sitting here, completing paper work, sorting client-staff disputes, discussing cases or exchanging 
community gossip.   Since the office was small the courtyard in front was used for in house-
needle syringe exchange and OST services.   On most days one would find Ansari, Umaid and 
Abhikh (all three peer workers) sitting under the shade of a large and old peepal tree, sitting on 
old chairs, interacting with clients.   Ansari and Umaid were old timers of the program and were 
in charge of providing needles and syringes to those clients that came to the DIC.   Abhikh was 
much younger and not a recovering user, he was in charge of OST services.   The courtyard 
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served as an important place to meet, interact, share information about the latest police raids, 
current trends of the drug markets and family troubles.   Most often the discussions would be 
centered on health issues, especially related to abscesses, lack of adequate care, problems with 
sleeping or breathing and most crucially drug withdrawals.    
  Rashid and Julie (peer workers) would spend the early part of the morning’s busy 
setting up the corner room for tending abscesses.   Ashfaq recounts: 
 I still remember the first time I came here there were so many clients and they were 
dirty, it was so crowded.   Now I see them and realize there is so much change in them.   
Earlier they were so dirty all wrapped in a shawl (lying on the street corner).   Even now 
one can see them but they are at least a little bit cleaner.   Even abscesses have reduced a 
lot.   During the days of our previous project almost 80-90 clients would come each day 
with abscesses caused by injecting.   Nowadays that is no longer there…the community 
people say what magic have you done over them.    
Today only about 10-15 clients would come for treating abscesses- a dramatic fall.   
Despite these claims I always felt that death and disease were on close call.   Some time later two 
incidents occurred, which both challenged Ashfaq’s claims and my assumptions about reducing 
harm.    
  The first incident took place a month after I had begun work at Ashray.   It was fairly 
early in the morning and as I was walking down the road that led to the NGO.   Sudhir, an 
elderly client, who I had seen a few times before stopped me.   Since most clients slept on this 
road it was common for them to greet me every morning, just as they would be waking up and 
doing their morning chores.  However, it soon became clear that Sudhir had not stopped me to 
exchange pleasantries.  He looked extremely troubled, “Can you help Amitabh didi (sister)? His 
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condition is very bad and these people (Ashray) they are not doing anything to help.   He will 
surely die”.   Amitabh, Sudhir revealed had severe abscesses in his groin as a result of injecting.   
He had been lying on the road for the past few days refusing all help.   I had not heard about 
Amitabh but promised Sudhir I would ask Ashfaq and Bhuvan, the counselor about it.   He 
quickly thanked me and left.    
  Later that morning I got the chance to ask Ashfaq who knew little and quickly deferred 
to Bhuvan for clarification.   Bhuvan in turn turned to Samir, an outreach worker for details 
about Amitabh.   Samir was clearly surprised by the interest but feebly responded that he had in 
fact seen Amitabh a few days back.   He had asked Amitabh to come to the DIC or go to the 
hospital but Amitabh had refused both suggestions.   Ashfaq looked uncomfortable at the report 
but not unduly perturbed either.  He instructed Bhuvan to send ‘someone’ to find Amitabh and 
take him to the hospital.   An outreach worker was immediately dispatched.   Bhuvan approached 
me and said, “You see Gayatriji, someone did go before, but if the client refuses to go (to get 
help) what can one do…I mean have so many clients… clients who want help…so going behind 
one person who is clearly refusing it…it is, it is their choice”.   Ashfaq added, “See we are here 
to give the client choices, but we can’t force them- our goal is to show client paths, it is up to 
them to choose them”.    
  A few days later I heard that Amitabh had died on the way to the hospital.   Bhuvan told 
me that after much insistence on the part of the outreach workers Amitabh had agreed to go to 
the hospital.   However, en route to the hospital, as he sat in an auto rickshaw he died due to 
complications.   “There already have been 5 deaths this winter and surely more will come.   This 
keeps happening.   It is sad but what can we do…especially in cases like this when the client 
wants to die”, commented Bhuvan.   He further added that clients ‘knew’ that injecting in the 
	   179	  
groin was dangerous and yet they continued doing so.   I was shocked and deeply disturbed, even 
though I had never met Amitabh, his death represented such a complete loss of faith not only in 
life, but also in these very systems, that were created to prevent such tragedies.   Bhuvan had 
called on  ‘choice’ and knowledge as critical elements to label his death as ordinary.   In doing so 
he had wiped out his own role or that of the NGO, state and other systems that had left Amitabh 
to choose death.   
  A couple of weeks later the second incident occurred.   I was sitting in the courtyard 
when I saw a small crowd collecting in the grounds opposite.   As I walked closer I could hear 
groans of pain and the crowd cleared to let me in.   One of the clients Ashish was sitting on a 
torn blanket, writhing in pain.   Ashish like Amitabh had injected in his groin and it was severely 
infected.   Barely able to hold his head straight he told me that his pleas to be taken to the 
hospital were being ignored by the NGO.   With Amitabh’s death still fresh in my mind I walked 
over to Bhuvan’s office to follow up.   Bhuvan, contrary to Ashish’s statement, informed me that 
they were in fact planning to take him once they found the necessary paperwork.   Ashfaq 
walked in at that moment and asked about the commotion outside.   After hearing and viewing 
Ashish’s condition he asked Bhuvan to take him immediately without wasting any more time on 
the missing paperwork.    
As we watched Ashish leave Ashfaq spoke about the intricacies around such medical 
problems.  In most cases of serious groin related abscesses, there was very little the doctors could 
do at such a late stage.  Added to which doctors were usually reluctant to treat drug users and 
often make them wait for hours before treating them.  Surgeries, like those needed for Ashish 
and Amitabh were also very expensive for the hospital and patients would be required to 
contribute a certain amount- especially for medication.   No client was able to do this and thus 
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was often sent back from the hospital with some pain medication but without much hope.   
Ashfaq also informed me that government hospitals would only accept patients if the NGO 
assured them that a peer worker would be present at all times to assist the patient.  For Ashfaq 
this meant sacrificing one of his peer workers for an extended period of time.  A week later, as 
per Ashfaq’s predictions, the hospital sent Ashish back claiming there was little they could do.   
  Both of these incidents were for a number of reasons. The first reason was that despite 
all claims otherwise there were clearly a number of people simply dying because of inadequate 
care and support.   In order to reach sheer numbers individual quality of care was suffering.   
Second, harm reduction as a philosophy was counting on primarily the rationality of its actors, to 
choose life over death.  But these logics are often not as clear as we’d like them to be, affect, 
hope, relationships with institutions, trust in the system and agency (of the person) all played a 
critical role for Amitabh and Ashish.    
    During the course of the day over 150 drug users would receive needles and syringes 
and close to 200 were on the OST program.  Overall close to 500 drug users received direct and 
indirect services from both sites of Ashray.  One of the main efforts of Ashray was to encourage 
clients to simply come to the center and develop trust.  This had meant the NGO needed to be 
flexible to the needs of the clients.  Injecting drug users unlike other marginal groups are 
extremely hard to access and due to the stigma associated with their behavior, they often remain 
at the periphery of most services/institutions.  Thus it was important to remain open to their 
needs and accept them despite failed attempts at non-risky practices.    
   In the previous two sections I attempted to outline the overall routines and approach of 
Sahai and Ashray, with a specific focus on abscess management as well as counseling services.   
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A key component of their risk reduction work was related to HIV –testing, support, counseling 
and advocacy.  I will now expand on these concerns in the next few sections.   
   HIV landscape.   
   Voices of the number 9s.   
Mushtaq Rahim, 47 years: 
I would work in fairs with light and sound, much later with the camera and then I got into 
drugs.   It was during this period that I met Sahai in 2008.   I used needles and syringes 
during drug use.   When I became associated with them then I got to know about HIV and 
after that I kept sinking.   I then got HIV.   Then this madam (outreach worker) told me it 
is important to be careful- I left drugs then… She would explain about the disease, gave 
us information.   She told us, ‘Don’t use each other’s needles and syringes and don’t 
share’.   We used to do it, we didn’t have much information- yes we have used each 
other’s needles.   At that time even the NGOs would not give us needles.   We had to buy 
our own new needles.   We didn’t know that by sharing we could contract the disease- we 
only got to know about this after the check-up.    
   Born in Uttar Pradesh, a north Indian state in the country’s heartland, Mushtaq grew up 
in a small village.   His story of rural-urban migration, injecting drug use and HIV is one that is 
fairly common but one which is seldom heard.   The HIV movement has found it particularly 
difficult to reach out to this demographic, which remains hidden and acutely disenfranchised.   
When I met Mushtaq for the first him I was struck by his gaunt face and his slight body covered 
in a dirty white kurta and pajamas.   He was suffering with throat ulcers, had lost a lot of his hair 
and was weak.  Like many of his peers, he left school at an early age to work with his family and 
support their income.   Charas was a common drug in the village as was alcohol but besides these 
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he knew fairly little about drugs.   When he came to city he first started using smack and then 
graduated to injecting without realizing the implications completely.   “One of my friends told 
me, ‘lets go to Kharagpur and get a ‘set’.   I didn’t even know what that was.   A ‘set’ has 
needles, two syringes and other equipment needed for injecting”.   These sets to inject are 
commonly available in the pharmacies in and around the community.    
   It was through Sahai he first learnt about his positive status.   Positive clients in Sahai 
are called ‘number 9’s’- a code between the staff to maintain confidentiality and yet 
communicate about the positive status of the client.    
 In the village (even) today I am afraid because I have the disease.   If I were to tell 
people back home then they would hate me…there is a lot discrimination (chua chooth).   
Even if there is utensils then they will say don’t let this person eat from these utensils- 
give him separate utensils to eat…I have not told people back home because the respect I 
had (would be lost)… This is the influence of being positive in our lives.   
 Once he tested positive he was asked to register at the ART clinic in the government 
hospital.   He didn’t do it immediately and only more recently decided to take the step.   His CD4 
count was around 300 and he told me he was not doing any drugs.    
  During our next meeting Mushtaq looked much better and sat talked with me for over an 
hour.   Unlike our previous conversation, this time he spoke less about his personal troubles and 
more about his rights as a positive person.    
In the beginning the staff was talking to us very nicely but now this new staff does not 
care about the client as much…many things have changed now look madam for us HIV 
people we come in the morning they should at least try and give us food once a day.   
There is no help for us- if tomorrow one of us gets fever or catches a cold or gets ulcers –
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then they send us to the hospice care facility of Sahai.   We stay there for 4-5 days and 
even if it doesn’t heal they discharge us.   Look the government is fully willing to support 
us (HIV positive people).  That day I had blisters in my throat, so I told Clive (NGO 
worker at Sahai), so he said let’s see and told the doctor.  The doctor wrote a medicine 
that I had to buy from the pharmacy outside.  The doctor only said one thing, Mushtaq we 
don’t have the medicine here, you have to buy it from ‘medical’ (pharmacy), it is 
expensive …let’s see maybe you could go to the care home of Sahai (reserved for critical 
patients), I will find out.  He wrote the medicine, I did not pay much attention to the 
prescription (because I couldn’t afford it). Today I asked him if he asked I could go to the 
care home.  He told me he had forgotten.   Carelessness is on his part not mine; we are 
coming here regularly to them.  That is what I am saying for us, for those people who live 
on the street there is nothing”. 
The resources that are coming in our name, we are fully getting those resources for 
example medicines for fever and diarrhea – everything come from there (government).   
Now these people come here and do ‘drama’.   I brought this issue up with the Delhi 
Network of People with HIV  (a rights based organization for HIV affected people).   
They told me Mushtaq you cannot complain alone, bring at least 4-5 people together and 
place a complaint with us, and then we can investigate.  They told us for you people 
everything comes, now if Sahai gives it to you or not that is a totally different matter.   
You positive people should be kept well by the NGO.   Who will listen to us? 
Mushtaq’s positive body had catapulted him into a new network of care and support.  But 
he soon realized that his positive status could not guarantee him much in terms of food, shelter or 
even free general medication. As a positive patient, the NGO frowned upon his using needles to 
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inject.  Sahai was keen to keep him on the rolls of the system but found him far from the ideal 
harm reduction client. Mushtaq, on the other hand, was keen to continue using drugs but also felt 
that it was his right to receive better treatment options. In, essence he did not see his continued 
drug use as a barrier to receive better care as an HIV patient.  
During his conversation with me he never once mentioned his rights as a drug user.      
After a few weeks Mushtaq dropped out from the program and we heard he had gone back to 
using full time.  He had stopped going to the ART clinic as well.  No one was clear as to why he 
left.  Later in the year when I was out in the field I met Mushtaq busy sorting garbage.  He 
looked even weak, dirty, his eyes were red and he barely looked at me.  I asked him what had 
happened, why had he stopped coming to Sahai.   “I don’t like it there, I fought with them”.   
Abandoning any pretence of neutrality or distance I asked him to perhaps give the organization 
another chance or at the very least go to Ashray.  Keeping his head down, he continued to sort 
garbage and said nothing.  I realized my time with him had come to an end and now he wanted 
me to leave.  
    Government Labs.   
It was going to be one of my first visits to the ART clinic, where I had planned to meet 
Victor (Sahai staff) to understand the mechanics of HIV testing within the government hospital.     
This large hospital was located a few kilometers away from Kharagpur.   It was both dilapidated 
and depressing from the outside.  Old rusted iron gates led into a large compound where patients 
seemed to occupy every square inch of the compound.  Many of them had camped out on the 
lawns with sheets spread out, lunch boxes and water jugs on display, as if in preparation for a 
long stay.  Children had found a small corner to play and families seemed to basking in the warm 
sun.   
	   185	  
  I followed Victor’s precise instructions and entered from the west end of the hospital 
and was assaulted by the strong smell of antiseptic, sweat and disease.  Slightly overwhelmed at 
the crowds that seemed to be jostling to enter into doctors’ offices I followed the prominent 
National AIDS Control Organization’s boards to reach the ART clinic.  Victor was waiting for 
me at the door.  Tall, broad shouldered with slightly long wavy hair and big bright smile, Victor 
stood out even in this crowd.  Dispensing with the hellos he told me to follow him.  In stark 
contrast to the rest of the hospital, the large room was well lit, clean and air-conditioned.  The 
patients were all seated in comfortable seats and there was little noise or confusion.  As the nurse 
would call out each patient’s name the person would get up and enter the doctor’s office.   
Structured, efficient, comforting and completely surprising given my experience outside.  I 
noticed that the walls were lined with posters of HIV awareness, support groups, HIV care and 
referral services.    
Victor quickly introduced me to Shahid, Ramesh and Ashok.  The three of them shuffled 
in their seats and flashed brief nervous smiles.  I realized they were clearly conscious of their 
appearance- the dirty and tattered clothes, deep abscesses and unkempt appearance jarred in this 
scene of middle class HIV patient citizenship.  But before I could think about this much more 
Victor started to explain all the tasks that lay in front of us that day.  “Its good that you came 
today Gayatri, you can see all the steps it takes to get them registered in the clinic”.  Shahid and 
Ramesh had come for their ‘khoon ka test’ or blood test.   Ashok on the other hand was waiting 
for his papers and get registered at the ART clinic.   After about ten minutes of waiting Ashok 
was called in to the doctor’s office, Victor went in with him and after a few minutes came out 
smiling and led us out of the clinic.   Once we were out he asked Ashok, “Did you understand 
what the doctor said?” Ashok nodded and looked away.   Victor took some time to explain 
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anyway.   “Your CD479 count is good, so doctor says you do not need to start ART.   But you 
must take care, eat well and injecting must stop injecting”.  “ I stopped long back…” Ashok 
hurriedly replied.  Victor was not convinced but told him to come to the center as he prepared to 
leave.    
   After Ashok left Errol told Shahid and Ramesh to stand in the line for the blood test, we 
both left to collect test results from a different floor.   Close to 100 people were in line.  Some 
were so ill they could barely even sit and were dragging themselves across the floor.  As Victor 
and I walked up the staircase he informed me that the lab would shut at 11:00 am for tea break.  
For most patients it was difficult to wait until 2:00 pm, when the lab technicians were “likely” to 
return.  This meant that a majority of those in line would have to come back again tomorrow.      
Victor shared: 
Clients registered in the ART clinic are given a number – they are given form with the 
number and if they have the form then they have to go and get the date and the number 
from another department.  So I take the client and go and take the blood samples- 
according to that file number we will get those reports.    
But the cycle of tests, reports and numbers does not end there.  Clients needed chest X-rays (to 
check for TB and other infections), a complete blood chemistry and liver function tests in 
addition to a number of other tests.  Each department gives a different file number and all results 
are sent to a central collecting department, which is where Victor was taking me.    
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
79 CD4 cells are a type of lymphocyte (white blood cell). They are an important part of the immune system. When 
HIV infects humans, the cells it infects most often are CD4 cells. The genetic code of the virus becomes part of the 
cells. When CD4 cells multiply to fight an infection, they also make more copies of HIV. When someone is infected 
with HIV for a long time, the number of CD4 cells they have (their CD4 cell count) goes down. This is a sign that 
the immune system is being weakened. The lower the CD4 cell count, the more likely the person will get sick and 
develop opportunistic infections. 
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         We walked fast through a maze of corridors; there was rush to get the paper work done fast 
before other departments shut down for their tea break.   We ignored the signs that pointing to 
the report collection office and headed in the opposite direction towards the Dental Outpatient 
Department.  The hospital had not bothered to update the signs and this caused delays and 
confusion for new patients.  To avoid these pitfalls, Victor usually collected all the reports for the 
clients.  The report collection office was small room at the end of the corridor.  The desk was 
littered with paper and sagging under the weight of files.  I saw files everywhere – falling from 
shelves, on the floor and on the chairs.  Victor confidently entered the room and began to look 
for his clients’ files.  He later confided that the hospital staff allowed only him this privilege.   As 
I looked around the shabby ‘office’ with its tobacco-smeared walls, dirty tiles and scattered 
paperwork I was struck by the precarious nature of this knowledge collected in this hospital.     
How could one trust these reports, if at all one found one’s own? This back office of the hospital 
made a mockery of the entire system of AIDS reporting and knowledge base.    
  Before we left Victor was asked to sign his name with the patient’s details in a huge file.   
After getting the doctor’s signature on the reports, we deposited them in another department 
office.  This ‘testing bureaucracy’ was both bewildering and overwhelming to me as a 
researcher.  I could easily understand how patients, especially drug users, would need an ‘expert’ 
to help them navigate this tricky system.    
Victor and I both returned to see that both Ramesh and Shahid were still in line to get 
their blood work.  Victor assessed the situation and decided to talk to the hospital attendant.   A 
quick word later all four of us were ushered in, much to the anger of many of the other patients.   
We entered a long corridor with six cubicles each occupied by a nurse and an attendant.  There 
are long lines here as well.  After about half an hour of standing in the suffocating and crowded 
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room finally Ramesh is able enter one cubicle.  The first two cubicles refuse to draw blood.  
Victor tells me later that this was common practice.  Most nurses found it difficult to find a vein 
on a drug user, since most of them are blocked due to incessant drug use.  He pointed out:  
Hospitals-they have their own way of working, they are scared to put their hands on the 
IDU.  It will take a long time- they search for the vein and they can’t find the vein – it’s 
going to take at least 5-10 min (during), which they could work with other clients who 
are not IDUs.   So this is the main frustration for the hospital also – if they can’t get it 
they should at least tell the client, hold on and hang on – they tell them go, go.  .  .  then 
the client comes out and the client feels bad why have I (been) sent back.  This means I 
have to again and give his number and get a new number.  (Therefore) I make sure that I 
go with client and talk to these people and say please… 
Then of course is the issue of HIV, which we encounter directly that day.  I hear the 
superintendent look at the clients and talk to another nurse.   “On one hand we have to deal with 
these crowds and then on another ‘these’ people come in…I mean it’s as if we don’t have 
enough”.  She continued in a loud voice talking about positive clients and why should they have 
to deal with them.  Victor tried to step in and talk to the superintendent and could see the crowds 
growing restless.  Both Ramesh and Shahid had lowered their heads desperate to leave.  Victor 
then left the room and few minutes later came back with the young doctor of the ART clinic.   
  The doctor shouted at the nurses and the superintendent asking one of the nurses to take 
their blood immediately.  Ramesh stepped into the cubicle for the third time.  Victor and I 
watched as the nurse desperately tried to find a vein.  She poked him about four to five times, 
each time I saw him wince and turn his head away.  Victor then offered to help find the vein- a 
routine that is familiar to both Victor and the hospital staff.  Victor later told me that nurses in 
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the past been allowed him to draw blood from the client.  He would take the client in the narrow 
alley way outside, make him sit on the road pavement and sit next to him a search for the vein.   
No gloves, no sterilized environment and no privacy.   
   About twenty minutes later all three of us stepped outside, Shahid and Ramesh were 
holding their arms straight pressing a cotton ball into the puncture to stop the blood from 
flowing.  They joked about the nurse’s ineptitude to find a vein.  Victor joined in the fun saying 
that no one could beat the drug user in finding veins.  After the two clients left I followed Victor 
to the advanced testing center in the opposite building where another client is waiting.  As the 
day reaches an end Victor returned to the ART clinic to submit all reports that he has collected so 
that his clients can see the doctor the next day.  He highlighted: 
People from the main ART clinic can collect it (reports), but they are so reckless and 
careless.  (Plus there are) so many reports… its scattered there sometimes the reports are 
missing so that means my client has to go in for another exam- which is going to be 
difficult.  If the client needs to be admitted and is hospitalized its and emergency then I 
go in fast- I ask the doctor if he can do it and within 45 min to half an hour I get the 
report.  Sometimes (I even) do the tests before meeting the doctor…its takes more than 
one and half weeks (for all the tests to be completed.  (I have to help them) because these 
people don’t know where to go – it was the same thing for me but now I know where to 
go…  
It almost seemed like a battle against the system, a battle that sometimes Victor lost.  He 
recounts the story of “my poor Danishq, who expired a few days back”.  Danishq, an injecting 
drug user was also HIV positive.  He needed a bone marrow transplant and his hemoglobin 
levels had fallen dangerously low. The hospital asked him to come back a week later, for reasons 
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not specified.  “After that he became more sick and he was admitted in Sahai’s own hospice care 
unit, (as his condition worsened), we took him to the emergency.  He expired before we can 
work on him”.   
   Getting tested.    
Farah (outreach worker Sahai), Kiran (outreach worker Sahai) and I had left for outreach 
to the famed Meena Bazar near Jama Masjid (Delhi’s largest mosque).   Notoriously known for 
the large sex workers community (immortalized in folk and film songs), the reality was much 
more stark than I had imagined.  Today’s mission was to take three women or more, depending 
on who was willing, to get their blood checked for HIV.  A long wide road led to the mosque to 
its right was a larger dried pool surrounded by a large field.  One couldn’t tell what it had been 
used for before, because today it had turned into a large slum settlement.  The mosque’s 
proximity to the city’s main bus and train station meant that a majority of the city’s new settlers 
found themselves in Meena Bazar.  Small tents, temporary houses and small shops littered the 
area.   However since Bakrid80 was a few days away the compound of Jama Masjid was 
especially buzzing with activity.  Large number of tents had erected next to mosque housing 
hundreds of goats, ready for the festival.    
 Farah told me that she had already visited them a couple of times before to prepare them 
(pre-test counseling).  She had identified Nusrat as the community leader and had given her the 
responsibility to round up the rest of the women.  Just then Nusrat who had been washing her 
clothes walked towards us, asking if we wanted water.  A small crowd of children and some 
teenage boys had gathered around us, curious; I could also see some of the men of the 
community eyeing us suspiciously from their perch on cots, where they played cards.  Nusrat 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
80 One of the most important Muslim festival where goats (Bakhri) are sacrificed to celebrate their strong faith in 
Islam 
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was barely 28 and the women that she brought with her seemed a much younger (some closer to 
15).  All the women were sex workers, already had at least one child and lived with either a 
partner or husband in the community.  Parveen told me they would earn anywhere from Rs. 15-
20 for each sexual act (below half a dollar).  They usually have sex in public bathrooms, in 
buses, trucks or taxis that are stationed or in their shanty shacks.  While many of them did not 
use injecting drugs, they did smoke marijuana and were at high risk for HIV because of 
unprotected sex.  None of them seemed concerned or worried about the eminent test that awaited 
them.  I wondered how much they understood.   
The testing center had a single nurse who seemed to know Farah.  Farah informed her 
that pre-test counseling had already been completed (pre and post test counseling are mandated).   
I was not sure what either one of them meant as pre-test counseling.  But the women were most 
likely not aware of the implications a HIV positive test would mean.   
   The women were told to sit and then each one’s blood was taken over much squealing 
and excitement.  Farah informed them that she would give them the results.  2 out of the six 
women who tested were positive.  I asked Farah what would be the next step for these women.   
She informed me that her main role was encourage women to test, once they knew who were 
positive, Sahai would encourage them to get registered at the government hospital and check 
their CD4 count (to measure the strength of the immune system).  For other women they talked 
about using condoms and constantly testing.  Current funding restrictions do not allow much 
work with this group (since the funding is for injecting drug users) and other NGO’s continued to 
work with them.  Rita in Ashray and Farah in Sahai continued to work with these women 
intermittently often just spending time to talk and share.    
	   192	  
    Later while talking to Kunal Rathod a project officer at UNODC about the issue of 
HIV, rights, bodies and gender I asked him the rationality behind such testing.  Knowing, he 
pressed, was important if they didn’t know they couldn’t possibly take any action.  Dr.Ambika 
Kapoor at the WHO felt that for too long “we have assumed that they are ignorant and poor and 
therefore not capable of any positive behaviors”.  Testing allows for individual action.  One of 
the women did act- she came to Sahai looking to enter the rehab for women.  After a few weeks 
of staying there she left, claiming she wanted to return to life on the street.   
  HIV testing and counseling was started in India in 1997.  Under the NACP III all testing 
and counseling facilities were brought together under the ‘Integrated Counseling and Testing 
Center’ and today the country has more than 4000 such centers — the largest network in the 
world.  However, according to NACO only 13% of the HIV population is aware of their status.   
This impetus to test is a part of a larger mandate globally that has in equal parts been critiqued 
and lauded.  On one hand global organizations like WHO, UNAIDS and UNODC highlight that 
as a result, without testing, many opportunities for increased access to treatment and care are 
overlooked.  Their argument draws on the basic premise that knowledge about being HIV 
positive or negative will help in preventing risky behaviors and promote safe behaviors amongst 
people.  While on the other hand research evidence on testing as a prevention strategy, shows its 
benefits to be limited and impacted by gender, class, social norms and public perception (Higgins 
et al., 1991; Exner et al., 2002; Yeatman, 2007; Biehl, 2007).  While there are many 
methodological and practical constraints in studying the overall impacts and outcomes of testing 
on actual risky behavior it continues to be promoted as a key strategy for prevention.   
 
 
	   193	  
 
   The battle for rights and life.   
The emergence of HIV, scholars argue, has changed the dimensions of how one 
understands disease in its totality.  It has evolved into a global social/health movement impacting 
policy, politics, law, human rights and social justice.  Despite the diversity of experiences and 
contexts within which HIV emerges, there are two critical components of which seem to resonate 
everywhere.  The first component is attention on the high-risk groups and their marginalized life 
conditions that make them most susceptible to HIV.  The second component is the focus on 
patients’ rights to medication and treatment, especially encouraging patient mobilization.    
  During the period I was in New Delhi I was acutely aware of both of these components 
and their particular dynamics for injecting drug users.  I had begun with questions like -had HIV 
changed meters of recovery for them?  Was there a new form of consciousness that being 
positive evoked? Did it separate them from other drug users?  And most critically how did it 
shape their survival in the day to day.    
 HIV prevention and treatment was a critical component of all work within Sahai and 
Ashray.  Funding institutions dictated specific targets for HIV testing, client registration in the 
ART (Anti-retroviral treatment) clinics and if needed ART regimes.  Sahai, I discovered, focused 
a fair amount of time and effort on assisting clients in this process whereas Ashray tended to let 
clients take the lead.  Even though the NGOs approached their interventions giving primacy to 
HIV, clients would always identify their primary problematic as addiction.  Despite this 
disconnect most clients were prudent in using their status in fighting for their survival- even 
though this still meant that their needs were under served.  Moreover, to me their worlds as drug 
users and as HIV positive clients were inextricably linked and it was difficult to separate them.   
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Being positive meant little without first acknowledging their addiction and being an addict could 
be no longer seen without their HIV status.    
   I could see some of these politics at play when Ashray introduced a nutrition 
component in its program.  Ashfaq Mohammed (project head Ashray) had put forth a list of 
clients eligible for the program.  He had informed me that the list prioritized clients who were 
HIV positive or had TB and Hepatitis.  Slots for food were few and such a prioritization was 
essential.  On the first day as the food arrive so did the clients and some community members 
ready with proof of their ART registration.  “We have heard that you are giving food for HIV 
positive people”, remarked a community member.   Ashfaq quickly had to clarify that the 
program was in fact for ‘clients’ i.e. drug users and HIV positive people.  Unhappy at this 
response, the community person responded “Even we are sick we also need this food…do we 
now have to take up drugs to be given food”.  At the same time many clients who were not on 
the list, as their condition was not considered critical enough, were equally angry.  However, the 
positive clients were quick to defend their position- highlighting their unique vulnerabilities and 
their special needs.  Ashfaq was frustrated by his inability to provide enough for all of his clients.   
He recognized providing even a basic essential like food in a poor and marginalized community 
was a potentially explosive issue.    
   What became most clear through fieldwork was that the disease of HIV had been able 
to, like in other global contexts, create a line of services for those impacted by it.  In doing so it 
had created a sense of consciousness within clients about the uniqueness of their condition.   
Clients were now also ‘patients’ who deserved special privileges not accorded to their peers.   
Also critical to recognize was the fact that these services were not equally available for all those 
who were positive, but in fact there were hierarchies, special sub populations based on risk 
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assessments and the current political focus.  On one hand, this super specialization of populations 
was essential to serve the most needy, but on the other, the ‘justness’ of its approach is clearly 
questionable.  HIV services were attempting to provide exceptional and in some cases an 
extraordinary type of service for these clients.  However the worlds of being positive, being 
addicts and being marginalized were not far apart as I mention before.  As these worlds collided 
the exceptionality of HIV services were severely undermined often creating contradictions in the 
type of care clients received.  Treatment was then experienced as separate from their lives as 
recovering drug users generating a fragmented and often split perception of their rights, recovery 
and health.   
   The final sections of this chapter address the needle syringe exchange component of the 
program as well as a discussion on the implications for risk and survival.   
   Exchanging risk/ calculating infection.   
Sharing of needles, syringes and other injecting equipment between IDU’s is one of the 
highest at risk behaviors, recognized to be a primary driver of HIV and HCV (Hepatitis C) 
epidemics among these populations (Sarkar et al., 1993; Panda, 2002; UNODC, 2008).  The 
provision of clean injecting equipment thus serves to reduce the likelihood of sharing and 
support their health.   
    The first formal needle syringe exchange program (NSEP) began in 1983 in 
Amsterdam, Netherlands for Hepatitis B (Wodak and Cooney, 2005).  Today NSEP is 
considered a critical aspect of any HIV prevention program (WHO, 2003).   Such programs are 
currently operating in 65 countries across the world (Wodak and Cooney).  Wodak and Cooney 
conducted a meta-analysis of 49 studies from 1989-2002 to study the effectiveness of NEP.   
Overall they found that NEP promoted health seeking behaviors, reduced the likelihood of HIV 
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infections or other blood borne viruses, increased exposure to primary care and different 
treatment regimes, reduced injecting behavior.    
    Ksobeich (2003) also studied the positive effects of NEP based on data from 1988- 
2001.   It also showed that there was in fact a reduction in risky injecting practices and overall 
positive health outcomes for the drug users.   Harm reduction programs that have used the needle 
syringe exchange and out reach have found benefits, especially for the hard to reach street users 
(Des Jarlais & Semaan, 2005; Gibson, Flynn & Perales, 2001).   Several studies have indicated 
that users understood the risk of HIV/AIDS and tried to reduce risks by exchanging used needles 
for sterile ones (Rhodes, et. al., 2003; Ksobeich, 2003; Des Jarlais, et al., 1994).   At times NSEP 
can also indirectly benefit the drug users via ‘secondary exchange’.   In such exchanges IDU’s 
obtain syringes from NSEPs and deliver them to those clients that cannot or choose not to come 
(Valente, Foreman, Jungue & Vlahov, 1998).   
   However, there have been a small number of studies where the results have questioned 
the effectiveness of NSEPs.   In studies conducted by Bruneau et al., (1997), Hagan et al., (1999) 
and Strathdee et al., (1997) the incidence of HIV and Hepatitis C actually rose despite NSEPs.   
Inadequate availability of needles, the involvement of riskier participants in such programs and 
the rise of cocaine injection has all been used to explain the rising rates (Bourgois and Bruneau, 
2000; Bruneau, Franco & Lamothe, 1997).   Bastos and Strathdee (2000) highlight that for 
needle syringe exchange programs to succeed other components of risk behavior must also be 
simultaneously addressed, such as condom use, Hepatitis screening and testing as well as referral 
to drug treatment.    
   Research has shown that the relationship between the provision of needles, behavior 
change and reduction in disease is dynamic and complicated.   In fact, a combination of factors 
	   197	  
such as adequate coverage81, the removal of contaminated equipment from the community, the 
monitoring of needle syringe exchanges between formal (between NSEPs and drug users) and 
informal (between drug users themselves) networks and prevalence or incidence of blood borne 
infections in the community all play a key role in the efficacy of NSEPs  (Des Jarlais et al., 1995; 
Kaplan, 1994; Kaplan & Heimer, 1994; Kretzchmar & Wiessing, 1998).    
   Currently needle syringe exchange programs are running in Manipur, Delhi, Mumbai, 
Kolkata and Chennai82 and have had varying degree of success (NACO, 2010).  In a study 
conducted by Sharma et al., (2003) in the state of Manipur it was clear that unsafe injecting 
practices were high but risk behavior itself was similar between IDU and non-IDU groups.   
Lack adequate coverage, paucity of injecting equipment, poor service delivery and residual risk 
factors like injectors tended to use the same equipment for more than 5 injections and 11% 
admitted to sharing were crucial factors that compromised the program’s efficacy.   With limited 
resources NSEPs in India continue to face multiple challenges.   But there is little research that 
provides an experiential picture of these programs itself- how services are delivered on the 
ground and in what manner are they received.   My effort was to both enrich this experiential 
understanding of NSEPs in Delhi and reflect on the implications for health and recovery.    
   Public injecting and outreach.   
 The needle syringe exchange program was an important component of the harm 
reduction services at Sahai and Ashray.   The outreach staff at Sahai covered Kharagpur and two 
large communities around it.   They would specifically target large open garbage dumps, 
abandoned buildings, public toilets and the ‘khet’ (field in Hindi), which was at the periphery of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
81 In the U.S. for instance there was a Congressional ban for decades on the use of federal funds to support NSEPs, 
which has only been recently lifted. This severely impacted the nature of programs and their coverage.  
82 In 1998, the Manipur government advocated the needle –exchange policy to halt the transmission of HIV amongst 
drug users and their sexual or needle sharing partners (Manipur State AIDS Policy). 
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the community.  While the outreach workers had certain set routes they would often deviate if 
they heard a new ‘shooting’ (drug injecting) site had emerged.  Clients would usually tell staff 
about these sites, since these would keep shifting depending on the conditions within the 
neighborhood.   For instance, once during outreach Gulzar and Mahesh found no clients in their 
usual spots because of a police raid the previous day.   The clients had all shifted their ‘shooting’ 
spots and gone underground.   At other times clients would have to move temporarily if 
community members were objecting.  NGO staff had to be constantly vigilant about these shifts 
in order to reach their clients.    
  Ashray’s staff would conduct outreach mainly within Nadi Nagar and focused 
especially on three big public parks turned shooting galleries in the area, namely Chottu Park, 
Jaggu park (which had a large Bangladeshi and Nepali immigrant population) and Dholak park 
(populated mainly by the transgender community83).   Chottu park84 is the largest of them all- a 
large green expanse that extends between the Yamuna river and the main over bridge in 
Kharagpur.   It is the most infamous in the area and it took me just one visit to understand how it 
had earned its reputation.   From the main road the view is blocked by small hillocks.   But as 
soon as I climbed over one of them, stretc.hed before me were literally hundreds of homeless all 
across the park.   It looked like an urban refugee camp, where the city’s unwanted were 
contained.   Almost all of the park’s residents were male and a majority used either drugs or 
alcohol.   During the end of my fieldwork Ashray decided to change its strategy and plant one 
outreach worker all day at ‘Peti  (meaning box in Hindi) market.   This was one of the largest 
metal sorting markets where most drug users would congregate during the day.   Ashray found 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
83 A large transgender community resided in Nadi Nagar 
84 This park is so famous that a film depicting its subculture has been made. 
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that having an outreach worker for at least 12 hours of the day in this heavy traffic area increased 
their outreach by 100%.    
Both Sahai and Ashray had three to four teams, composed usually of two peer workers 
and at times a client volunteer.   These teams conducted outreach with sixty to a hundred drug 
users each day, except Sunday.   The teams would meet as well as interact with clients, provide 
clean needles and take old ones but most importantly engage and encourage clients to come to 
the center to seek OST, abscess and HIV related services.  During the earlier phases of outreach 
both NGO’s would also provide bleach and cotton.  Providing other paraphernalia like cotton 
and bleach, have been shown to be effective in reducing the disease burden (Hilton, Thompson, 
Moore-Dempsey & Jansen, 2001; Bluenthal, Kral, Erringer & Edlin 1998; Vlahov & Junge, 
1998; WHO, 2004).   
However, after the government took over Ashray’s funding, these additional services 
were dropped.  Sahai was facing severe financial problems and thus had limited its activities.   
The NGOs also distributed condoms to the clients during outreach and I would notice place a 
few boxes of condoms with key community members.  This way clients or people from the 
community would have multiple sources and access points.  Even though funders and policy 
makers stressed on condom promotion, outreach workers noted that only a few clients would 
actually ask for condoms and even less would use/need them.  In fact outreach workers felt that 
clients would simply take the condoms to appease the outreach staff.    
   During this initial interaction with the drug user, the staff would at times pass out 
educational material, discuss both addiction and HIV related concerns and connect them with 
social services; research shows that these are effective strategies for outreach (Heimer, 1998; Des 
Jarlais, et al., 2000; Bastos and Strathdee, 2000).    
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Dr.   Ambika Kapoor from the WHO highlighted that the latest research suggests that the 
actual ‘exchange’ of the needle and syringes are less important than the actually flooding the 
community with enough clean equipment.   Dr. Rohan Chatterjee claimed that in addition to 
lowering HIV rates needle syringe exchange plays an important role in creating discipline among 
drug users.  In fact, this discipline then helps to transition drug users to OST.    
    The relationship between outreach workers and clients has considerable influence on 
users’ ability to inject safely (Kral, Anderson, Flynn and Bluenthal, 2004).   Ideally, out reach 
workers were expected to stop and talk with all drug users and inform them about HIV and harm 
reduction services.  As I discussed before, such a strategy was needed, since street users would 
often shift from injecting to non-injecting modes depending on the availability of their drug of 
choice, its quality and their financial position.  Moreover, many non-injectors were equally at 
high risk for HIV and other diseases through high-risk practices such as unsafe sex or sharing of 
drug equipment.   However in practice, outreach workers were usually pressed for time would 
only interact with the established injecting groups.  At times, new clients would themselves 
approach the outreach workers and seek services.  Funding restrictions prevented the NGOs from 
employing more staff and expanding the scope of their work.    
     Harm reduction interventions are seen as a continuum of care and needle syringe 
exchange in many ways is considered the first step in this process.  Drug users, once having 
established a relationship with the outreach workers, are more likely for other services and move 
from harm-inducing forms of behavior to less harmful approaches.  I will now detail some of 
these experiences from my field notes and to provide an in depth and intimate picture of the 
varied nature of outreach, needle syringe exchange programs and harm reduction.   
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  Man and Matter, (September, 2008).   I set out with Saif, Manish and Mushtaq (client) to 
observe their outreach activities in Kharagpur.  I had tucked my dupatta85 behind my ears 
covering my head, mimicking the other women on the street- a deliberate move in an attempt to 
blend in as well as protect myself from the scorching heat beating down on us.  I walked a few 
steps behind the outreach workers, but I could see that my presence was already creating a lot of 
interest on the streets.  We began at a small public ‘park’ that had deteriorated into a large 
garbage dump.  One had to be careful while standing in this ‘park’, because sometimes people 
would throw garbage directly from their windows of the apartment complex next door.  To enter 
the ‘park’, I had to jump over a narrow ditch and climb over rubble before I landed on a pile of 
garbage.  The first thing that hit me almost immediately was the stench of decomposing garbage, 
then I began to slowly take in the ‘park’ itself and the clients – man and matter almost seamlessly 
molded together.  I followed the outreach workers carefully, often looking down making sure I 
didn’t step on the many needles and vials scattered around the ‘park’.   
    Fieldworkers are allowed to give out only one needle and two syringes, because of 
shortage of funding.  For most drug users this was barely enough and I saw many of them 
arguing with the out reach workers, demanding for more.  I noticed that the staff would tear the 
sealed packet of the syringes, before handing it over to the client.  The NGO workers told me 
that this was necessary, because, clients would otherwise sell these unopened packets to make 
money for drugs.    
   There were close to ten clients in the park that day.   Some were injecting or smoking 
up, others had covered themselves with torn and tattered blankets and found a corner to sleep in 
the mounds of garbage.   I noticed Sadiq, a young client of Sahai, who came sometimes for clean 
needles to the center.   He was clearly high and barely noticed me.   He had brought some rice 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
85  Indian scarf worn with a long tunic and pants –salwar kameez 
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and dal (lentil) from the temple and was sharing the food with his friends.   Just as we were about 
to leave Sadiq asked Mahesh to come with him to see Rafiq.   Sunburnt, weary, with tattered 
clothing Rafiq lay writhing in pain in one corner of the park.   He could barely speak, eyes red, 
face covered with flies that he was too tired to push away.   Like other drug users around him 
Rafiq had been injecting for years.  Once all his veins on his hands and feet were blocked, he had 
resorted to injecting in his groin and the day before the vein had become infected.    
    Both Mahesh and Saif sat down next to him, pushed away the flies and stroked his 
forehead.   Saif then gave a few rupees to Sadiq to get some chai and bread for Rafiq.   
Meanwhile, they called a few more clients to help them lift Rafiq to a relatively clean and sunny 
area in the park.   They gave a small card containing Sahai’s address and asked one of the clients 
to run and inform Clive about the problem.   Clive and other staff members helped Rafiq get to a 
hospital later that day but nobody was hopeful.    
   Static, (February, 2009).   I had accompanied Julie, a young and smart outreach staff member 
and Ismail, a tall and wizened old peer worker, both of who worked for Ashray on outreach.   We 
walked along the main road stopping near bus stops, toilets, between road dividers and small 
tents that substituted for homes for the street drug users.  Each time Ismail would open the beaten 
up tin box and offer it to the drug users, who would dump their bloody and dirty needles and 
syringes.   He would then open his bag and give clean injecting equipment.  Meanwhile, Julie 
would take down their names, age and ID numbers.   I noticed that almost every client gave his 
or her names as Salim or Mohammed.  It was as if we were meeting the same person in 
repetition.  The poignancy of this was not lost on me.  The history of use, abuse, neglect, chaos 
and pain seemed to almost merge into one and another- sharing a name only seemed most 
appropriate.   
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     Unlike some of the other outreach workers I had observed, Julie would take time with 
each client asking many questions, “Since when have you been injecting? Do you have a home 
or do you live on the street? Do you have any abscesses that need to be tended? Have you tried 
OST ? Have you come to the center?” While some of the clients were too drugged to answer, 
others would briefly talk with her, show her their wounds or ask for specific services.   As we 
walked away Ismail mentioned that during outreach we were more likely to encounter much 
younger clients as compared to OST.   The reason for this he said was simple, they have ‘young 
blood’, death and disease still seemed distant and therefore these young clients were more likely 
to take risks86.    
This comment stayed with me, when I met Ajith a young drug user in Nadi Nagar.   I 
happened to ask him his age.  He quietly replied 28.  Ajith was a poly-drug injecting user and 
had already lost both his legs because of abscess related complications.  He would push himself 
on a wooden plank that had attached wheels to move around.  Despite losing both his limbs he 
had not stopped injecting.   Ismail handed him the needles and syringes and jokingly commented 
“For as long as I have known you, you’ve been 28…why don’t you tell us you real age’.  Ajith 
looked up, pocketing the needles and syringes and said ‘ Until I have this nasha (addiction) I will 
always be 28”.   After taking the needles he pushed himself across the street and towards the 
direction of the pusher, while we walked on.    
   Traces (November, 2008).   The mobile and transitional nature of drug users lives mean that 
they usually carry all of their possessions in a large burlap bag.   I never get to see inside it but 
often I see things that come out of it- old clothes, pieces of broken plastic, newspaper, metal, 
cups and plates, soap and some times food.  I wondered if they left anything behind to mark their 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
86 While the demographic was largely young males in both sites, there were some women and transgender clients 
(the latter were usually contained in specific neighborhoods). 
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presence.  I began to look for the signs that they chose to leave in the parks, bridges or streets.   
During outreach, NGO workers would point to these nooks, which were home to some of their 
clients.  In these ‘home spots’, I would find the portrait of Goddess Lakshmi hung from a nail on 
the bark of a tree (perhaps under which one of them slept), etc.hings of their names across a wall, 
a line of clothes left to dry on the water pipe in which they stayed, a small chulha (mini stove) or 
a bundle of blankets and bedding stashed under a bush.   Small traces of themselves - they had 
been there, live there, were here.   
    Many clients would leave behind old injecting equipment- vials scattered, blood 
stained needles/syringes, cotton balls and bent spoons.  Outreach workers would often pick these 
up commenting about the addicts’ carelessness knowing fully well who slept there.   Usually if 
we would encounter them later on the street they would request them not to leave the 
‘dangerous’ equipment lying about.  The addicts’ wouldn’t even have to say a word, for their 
matter had already betrayed them - just like their bodies.  These traces would carry from the 
community into the recovery spaces.   Clients who would return their needles-syringes and make 
an effort to use ‘safely’ in public were trusted and at times even given small privileges (such as 
more needles, higher priority in the list for medication or detoxification and even opportunities to 
volunteer within the NGO).  	  	  	  	   
   Sharing lives.   
    Injecting behavior in the communities of Nadi Nagar and Kharagpur was not hidden.   
In fact, it was public and open even though it was heavily stigmatized.   Sharing of needles, 
syringes and other equipment was common among clients- both in Ashray and Sahai.   Drug 
users, claimed that one of the main reasons for sharing injecting equipment was the inadequate 
number of needles and syringes provided by the NGO.   Further, since out reach services lasted 
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only until the afternoon clients would often miss the outreach worker as they would leave to find 
work, money, drugs or food.   This meant they were forced either purchase clean equipment from 
the pharmacy or share.    
 Ajay (client of Ashray) shared his perspective with me about this: 
 No there isn’t enough needles and syringes being given out here – for one person 4 
needles and 2 syringes are needed.   I mean the first time I put time I put in 5ml with 
needle and syringe and suppose it doesn’t go then I would have to use another needle.   .  
.  now I wouldn’t have another needle to use .   Or suppose my friend comes and he 
doesn’t have any money so he may say why don’t you give me some so I would take the 
same needle and syringe and I would give him a fix  …its not the case that each time I 
use a fresh needle and syringe.   If there were more needles available then one could save 
oneself from disease.   
 In consideration of the international standards set by WHO – a new needle and syringe 
for each injection, the actual number of needles and syringes given during outreach massively 
under met the demands.  In fact, Sharma (2003) based on a study conducted in one needle 
syringe exchange site in Delhi, showed that on an average a needle was used twice and a syringe 
was used 3.66 times before disposal, exchange or passing onto other IDUs.  Thus, clearly 
violating standards of safe use, endangering their own lives and those of the community.   
    Dr.   Chatterjee (leading harm reduction specialist) placed the blame partly on funding 
organizations and the government that did not adequately account for needles and syringes per 
drug user.   He related this to lack of knowledge regarding prevalence and drug taking behavior.   
He pointed out, that NGO’s too, felt pressured to reach a certain number of target drug users, 
with the logic providing the minimum to the maximum.  “They must learn how to say no”, Dr.   
	   206	  
Chatterjee concluded.  However, Clive (staff Sahai) contended that this was difficult to execute 
in a community setting.   He argued that clients would get angry and it could place the entire 
program in jeopardy, if they began to refuse clients.   During my fieldwork period Ashray was 
lobbying hard with the government to change its guidelines, however the government had not yet 
changed its stance.   
     Panda and Sharma’s study in 2006 found that nationally in India most drug users 
purchased injecting equipment from the pharmacies.   They cited a number of other reasons 
besides limited time and equipment.  These reasons included- high drug user mobility, stigma 
attached to entering a NSEP facility (the person would be then categorized as a drug user), 
perceived or actual poor quality of injecting equipment disbursed by the program and 
requirement of different sizes of injecting equipment than those disbursed.   Research has shown 
injecting drug users may avoid needle syringe exchange programs or purchasing from a 
pharmacy out fear of arrest, drug users are afraid that carrying injecting equipment would place 
them at legal risk and they would rather share needles at the public injection site (Rhodes et.al., 
2003; Bourgois & Schonberg, 2009).    
    My study supported some of these findings.  I noticed that a sizeable group of drug 
users were indeed mobile- they were in search of better quality of substance or were escaping 
from the law.   This clearly jeopardized their access to free injecting equipment.  However, a 
majority of the clients remained in the area and were associated with the NGOs for years.  In 
fact, older clients would often induct new clients into the program.  Stigma attached to entering 
the NGO was not a major factor in accessing equipment.  Most drug users would readily agree to 
come to the center, since the NGOs were embedded within the community for a long period of 
time, the clients were comfortable and would freely move in and out, accessing a variety of 
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services.  However similar to the study by Rhodes et al., (2003) and Bourgois & Schonberg 
(2009) I found that clients were fearful of arrest and on days of an imminent police raid they 
would disappear, not accessing any service.  The local police were well aware of the work of 
Ashray and Sahai and would usually leave the clients alone.  In fact, Clive and Muquim told me 
that the police were not keen to arrest drug users, since then they would have to deal with their 
withdrawal symptoms as well.  The police only arrested clients in case they suspected theft or if 
a community member complained.  The other times raids were usually conducted to ‘clean up 
the streets’, but things would return to normalcy in a day or two.  During the course of fieldwork 
however clients would at times complain of being brutally beaten by police personnel but they 
had little recourse.    
   Panda and Sharma (2006) highlight that injecting equipment can cost up to Rs. 5-6 each 
time and when one multiplies these costs over the month- they can be very steep for a user living 
on the street (more than the cost of food).  A large number of street drug users were engaged in 
some form of informal labor like rag picking, metal sorting, recycling, rickshaw pulling or 
working in marriage parties as temporary staff.   A majority of the drug users would live on the 
streets i.e. either in the ghats of Yamuna or within the radius of the three big parks.  Most lived 
without a roof, some within old abandoned buildings, inside broken water pipes, under makeshift 
tents and trees.  Therefore with limited resources there was precious little left to spend on 
new/clean injecting equipment.    
    The final aspect of sharing behavior was the street culture of using itself.   At the 
interpersonal level sharing needles with friends or partners was often seen as a sign of trust and 
intimacy and may prevented drug users from using sterilized injecting equipment.  Rakhi found 
it natural to not only buy drugs together with her partner but also share with him.  Ajay, Dalbir, 
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Mushtaq and Santosh all spoke about buying and sharing drugs with friends.  While most of 
these groups were all male, sometimes a female partner or a transgender would also be a part of 
their circle.  Usually, those who contributed the maximum would take the first hit and others 
would follow.  Drug users who are unable to inject themselves, and 'hangers on' who 'contribute 
nothing to the acquisition of the drugs, are often the last to use the needle and at the highest risk 
(Bourgois, 2009).    
     Clients in my study reported that often did not know who was positive and it did not 
feature significantly in their drug taking/sharing behavior.  A few of them commented that if they 
knew about their HIV positive status they would allow others to inject first before injecting 
themselves.  Being positive then did not necessarily stop sharing especially when clients were in 
severe withdrawal.  They reported wiping the needles/syringes with a cloth, washing it water and 
even using saliva to clean.  These findings reflect other research studies that have found drug 
users often had misinformation about the status of asymptomatic HIV infected people, 
inadequate knowledge on how to cleanse needles effectively and lack of awareness of one’s own 
HIV seropositivity (Bryant & Treloar, 2006; Perngmark, Vanichseni & Celentano, 2008 ; Golub 
et al.  , 2007; Loxley and Ovenden, 1995).  All of these factors impact sharing behavior and 
increase the likelihood of infection.  The fear of being known as HIV positive person was 
another barrier against safe injecting practices (Golub et al.  , 2007).    
     Sharing of injecting equipment was a part of the larger ethos of living and surviving 
on the streets of Nadi Nagar and Kharagpur.  Limited availability of equipment, management of 
withdrawal symptoms, NGO policies, legal and funding barriers, fear of arrest, poverty, 
misinformation and lack of alternatives were crucial in shaping this risky behavior.   As I began 
to understand how they participated in these harm reduction programs, I began to reflect on these 
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‘risk –creating environments’ themselves.   Survival it seemed was negotiated through 
navigating these multiple risky conditions.  In the final section of this chapter I discuss my 
understanding of this risky survival.   
   Reframing risk and the making of survival.    
  My chapter began with the stories of Usha and Dalbir and it only seems fitting to end 
this chapter with their lives.  Both were the quintessential clients of Sahai and Ashray- poor, 
struggling with recovery, unemployed, unsure of their (HIV) positive status and clearly lacking 
adequate support to bring any lasting change in their lives.  They continued to use drugs, share 
equipment and pieced together an existence through many risky not to mention often illegal and 
problematic practices.  On the face of it, harm reduction seemed to be failing to deliver on its 
promises.  Not only were clients like Usha and Dalbir frustrated with the system, but also saw 
little change in their own lives.  However, as one looked closer the implications and 
transformations were far reaching.   
 The daunting numbers of HIV had placed the Indian public health sector under great 
stress.  It had become important to launch a program that was ‘at scale’ and fairly swift, to halt 
the epidemic.   India thus followed the global model and engaged with groups that were 
considered most ‘at risk’.  High prevalence rates of HIV, Hepatitis and other STD’s within these 
‘high risk’ groups reinforced the need for such an approach.  Risk, was a calculable and 
relatively reliable measure to divide the populations and implement programs.  However, risk in 
its essence, was not supposed to be a stable or bounded category simply applied for designing 
interventions.  It was clearly based on multiple assumptions, context specific and governed by a 
number of uncertain factors.  Despite these limitations of ‘risk’ as a notion, has gained enormous 
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social currency and reigns as the dominant form of organizing and providing HIV services across 
the world and now in India.   
 My fieldwork also showed that indeed a greater focus on risk based assessments and 
interventions had coincided with the emergence of a neoliberal approach within the social sector.   
However, the conditions were considerably more complex.  While on one hand India saw the 
growth of a neoliberal approach to many social concerns it has not necessarily lead to a 
dewelfarized state as is assumed.  In fact, while ideas of economic efficiency, markets and 
profitability have entered the social sector, the government especially in the case of HIV 
prevention has continued to engage, invest and implement many welfare and social justice 
oriented programs.  Further, in most developing nations executing harm reduction services the 
public health systems are almost non-existent and privatization of health care occurred far before 
the advent of neoliberalization.  Re-investment in HIV services has some scholars would argue 
forced the government to re-evaluate its entire stance on health.  Despite controversy about 
whether HIV has invigorated the entire health sector or not, one thing was clear –there was an 
intermingling of neoliberal and welfare approaches.  Sharma (2008) points out, this uniqueness 
or ‘exception’ (Ong, 2006) to neoliberalization’s totalizing influence can be seen in many 
spheres of development in India.    
In the specific case of harm reduction this has meant that older welfare ideals of health, 
influence of the AA model of recovery and the presence of rights based movements shape a 
‘risk-focused’ environment.   Risk, was clearly perceived very differently by the clients than by 
the service providers themselves.   Risk reduction services were focused on reducing HIV 
infection and mainly through a focus on individual behavior.   However, clients responded to the 
services in the context of their overall lives.   For clients, HIV infection was less of a risk to their 
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immediate lives, than getting access to food, shelter, and medication or most importantly avoid 
withdrawals.   Risk to them was embedded in their needs and desires, which often did not reflect 
the same rationalities and logics that harm reduction services employed.    
   However, these risk-focused interventions had opened a realm of possibilities that were 
not available until now.   Clients who were the most marginalized and neglected were now the 
center of services, HIV had brought their plights to the notice of policy makers and service 
providers.   More than quality, it was the sheer availability of services itself that was remarkable 
and gave these drug users a fighting chance.   Risk had thus opened the chance to survive but not 
necessarily in the ways it had imagined.    
Survival for a majority of drug users now meant becoming visible to service providers, 
government institutions and social systems.   By this I mean that for a long time drug users were 
hidden- both fearful of authority and treated with apathy by civic institutions.   Harm reduction, 
with its focus on access, outreach and engagement was bringing the drug user back into the fold.  
In fact, the drug users themselves were learning to seek out help in different forms.   However, 
this new induction did not necessarily mean that drug users were being disciplined into 
productive, responsible and rational subjects (Rose, 2007).   The resource poor setting with 
limited staff permitted only the bare minimum surveillance and enforcement of discipline.    
    Clients used services in somewhat a judicious and agentive manner, to suit their 
lifestyle rather than conform to the services.   Clients would adapt these services into unique 
forms of harm reduction for themselves, creating a plethora of harm reducing lifestyles.   For 
instance, they would take needles from the program and share it with only their partner; they 
would access Buprenorphine from the Opioid substitution program and clean needles from the 
center to inject safely; they would even take ‘breaks’ in their injecting cycles and go into 
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rehabilitation programs to rejuvenate their bodies.   They seemed to be applying the basic 
principles of risk reduction in diverse ways to maintain their bodies functioning.   They had 
found a way to make this new system adapt to them.    
Keeping target numbers enrolled in the programs meant that NGO’s could not refuse 
them services and this meant drug users retained a fair amount of flexibility.   Moreover, with an 
equally strong rights based philosophy and overarching influence of AA, the harm reduction 
environment was operating under multiple pulls and influences.   Care was limited and services 
deeply fractured- clients more than anybody else in the system intimately understood this.   
Health had to be sought through and within this patchwork system and not despite it.   Instead of 
a continuum of care model, my work shows that harm reduction was a cyclical model of 
survival.   It re-constituted both risk and health constantly generating new modalities of being a 
recovery subject in India.    
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CHAPTER 6: PHARMACEUTICALIZATION OF HEALTH  
It flows inward and outward 
Through me and on the street 
It leaves its trace quietly. 
 
I cannot remember when it began 
I keep these keepsakes of injury 
Drawing it out will erase 
Old memories. 
 
Bottled up inside this pill 
Can it really be the same? 
It is not of the street 
The same DNA 
But more polished in its affect. 
 
They tell me I am ok. 
Now, with the pill. 
Traces are few  
But the injuries remain. 
(Moorthi, 2011) 
 
 
   Pharmaceutical survival.  
    In the previous chapter, I outlined how a unique type of survival was being shaped 
through risk-mediated practices.  This risk regime was the result of a new focus on efficiency, 
calculation and containment of the HIV epidemic.  Though injecting drug users were now able to 
access a number of harm reduction services, my work showed, these services were 
conceptualizing risk very differently from the drug users own experience and their engagement 
in risk.  Moreover, the drug users continued to struggle with recovery as these interventions were 
unfolding within a larger milieu of apathy and impoverishment.  In response, the drug users were 
creating unique expressions of risk reduction that often did not follow protocol.  Further, the 
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presence of rights based struggles and older models of recovery such as AA, continued to exert 
their influence on the nature of survival.   
   In this chapter on clients’ lives I will specifically focus on the drug users experience of 
Opioid Substitution Treatment (OST).  The introduction of OST was (as discussed earlier) an 
important turning point in the development of the harm reduction model in India.  It was 
introduced, on a large scale, after much struggle on the part of NGOs and international 
organizations.  However, larger conditions of poverty, stigma and paucity of infrastructure were 
endemic to these drug users lives and impacted how OST services were delivered and received.  
I intend to examine how this increased pharmaceuticalization introduced a specific type of ‘care’ 
environment and explore its efforts to promote recovery.    
      I also return to the notion of survival, but this time engage with the form and shape it 
takes under OST.  Survival, was clearly now conceived for these drug users via the chemical 
introduced to support it.  As drug users battled for health and healing they were, I argue, being 
constituted into ‘pharmaceutical citizens’.  This term has recently gained much attention within 
the sphere of medical anthropology to understand the growing dominance of pharmaceuticals in 
shaping health, disease and rehabilitation.  The pharmaceuticalized existence, of course cannot 
be examined or understood without the context of the pharmaceutical industry that produces, 
supports and proliferates such a life.  Most crucially, some scholars argue, governments or states 
are increasingly replacing care, therapy and social institutions with provisions of pharmaceuticals 
(Biehl, 2007; Petryana, Lakoff & Kleinman, 2006).  From the perspective of citizens –
pharmaceuticals are seen as life extending technologies, and are often used to center demands 
from the state.  The most obvious example of this strategy, in recent times, is the social 
movement for free Anti-Retroviral treatments for HIV across the globe.    
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     In the case of harm reduction in India, the growing focus on OST and provision of 
pharmaceuticals to sustain recovery has raised many questions- what does survival and health 
look like under this pharmaceuticalized regime? What does such an intervention reveal about the 
nature of relationship between the state and the citizens in the sphere of health? How does social 
work respond to such developments and shape its perspective? 
 The promise and possibility of becoming stable, less risky recovered and responsible is 
now increasingly the focus of harm reduction intervention in India.  Pharmaceutical interventions 
are seen as a solution that not only can resolve addiction but also socially re-integrate potential 
clients/patients.  At the same time there are clear boundaries about who can and who cannot 
access these medications- as decided through risk profiling of the populations.   OST medication 
in India is still restricted in terms of coverage, especially when compared to the larger drug 
addicted population excluded from this service.  OST is provided by a single pharmaceutical 
company and heavily subsidized by the government.  Since the legitimate market is still small we 
do not see the same kind of politics of ARV- around access to medication, competition and 
struggle to gain legitimacy within patient groups.  In fact, the main focus until now has been to 
increase the reach of the pharmaceuticals across India.  I argue, similar to Biehl’s (2007) 
experience in Brazil, the condition in India is such that, this pharmaceutical intervention is not 
really a tool to govern/discipline bodies.  Instead, drug users are temporarily drawn into 
relationships with NGOs, the state and other bodies that provide pharmaceuticals.  Drug users are 
governed by their instinct to chart out a survival and pharmaceuticals have become a crucial way 
to negotiate their existence. 
    As social workers it becomes important to understand what are the new ways in which 
citizens are managing their lives and the forces that shape their behaviors.  Pharmaceutical 
	   216	  
citizenship is an important theoretical concept that helps to make sense of these new conditions 
where pharmaceuticals attempt to take over care and health.  In the next sections I detail the 
government protocol around OST and compare it with the actual experience of OST on the 
ground.  Further, I detail the transgressions and politics surrounding OST.  Finally, I comment on 
the issues that govern the unique survival generated through such an intervention. 
   Government pharmacopeia.      
 The Government Manual for Buprenorphine Maintenance Therapy (OST) describes the 
program in this manner,  
    OST involves replacing the client’s drug of use with a medically safe drug.  For 
instance, an Opioid such as heroin, which is considered unsafe  (it requires repeated 
administration through unsafe/ hazardous route) is substituted with a medication (such as 
Buprenorphine) which is safe, and administered through oral / sublingual route with a 
longer duration of action.  The medication used in OST helps in achieving an opioid level 
in the body, at which the client does not experience either withdrawal or euphoria 
(‘high’).  As OST helps in achieving a comfortable level, the client stops using injecting 
drug, thus preventing the potential harm of contracting HIV and other diseases 
transmitted through injecting route (e.g. Hepatitis B, Hepatitis C).  While on OST, clients 
do not require to spend all their time looking for their next ‘fix’.  Thus, they can be 
engaged in other activities including counseling and group discussions, which help also 
in delivering Behavior Change Communication.   In addition, there is also an 
improvement in the psychosocial status of the clients, leading to an overall improvement 
in quality of life. 
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In the 1990s, Buprenorphine, a partial agonist87 synthesized from the product of poppy, 
was a commonly abused substance.  It was easily available without a prescription at the local 
pharmacy under the trade name Tidigesic.  Drug users realized that it had a low risk for overdose 
and was relatively cheap.  It fast became the drug of choice for many street users.  In fact, till 
date it continues to be one of most abused licit substances in the country.  The government in an 
attempt to prevent abuse of Buprenorphine pills removed it from the shelves of pharmaceutical 
shops, however ironically enough they continued to stock the liquid form of the medicine, which 
was easier to inject.  While it is illegal to purchase Buprenorphine without prescription, a healthy 
black-market for the medicine exists.  Both Nadi Nagar and Kharagpur are over populated with 
small pharmacies that sell most licit drugs without prescriptions to drug users 88.   Addiction is 
heady business in these communities.   
    The threat of HIV changed the dynamics on the ground- drug users were now risky 
property.  Ashray was one of the first NGO’s in the country to suggest a ‘modal substitution’ and 
not a drug substitution as ‘harm reducing’ solution.  Hence, instead of promoting methadone 
maintenance- a common pharmaceutical substitute in the west, drug users were simply 
encouraged to switch the mode of using Buprenorphine, i.e. from injecting to oral use.  Owen 
(NGO head of Ashray) argued that this modal substitution was more efficient for two main 
reasons.  First, to replace Buprenorphine a partial agonist with methadone a full agonist seemed 
‘counter-intuitive’ –it would be increasing addiction rather than reducing it.  Second unlike 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
87 The opiate µ receptors are believed to be responsible for most of the analgesic effects of opiates and side effects 
like dependence, euphoria, depression etc.. Buprenorphine binds very strongly with the µ receptors preventing other 
µ receptors from binding. Concurrent use of heroin will not give any additional euphoria. When Buprenorphine is 
discontinued, a withdrawal syndrome is developed. The withdrawal features are similar to morphine; however, the 
features are not very severe. They include nausea, sweating, drowsiness, headaches, disturbed sleep and 
constipation.  
88 Mukund, a client at Ashray informed me that when a ‘new’ drug user goes to these pharmacies (or chemist shops 
as they are called) they receive a ‘starter’ kit- Avil, Buprenorphine, syringe and needle. The shop keeper may even 
show you how to inject. 
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methadone, Buprenorphine was locally produced and therefore a cheaper and more viable long 
term option in terms of treatment.  A modal substitution, it was believed, would help clients to 
graduate from invasive and dangerous forms of consumption to safer methods.   
Research shows that substitution programs are effective in that there is greater retention 
of drug users and less unemployment, criminal activity and deaths of drug users as well as more 
economical in terms of costs of drug treatment (Gibson et al., 2008; Zaric, Barnett, Brandeau, 
2000).  Methadone programs in a variety of community contexts have been successful in helping 
to stabilize the drug user and promote long-term recovery (Sacerdote et al., 2008).  Today 
marketed as Addnok by Rusan Pharma - the only Indian formulator licensed to manufacture and 
distribute Buprenorphine, it is available .2mg, .4mg and 2 mg sublingual tablets89.  It is also 
available in India as a mixed tablet of Naloxone and Buprenorphine.  This is done to prevent the 
misuse of BP through injection, as this combination causes severe unpleasant withdrawal 
symptoms (not providing a high).  Buprenorphine is then according to the government, the 
medical establishment and the NGOs a safe, non-euphoric, stabilizing pharmaceutical treatment 
for addicts.  In fact, almost every stakeholder I met hailed OST as the single most significant 
development in addiction treatment.  My experiences in the field however challenged some of 
these assumptions and highlighted the complicated stakes of this intervention. 
   An unending wait. 
     It was during outreach that most clients first heard of this ‘dawai’ (medicine in Hindi).  
Even though most clients are familiar with Buprenorphine as a drug, its status as medicine is 
something that is not as well understood (will discuss in detail later).  I noticed on many 
occasions outreach workers would tell the clients to come to the center, where they would help 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
89 During the period of my fieldwork only Buprenorphine was given as an Opioid substitute, however since then 
methadone has also been introduced in some centers. 
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them get over their ‘nasha’ (addiction/drugs).  When they did come to the NGO they would 
usually be told little about the medication itself except for its ability to remove withdrawals and 
help them stop abusing.   
Tukaram a thirty five year old drug user, recalled his first interaction at the NGO Sahai:   
They told me this (drugs) is not a good thing.  If you eat this medicine then you if you do 
drugs then it will be useless, in fact there can be some opposite reaction.  The medicine 
tastes sweet.  There is no difference (between drugs and medicine itself).  I felt no 
discomfort – well for one or two days I definitely felt uncomfortable, medicine is less and 
I was using drugs much more… in fact in my feet I felt some amount of pain.  After 2-
3days they increased the dosage of the medicine and then ‘continuous’ slowly the pain 
went away.  Now I want to get out of this, I have a daughter.   
Tukaram had begun using in his 20s.  He had planned on helping his younger brother 
who was involved “in some bad company…however in trying to change him for the better I 
myself went the wrong way”.  He told me, it wasn’t easy to get on the list for medication, in the 
first place:  
I (first) came here 2-3 times(Ashray) , they didn’t give me anything , they kept telling me 
to come this day, come that day, so I went back to using drugs.  For about 2-3 days I kept 
doing this – sometimes they would say come on Monday, but then I couldn’t come on 
Monday because I got some ‘jugaad’(slang Hindi term for hustle) and then I tried coming 
on Tuesday and Wednesday and they told me to come next Monday.  Then one day I 
went to Ajmal (coordinator of Ashray) and told him that I was feeling really ill, so he told 
me there isn’t enough medicine (here) why don’t you go to Sahai.  So I went to the 
counselor at Sahai and told him how I felt, I told him my problems and he started my 
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medicine.  So I gained courage at that point.  Otherwise I would have broken down…I 
had actually broken down.   
Tukaram had silent tears streaming down his face as he narrated his struggle to get 
medication.  “ With the medicine everything good is only happening nothing bad is happening .  
When I was on drugs then only bad things were happening.  Now only good (things are 
happening)”. 
   Slots are limited as funding requirements limits the number people who could get 
medicine.  Both Sahai and Ashray had a policy “waiting”.  New clients on most occasions 
(unless recommended by another NGO worker or were in severe withdrawals) could not access 
the medication on their first day.  They would be often asked to come back and wait.  This 
waiting period was seen as a test of their interest in recovery, but more significantly it became a 
test of worthiness to be on treatment.  Showing their patience, regularity and ability to adjust to 
the system (which was often arbitrary) were key facets of a model client- a client who the NGO 
could trust would adhere to the treatment protocol and not use the center’s resources to tide over 
a difficult time90.   
     Over my time there, I saw many clients get angry, anxious and desperate- resorting to 
begging for treatment as they ‘waited’.  This waiting period could last anywhere from 1-7 days.  
The staff informed me that such tactics used to move them in the beginning but now they were 
used to it and realized that the clients were ‘using/playing’ them.  Neither government harm 
reduction literature nor public health documents recommend such waiting periods.  The waiting 
period was a useful tool for practical reasons.  For instance, if the NGO did not have enough 
slots for medication it was a possibility that during the ‘waiting period’ an older client dropped 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
90 Some clients would come to center on days when they could not ‘hustle’ enough money for buying drugs. They 
would show interest in the program but often drop out after a few days. 
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off and the new client was given his/her slot.  By making the client wait- the NGO workers 
argued at least the client was (potentially) keeping away from the drugs for that period of time.  
Overall a majority of the clients seemed to cycle in and out of the system on a regular basis- 
waiting, joining and quitting (repeat).   
   Kneeling patients- Pharmaceutical Transgressions. 
     After morning prayers the in-house staff would quickly begin dispensing the 
substitution medication, knowing fully that many clients were showing signs of withdrawal and 
would not hold up long.  I would usually sit next to Clive, Brian and Atif in the dispensing room 
most mornings to observe this Opioid/Oral Substitution therapy (OST) at work.  The three NGO 
workers would sit behind a large old wood table close to the entryway.  The table held all the 
dispensing equipment – strips of Buprenorphine, a steel spice masher to crush the pills, as well as 
the registers and files to log client details.  A small locked steel cupboard on the extreme left 
corner housed all the medication- its keys were guarded zealously by Brian.  There were a few 
chairs for clients in front of the desk but usually the staff, community members or the doctor who 
consulted at the clinic occupied them.  Thus, clients who would come in to take their medication 
would end up sitting on the floor, right next to the small narrow bed used for tending abscesses.  
A small table with medical supplies and boiler to clean medical equipment was wedged between 
the main door and the bed.  The peeling yellow walls were covered with a few HIV posters, an 
old mirror and a wall clock, given by a client- that never seemed to work.  The medium sized 
room was always buzzing with activities of dispensing, abscess management, and record keeping 
but it was also a hub for socializing among clients, staff and community members. 
   To receive their dose of oral Buprenorphine clients needed to present their ID cards, 
this also contained the dosage taken by each client.  Almost every day two-three clients would 
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forget or lose their ID cards- a phenomenon common in both NGO sites.  A fight would ensue 
between clients and staff, as the NGO workers would usually refuse to give medicine.  The ID 
cards Muquim (project manager, Ashray) told me is not only necessary for records but also 
imposes discipline, hitherto lacking in their lives.  As an added incentive, it also legitimizes them 
as patients/clients of the NGO.  The police was less likely to harass them if they showed their ID 
cards (knowing that they were undergoing treatment) and they were likely to receive better 
treatment in hospitals and access other social services.   
    The NGO worker would usually place the assigned dosage of medicine into the spice 
masher and crush it into a fine white powder.  This powder was then poured onto a small piece of 
paper.  The drug user was asked to bend down or would kneel on the floor as the NGO worker 
poured the crushed contents directly the client’s gaping mouth.  The clients were not allowed to 
touch the drug physically at any point.  However exceptions were made for certain clients.  At 
Ashray, the procedure for medicine giving was similar in style to Sahai but given the large 
numbers and lack of space or time, the pace was much faster.  Anil a thin wiry chain smoker 
would sit at the register to note names and check ID cards, Kalyan a young novice with little 
experience was made to smash the pills and pour it into the clients’ mouths.  Usually a third 
NGO worker stood at the door, directing traffic and making sure the clients had swallowed their 
entire medicine before leaving.   
Don’t eat or drink anything for at least 15 minutes before you want to take the 
medication’.  ‘Don’t smoke your beedis’.  Keep your mouth shut, don’t try to talk while 
the medicine is in your mouth’.  ‘Look straight and keep your hands where we can see 
them’.  ‘Open your mouth wide, wait let me check properly’.  ‘Don’t make a fuss, don’t 
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come too close- I will fall ill, close your mouth and cough, if you must’.  ‘No we don’t 
have any medicine for fever, ask the doctor to write you a prescription’.   
These dictums, given by workers, were common in both the NGOs.  It kept clients 
reminded of who they were- ‘untrustworthy and risky subjects’.  Day after day as I sat in Sahai 
and Ashray I would watch this drama unfold with literally hundreds of drug users who would 
come for their daily medication and leave.    
The kneeling- open mouthed submissive drug user, to me, has in certain senses, become 
the new symbol of ‘recovery’ of harm reduction in India.   An ironic choice considering the 
broader ‘rights based philosophy’ that harm reduction experts claims drives this paradigm.  
However, I also recognize that this symbol of a kneeling subject is unstable and extremely 
fragile.  For instance, whenever the clients got a chance they would remove the Buprenorphine, 
store it for injecting later.  Jamal an aging client was one such rebel.  He had become such a 
nuisance for Ashray that it was comical to watch his arrival.  Tall, almost 6 feet, matted hair, 
with a ratty bag that included all his belongings he would walk in and produce his ID card with 
great flourish.  Anil looking up immediately smiled and loudly said, “Look who has arrived, 
everyone be alert, this one always leaves with medicine”.  Kalyan chimed in, “Don’t you dare 
show your ‘kaalakari’ (smarts) here”.  Then turning to me he remarked, “We have try to explain 
to them so many times that this is medicine, it must not be misused, but do they listen...  We are 
tired, no matter how much you explain it to them, they just don’t understand”.   
Jamal looked at me his eyes twinkling and his thick beard seemed to be hiding a smile.  
As he sat down on the bench waiting for the medicine to dissolve I looked over at the workers- 
all three of them- Anil, Kalyan and Raghu (the third worker on duty) were staring at Jamal 
waiting expectantly, nobody moved as they watched him swallow, hum and smile intermittently.  
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Jamal tried to check for something in his pocket and all three workers jumped at him to stop and 
sit quietly.  After five minutes of such non-stop staring, another client walked in and their 
attention got divided, Jamal recognizing the opportunity, put his hand in his mouth and took out 
the medicine, storing it in a small piece of paper.  After giving it another ten minutes Jamal got 
up to leave.  Raghu asked him to show his mouth- all clear.  Raghu was not satisfied and began a 
physical pat down asking him to empty his pockets.  Kalyan joined in as they checked every little 
scrap he was carrying, even asking him to open his bag –rifling through his belongings.  By now 
a few other clients had also come to watch, as were the nurse and some of the outreach staff.  
Throughout this humiliating experience Jamal kept smiling.  They finally did find the little 
folded piece of paper with the medicine.  Once outside Jamal and other such ‘rogue’ clients 
would carefully remove the stored contents, dry in the sun, mix it with another pharmaceutical 
like Avil or with smack (street name for heroin) and inject it right back into their bodies.   A 
triumphant Raghu a large man himself pushed aging Jamal out of the center.  Kalyan let out a 
string of Hindi abuses as he shouted at him for being so ungrateful.  The entire NGO came to a 
standstill- Jamal was being a made an example and everyone was made to watch.  A week later 
Jamal convinced Muquim (project head) to give him another chance and returned back as a 
client.  Jamal story was hardly unique, many such Jamals’ came and disappeared during my time 
at Ashray, however practices of medicine giving, stealing and injecting continued.  The return of 
Jamal to the system was inevitable as were his attempts to misuse the drug.   
     Ajay, a client from Ashray who also told me that he regularly stole and injected 
medicated Buprenorphine.  Mukund an immigrant from Nepal had lived in Delhi now for many 
years. 
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 I try to take it out, if I can then great if not…the days I have friends (who are using) or I 
am sorting garbage and I make enough money to buy my medicine.  But I don’t take 
chances here.  I first look around and then see that I don’t steal in front of any and every 
client.  I want the respect of the staff to be maintained, so that as a result of one- another 
person doesn’t lose respect.  So that they (client) don’t say why do you let him go and not 
us. 
 He was almost certain that he needed to steal dosages to keep the withdrawals at bay.  
Ajay was at all times careful of what he revealed to me, making sure that no one heard us.  He 
seemed to be more concerned about losing face (for himself and the NGO workers) than 
necessarily acknowledging the conditions that prompted his misuse.  His experience (both 
corporeal and psychological) of OST was very much grounded in this community and these 
NGO worker-client dynamics- it was this life politics that were the techniques of his survival.   
    Uma who I had met on the very first day of my fieldwork at Ashray, also echoed 
similar sentiments.  She had stood out not only because she was the only woman coming to 
receive medication (in both NGOs), but also unlike her male peers she was allowed a ‘take home 
dose’ of Buprenorphine and bypassed some of the bodily disciplining of OST that I have 
previously described.   
I don’t share only sometimes- these people (Ashray) don’t know that I still use, they think 
I have left drugs, so why should I get a bad name, so when others are using…My drug 
use has become less as a result of the drugs (she uses the word ‘nasha’ both for the 
medication and her drug use) , without it would be a wasted away- because of it I stay all 
right, I don’t have any problem..  I can do my work.  When I was using drugs I wouldn’t 
even like getting up until I had my drugs, but now look at me I look fine, I get up at the 
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right time.  I do all the things that are needed to be done, there are no problems, no 
worries- no need to do ‘jugaad’, medicine is good.   
Both these clients highlighted how the appearance of recovery was as important as 
recovery itself.  In fact, recovery under harm reduction was more akin to managing their drug use 
in controlled ways rather than addressing inherent issues surrounding drug use. 
   For Uttam a fifty-year old tailor who had started abusing drugs almost twenty years 
ago, his harm reduction treatment was a part of a continuum that carefully wove use and abuse 
with his desire to be considered ‘treatable’.   
I had heard about this organization in Kharagpur and felt it would be beneficial for me to 
join , there is benefit…but again after one month I left them and after one and half 
months I ‘relapsed’.  Then I fell back in the hole again and again I returned to Pawan 
(counselor Sahai) – I talked to him and started my medicine again.  From that day until 
today I have been on medication (he started coming to Ashray after Sahai’s project site 
changed).  I tell Raju (counselor, Ashray) brother increase my dosage by two pills he tells 
me he will do it on Thursday, sometimes Monday …that is why I need to take one and 
half pills on my own.   
    Uttam claimed he was too old to completely change and harm reduction offered a 
comfortable space in-between.  He told me: 
 The experience of the medicine is just like smack.  It tastes like opium- its that ‘taste’.  
After taking the medicine, have some chai then it (the taste) really blossoms - it just 
seems like as if I have just taken ‘nasha’ (drugs).  Besides that it has helped stopped a lot 
…medicine makes the person stop engaging in bad things.  Now that I have got my 
medicine , now I can relax and quietly talk to other people.  I don’t have (to worry about) 
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money, I don’t have jugaad (hustle) or that I have to go and pick pocket.  If I had to go 
for work (legal or illegal) then I wouldn’t have been even able to talk with you, my mind 
would be flitting from here to there…now this medicine it doesn’t allow the mind to 
move here and there, only in one direction the mind moves- towards food or home. 
   Harm reduction had opened the possibility of using drugs without remorse, guilt or 
stigma.  However, there was ambiguity of what was this status that it had acquired in their lives.  
Without necessarily labeling these transgressions as relapses as they did in the previous 
abstinence paradigm, drug use was now seen as a part of their lives a chemical that sustained life, 
made it normal and livable.   
     Bharat was considered an ideal client and a success in many ways for Sahai.  Six feet 
tall with a slightly long and curly hair and a big beard this lanky man would be at Sahai’s offices 
just as they opened the shutters and leave only when the staff left.  Usually quiet but when he 
spoke his booming nasal voice garnered everybody’s attention. 
 Someone told me that sometimes you pick it up and sometimes u drop it , why don’t you 
go to that organization they give medicine.  It was about 10-12 years back …in the 
beginning they gave me a medicine and then the whole day I felt drugged – I said well 
there is nothing better than this – it’s a free drug.  I became linked with Ashray – I would 
take the medicine, mix it with Avil and …then pull it in the syringe, then mix it like 
(makes a motion as if he is shaking the needle)- mixed it like this and then inject the 5ml 
in my bloodstream, then again after 2-4 hours I would do the same again.  Then I started 
seeing that many boys, some had put the drugs in their groin, some had lost their legs – 
their hands...their groin was bursting.  Then I became scared and said I have to leave this.  
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After five years of injecting I decided to go for rehabilitation.  I stayed in the 
rehabilitation center for about one and half months. 
But once out of the rehabilitation center Bharat started using again.  He would earn 
money by sorting garbage buy a vial for about Rs.  50-60 and some food for Rs.10-20.  The day 
he wouldn’t be able to make as money to get his usual fix then he would inject Buprenorphine.  
“The staff of Ashray itself would sell the medicine and would be fixing it as well.  We would be 
injecting them and they would be injecting us”.   
   However in the past year things changed dramatically, he decided to commit fully to 
the program at Sahai and had not abused any drug (except taking medicated Buprenorphine).  He 
was also willing to try rehabilitation again.   
I am telling the truth, I am sick, I am tired and without any aim –stealing, jugaad, stealing 
things at night , getting beaten up, not getting food .  I left my household and am living 
under the bridge – I have broken down completely , now I want medicine in a regular 
way in the mouth.  So when I came to the Sahai they started my medicine.  For the past 
one year I haven’t touched a needle or a foil.  I only had the medicine, and in the evening 
had my food, and gone back to sleep.  Then in the morning my eyes open and I straight 
come to the center.   
Bharat like others has found many benefits to this medicated life:  
Firstly we are away from crime, I have stopped stealing and all those kind of things.  Nor 
do I have to do so much “jugaad” for instance I had to steal this bag, nor do I need to be 
in such withdrawals.  I know that I have eaten my medicine, I have to eat food and then 
go to sleep.  I have that much belief that if I come here tomorrow we will get the drug 
tomorrow.  I don’t have to actually spend money at all.  We also get the drug, two three 
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times we get tea, they talk to us nicely and our time passes – we are away from that life – 
breaking somebody’s lock, stealing someone’s luggage, stealing someone’s cycle- people 
are beating us, they are breaking our hands, going to jail…this life is better than that life 
that I had before. 
Over time, I began to understand how these were examples of OST’s most basic 
functioning at best, while simultaneously OST’s most acute failure.  Dr.  Rohan Chatterjee a 
leading harm reduction specialist (heading a large government harm reduction program in the 
city), met with me to discuss these transgressions and how he saw harm reduction’s function in 
the addicts’ daily lives.  He told me he was very aware that clients often misused Buprenorphine 
and even abused other substances with OST.  But he argued that their (NGOs/medical 
establishment) main effort was to reduce harm, even if it was for a small number for a short 
period of time.  He pointed out that statistically if one were to calculate, even if one drug user did 
not share one time the possibility of reducing HIV was multifold.  While it seemed to be 
shortsighted at first glance Dr. Chatterjee argued that for a country like India where people did 
not have any experience with OST, the act of coming to a center to receive medication itself was 
a radical move.   
With family we have had 2 contrasting response some family perceives that these are 
addictive medication, doctor you are not helping my husband or my son and there are 
people whose families are thrilled- that my husband is now well he gives me money from 
his earning 80% of his money.   
These drug users, in that sense were not a failure but recovery in progress.  Every day the 
drug user had less chance of sharing because he received closely monitored doses of 
Buprenorphine and clean injecting equipment, every day he was less likely to engage in criminal 
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activities since he was getting his drug free of cost and everyday the possibility of him spreading 
HIV reduced.  As a by-product of these rituals he was inadvertently and slowly reducing his 
chemical dependence, more engaged with some form of civil society and no longer invisible but 
had become a pharmaceuticalized citizen.  In his own facility Dr.  Chatterjee had seen many 
successful patients who had not only stopped using drugs (not dependent on OST) but also had 
returned to their families and even taken up jobs.  During my time at Sahai and Ashray I only 
saw 3-4 clients successfully transition into such a life, out of the hundreds that came to seek their 
services. 
   Dosage politics. 
     Ashray struggled with such ‘rogue’ clients more than Sahai.  Ashray’s clients told me, 
that this was partly because only recently had the protocol around medication changed in this 
site.  Previously, all clients would be given take-home dosages, clients were used to misusing the 
pills as they were without supervision.  ‘The clients have been spoilt by such practices and it 
becomes difficult when we try to enforce some discipline’, Muquim told me quietly when I 
asked him about these shifts.  Clients like Ajay were also quick to inform me that the staff was 
selling Buprenorphine strips in the black market.   
Earlier we would do outside drugs and we would get these drugs as well.  I mean if our 
dosage was two pills then openly we could get as much as we wanted (via the black 
market).  But in the middle what has happened is that the dosage has reduced now they 
are only giving us one pill.  The number of pills has reduced and also they are being 
crushed, so we have to go outside and find pills for injecting.  In the middle when they 
would give us medicine it wasn’t enough so one had to go outside and search for more 
medicine.  The amount they give us is enough but what to do its force of habit and 
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secondly a drug user must use drugs there will never be a day when he/she will say 
reduce the drug , the drug user will always think that this is less- what one is getting from 
here , he will want to do more drugs.  The drug user will never say I want less medicine, 
reduce my dosage…he will only think that one day I had this dosage I did not have any 
enjoyment so today I need to fix (in addition to the medicated dose) so slowly it will keep 
increasing.  But I do feel what they are giving from the point of view of the NGO is 
enough.  In our minds we keep thinking that if we do more drugs then we we can work 
more, so we then we pick up more drugs. 
It was an allegation that was brought up on many occasions including by some of the 
Ashray staff members themselves.  For poorly paid staff this was a lucrative side business.  Even 
if clients felt they were not being given enough medication, they assured me they could easily 
procure it via the black market.  The lines between licit and illicit were constantly crossed and 
never clear.  Thus, there was a culture of abuse that seemed to link the community and the NGO.  
Injecting drug use was not only a public fact, but in some senses nurtured through these NGO 
channels of unlimited availability and misuse. 
    One of the easiest ways to gauge clients’ adherence and compliance were the rate of 
abscesses.  If injected oral Buprenorphine could block veins and cause severe abscesses.  Hence 
if a client on OST came to the center with abscesses it was evident that not only was he/she 
continuing to inject, most likely abusing medicated Buprenorphine.  As compared to before, 
abscesses have drastically reduced and in most cases they are attended to, more quickly. 
   Closely linked to this ‘undisciplined behavior’ of misuse of medicine was the issue of 
dosage.  Both in Sahai and Ashray the issue of dosage was mired in controversy for a variety of 
reasons.  Universally clients complained that their dosages were inadequate and their effect only 
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lasted for 24 hours.  NGO workers on the other hand assured me that the doses being given were 
adequate to manage withdrawals for at least 72 hours.  There were no set criteria for deciding the 
dosage- it was usually a collaborative process between the doctor , NGO worker and the client.  
In some extreme cases (SOS), when the doctor was unavailable it was the NGO worker that 
prescribed medication.   
   At Sahai at about two in the afternoon the center’s doctor would arrive on his old green 
moped.  Dr. Choudhary, was a balding middle aged physician who had been working for Sahai 
for a number of years.  He would usually amble into the center, open the newspaper and demand 
a cup of tea before opening a single client file.  Flipping disinterestedly through the charts he 
would begin with the most ‘serious’ cases.   Glasses perched on the edge of his nose, legs 
crossed he would ask “Kya dosage okay hai? Koi mushkil to nahi, sone mein?” “Is the dosage of 
the medicine okay? Did you have any difficulty sleeping?” Jairam a relatively new client to the 
center had just begun the OST treatment and he wanted to increase his dosage.  Clive (NGO 
worker) had informed him that only the doctor was allowed to change dosages.  Thus, Jairam 
was here, clearly nervous, he mumbled quietly that he was in ‘tootan’ or withdrawals.  The 
doctor assured him that it was likely his body would face such difficulties-especially since he 
had just shifted from injecting to oral use.  Jairam looked unsatisfied with the explanation and 
then reluctantly talked about his lack of sleep, difficulty in concentrating and not being able to 
work.  The doctor at this point looked over to Brian and Clive – as if asking for some form of 
confirmation about the authenticity of these symptoms/conditions.  Clive looked over at Jairam 
and said “The whole point of coming here is that you reduce drugs not increase them.  You will 
have some difficulty in the beginning but it will soon become okay”.   
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       The doctor now clearly keen to move to the next patient increased Jairam’s dosage 
slightly “I am increasing it by two pills”.  He did not tell Jairam the potency of the dosage, the 
effect it will have on his body or the future course of the medication.  Jairam, satisfied left his 
chair for the next client.  This type of collaborative prescription was common.  Doctors often 
relied on the NGO workers to provide a patient history and determine the client’s trustworthiness 
(necessary to maintain adherence) or condition.  However, since dosages had to be managed in 
response to client’s physical needs, the client was an integral part of this prescriptive process.  In 
most cases the dosage that was assigned was started low and then based on the client’s 
physiological state, adherence to regime and behavior increased over time.  Even though there 
were major differences in the types of drugs abused, the length of abuse and nature of addiction, 
most clients were given the same starting dosage.  Depending on the clients’ condition the 
dosages would then be tapered in the coming months, with an aim for achieving a drug free 
status.  Clients often found the initial dosage too low and would face withdrawals, which 
prompted their return either to full blown drug use or using other illicit drugs simultaneously.  
For clients the number of pills mattered as much as the actual the strength of the pill itself.  
Hence NGO workers had to make sure they conveyed the strength of the pill as well as the 
number clearly to the clients during each interaction (especially if there was going to be a 
change).  Most clients in Sahai were constantly encouraged by NGO workers to reduce dosages- 
maintenance, as a concept, was not encouraged.   
   Ashray, in comparison, tended to focus less on abstinence as a goal.  In fact, a 
significant group of clients were taking medication for over 5 years.  During the course of my 
fieldwork however, Ashray workers shared that their policy of maintenance may undergo a 
change.  Until Ashray was funded by private /bilateral donors they were free to dispense 
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medication as long as they deemed fit.  However, under government funding they faced certain 
restrictions.  Government policy stated that after 9 months dosages must be tapered off.  By late 
2008, after massive lobbying from the NGOs, this policy was revised and extended to a longer 
period (approximately to 18 months or determined case by case).  Government actors who 
wanted clear timelines of recovery and were daunted by the prospect of funding medication in 
‘unending’ fashion.   
    Often dosages were also reduced because there was a delay in the medicine supply 
chain.  Other times the NGOs were fearful, that the funding for the medicines would cease, since 
most contracts with the government were six months long and those with private funders lasted 
for one year only.  This sudden withdrawal of funding could potentially create a situation where 
the drug users, would be left without any support or medication.  Hence the NGOs would often 
create a buffer of stock to protect against such future shortages.  At other times there were during 
periods of plenty, NGO workers would encourage drug users to increase their dosage- so that 
they would feel ‘comfortable’ enough not to use other drugs.  These shifts in availability, 
perceived shortage and thriving black market generated ambiguity in terms of what was adequate 
dosage or medication.   
   When dosages would be reduced clients would get extremely agitated, angry and 
sometimes even get violent.  Withdrawals to Buprenorphine, clients told me, were far worse than 
any other drug they consumed.  For many clients the medicine provided them with certain 
stability and even a slight shift in their pattern would have major repercussions to their street life.   
On one such day the medicine had been delayed at Ashray.  One by one clients had to be told 
that today their dosages were going to be cut in half.  Both Anil and Kalyan had been especially 
patient with clients- trying to explain that the medicine had simply not arrived from the office.  
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While some clients took the news calmly, others clients like Raju became very angry.  “This is 
our right, you are here to serve us…how can you do this, stop our medicine suddenly”.  Anil 
tired of the explanations began shouting, “What can I do, I am only an employee here…”.  As 
the morning wore on the situation remained tense.  Many clients refused to leave the center 
premises even after collecting their ‘half dosage’.  Muquim (project head) had to specially 
address the group and force them to disperse.  The staff clearly outnumbered was scared about 
their anticipated response.  The clients seemed to calm down once Muquim spoke with them.   
Over the eight month period of my stay this happened twice, Muquim told me that these rare 
occurrences were ‘tests’ for the clients and the staff as well.  “There could be a riot here, if we 
one day decide to stop giving them medicine.  There are too many people who are dependent on 
it”.  Muquim was right, in some senses these clients had stopped imagining their lives without 
the medication and any threat to its regular supply was seen as a clear threat to their sustenance. 
    Abuse of OST was intrinsically linked not only to under dosage, lack of social support 
and easy availability of drugs but also with the inherent act of drug taking itself.  As Salim 
(client of Ashray) explained it to me, “We miss the prick of the needle”.  The needle prick, the 
abscesses and the sores reflected a semblance of normalcy, continuity and even nostalgia for 
these ‘overused’ bodies.  It gave them a sense of control on the drug and themselves.  Thus, even 
if though, injecting medicated Buprenorphine did not provide the necessary affective response 
(because of the new chemical combination) and led to abscesses, the act itself was an essential 
element of their lives.  Abdal Khan shared, “When you prick it goes into your body, then (you 
know) that yes we have felt the drug…for an injector this is his/her identity until the needle 
doesn’t prick…”.   For drug users scoring, preparing and using were deeply entrenched rituals 
and activities of their day-to-day drug life.  However, now they received measured and crushed 
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doses of their drug as ‘medicine’.  Moreover, clients were not only prevented from touching the 
medicine but also stopped from manipulating its form -some clients would request to be given 
the tablets whole as they preferred it to crushed powder.  Drug taking, was then not only the 
disease- exterior and alien, but over time, had come to represent who they were as people.  It 
defined the textures of their lives and how they understood their roles in society. 
   I have drawn out the various aspects that made up the ritual of medicine taking and the 
processes and practices that surrounded them.  In this final section, I attempt to highlight the kind 
of survival, health politics and medicalized recovery that governs drug users’ existence today.   
   Surviving through a new kind of recovery. 
 The provision of oral Buprenorphine in a medicalized setting was intended to help drug 
users move away from harmful injecting use and keep them away from criminal activities as they 
were assured the dose of Buprenorphine.  OST, according to the government was to serve only as 
a transition point, from where drug users could move to rehabilitation services and ultimately 
live a ‘drug free’ life.  However, my ethnographic work showed that the experience of OST on 
the ground was a much more complex process- affected by a number of conditions that generated 
new modalities of survival.     
   Recovery talk.   
Pharmaceutical medicines have managed to bring the notion of measurement into the 
understanding of recovery and more broadly living.  When asked about their stage of recovery 
clients would often answer in terms of the dosage they were on-.2mg or .4mg etc..  Lesser 
medication meant they were doing better than before- abstinence remained the gold standard of a 
recovery lifestyle.  The length (time) of recovery was also broken down in terms of medical 
dosages not in terms of psychological breakthroughs (as was common under the AA/NA 
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models).  Talk about recovery, is now significantly different as well.   Largely spoken about only 
in these indices of dosage with amount of medication as the only indicator of well being.  Drug 
users have quickly began to emulate the local harm reduction experts and use the language of 
measurement to speak about their health and addiction.  Pharmaceuticals have single handedly 
manage to remove other idioms of recovery and health- leaving the psychological component an 
important core of the addictive life untouched.   
   Social support or health care assistance was also now measurable in new ways.  
Reduction in medication became a critical indicator to measure the quality of care and clients 
would argue that their rights were being violated.  This model (as discussed above) allowed the 
client to participate more fully and actively in the management of his/her medical recovery.  This 
was quite unlike the heavily psychologically focused model, where the doctor/counselor was the 
only expert.  Armed with their years of expertise in managing their drug dosages, this new 
management of medicine is far more familiar than any psychological framings of their disease.  
They would often make demands to increase and even reduce dosages depending on their 
condition and doctors had to listen.  However, government guidelines and NGO interventions 
clearly carry traces of a historical medical model of doctor and patient, which are also uniquely 
Indian in its texture.  Doctors, within the Indian context are seen as key authority figures and 
patients do not necessarily participate as vocally in their treatment.  In fact, patients’ class 
positions play a key role in the status they occupy in this interaction; marginalized groups such 
as drug users have never occupied an equal space in this medical arena.  Submissive bodies, 
bowed heads and unquestioning agreement with establishment continue to reign medical 
interactions across the spectrum of health, not only in the sphere of addiction.  While inherently 
problematic, the medical model offered harm reduction a way to legitimize this new and radical 
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model of intervention in local communities.  It helped to situate something unfamiliar through a 
more familiar relationship.  Most critically, this was to serve as an important break between the 
drug (Buprenorphine) and the person, between addiction and medication and between a private 
concern and public health.    
   Ambivalent medicine. 
    The government framing of the consumption of medicated Buprenorphine is 
significant, as it tried to shift the conception of this drug from the ranks of illicit, addictive and 
pleasurable to the platform of legitimate, controlled and emotionally abstracted.  But as my 
fieldwork progressed it became clear that the easy availability of Buprenorphine in the black 
market was undermining these official efforts of separating Buprenorphine as an illicit drug from 
its guise as a medical intervention.   
    Lovell (2006) describes this movement of ‘addiction pharmaceutical from the site that 
legitimizes it  (the treatment context in which its commodity status is downplayed before its 
status as a pharmaceutical tool or a medicine) to an informal illicit network (the drug economy 
where it morphs into a symbolically charged dirty commodity that escapes market and state 
regulatory mechanisms)’ as pharmaceutical leakage.  She highlights that ‘ what distinguishes a 
good substance from a bad one is not inherent to the substance itself; it depends on the effect 
sought, the quantity taken, the means of administration, the frequency of the practice, the 
context, individual vulnerability, all of which are highly symbolized.  The ability to differentiate 
between poison and remedy, to generate a dialectic between these two poles of the pharmakon, 
depends upon the lay knowledge and scientific knowledge that circulate among drug users’.  
Lovell points out that is not the drug itself, but the knowledge about the drug, value judgments 
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attached, information provided by health practioners and the indigenization of pharmaceutical 
knowledge (Kleinman,1986; 1988) that ultimately governs its use/misuse.    
   This confusion between medicine and drug was most evidenced in the terms of 
reference used by drug users.  They often continued to refer to Buprenorphine as ‘nasha’ or drug 
very rarely calling it ‘davai’ or medicine.  Uma was clearly very aware of these differences and 
what they would mean for her recovery: 
When you do drugs you don’t feel like anything else, when you are facing withdrawals 
then you are having problem, your mouth starts to burst, tears start rolling down your 
eyes, you start feeling lethargic and .  However, now when you have one pill you don’t 
tend to feel too much.  Its not like I don’t use drugs at all sometimes I do fix medicine- 
once or twice in a month …I know that for so many days I was doing drugs and I was 
unwell.  Now I need to have this medicine –it’s important that is why I take this 
medicine.  Medicine- for disease, if I think of it as drugs and consume it then my mind 
will lose control – that is why I am unwell I am taking this medication. 
 This slippage in language also translated to their very consumption patterns as well.  
Clients were after all taking the same drug except the conditions surrounding its intake differed 
vastly.  This difference in perspective made a great difference in how they used/abused the 
medication/drug.  I argue that the abstinence paradigm created a break both in their 
consciousness and their actual material life- separating or purging the drug from the body, while 
harm reduction promotes a continuity in experience – where neither the body, the senses nor the 
consciousness realize any vacuum or shift.  Thus previously clear lines of recovery and use are 
made muddy.   
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    While clients understood the legitimacy that the NGO provided pills gave them- 
protection from the law, acceptance by society and social currency to negotiate their concerns in 
other civic institutions (hospitals, social service organization etc.), they also claimed that the pills 
were a way for the government/NGO to keep them addicted and controlled.  The medicine they 
recognized only helped to keep their addiction under control not help address multiple concerns 
that surrounded their use.  Dalbir (client) told me: 
The withdrawals to this medicine is even more than smack.  By taking smack there is not 
as many withdrawals- you don’t want to work, your limbs hurt, you don’t feel like 
eating…as soon as you eat the medicine you start feeling hungry as well, you start to 
drink more water as well.  We get the medicine in the morning and then we keep sitting.  
he says it works for 48 hours but not for 72 hours.  They are lying to us because after that 
you do need the medicine, withdrawals for the medicine keep coming back – mouth starts 
to burst, you are in a bad condition.  I don’t want to take medicine all my life, I want to 
leave this as well.  Because we have to come here on time we can’t even go to work- we 
come here straight to eat the medicine.  One has to leave this slowly slowly – you can’t 
be eating this all your life. 
This ambiguity between medicine and drug was deeply implicated in the way they 
conceived of their current recovery and future life.  Almost every drug user that I interviewed 
viewed drugs use as problematic and painful.  Shahnawaz , a client/volunteer at Sahai was 
struggling with recovery often relapsing into full blown drug use.  At almost fifty his struggle 
with drugs had lasted almost all of his adulthood.  His grown children and wife had all but given 
up hope.  “In this its not like one gains anything, man always loses and loses- loses everything, 
loses his land, the respect he has in society, things…one doesn’t gain anything.  His thinking is 
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like that he gets peace when he gets his drug”.  Drugs were not neutral they had caused grievous 
harm to their lives –loss as a theme was recurrent in their renditions of these addicted lives.  It 
was not merely a loss of material things but a loss of control over their bodies and most 
significantly a loss of hope.  Dalbir in one of our last conversations had this to say: 
 Any drug is bad, no drug is good.  Because of it one loses their home, their friends, their 
relatives, one loses everything.  Drugs breaks a person, first it breaks the family 
members, then it breaks relationships with relatives...any relatives that would come by 
would say he look a ‘smackiya’ (local term for smack  user), hide your things.  He will 
steal your things.  One has only negative impacts as a result of this , no benefits, 
everything is broken as a result.  Drug use is a disease – you do drugs and it gets over.  
There is no correct time for eating and drinking- if we get food then we eat it otherwise 
mostly we drink tea.  Tea chases away the hunger.  Drugs are a bad thing, they are not a 
good thing.  This we only find out when our lives are ended.   
Thus, Buprenorphine once an injectable, illicit, pleasurable and unsafe drug despite the 
government’s best efforts never completely moved to the platform of neutral, safe and non-
euphoric.  Ingrained in its very bio-chemistry, medicated Buprenorphine has a more 
fundamentally organic intent- delinking the drug from its uncontrolled past.  However, it 
continued to carry traces of its previous life as drug users time and again referred to its ability to 
provide comfort, familiarity, suffering, pain and pleasure.  Therefore the government’s re-
framing of Buprenorphine as a neutral agent that leads to neither withdrawals nor euphoria is, in 
practice impossible to conceive for drug users.  In fact, it was perhaps this very feature that made 
the intervention successful and led to high adherence rates.  Further more, at the macro level, 
pharmaceutical substitution functions in a system where drug use continues to be seen as a 
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criminal activity with a heavily punitive approach (as ham reduction approach remains a 
minority).  In fact, the government’s welfare arm continues to support abstinence-based 
programs.  This contributes to social context within which drugs remain as problematic and 
negative.   
    This unclear position of Buprenorphine and its inability to fully shape recovery as a 
rights based, choice induced and progressive public health strategy, produces a chemical survival 
that retains a transitional and artificial quality to the life it sustains.  Drug users are already 
implicated ‘pharmaco- subjects’ not only in terms of consumption but also in terms of how their 
identities, values and behaviors are heavily shaped by this activity.  OST is attempting to shift 
their identities, values and behaviors by inserting an old abused substance into a new ‘drug 
system’ (I use the term system because the drug use is organized around institutions, rules and 
ideologies).  However, it is not a mere reframing of the substance that is at stake, but by 
rearticulating the role and position of the drug user; it is in fact a repositioning of survival or 
living itself that is at stake.  No longer must life be thought of devoid of substance, but instead 
life is in fact measured through the meter of substance.  As ‘pharmaco-subjects’ enter into this 
new system the pharmaceutical is no longer seen as alien or synthetic but instead is seen as 
integral to the continuation of life- personal and organic.  As healthy life becomes inseparable or 
dependant on a pharmaceutical life, it will slowly blurs the difference and shapes a unique 
subject for whom survival exists only within these parameters.   
   Empowerment or Dependency: Excavating the drug subject. 
    As I was coming close to completing my fieldwork in India, I continued to grapple 
with an essential question about what defined this harm-reducing drug user.  Was he/she a 
choice making individual or a dependent subject? Were harm reduction services encouraging 
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empowerment or were these drug users simply making day to day choices to survive? These 
questions of agency, dependency, freedom, rights, choice, discipline and governance seemed to 
be at the heart of the harm reduction project.  In this final section of the paper I attempt to 
tackle some of these key concerns.   
For a majority of this chapter I have drawn from Foucault’s theoretical body of 
knowledge that in some senses is less concerned about individual agentive capacities in local 
spaces and more concerned about the affects that disciplinary forms of power have on social 
bodies.  Even Foucault’s notion of biopower and the related literature on citizenship links the 
growth of omnipresent knowledge, expertise with these drug populations, leaving less space 
to reflect on local activism, rights focused struggles and innovative efforts to chart out a 
living.  Finally, using Foucault as Bourgois (2000) writes, can at times lead to a paralysis in 
thinking about practical concerns, which are the focus of practioners and disciplines like 
social work.  Therefore, my effort is not only to understand more theoretically how drug users 
are being shaped but more practically what can we as social workers do in making the 
services more supportive of drug users’ needs. 
One of the biggest concerns around OST and more generally with pharmaceutical 
substitution is that this form of treatment continues the individual’s dependence on drugs 
(Holt, 2007; Bell, Dru, Fischer, Levit & Sarfraz, 2002).  However ham reduction supporters 
argue that by replacing street drugs with medically provided substances under supervision, 
clients are more capable of acting in responsible and rational ways.  The quandary was 
evident in my fieldwork context as well.  As I described before, drug users and NGO workers 
alike would question this very dependency and yet had few options to independently seek a 
stable life style (Bell, Dru, Fischer, Levit & Sarfraz).   
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Some scholars have rejected an either or stance and instead shown the range of 
strategies and behaviors that clients’ tend to adopt –leaving the question of empowerment or 
dependency almost unnecessary.  Gomart’s (2002,2004) work in the methadone clinic 
highlighted how freedom and constraint can be viewed from the perspective of drug users 
who are trapped in their own addiction.  Despite the freedom the drug users’ lifestyle 
provided, for most clients’ in the field it held little meaning.  Without being connected, related 
and functional within a societal context, autonomy was almost useless.  This notion of 
attached autonomy was cleverly used by the clinic to harness drug users into behaving in less 
risky ways.  In my fieldwork setting while such an approach was missing, it was clear that 
clients were unwilling to passively submit to the restrictions of the NGOs.  They would 
manipulate, divert and use Buprenorphine in different ways than expected yet at the same 
time wanted to remain engaged with the NGO itself.  These tactics to remain independent but 
connected and resonate with Gomart’s findings.  Ning (2005) also has commented on these 
issues on her work in a methadone clinic in Canada.   
This was similar to my own findings in the field, as I have reported before.  Given the 
cultural focus on abstinence and a chemical free life, this dilemma is fully understandable.   
For Holt it was important for practioners to acknowledge the clients’ efforts for ‘controlled 
and strategic use of methadone with other drugs to maximize both treatment stability and the 
maintenance of pleasure’.  However, considering the political climate under which most harm 
reduction programs operate, this might be difficult to achieve.  In his work Holt suggests that 
treatment should attempt to encourage clients’ decision making on one hand without a fear of 
dependency and increased responsibility on the other.  It is a delicate balance between 
fostering reflexivity and independent action as well as success in the treatment, though the 
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latter can inadvertently “induce fear of losing that independence and capacity for action” 
(Holt).   
While reflecting on my own fieldwork experience these suggestions are indeed 
important and useful.  Within the Indian context medicine taking for treatment of addiction is 
still a fairly new phenomenon.  But the clients were clearly facing the same challenges as 
outlined by the researchers above- in adopting the treatment regimens fearing both 
dependency and loss of control yet recognizing its potential for leading stable lives.  Similar 
to Ning’s clients, the clients of Ashray and Sahai were clearly agentive in their compliance, 
realizing that their ‘good behavior’ could help them survive in a context that was mostly 
hostile to their needs. 
 At the same time in India there was a strong rights-based movement around HIV 
services, which promoted the right to OST (among others) for injecting drug users.  In fact, 
active drug users were involved in service provision, advocacy and management of OST 
services.  Hence unlike the western contexts, there was less of a sense of being controlled or 
disciplined through treatment.  The two NGOs that I studied were also community-based 
organizations with long histories of working with these groups.  All of these factors greatly 
influenced the nature and perception of OST in the community.  The right to OST medication 
was being spoken about in the same vein as ARV treatment and several drug users were 
advocating for expanding the programs to new areas and increasing dosages since most clients 
were given the bare minimum.  The fight in some senses was for increased 
pharmaceuticalization rather than reducing its reach.  Further, as the OST programs move to 
the next phase, there will be a greater emphasis on the empowerment of communities.  In fact, 
the goal is to transfer a majority of these harm reduction services to community led 
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organizations.  The question of dependency becomes even more important to answer in such 
conditions. 
Overall, this effort to understand who drug user is being shaped to become, is a 
complicated one to answer.  I do argue against some scholars, who cite that harm reduction’s 
goals to empower its participants could be understood as another way to discipline them into 
responsible subjects.  Agency and empowerment, I recognized, were clearly more than 
concepts for NGO’s like Sahai and Ashray, who pride in harnessing and creating human 
potential within their clients.  Their ideas of empowerment were far from singular, empty or 
unchanging.  The two NGO’s accepted both- a wide range of harm reducing behaviors as well 
as clients who would relapse and return to drug use.  Their belief in the clients’ ability to 
change was in some senses unflinching, courageous and refreshing and not centered around 
disciplining rogue populations.  Ironically, this belief pre-dated the harm reduction model, and 
actually was a core principle of their philosophy as community based drug rehabilitation 
centers that drew inspiration from not only philosophies of AA but also religion, human rights 
and community action.  It is not clear how these ideas will evolve as harm reduction is 
adopted by other agencies that may or may not share similar values.  But what is clear, is that 
harm reduction more than any other model of recovery and rehabilitation draws on the 
precarious but powerful belief about human potential, freedom, values and most crucially the 
ability to transform.   
Whose deaths matter and why?  Is harm reduction renewing the hope of those who 
live? Can this new focus generate a greater likelihood of survival?  What are the parameters 
by which we judge our impact? Drug users in effect represent one of the most marginalized 
categories. Their lives have little political and social significance in most spheres- rendered 
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important only through their potential to spread disease and harm.  My effort in this chapter 
has been to show how they gain political and social significance, piece together their survival 
and generate new forms of living.  Survival for drug users and other diseased groups is in the 
process of being re-crafted and re-defined.  The potential of pharmaceuticals, to increase the 
chances of survival for drug users, is undeniable in India.  As drug users learn new ways to 
manage and negotiate this pharmaceutical regime, in the absence of other forms of care, it is 
more than their health at stake.  To fully understand their implications one must take into 
account how these inorganic substances are entering bodies, voices, values and actions.  
Social workers can no longer remain outside this dialogue, especially in countries like India, 
where they are a crucial liaison between different stakeholders.  As social workers, we need to 
engage with the implications of this pharmaceuticalization, at the same time not lose sight of 
our core beliefs in our clients and their potentialities.   
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CHAPTER 7: MODELS, MUTANTS AND EXPERTS  
Tin boxes, papers, codes, bags, medicines and cigarettes. 
Clean and organized. 
Foil, spoons, cloth sacks, medicine and cigarettes. 
Dirty and lost. 
 
Just revealing enough. 
Bruised but not broken 
Undone and unfinished. 
 
With them and them…both and none. 
Rebels disciplined 
Fighting for the same side. 
                                                              (Moorthi,2011) 
 
‘I would go back 7-8 years when Sahai was switching from the abstinence program to 
the harm reduction approach.  Most of the guys were working at the head office …and here 
careers are made and people are made… (it is that) kind of thing (here in) Sahai.  So the group 
that was working, they were very committed people, working 16 hours a day, 14 hours a day… 
in the course of time, it was observed that all work and no means of entertainment …was 
making people to go for a major relapse.  So that was the time when they started – weekend 
parties and all that...  apart from that they would buy a small bottle of liquor for themselves, 
have a few drinks and chill out and this was the weekend.   
Then next day they would come all pepped up and ready for work, (work) the next 
week and (again) they would slog for hours.  So here it was seen that they need some means of 
ventilation- now it was not like harm reduction black and white on paper, prevention of HIV 
and all of that but it was like a practical stuff where a person who is coming out of drugs, hard 
core drugs and is trying to main stream himself, re-integrate in the mainstream society, there he 
needs some kind of you know…say push or some kind of a support…  social support has 
always been there but this kind of support, where he would feel good about himself ...’ shared 
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Alfred Da’Cunha, a peer worker from Sahai.  For Alfred, harm reduction was ‘what he did’ and 
not ‘what he lived’.  But Alfred was a part of a small minority of peer workers who chose not 
to experiment with harm reducing measures.  Over the course of my fieldwork I noticed many 
peer workers using alcohol and even drugs.  On most evenings, a few staff members at these 
NGOs could be seen drinking and sometimes even using.  They claimed this choice was made 
consciously and after much consideration.  Harm reduction had reduced the shame of seeking 
treatment but had also allowed alcohol and drugs to legitimately enter the sacrosanct space of 
the treatment center itself.  
As Alfred and I sat one evening discussing my project, he shared with me the stories of 
his peers, many of whom, had got grand opportunities to work for larger organizations in South 
Asia.  However, after a few months they inevitably returned- emotionally broken, out of 
control, broke and often deeply entrenched back into the world of drugs.  These peer workers, 
Alfred pointed out, were unable to “control” their drug use, despite claims of being “harm 
reductionists”.  Their experimental use would usually lead to “relapses” and soon “full-blown” 
using behavior.  
When I began this project I thought I knew where the lines between abuse and harm 
reduction needed to be drawn but watching these peer workers use substances tested my own 
perspective on this issue.  The impact of harm reduction in the private lives of peer workers, 
who were the very harbingers of this movement, was both extremely poignant and baffling.  It 
was easy to see that such conceptions of harm would seem containable under a system of risk 
and public health, but here in the nooks and crannies of peer workers’ lives it got to be both 
convoluted and confusing. Until now, my dissertation has dealt with harm reduction policy and 
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its implications for drug users.  This final data chapter focuses on the lives of peer workers who 
were in the middle of it all.  
   The precariousness of their lives underscored the potential of harm reduction to shape 
a new type of recovery, while at the same time alerted us to the ever-present danger of 
completely losing control.  Peer workers, I argue, became “models” for their patients.  They 
demonstrated- the possibility to control drug usage, assert rights and take responsibility for the 
community’s health as much as their own.  Also peer workers, I show, were experts of the 
street and the larger system.  They were able to navigate the complicated institutional and non-
institutional pathways to create possibilities for a healthy life.  These multiple identities gave 
them what I call a “mutant form”, which meant that they were unable to completely inhabit any 
single role of patient or service provider, they remained constantly adrift never completely rid 
of their addictive lives and struggled with the ethics of their profession while at the same time 
trying to survive.  As I detail the lives of these frontline workers I explore the boundaries of 
recovery, empowerment and its implications for long-term health.  In engaging with these 
issues my chapter also addresses questions of social work ethics, that these peer led models of 
interventions bring forth, especially in terms of legitimacy of care, professional ethic and ethics 
of care. 
   Organizing care. 
  The challenging task of running the day-to-day programs of harm reduction largely fell 
on the peer educators or as NACO labeled as the ‘foot soldiers’ of the program (NACO, 2008).  
NACO defines a peer educator (PE) as a ‘person from the high-risk group who works with 
her/his colleagues to influence attitude and behavior change.  PEs are responsible for providing 
information on HIV/STIs, harm reduction, and promoting condom use and other risk reduction 
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materials among colleagues/peers, which ultimately results in building peer pressure for behavior 
change’ (NACO).  Peer education is especially useful since most high-risk behaviors are highly 
stigmatized and PEs can ‘build trust and establish credibility with the vulnerable groups; they are 
a vital two-way link between the project staff and the community; they provide important 
information about the vulnerable group to other stakeholders and the wider community; they act 
as a link between the services and the community (for instance, by introducing people or 
accompanying them to the service facility)’ (NACO).   
According to the protocol PE’s must typically serve approximately 40 clients but in 
practice they often served up to 80 clients each day.   This is because there are far fewer NGOs 
with peer workers than is needed.  Their role includes but is not limited to ‘identifying new 
clients, providing motivation and follow up through outreach services to access OST clinics, 
assist IDUs with STI, abscess and other related issues; assist in organizing support group 
meetings and group discussions and helping conduct home visits, and other follow up activities’ 
(NACO).   
    NACO also had created another layer of workers called Outreach workers91 who 
were above the PEs.  They did not have to be current/ex –drug users but needed to be familiar 
with the context and community as well as be literate.  In most cases these workers were also 
undergoing treatment or were following the harm reduction paradigm.  They were expected to 
‘identify and motivate IDUs about the harm reduction programs, provide support in registration 
as well as dispensing Buprenorphine and supervise peer educators.  Their role also included 
conduct follow up and home visits, help establish peer support groups, conduct information 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
91 I have used the term outreach worker, elsewhere in my dissertation to signify worker conducting outreach, and not 
specifically related to this definition. 
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sessions and assist the clients in receiving various other referral services among other 
activities’.   
  In addition most sites had volunteers who were also from the drug using community 
and supported the NGO in a variety of tasks such as cooking, cleaning, guarding the premises, 
supporting the administration, organizing clients, supporting the workers in dispensing needles 
or condoms and acting as a conduit between the client and the NGO.  Volunteers also served as 
community watchdogs and were often aware of changes in the political, social and 
psychological facets of the neighborhood and its people.  The staff at the Drop-in-center also 
included a project manager, doctor, nurse and counselor. 
   Beyond these field level positions, peer workers, especially those belonging to 
English speaking middle class were able to deftly rise in the ranks of this cut-throat world of 
the HIV development industry.  They ran NGOs or government supported projects, engaged in 
advocacy and activism, conducted or supported research initiatives, participated in developing 
policy initiatives and conducted trainings and workshops based on their technical expertise.  
Sankalp Sinha, from NACO, stated that most NGOs did not have clarity about these 
different roles.  For instance in the case of the peer educator, ‘the NGO tells them that they are 
full staff, actually they are not, they are just volunteers and we are actually engaging their time 
that does not mean they have to be in the drop-in center all the time’.  The contradiction in the 
actual position of the peer worker and his/her assigned role was clearly evident in the project 
sites.   
Even though the peer workers were assigned a large number of tasks they were not given 
the status of a full time employee.  The peer educators were paid below minimum wages, kept on 
loose contracts and never fully absorbed into the system.  Working for an extremely low pay 
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meant that many peer workers continued to live on the streets next to their old drug using friends 
and now ‘clients’.  As one client pointed out, ‘When the sun goes down they become one of us’.  
I often observed the tensions that were created as a result of this unclear status of relationships.  
Clients banking on these street-friendships would ask for favors like more medicine, 
recommendations for a job in the NGO, better services or special treatment.  Peer workers found 
it hard to balance these social and professional commitments.  On one such occasion, a client 
told me ‘ what’s the real difference between him and me…I use so does he…I also know about 
drugs and HIV…its just he dresses up well and comes here (to work), that doesn’t make him any 
different from me…’  
Peer educators were rarely if at all included in devising programmatic interventions.  
Their opinions were only sought in specific client related matters or field strategies.  Such a 
distinction in the role of the peer worker created a “de-linkage” between the street, NGO and 
government, replicating older patterns of disjuncture between the policy and practice arms of the 
system.  It severely challenged the harm reduction model’s claim that it encouraged 
empowerment and participation 
     In the upper ranks of harm reduction workers, especially those involved in the NGO 
head offices or with bi-lateral organizations the scenario is considerably different.  The English 
speaking, educated, middle class workers usually occupied these posts.  This ‘creamy’ layer of 
workers, have probably gained the most in this process of ‘expertization’ of street level workers 
within harm reduction.  They have been able to parlay their street experience for a position at the 
decision making table.  Many of them now possess a sophisticated understanding of the health 
discourse, which in turn opened a new career pathway and a lifestyle that was not possible before 
the advent of harm reduction.  While the instability of the development sector due to irregular 
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funding cycles, and shifting agendas continues to plague these workers, most stakeholders agree 
that today HIV and harm reduction have created a spectrum of opportunities where previously 
none existed.    
   Sankalp Sinha, a technical officer at NACO, was a good example of a peer worker who 
had been able to rise in the ranks.  A drug user for many years, Sankalp underwent rehabilitation 
and later joined a peer led organization in the northeast region.  In the next few years he gained 
expertise in programming and policy through a variety of projects.  His intimate knowledge 
about drug use, particularly in the region and programmatic experience led him led him to his 
current role in the national government’s harm reduction program.  Over the course of my 
fieldwork I had the chance to meet with many ‘career’ harm reductionists and understand their 
growth trajectory in public health.  Their street credibility combined with their programmatic 
knowledge made this breed of workers high in demand.  As a final note about these roles, 
Sankalp pointed out that not all peer workers had taken the knowledge, funds or experience back 
to their ‘communities’ of origin.  These careers, he shared, had helped launch a chosen few into 
the global development orbit without necessarily creating a “trickle down” affect that could bring 
long lasting changes to the local communities.  
      All in a day’s work.  
To understand the breadth and diversity of the roles occupied by peer workers I 
shadowed a few workers as they went about their day.  I now provide a brief glimpse of their 
lives through some of the pages of my own fieldwork diary.  
Karthik Kapoor 
8:00 AM: I stand waiting for Karthik’s car to arrive.  He is the head of the harm reduction 
programs for Ashray, and had agreed to allow me to accompany him as he went about his typical 
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day visiting Ashray’s project sites.  An ex-corporate executive, Karthik was on old- timer at 
Ashray.  He prefers to keep his ‘addiction story’ private, but was otherwise fairly talkative on our 
drive to the first project site at Nadi Nagar.   
‘It is important to keep coming (to the project), my presence is very important, there is a 
style…a culture, which we have always lived and worked with and one of my main roles is that 
we don’t lose the style, we don’t forget the (way we would) work- that is reason we are the best 
at what we do.  I don’t come and look at records, and all…I know there are people efficient and 
well versed to see and know what they are doing but…my main thing is to keep the base there, 
which provides the energy and strength to do this kind of work, otherwise believe me, its not 
possible.  If you go purely technical and say what the plan says and what the budge says you 
wont survive- you have to have your own philosophy and beliefs that take you forward.  Times 
that are good very rare, always more people coming in, relapse, fall outs, crisis is happening all 
the time- its never good for them…’ 
10:00 AM: As the landscape of city shifts from wide roads and tree lined streets to 
bustling and overcrowded narrow lanes, open garbage dumps and drains, the car slows down; it 
must now wrestle with bullock carts, overflowing buses and careening cyclists.  We enter the 
project site and in spate of few minutes the small office is cleared of the clients, tea is brought in 
and jokes are exchanged.  Karthik tries to be one of them and yet I can see that Muquim, the 
project head, is acutely aware that Karthik is the boss and this visit for all intents and purposes is 
an inspection.  I see a steady stream of clients come over some touch Karthik’s feet, while others 
shake his hand and brightly say ‘Good Morning’.  This is quickly followed with an update about 
how they are feeling, the current dosage of medication and the status of their other ailments.   
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11:00 AM : Karthik is now busy walking to the other project site, situated a few blocks 
away, he reprimands the workers on keeping the premises dirty and asks why the room does not 
have any posters, as was discussed in his previous visit.  Quickly Ramlal brings out the dusty but 
mint condition HIV/AIDS posters provided by the Government.  He supervises the workers, who 
hastily put them up on the ‘paan’ stained brick walls of the center.  The posters are in Hindi and 
English, with pictures about modes of HIV infection and safe use of drugs.  The cynical staff 
make jokes about the posters, clearly not convinced about their efficacy, given that most clients 
are illiterate or simply did not seem to care about reading them.  Karthik informs them, that it 
was important to ‘use’ the posters and keep the premises in order, since the accreditation process 
for the site was going to begin soon and each NGO must meet the criterion set out by the 
government92 for continued support. 
12:30 AM: A client who wants to complain about the project staff waylays Karthik.  The 
client accuses the staff of stealing Buprenorphine and abusing the drug.  A common problem, 
Karthik assures me; it is an issue he addresses on each visit with no real solutions.  He has learnt 
that ‘flexibility’ is key for the success of such a program, ‘Lets remember that the working 
population (peer workers) here is also homeless.  (They are here at the) same spot after 5 o’clock 
where the client is, so, if he uses a bit of drugs and alcohol and goes a bit wild we understand 
that… but we have learnt to, over the years to pin point that the next morning or (the next) 
opportunity that we get… because its like a constant reminder that (while) working here as a 
service provider, you need to be a ‘little different’ from the receiving end…there has to be that 
line.  I have to say these guys have come a long way I personally think its good they have 
stabilized lot more than they were a couple of years back…’ 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
92 Ashray’s staff was involved in developing some of the guidelines for the accreditation. 
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1:30 PM: After some lunch, we get ready to visit another site located in Jagatpuri.  It is 
much quieter and has only one or two clients compared to the bustling Nadi Nagar project.  Hira, 
an aging former sex worker, an outreach staff member, informs Karthik that there were several 
problems in the supply of medication and needles.  Medicines were often delayed because of 
blockages in the supply chain and problems with the flow of funding.   
2:30 PM:  The doctor walks in and was pleased to see Karthik.  He too was upset about 
the delays in medication.  Karthik assures him about addressing this  with Ashray’s leaders.  He 
also asked the doctor to adjust his timings to suit the clients better and after paying the staff for 
the month, we leave. 
4:00 PM: Upon returning to the head office Karthik finishes preparing for a talk he is 
going to give at a training session for peer workers, arranged by NACO.  ‘Working with harm 
reduction IDUs is hard area to tap, understand …difficult to work with.  (We are now) forming 
training units, sharing knowledge and expertise with other states within India that have no clue 
about IDU’s and harm reduction’.  Karthik served as a consultant for the Government and spent 
a large amount of time training other NGO workers and civic organizations. Karthik played 
many roles in a single day- administrator, peer, friend, boss, doctor, harm reductionist and 
teacher, often juggling these multiple identities at the same time.  
Gautam Kumar 
8:00 AM: Prayers had just ended and Gautam, Sahai’s resident counselor was taking 
notes after consulting with the outreach workers.   Always dressed in colorful shirts tucked in a 
pair of jeans with sneakers, he was one of Sahai’s strongest workers. ‘ I have been a peer 
outreach coordinator with UNODC’s harm reduction program.  There I learnt about harm 
reduction, there I also understood about substitution program- those people who are injecting are 
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getting injured, they are getting afflicted by HIV/AIDS.  To reduce those dangers, first and 
foremost make sure they are not sharing needles and syringes…after some field observation, I 
conducted group sessions (to address this issue)…as a result of sharing I knew that some people 
had (HIV positive) status- they were sharing the needles very easily amongst themselves.  First, I 
talked to those who had (HIV positive) status- you have a responsibility to society.  If this 
disease only spread to you and stopped, then that would be the most smart thing- it is a matter of 
responsibility to society’.  His role as a counselor was to persuade drug users to use safely and if 
they wanted to quit, he would connect them to the Buprenorphine program.  He felt that the 
biggest problem with all the programs was the fact that after the drug users left the premises, 
they had nowhere to go but the very same streets laden with drugs.   
9:30 AM: An old lady wants to meet Gautam to talk about her drug-addicted son.  
Gautam asked me to sit in for the session.  In a tone barely audible over the din of the center, she 
shares about her son Sharif.  Barely 20 years old Sharif is injecting drugs and alcohol, had 
already sold many things from the house, lived on the street and refused any help.  By the end of 
the story she had tears and begged Gautam to help.  After listening carefully he asked her to 
bring Sharif to the center.  She then asked him if they could forcibly put him in treatment, 
Gautam explained that the center only accepts clients ‘voluntarily’.  He then proceeded to 
describe the continuum of care model, she seems fairly unconvinced at this ‘new’ approach to 
treatment.   
10:40 AM: Gautam spends the rest of morning writing.  Most mornings are spent 
completing case records and field notes.  All funders - government and non-government, have 
become very strict about paperwork.  Until client logs are complete it becomes difficult to gauge 
the progress made and NGO workers spend a considerable time during the day tracking their 
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work.  In a center like this one, there are only a few literate workers, which burdens them with 
the task of writing and reporting for the entire project staff.  Each client, every interaction on and 
off the field, sessions, workshops and advocacy efforts- all of it must be recorded, reported, and 
written out.   
1:00 PM: Gautam has tough afternoon ahead of him.  Each week, a local rehabilitation 
center sends their officials to pick up willing clients and take them back to the rehabilitation 
center.  Gautam’s role is to convince, cajole and persuade those clients, who have made 
significant progress to take the leap forward towards abstinence.  This is a hard task, because 
clients are usually comfortable with their routine and life in the community and unwilling to 
leave for an abstinence program.  ‘There is no system, because we are not the decision makers.  
Nor are we the one’s making decisions.  We ask them what is your problem now and what do 
you plan to do about this problem.  How can we help you?’  Despite all this talk about choice, I 
find that most clients are encouraged to graduate from the programs.  A couple of clients agree to 
leave, Gautam had been talking them for a few weeks and hopes that they will stick through the 
entirety of the abstinence program and re-integrate.  He was wrong. All quit and return within the 
month to the community and then to the NGO seeking harm reduction services.   
2:00 PM: The rest of the afternoon is spent with clients discussing issues around their 
ART treatment and HIV testing.  ‘We first talk to them about self knowledge…then we hold a 
session and tell them about the four ways in which people contract HIV.  If you have done any of 
these high-risk behaviors, then you have full right to know about yourself.  This test is a 
volunteer test and is fully confidential…it is also free of cost and you can know about your self’.  
Gautam is one of main workers who prepares clients for testing and also engages in post 
counseling.  He often co-ordinated between the outreach worker and Victor, who helps clients 
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navigate the health system.  He was also responsible to encourage reluctant clients to seek ART 
treatment and this is especially difficult, given that many clients are unwilling to give up using.  
In all of his work he emphasized their rights to choose and shape their treatment.  I wonder if he 
himself is as convinced about harm reduction’s promise as he continues to remain committed to 
abstinence. 
Alfred Da Cunha 
9:30 AM: We had decided to meet at a training session for Samarth’s (NGO) workers. 
This NGO was primarily focused on women’s issues but recently had stepped into the field of 
HIV and drug use.  Alfred, a veteran Sahai staff, was hired to conduct a two-day program to train 
Samarth workers before they began implementing the harm reduction programs.  Besides 
addressing the basics of drug use and harm reduction Alfred spent time discussing the main 
issues facing workers during their interactions with drug users. 
11:40 PM: He announced a break for lunch and asked my opinion about the training.  
Alfred identified that one of the biggest issue was the moral stance most ‘non-users’ held against 
drug use.  Now with HIV in the picture these moral opinions and ideas had to be put on hold.   
1:00 PM: After finishing with the session I agree to accompany him to a UN meeting, 
which would include other NGOs also working on harm reduction.  Unlike the first half of the 
morning where Alfred was the expert, here he was very much the recipient of knowledge.  Alfred 
barely acknowledged this type of role reversal, slipping from one position to the other fairly 
easily. 
4:00 PM: Back at the NGO office, he is busy finishing his report for the government, 
which includes a proposal for training of peer educators.  He is one of the few at the office, who 
has experience in developing grant proposals and thus was often burdened with the task of 
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compiling and writing.  He claimed that with cuts in funding the NGO was barely able to pay 
him.  Consulting assignments, such as the training he conducted that morning, were a means to 
secure an income each month (he provides a portion of the payment to the NGO).  Despite being 
offered many positions with international organizations he had chosen to stay with Sahai out of 
loyalty to the organization that had helped him become healthy.   
5:00 PM: He got a call from an Ashray worker, asking him to participate in a workshop 
on advocacy for IDU’s impacted by HIV in the coming week.  He confessed that the daily chores 
of running programs and supervising took away the bulk of his time.  It left very little time to 
address the larger macro pieces of the harm reduction puzzle.  However, such opportunities were 
great to network with others in the field of HIV.   
      The diversity of roles of Karthik, Gautam and Alfred occupied was not surprising 
given the way NGO’s have grown in stature within the harm reduction paradigm.  Until now 
NGOs were fairly flat organizations with quite a bit of fluidity in roles and responsibilities.  With 
the entry of NACO and other international funders there have been considerable changes in the 
system of functioning.  As detailed in the previous section there were now clearly demarcated 
hierarchies of functions within the NGO.  Operational guidelines for each harm reduction 
intervention now clearly stated the roles to be occupied by each type of worker.  These roles 
were largely seen as stable/permanent though it was possible for the workers to rise in the ranks 
by meeting the new standards of skills.  However, given that most peer educators were illiterate 
and not given any special support to upgrade their skills it was very likely that they would 
remain in their current role without much progress for their entire careers.   
This ‘choice’ to work for an NGO was often made because most recovering users found 
it difficult to get jobs in the ‘community’- due to stigma, lack of skills and lack of employment 
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opportunities.  Since these NGO positions are limited they are highly coveted but not necessarily 
always desired.  As a result of all of these factors peer educators tended to move from project to 
project creating an environment of great flux and instability.   
   The re- education of peer workers: from the street to the boardroom. 
   Jared Richards a peer worker from Ashray, was one of the few who had been able to 
successfully navigate the harm reduction –HIV industry and evolve a new persona from a drug 
user to an expert.  I would often end up meeting Jared during my fieldwork at policy meetings 
and workshops.  The few times we met at his air conditioned office located in a posh south Delhi 
neighborhood, he was usually either finishing a report or a grant application and at other times 
preparing to present at an international conference or writing a research article.  This was a far 
cry from the early days of Ashray where peer workers like Jared would spend bulk of their time 
running programs in the field, looking for funding to meet their budgets each month and working 
under resource poor conditions.  Beyond the superficial change in the roles, a more fundamental 
“re-education” had occurred.  Jared himself had only recently begun to fully process the 
implications of this change.  
‘In  2005 I was at a DFID conference just before NACP III, NACO had asked for help for 
putting together NACP III, to see if we could raise issues and give recommendations.  Not 
knowing any better I took the M & E (Monitoring and Evaluation) part of NACP III and tore it to 
bits.  (I had pointed out that) all monitoring indicators were geared in such a way to show a 
reduction in HIV prevalence irrespective of any (actual) reduction...at that conference my 
standing was that of a minor person working in Ashray and a drug user so, I had other people 
standing up and saying I have no national integrity and patriotism, how can I say that the figures 
are wrong for India.  I didn’t know the right jargon that time, so no matter what I said it wasn’t 
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looked at ...’.  A few months later Jared shared that corrections were made and his point was 
proved.  ‘I never made that mistake again.  If I have to make a point and if I have to make that 
sound credible then I better speak the language they speak in’.   
  Jared quickly learnt that he had entered a new world where words carried a heavy price 
tag and the frames of reference were no longer the same.  He learnt how to communicate in a 
variety of settings without leaning on the ‘emotional’ stories of his addiction, making himself 
now heard as a drug expert.  His exposure to international organizations and their experts and his 
participation in multi-stakeholder projects had a critical role to play in this change in approach.  
Technology and the Internet in particular, had made information gathering, networking, 
knowledge dissemination and accessibility to a wide variety of stakeholders much easier, thus 
also transforming his knowledge field.  
Unlike before where ‘being an addict’ was the highest qualification needed, these harm 
reduction workers were now being given a more formal ‘re-education’. In Jared’s opinion 
organizations like BMGF, DFID and the UN had done more to ‘professionalize’ the field of 
social work and support the evolution of peer workers into experts, than any institution or school 
within the country. These stakeholders played a key role disseminating knowledge through 
workshops, trainings and seminars.  Over 960 new peer workers were being trained to implement 
harm reduction programs across the country not to mention a large cadre of outreach workers, 
program managers and health volunteers were learning new ways to intervene and run programs, 
social work education was indeed witnessing a change. While services like needle syringe 
exchange and outreach were fairly straightforward other services like OST required an 
understanding of the medication, its affects and dosage management (even though the doctor 
prescribed the dosage).  
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The notion that expertise was earned through an education was actually quite new for this 
sector, which was used to drawing on instinct, guts, intuition and experientially learning.  Also 
the shift from a more psychological and social mode of recovery, to a behavioral focus meant 
that these workers had to learn a new language of treatment.  The workers were also learning 
how to record, review and learn from practice in a much more organized fashion; they were 
adjusting to concepts of privacy, confidentiality, rights and choice; finally they were examining 
their own practices through frames of evidence and efficacy.   
   In all of this shaping of new experts, there were two important elements.  One was the 
fact that quite often though the impetus for such expertise came from outside i.e. funders, global 
organizations and even the government, the people conducting the trainings and disseminating 
knowledge were coming from within the NGO community itself.  Second, despite efforts to 
completely ‘convert’ the peer workers to this new modality of functioning there were still several 
traces of their ‘old ways’ of thinking and behavior.  For instance these contradictions became 
quite evident during my conversation with Dileep, a peer worker from Sahai. In order to 
motivate his clients to remain committed to harm reduction, he used a much older abstinence 
narrative drawn from the Narcotics Anonymous model.  ‘ I give them motivation through my 
own story.  I was also a drug user.  I used to also stay in the garbage dump.  I also have a 
counselor, he has taught me a path I walk on that road.  So I am away from drugs.  I don’t push 
my ideas- if you do this then will change’.  Saif, another peer worker, also shared that while he 
provided his clients options of needle syringe and OST he would also talk about rehabilitation 
and recovery in a treatment facility.  This mingling of abstinence philosophy with harm 
reduction was common among most peer workers. 
  Expertise is a fragile concept and in the arena of care, it is often subsumed under much 
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more complex and controversial concerns of peer workers that are loaded with ethics and values.  
For many peer workers harm reduction’s promises seemed hollow and incomplete for them 
recovery was still wedded to the notion of abstinence.  While they understood the program, they 
also understood addiction and its temptations.  Gautam shares, ‘ I know myself , anywhere if I 
get alcohol after 2-3 days I will start to use again, I am not able to maintain myself…very 
quickly I will return to my drug of choice’.  On the ground this becomes harm reduction’s 
biggest challenge as many peer workers with long traditions in abstinence-based models 
combined with their own powerful personal experience are unwilling to fully buy into the harm 
reduction paradigm.     
   Involvement of affected groups in service provision- issues of efficacy. 
   While drug treatment NGOs in India have always used peer workers to provide services 
the inclusion of active drug users and harm reducers in the harm reduction paradigm is slightly 
more unique and deserves some discussion.  Until now, sobriety was usually considered as a 
minimum criterion to engage in NGO drug related work.  This was done for a number of reasons, 
the foremost being to have peer workers who were mentally, socially and psychologically 
equipped to handle the stress of providing care for others.  Usually, clients who were able to do 
well in drug treatment programs and maintain their sobriety were absorbed by the drug treatment 
NGOs (this was not the case with government run programs).   
   Harm reduction however, did not place as much stock on sobriety as it did on 
functionality, responsibility, rights and choice.  In this vein, all drug users irrespective of their 
position in the recovery continuum could now theoretically participate in providing services.  
Despite this “liberal” position on drug use, I found that peer workers who used drugs were often 
given less respect and value than those who chose to abstain.  Abstinence was still held up as the 
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gold standard for recovery.  This often prevented the peer workers from sharing the exact nature 
of their use/ abuse of substances, though in most cases the project manager could easily tell who 
among his staff was “clean”.  I will now detail some of my field experiences that explore these 
dynamics.   
On a cold wintery day of late January I was getting ready to accompany Shyam and Jeet, 
peer educators from Ashray, as they conducted outreach.  Packing their old backpacks with clean 
needles and syringes, health pamphlets, condom packets and notepads for record keeping, they 
were getting ready for the day.  Both were recent graduates of this recovery program and in fact 
continued to be on the Buprenorphine maintenance therapy.  As the morning wore on I noticed 
that something was definitely amiss with Jeet.  His quivering hands, bloodshot eyes poorly 
covered by a pair of cheap flashy sunglasses, slight slur in speech and frequent tea stops were 
clear indicators that he had been using.  The clients on the street were of course quick to pick up 
the telltale signs of the body that had used and refused to lie.  Yet roles of client and out reach 
worker seem to be maintained.  Not one client outwardly challenged or questioned Jeet as he 
went about dispensing advice on using, distributing needles, and making referrals.  Shyam 
seemed subtly shoulder a majority of the tasks of the outreach that day – a routine that possibly 
shifted depending on the physical state of either one of these outreach partners.   
  Later that day, Muqim, the project manager (and one of the two employees who did not 
have a drug using history; the other being the counselor) shared his frustration of having to 
manage ex and current drug users on the program.  Muquim recognized the benefits of having 
peers, given the dynamism of street life.  Also certainly the employment helps clients financially, 
gives them a sense of ownership of the program, and generates a sense of empowerment.  But as 
a project manager, future outreach planning often becomes hard with such an unstable staff.  He 
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was forced to plan day-to –day depending on staff turnout and their condition.  Peer workers, he 
claimed, often did not come in for work at all or did not perform optimally due to their drug use.  
Muquim would then have to send others to cover for this staff member, hindering any progress 
made on the field.   
    Alfred too, on many occasions had voiced such frustration of working with peer 
workers who were using and thus unable to perform their usual tasks, ‘…at some places harm 
reduction has also been manipulated… like my colleague, he will not turn up for work and he 
would say that he is having a stomach bug and then when you call him up at 8 o’clock in the 
morning he would be sounding drunk so what do you say… that because he is having a hangover 
that’s why he cannot turn up for work …’ 
   During another afternoon, as I was sitting and talking to Muquim, the project manager, 
Salim, a peer worker stumbled into the office slapping down his record register on the table in 
front of us.  A minor argument broke out as Muquim reprimanded Salim for rudely interrupting 
our conversation.  Salim, disheveled, droopy eyed and slurring quickly apologized and said that 
he only wanted Muquim to cross check the data he had spent all morning entering.  ‘ Yeh kya 
halat bana rakha hai tumne’ What have you done to yourself? You haven’t shaved, look at your 
clothes- go have a bath, wash your face and then come.  Muquim, of course functioning strictly 
under protocol, could not tell him the one thing that was staring us in the face more than 
anything else- his obvious consumption of drugs.  He later told me ‘Kya karein inke saath 
flexible hona padta hai.  Agar strict rahenge tho mere paas koi staff hi nahi bachega’.  What to 
do, we have to be flexible.  If we are too strict, then I will have no staff in the project.   
   Later that week, Ashray’s project manager Karthik was visiting from the head office.  
Salim’s name came up during the discussion.  Muquim just smiled and said ‘well you know how 
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he is doing…’ Karthik told Muquim that he should watch Salim- ‘We have given him enough 
chances, if he doesn’t behave…he can leave, he has a choice…why don’t you ask him to go for 
detox’.  Muquim replied-‘ He has been, many times…but I will talk to him (again).’ Karthik 
getting up to leave said –‘ We have many others, he can’t take this for granted…’ Clients on 
many occasions ‘knew’ which staff had used and Muquim felt it created a tense dynamic.  It not 
only attacked the integrity of the program and its efficacy but also reduced the legitimacy of the 
worker in the clinical sense.  Even though sobriety itself was not Muquim’s goal, with either 
workers or clients, the appearance of sobriety was very important so that the clients would 
respect and listen to the workers.  Muquim brought forth a crucial point-clients were used to their 
‘caregivers’, doctors, counselors and NGO workers as clean, sober, efficient and in control of 
their addiction.  This blurring of lines not only challenged the old assumptions but created 
confusion of what this new breed of workers would/should look like. 
    Sankalp Sinha highlighted that, ‘there needs to be clarity of the ideas of how to use an 
active user in the program.  It needs to be very clear with the program implementer and the 
functionaries.  They say these people are always high they don’t know what they are doing so I 
mean what can you expect from active drug user but we have also seen NGOs whose program 
managers are skilled enough to actually not motivate them, to actually make them understand 
that they are part of this program and they are the best person to go out and give information.  If 
we look back and if we go back the history of drug use scenario not only in India but all over the 
world when someone starts injecting , it is someone is helping him to start injecting because we 
don’t know how to inject by our self and in he process we learn, so that’s the peer norm all over 
the world.  When we started injecting we also started learning how to share the injecting 
equipment with friends...at that point of time if we were taught that it was not good to share 
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injecting equipment no one would have shared until now.  …what we are doing now with the 
help of peer educators is (that) because he still fixing it now and drug users normally listen to 
another …very easily( and we just go by one word from another drug user saying that oh after 
taking drug you take alcohol you get a good kick, without thinking twice people do that)…, so if 
you can use those opportunities to provide information and people if they can start, positively, 
start using those information then we can reduce lot of incidents of sharing of  (needles)...’  
   Alfred points out that while it peer interventions have many great components and 
organizations like Sahai were built on strong foundations of peer support. However, when this 
model was taken into ‘the community where I am a peer but I am surrounded by active drug 
users, how long can I sustain.  It’s the same thing where you have male out reach workers for 
female sex worker programs and they once in a while go and have sex with their clients so it’s 
the same thing happening in the drug domain… there are out reach workers and peer educators 
who are like clean for some period and they once in awhile go and trip, they sit with their clients 
and share a injecting injection…buy a drug together and trip’.   
  Due to the problems associated with such using behaviors, Alfred says the organization 
makes a great effort in choosing their staff.  He shared, ‘to select staff members who were 
outreach workers who would go in the field, we had to pull them out of other programs and then 
send them for this particular outreach…these were like those strong guys who were like five 
years…(clean or in recovery) so we had to pull out strong guys …’.  In the beginning when one 
of the staff members would relapse it was considered as a major concern.  Bur now Alfred 
claims, it is ‘openly accepted’, if a staff member uses, then he goes to the rehabilitation center of 
Sahai, spends ten days, undergoes rehabilitation, detoxification and joins back.  It is ‘like a 
cycle’, when it happens again they wait and support the peer worker.  Alfred calls recovery a 
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‘process, where one falters, relapses and then recovers and then relapse…’    
   Not good enough. 
The ‘ peer workers’ are not only the frontline providers of harm reduction services but 
also the walking symbols of the ‘success’ of the program itself.  On one hand, these peer workers 
must become and often are perceived to be the harbingers of a controlled, if not drug free, 
lifestyle.  While, on the other hand, the peer workers constant return to drug use or failure to 
reduce harm in their lives reveals not only the dangers of drug use itself but more significantly 
the fragility of this ‘bio-regime’ as a whole.  These ‘not good enough peer subject’s’ are then, at 
once harm reduction’s ideal front and its most vulnerable or destabilizing link.  This tension 
between the progressive and the risky peer worker represents harm reduction’s own strains 
within the Indian context.   
 The peer worker can emerge as a role model/ empowered political force only when 
‘problematic/ continued drug use’ is suppressed or hidden.  One cannot be both an active drug 
user and an ideal public health subject in the current Indian context.  Drug use, conceptualized as 
brain disease or immoral/criminal behavior has forcibly pushed out of ‘normative’ action, thus 
forever rendering drug users outside society, marginal in health concerns and under-represented 
in public policy.  Harm reduction and HIV have managed to changed some of this, but as peer 
workers demonstrate reformulation of recovery does not necessarily challenge underlying beliefs 
of drug use or re-craft justice, empowerment and rights in this context. 
   Often times the peer social workers may still be using drugs (albeit in less risky manner 
or using legal pharmaceutical substitutes).  Even though this may be the ‘right’ of the worker, it 
often undermines the position of the peer social worker in the mind of the clients (who still 
consider abstinence as the ultimate goal).  Peer social workers also tend to receive more benefits 
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than the ‘average’ drug user.  This creates tensions and zones of exclusions, which challenge 
community-building efforts of harm reduction services.  Further, harm reduction interventions 
have not critically challenged broader laws or social structures that shape drug use and recovery 
(Bourgois, 2000; Hathaway, 2001).  Peer workers thus often feel that harm reduction services are 
temporary solutions to their broader medical, social and economic concerns; for the drug users 
this crucially displacing responsibility from the state to the community organization and peer 
social workers.  Peer workers become the face of the program, a program, which is not itself 
completely sure of what it promises and what it can deliver. 
  Peer workers are an important layer of the harm reduction enterprise, on them rest its 
success and failures, through them we can study the remaking of subjectivities, contradiction in 
values, and interaction between old systems and new.  While not completely ‘cured’ of their 
addiction they form the most appropriate backdrop for harm reductionists to demonstrate the 
success of the program.   At the same time as I witnessed the break down of many drug users 
who were trying to tame their addiction into a steady disease I saw them fail as often as they 
succeeded.  For many peer workers the ability of living without drugs was a goal that seemed to 
be receding in all of this harm and risk minimization strategies.  While they recognized the short 
-term value of such a program, they were clearly thinking about the long-term dangers of 
remaining on drugs.  Here was the unintended consequence of harm reduction, it had led to the 
shaping of the subject, who was prudent and rights bearing, but at the same time was questioning 
the very system that had made such a life possible.  The liberating power of the paradigm is not 
even and not always positive.  The pressures and limitations of a overburdened health system, 
under resourced NGO and partially informed staff creates conditions where there is a race to 
simply survive rather than discipline or even govern. 
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CHAPTER 8: CONCLUSION 
I am reminded of that place when I hear an old Hindi movie song 
Sung in a high pitched voice, straining, 
He sat there getting bandaged 
We all clapped. 
He stumbled down from the bed, combed his hair over, tightened his scarf 
As he sauntered into the street singing 
We stopped clapping. 
 
I crawl because I don’t know how else to move 
The city seems like a war zone 
In each passing moment bullets fly 
We tend to those who we can. 
 
Battles lines are drawn and then rubbed off quick 
Slowly they emerge again 
Difference, exclusion and exclusivity 
In drawing them in what and whom do we leave out. 
 
There is a place where we walk with care 
Because as we walk we break the silence which has remained 
Filling the void of noise seems important 
But we realize unnecessary. 
 
They remain with me, as a whimper of protest and a vibrant memory 
Unfettered fluttering in the sky. 
(Moorthi, 2011) 
 
 In this final chapter I revisit the key arguments of my dissertation and highlight the 
implications of my research for social policy and practice. I also discuss the areas for future 
investigation and further research.  Through the course of this dissertation, I have attempted to 
carve out a number of diverse conversations between the concerns of HIV, addiction, rights, 
power, governance, citizenship as well as drug policy and treatment. To shape my ideas, I have 
drawn from the scholarly traditions of social work, medical anthropology, public health and 
political science while simultaneously engaging with both the issues on the field as well as the 
theoretical challenges facing social work. Through this multi-layered approach I have raised 
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questions about the possibilities of life under a ‘harm reducing’ paradigm and the future of health 
within the developing world. 
        The game of survival. 
My dissertation shows how harm reduction has evolved in the shadow of the dominant 
abstinence model of drug treatment in India. The terrifying HIV pandemic acted as a crucial 
precipitating context that pushed the government to respond to the voices of grassroots and 
international organizations, leading them to ultimately support the harm reduction model. 
Initially, many critics claimed that harm reduction was poised to fail given its uncertain political 
status, undemocratic reach, inadequate infrastructure and ill-formulated policies, all of which 
were considered as major drawbacks. Beating all odds however, harm reduction grew into a 
program of national repute. Harm reduction was able to adapt to changing local conditions and 
emerge as a flexible program that engaged multiple actors- both traditional and non-traditional, 
in a variety of capacities in different regions of the country. It functioned in a loose and 
amorphous form both at the policy level and on the street. It was in-part transported from the 
global health paradigm and partly indigenous in character. Harm reduction ended up altering the 
overall context of drug treatment within the country. 
Unlike traditional public health projects that focused on shaping the health patterns of the 
entire population through a singular and a static model of health, harm reduction approached 
drug treatment in a different way. Harm reduction programs aimed their interventions only at 
certain high-risk groups, with unique treatment and prevention packages for each of their client 
constituencies. Under harm reduction, health was no longer a rigid ideal but an adjustable 
concept that could evolve with the needs of people. One could argue that such an approach to 
health was emblematic of shifting trajectories of public health programs across the globe. At the 
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same time, such changes in thinking were far from widespread and harm reduction faced severe 
critiques on many fronts. It was difficult for people to agree on the goals, the limits and the focus 
of treatment under harm reduction. What did recovery from addiction look like? Who would be 
considered an ideal candidate for harm reduction? How could health be secured for the 
disenfranchised and who would be responsible for its provision? In many ways this project 
shows the tension between the socio-economic contexts of drug use treatment and the heavily 
risk based technical/pharmaceutical approach that tended to frame the harm reduction movement. 
Harm reduction had managed to open up new debates in the light of HIV. It now challenged 
lawmakers, public health scientists and civic society to restructure their thinking about addiction 
and recovery to forge a new path for seeking health.  
Prior to the advent of harm reduction, drug users had limited options in the mainstream 
health infrastructure of the country. They were and, in some senses, continue to be one of the 
most underrepresented, unprotected and controversial patient figures within the Indian health 
landscape. Drug treatment within the abstinence paradigm was confined largely to individual 
initiatives and rarely drew on community or societal resources. Due to the influence of harm 
reduction, drug abuse treatment was freed from such narrow confines. Not only did this open up 
the field of drug treatment it also allowed for a close examination of its inter-linkages to 
political, social and economic conditions.  
In addition, harm reduction gave drug users a global platform through which they could 
find and express a political voice. As my dissertation suggests, only a few enterprising peer 
workers and recovering drug users were able to harness the potential of such a biological 
collective. Most drug users that I encountered during fieldwork were the most unlikely of 
“biocitizens”. Governed by the need to survive, their participation in the harm reduction 
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paradigm was both dispersed and mercurial. Pharmaceuticals were sought, used and abandoned 
as were needles and other treatment options in an effort to extend life, alleviate pain and 
overcome suffering. It would be difficult to attribute a political consciousness of health to such 
behavior. However, the very utilization of services and engagement with bureaucracy imparted 
their health practices with political flavor. Survival then became about politics, health and 
economics; all of which were heavily entangled in the personal narratives of addiction and 
recovery.   
The question of survival was not only limited to drug users. It also extended to the 
stakeholders who were trying to establish themselves in national health politics. The emerging 
contentious and overlapping roles of the government, NGOs and bilateral agencies created an 
environment difficult to understand or even neatly categorize. Instead of the typical top-down 
type of relationships, my project showed that these stakeholders were engaged in loose and 
dynamic configurations that tended to both challenge their scripts while at the same time re-
instate them. The government was present, albeit in a limited form and often misunderstood by 
the direct participants of the programs. These harm reduction participants on the street found it 
easier to revert to older constructions of the ‘welfare model’ of the state rather than understand 
these complex equations with non-state stakeholders.  
Adapting to these changing conditions quickly required a “survival politics”, which was 
based on compromise, collaboration and often some chaos. During my fieldwork I saw many 
new actors preparing to enter and old ones getting ready to leave- a phenomenon quite common 
in the development sector in India. Most stakeholders understood this temporariness and were 
more likely to invest in “high yielding” short projects rather than make investments to bring forth 
long lasting structural changes in poverty, disease and marginalization.  Instead of defining their 
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position regarding the harm reduction paradigm, stakeholders often preferred to remain cautious 
and somewhat open ended in their views about harm reduction.  They called this a non-
ideological and non-political stance towards drug treatment.  Such a position was useful 
considering the underlying uncertainty of the development/health context of the country.  This 
dynamism in the sector partially revealed the difficulty for its many players to ascertain their 
positions long-term, while underscoring the dependency of these social actors on each other. 
Ultimately my project argues, that harm reduction in India can be viewed as a battleground of 
survival- it is the site of contestation, debate, innovation, collaboration and transition. 
     Contributions.     
           My project makes several contributions both in terms of social theory and practice.  First, 
the Indian state adopted many diverse positions as reflected in its activities and approach during 
the course of my study.  For instance, the state was at times ‘activist’ like (Biehl, 2007) in its 
efforts at certain other times it acted in a more neoliberal managerial (Foucault, 1991) format 
and, at yet other moments it reverted back to its welfare roots.  I argue that similar to Sharma’s 
(2008) claims of  “selective implementation of neoliberal technologies”, the case of harm 
reduction in India can be viewed as a site of “exception” (Ong, 2006).  While the state’s welfare 
arm continued to influence and shape the larger discourses of health in the country and define its 
day to day functioning, harm reduction interventions reflected a different ideology.  Not only 
was the state contracting these harm reduction services out to the NGOs and community 
organizations, it was also, involving a large number of players in the actual construction and 
development of policy.  Unlike other health programs, it was trying to adopt a more calculable, 
evidence –based approach, this was geared towards reducing risk, increasing the use of 
pharmaceuticals and pushing for the empowerment of “rights bearing diseased-citizens”.  
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Such an explanation of “exception” however, may not completely describe the shifts in 
the state’s positions that I observed during my research.  My project showed that the state was in 
a type of “transition” revealing new postures and possibilities at different times.  These multiple 
shifts produced a variety of frameworks via which the state operated and made its presence felt 
in people’s lives.  These diverse approaches in governance were most likely the result of 
emerging global influence in statecraft, internal pressures from constituencies and lobby groups, 
rapid economic and political transformations and bureaucratic hurdles.  The state was in part 
adapting to evolving conditions while at the same time trying to retain its old character and 
influence.  My research highlights new areas of study of the state and its practices within spheres 
of development. 
Second, health in India was already a heavily privatized sector even before the emergence 
of these neo-liberal shifts.  Large gaps in health infrastructure, with scarce resources within a 
broken public health system had left drug users especially marginalized.  Hence the question of 
“rolling” back of services does not necessarily hold true for this particular case.  In fact, harm 
reduction had introduced an entire new spectrum of services, which, until now were not available 
for drug users.  Sharma points towards the power of democratic populist politics that seems to 
place equal but contradictory pressure on the government as the neoliberal forces.  The welfare 
functions were not fully erased even while newer forms of health initiatives were being 
launched.  My research demonstrates the complexities in understanding how health policies 
function within evolving conditions of neoliberal rule.   
Third in terms of privatization of state functions, in many ways the NGOs had become a 
service wing of the state.  NGOs were now closely monitored through state laws, funding, 
administrative strictures and regulation.  My fieldwork participants reported that NGOs were 
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often times considered a type of government agency or a symbol of the government.  NGOs were 
also becoming sites of expertise and knowledge.  In fact, the government had reluctantly come to 
understand and even rely on their expertise to run these harm reduction projects and train other 
stakeholders.  Also, the NGOs had associations and links with bilateral organizations and 
international donors, which, in many ways superseded their collaborations with the government. 
This provided the NGOs with greater social currency and value than would have been otherwise 
accorded to them. NGOs occupied a much more flexible position in this multi-stakeholder 
environment, often transforming their identities and building linkages anew. My research brings 
attention to the roles of NGOs and their influence within global development. 
Fourth, the participation of international and bilateral organizations in the harm reduction 
arena has both challenged the Indian state’s role, at the same time opened surprising avenues for 
convergence.  These global players have changed the playing field of development by drawing 
on their vast resources, international experience and significant exposure.  The Indian state has 
been able to evolve it own perspective towards health at the same time retain its significance in 
this multi-stakeholder environment. This research highlights the nature of development and 
health under contexts involving both local and global players- especially highlighting the 
possibilities and limitations of such collaborations.  
At the implementation level my project revealed many key areas of learning.  First, these 
specialized harm reduction services provided drug users an entirely new set of treatment choices 
that seemingly accorded them greater participation in the treatment process.  Clients were, thus, 
asked to assume responsibility for their health and engage in risk reducing rational measures to 
improve their condition.  At the same time however, they were subsumed under the larger 
context of draconian laws, an outdated public health system and societal stigma.  For clients, this 
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often meant that despite the presence of excellent harm reduction options, their daily lives 
continued to be plagued by poverty, inequity and discrimination.  Structural links especially with 
public health systems is important for the success of the program.  The drug users need 
assistance with drug dependence, basic health care as well as larger socio-economic protection. 
Until these links become strong drug users- with or without harm reduction, will continue to face 
challenges. My research identifies the gaps and limitations within the current harm reduction 
regime in India, while highlighting the areas of success. 
Second, these programs worked towards reducing risk related to drug use and HIV.  The 
drug users did not perceive risk the same way as the state or other actors.  Drug users often 
viewed risk in terms of “ overall living conditions” and not “disease focused” behaviors.  For the 
state, international donors and bilateral agencies calculable measures of risk were essential to 
show the efficacy of their programs.  Thus, the number of needles exchanged, amount of 
pharmaceuticals given out, number of people accessing programs, amount of condoms 
distributed and the scope of outreach were crucial indicators of risk reduction.  Even though 
clients continued to voice social, psychological, physical and economic concerns, these remained 
outside the purview of risk reduction.  NGOs often saw the contradictions between reported 
changes and experiential transformations.  Even as they made attempts to address this gap, there 
were no critical evaluations of the very nature of risk as perceived by the drug users and its 
impact on survival.  
Risk had also led to a segregation of population based on behaviors (drug users, truckers, 
sex workers etc..) generating an entirely new hierarchy and language around stigmatized 
behaviors.  Harm reduction programs emerged with specific “solutions” catering to these 
“specialized populations”.  While bringing attention to these hidden groups, such a strategy had 
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also simultaneously isolated them, overriding some of the broader concerns that surrounded all 
groups vulnerable to HIV.  My research critically shows how risk as a notion comes to both 
shape and restrict harm reducing endeavors within the Indian context.   
Third, drug users were compelled to think of their harm reduction treatment as adhoc and 
partial.  Harm reduction programs remained ill equipped to consider and support long-term 
treatment, leaving drug users stuck in a system with uncertain future.  This was partially due to 
the larger structures of funding and organization of harm reduction services.  But also more 
fundamentally treatment was no longer viewed in a holistic manner, quite contrary to the ideals 
of continuum of care that are considered integral for harm reduction interventions.  My project 
identifies the inherent contradictions of harm reduction’s promises and its day-to-day impact on 
drug users.  
Fourth, instead of claiming that these harm reduction programs were pushing 
pharmaceutical treatment over and above other forms of treatment, I argue that health and 
treatment itself was being viewed through the presence of chemicals.  Drug users understood the 
power pharmaceuticals held for both “legitimate” recovery and “illegitimate” addiction.  No 
longer, I argue was life thought of devoid of substance, but instead life was in fact measured 
through the meter of substance.  The pharmaceutical was no longer seen as alien or synthetic but 
instead is seen as integral to the continuation of life- personal and organic.  As healthy life 
becomes inseparable or dependant on a pharmaceutical life, it slowly blurs the difference and 
shapes a unique subject for whom survival exists only within these parameters.  My research 
shows how new ways of healthy living were being constructed via the pharmaceuticals not 
beyond it. 
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Fifth, the harm reduction model has generated diverse types of biological citizens who 
have come to define themselves, relate to social systems, address their needs and participate in 
social lives through the rationalities and logics of this paradigm.  This is most visible in the lives 
of those peer workers who occupy both categories of client and service provider.  These workers 
must “live and recover” while “promote and believe” in harm reduction.  In this interchange of 
roles and responsibilities they redefine both the paradigm and themselves.  The clients are also 
clearly the inculcating new ways of survival both through and outside of the paradigm.  The 
delicate balance of freedom, social justice and compliance become the substance of this type of 
citizenship.  Harm reduction, though was focused on injecting drug users- a “privileged” 
subsection of the drug population, it managed to also create opportunities for drug users in 
general.  My project shows that while the landscape of treatment is uneven, drug users adapted, 
adopted and put forth new ways of relating and engaging in this system. 
Recovery has ultimately always been about possibilities- predicting the chances of 
improvement and change, generating hope for a potential future and imagining new ways of 
being.  As India and other nations look into the future of drug policy, harm reduction and HIV 
they must re-craft the notion of treatment and recovery, allowing for such possibilities of a 
“healthy life”.  Harm reduction is about shifting the narrative, building new bridges as well as 
embodying new stories and identities.  But most of all my participants showed me, that harm 
reduction was about making claims for the ordinary life. 
Looking forward. 
My project emphasizes the need to undertake more studies within social work, which 
examine the state, via its processes, appearance and affect.  Social work has traditionally viewed 
the state in certain circumscribed ways i.e. provider of services, law maker and securer of justice, 
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but with a growing diverse network of stakeholders now involved in state activities, there needs 
to be a robust re-examination of the state.  There are vast implications for the study of social 
policy and practice, which are changing under this new environment.  It is no longer sufficient to 
conduct studies that do not account for both global and local players that work with the state. I 
intend to conduct future research in this direction to develop a more thorough understanding of 
the state and its new modalities.    
My research focuses on the way social problems are defined and the manner in which 
solutions are sought within social work.  Multiple social actors with blurry boundaries often 
come in with competing interests (in opposition to the state) and ways of understanding the 
problem.  In such circumstances, social workers are forced to compromise, adjust and create 
consensus amongst these contested explanations in the field.  Social work research, I argue must 
engage and investigate the underlying differences in problem constitution and the implications 
for policy/practice.  This is not merely an issue of implementation but rather what is at stake is 
the way in which, vulnerable groups get categorized, understood and in some senses “produced”.  
As social work researchers’ we must examine not only the basis of our own assumptions about 
social issues but also the way problems get shaped in the arena of public policy and social 
intervention. My future research will address such issues of knowledge construction and their 
implication for social solutions.  
This dissertation also attempted to understand the manner in which neoliberal conditions 
are transforming the field of social rights and responsibilities and the inadvertent consequences 
of such shifts.  My research drew attention to the way previously overlooked populations were 
brought into the governance fold through complex mechanisms of the drug-HIV policy.  Health 
and development, I showed, are increasingly becoming sites to investigate the new ways in 
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which rights are distributed as well as the possibilities and the limitations of welfare.  I intend to 
continue conducting research to examine the diverse implications of neoliberal governance in 
transforming communities and marginalized individuals.  
My work will also contribute to the growing field of health research in India, especially 
adding ethnographic richness to the understanding of harm reduction and addiction. With the 
new policy for HIV being instituted there are changes being made to the existing harm reduction 
interventions; my research can help shed light on some of the gaps and issues around 
implementation.  The growing development sector in India is a fascinating field of diverse 
pressures, new alliances and contestations.  Bulk of the attention is drawn towards HIV related 
work, with not much focus on the evolving drug treatment sector.  Given the large investments in 
drug treatment and the growing cadre of workers receiving training in harm reducing techniques; 
my future research hopes to contribute to a better understanding of this newly evolving sector.   
As I came close to completing fieldwork many questions remained unanswered – How 
will harm reduction transform “drug affected” communities? What are the long-term health 
implications of harm reduction? What are the political consequences of such a movement? What 
was the way harm reduction was adapting its tenets within the Indian context? How are peer 
workers battling these uncertain terrains of health politics and economics? There were also 
ethical and practical questions about harm reduction that continued to plague me- Was harm 
reduction able to offer options to extend life or curtail it? What was the impact of such harm 
reducing measures on the families of such harm reducers? What was our responsibility as social 
scientists in the promotion and acceptance of this model? Would such a model indeed usher in 
better rights and living conditions for drug users who are at the margins of our society? I intend 
to continue to write and examine these issues in my future work I hope to draw from the lives of 
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those living through, within, outside and in-between this regime of harm reduction and distill 
new ways to think and work on issues of addiction and health.  
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